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Abstract
DNA Double Strand Breaks (DSBs) are induced by ionising radiation, but also arise 
during normal physiological processes such as V(D)J recombination during lymphocyte 
development. The induction o f DSBs leads to the activation o f proteins involved in 
DNA repair, but also initiates p53 dependent pathways that can result in cell cycle arrest 
and/or apoptosis. Defects in this damage response network may therefore result in 
immunodeficiency and cellular radiosensitivity. Skin biopsies obtained from undefined 
immunodeficient patients were used to generate primary fibroblast lines, and a group o f  
these demonstrated cellular radiosensitivity using fibroblast survival assays. Whilst 
radiation-induced lymphocyte apoptosis was found to be an unreliable measure o f  
intrinsic radiosensitivity, the examination o f fibroblast division early after irradiation 
determined that radiosensitive fibroblasts undergo distinct cell fates after irradiation. 
Further characterisation revealed that all the identified radiosensitive lines were able to 
initiate p53-dependent gene transcription after irradiation. Analysis suggested that one 
undefined line (F96) might harbour a defect in DSB repair. Sequence examination o f  
F96 candidate genes confirmed the presence o f 2 novel mutations in the Artemis DNA 
repair gene that were expressed from separate alleles. Cloning o f the Artemis gene also 
allowed the discovery o f a new alternative exon and many novel splice variants. 
Concurrently, the F96 line was found to induce abnormally high levels o f p53 activation 
after irradiation, which was associated with a more widespread induction o f p53 target 
genes. This indicated that after DNA damage, defects in DSB repair might combine 
with other genetic factors that impair cellular survival to confer a radiosensitive 
immunodeficient phenotype.
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Figure 1-1: Organisation of the metazoan DNA damage response network
Figure 1-2: Detection of DSBs leads to the recruitment of damage response proteins into sub- 
nuclear foci, and the activation of ATM dependent signaling pathways. DSBs are detected 
by the Mrell complex which then activates the ATM protein kinase, although this is 
probably not the only mechanism of ATM activation. ATM can phosphorylate Nbsl 
which amplifies the signal leading to the enhanced phosphorylation of ATM substrates 
such as H2AX. Phosphorylated H2AX (y-H2AX) is able to retain the Mdcl, Brcal and 
53bpl adaptor proteins in nuclear foci along with additional M rell complexes, and 
together these are able to facilitate the phosphorylation of downstream ATM targets that 
function in DNA repair, cell cycle arrest and apoptosis.
Figure 1-3: Ionising radiation induced DNA damage checkpoints in mammalian cells.
Figure 1-4. p53 genetic damage assessment, survival effector genes and mechanisms of p53 
induced apoptosis. (Modified from Hofseth et al, 2004)
Figure 1-5: Factors that may influence the choice between p53 dependent growth arrest or 
apoptosis. (modified from Meek et al, 2004)
Figure 1-6: Schematic representation of Homologous Recombination (HR) repair of a DSB. 
Duplex DNAs are indicated by ladders with the rungs representing base pairs. Pre­
synapsis consists of stages A-C. The damaged DNA molecule is nucleolytically processed 
to result in 3' single-stranded tails. The white duplex DNA molecule represents a 
homologous DNA molecule such as a sister chromatid. Synapsis, comprised of stages D 
and E, involves the formation of a joint molecule between the processed broken DNA and 
the intact homologous template using the strand invasion and exchange properties of the 
Rad51 protein. Post-synapsis, stages E-G. Base pairs between the joint molecule and 
second DNA end are established, DNA is re-synthesised, and Holiday junctions are 
resolved by structure specific endonucleases. (Modified from Wyman et al, 2004)
Figure 1-7: Non Homologous End Joining (NHEJ), the predominant DSB repair pathway in 
vertebrate cells. DSB ends are first recognised by the Ku heterodimer, which then recruits 
the DNA-PK-Artemis complex. To allow subsequent repair steps to proceed the two ends 
must be held in close proximity. This step is referred to as synapsis and evidence suggests 
this is performed by two DNA-PKcs molecules. For complex (incompatible) DNA ends, 
as would be generated by ionising radiation, there is often need for nucleolytic processing. 
This is carried out by the Artemis-DNAPKcs complex, and the P-lactamase domain of 
Artemis is essential for this nuclease activity. End processing may also involve the filling 
in of gaps by polymerases. Ligation is the final step in NHEJ, and is performed by the 
XRCC4-ligase IV complex. A simpler pathway that involves only Ku and the XRCC4- 
LigaselV complex may occur at blunt or compatible ends that do not require a nuclease or 
polymerase. (Modified from Lieber et al, 2004)
Figure 1-8: Mechanism of the V(D)J recombination reaction. RAG1, RAG2, and HMG1 form a 
complex that binds recombination signal sequences (RSS). The RAG complex creates a 
nick adjacent to the coding end side of each RSS, and the two nicked species are brought 
into synapsis. The RAG complex then catalyses a trans-esterification reaction to create 
hairpinned coding ends at the end of the V, D or J ends. Ku binds to the coding ends and 
recruits Artemis-DNA-PKcs which opens the hairpins. TdT then conducts template- 
independent DNA synthesis to increase coding join diversity. Ku also binds to signal ends, 
and the XRCC4-Ligase 4 complex is recruited to complete the end joining reaction for both 
coding and signal ends. (Modified from Bassing and Alt, 2004)
Figure 2-1: Strategy for the transferral of Artemis from the pcDNA3.2/V5/GW cloning vector to 
the destination vector pDEST47 using gateway recombination reactions. The Artemis 
genes cloned into pcDNA3.2/V5/GW were first transferred to the donor vector pDONR221
in a BP clonase reaction to produce pENTR221-Art entry clones. The pENTR221-Art 
entry clones were then recombined with the destination vector pDEST47 in LR reactions to 
produce pEXP47-Art expression clones, which code for GFP-tagged Artemis recombinant 
proteins.
Figure 2-2: Standard curve for measurement of protein concentration using the BCA Protein 
Assay Kit. The absorbance of known concentrations of BSA allowed the relationship 
Absorbance = Protein concentration (pg ml'1) x 0.0012'1 to be calculated from the line of 
best fit, R2 = 0.9976.
Figure 2-3: Standard eukaryotic gene expression assay using Affymetrix GeneChips. The basic 
concept behind the use of GeneChip arrays for gene expression. Labelled cRNA targets 
derived from the mRNA of an experimental sample are hybridised to nucleic acid probes 
attached to the solid support. By monitoring the amount of label associated with each DNA 
location, it is possible to infer the abundance of each mRNA species represented. Taken 
from the Affymetrix website, www.affymetrix.com.
Figure 2-4: Analysis of total RNA quality and concentration using an Agilent 2100 Bioanalyser, 
a) Agilent 2100 Bioanalyser gel image of all 12 total RNA samples isolated from primary 
fibroblasts to be analysed by gene chip analysis. A, B and C refers RNA obtained from 3 
separate expriments. b) Electropherogram (from Agilent 2100 Bioanalyser) of a 
representitve total RNA sample (1BR lGy B, lane 6). For a high quality RNA sample, two 
well defined peaks corresponding to the 18S and 28S ribosomal RNAs should be observed, 
with ratios approaching 2:1 for the 28S:18S bands.
Figure 2-5: Analysis of cRNA samples after in vitro transcription using an Agilent 2100 
Bioanalyser, a) Agilent 2100 Bioanalyser gel image of the 12 labeled cRNA samples 
generated by in vitro transcription to be used for GeneChip analysis. B) Electropherogram 
(from Agilent 2100 Bioanalyser) of a representitve cRNA sample (1BR OGy B, lane 6).
Figure 2-6: Fluorescent staining of the hybridised GeneChip arrays incorporates a signal 
amplification step involving SAPE, Anti-Streptavidin (goat) and biotinylated Goat IgG.
Figure 3-1: Selection of criterion for data analysis from a control of average radiation response, 
(a-b) Dot plots of cell size versus cell granularity 24 h after (a) 0- and (b) 3-Gy y-radiation. 
The cells in the gated areas are lymphocytes, (c-d) Dot plots of Annexin V staining versus 
7AAD staining showing lymphocytes (selected from the previous gated areas) 24 h after 
(c) 0- and (d) 3-Gy y-radiation. Red dots are unstained cells, green are both annexin V 
positive and 7AAD negative and blue are both Annexin V and 7AAD positive. Their 
percentage is given, (e-f) Histograms of annexin V staining of lymphocytes 24 h after (e) 
0- and (f) 3-Gy y-radiation. The percentage of cells stained with annexin V is given (these 
data are from a control donor of average radiation response)
Figure 3-2: Effect of gating out activated lymphocytes for a patient of average radiation response, 
(a-b) Dot plots of cell size versus cell granularity 24 h after 3-Gy y-radiation. (a) All 
lymphocytes gated (Population X (resting) and Y (activated)), (b) Resting cells gated 
(Population X). (c-d) Histograms of annexin-V staining of lymphocytes 24 h after 3-Gy y- 
radiation (selected from the previous gated areas), (c) All lymphocytes gated (Population 
X (resting) and Y (activated)), (d) Resting cells gated (Population X). The percentage of 
cells stained with annexin-V is given (these data are from a patient of average radiation 
response). Note the clearer peak separation when resting cells are gated.
Figure 3-3: Spontaneous (0 Gy) levels of apoptosis for control and patient samples
Figure 3-4: Establishment of a mean control response, (a) Radiation induced apoptosis of control 
lymphocytes. The majority (9/14) of control samples demonstrated radiation induced 
apoptosis of approximately 10 - 1 8 %  at 3 Gy (solid lines). 5 control samples deviated 
from this and appeared to have abnormal levels of radiation induced apoptosis (dashed 
lines), (b) Mean of the 14 control responses. Grey shaded area represents one standard 
deviation from the mean.
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Figure 3-5: Patient dose response curves compared to the mean control region. Dose response 
curves of radiation induced apoptosis for patient lymphocytes (red lines). Shaded area 
represents the normal control region. Patient responses fell into 3 categories; high 
responses compared to control (7), medium responses comparable to control (9) and low 
responses compared to control (2).
Figure 3-6: Bar chart of patient lymphocyte apoptosis 24 h after 3 Gy y-radiation. Values are 
expressed as % of the mean of 14 control responses to 3 Gy y-radiation. Error bars 
represent standard deviation. 9 responses fell within (clear bars), 2 below (grey bars) and 7 
above (red bars) the normal range. 1) and 2) represent first and repeat experiments 
respectively.
Figure 3-7. CFSE profile of control fibroblast division after 6 days. Cells were labelled with 
CFSE and fixed in Paraformaldehyde immediately (blue line) or incubated for 6 days (red 
line). Cells were then analysed by flow cytometry
Figure 3-8: Effect of 4Gy y-radiation on CFSE cell division profiles of control cells incubated for 
(a) 3 and (b) 6 days. Control 1BR cells were labeled with CFSE and then either mock 
irradiated (-y) or exposed to 4Gy y-radiation (+y) on day 0. Cells were then incubated for 
(a) 3 or (b) 6 days after which FACS analysis was performed, (a) 3 days after irradiation 
the majority of cells had arrested after only 1 division (+y), whereas mock irradiated cells 
had divided 3 times (-y). (b) 6 days after irradiation although the majority of cells
remained arrested after only 1-3 divisions, a minor population of cells had divided 5 times 
similar to mock irradiated cells.
Figure 3-9: CFSE profiles of a) 1BR and b) CJ179 fibroblasts 6 days after irradiation. With 
increasing doses of radiation more cells arrested after only 1-3 divisions, and the 
percentage of cells that have completed 5 divisions decreased. This effect was more severe 
in the radiosensitive CJ179 line (b) than in control cells (a).
Figure 3-10: Fibroblast division early after irradiation in a control and radiosensitive line; 
reduction in the percentage of cells that have completed 5 divisions within the first 6 days 
of irradiation. Compared to control 1BR cells (blue bars) the radiosenstive line CJ179 (red 
bars) demonstrated a signgificant reduction in the percentage of cells that have completed 5 
divisions. This was evident even at the lowest dose of 1 Gy. Error bars represent SEM 
(standard error of the mean).
Figure 3-11: Increase in a population of large arrested cells in control fibroblasts 6 days after 
irradiation, (a-c) Forward scatter, side scatter plots with small cells shown in blue, and 
large cells shown in red 6 days after (a) OGy (b) 2Gy and (c) 4Gy y-radiation. Percentage 
of large and small cells is shown, (d-e) Corresponding CFSE plots with large cells shown 
in red and small cells shown in blue 6 days after (d) OGy, (e) 2Gy and (f) 4Gy y-radiation.
Figure 3-12: The CJ179 line is more prone to the induction of an arrested population of large 
cells within 6 days of irradiation. CFSE plots with large cells shown in red and small cells 
shown in blue for a) 1BR and b) CJ179 cells 6 days after treatment with 0, 2 and 4Gy y- 
radiation as indicated. The Artemis deficient CJ179 line was more prone to the induction 
of a population of large arrested cells compared to control cells.
Figure 4-1 Sensitivity of control, mutant and patient fibroblasts to ionising radiation. 
Exponentially growing fibroblasts were treated with y-radiation and plated immediately. 
Patient cells were compared to normal controls (1BR and 48BR), a typical AT cell line (A- 
T1BR), and a DSB repair deficient line (CJ179). Cells demonstrated normal, mild, 
intermediate or severe levels of radiosensitivity. Error bars represent SEM.
Figure 4-2: Survival curves for 10 patients that demonstrated normal radiosensitivity. 10 patient 
lines (light blue lines) demonstrated normal levels of sensitivity similar to control cells 
(blue line). AT cells demonstrated severe radiosensitivity (green line) and CJ179 cells 
displayed intermediate sensitivity (red line). Lines represent the mean of at least 2 
experiments.
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Figure 4-3: Bar chart of relative survival after 4 Gy y-radiation for 10 patients that demonstrated 
normal radiosensitivity: 10 patients demonstrated normal sensitivity (light blue bars) that 
was not significantly different from controls (blue bars). CJ179 cells (red bar) displayed 
significantly less survival compared to the control lines. Error bars represent SEM.
Figure 4-4: Survival curves for 10 patients that demonstrated significant radiosensitivity. 7 
patient lines demonstrated mild radiosensitivity (light purple lines) and 3 patient lines 
displayed intermediate sensitivity (dark purple lines) compared to control cells (blue line). 
AT cells demonstrated severe radiosensitivity (green line) and CJ179 cells displayed 
intermediate sensitivity (red line). Lines represent the mean of at least 2 experiments.
Figure 4-5: Bar chart of relative survival after 4 Gy y-radiation for 10 patients that demonstrated 
significant radiosensitivity: 7 patients demonstrated mild radiosensitivity (light purple
bars, p<0.05) and 3 patients displayed intermediate radiosensitivity (dark purple bars, 
p<0.01) compared to control cells (blue bars). CJ179 cells (red bar) displayed intermediate 
levels of radiosensitivity (red bar, p<0.01). No patients demonstrated severe 
radiosensitivity similar to that of the A-T1BR line. Error bars represent SEM.
Figure 4-6: Early division experiments with radiosensitive fibroblasts; Reduction in the 
percentage of cells that have completed 5 divisions within the first 6 days of irradiation. 
CJ179 (cream bars) and A-T1BR (dark red bars) cells demonstrated an abnormal block on 
proliferation that was similar in magnitude between the two lines. GOS5 cells (purple) 
were also sensitive to this endpoint, although this effect was slightly less pronounced than 
that of the known mutant lines. F96 cells (pale green) demonstrated only a modest 
reduction in the percentage cells that have completed 5 divisions compared to controls. 
Error bars represent SEM.
Figure 4-7: Radiosensitive lines are more prone to the induction of an arrested population of 
large cells within 6 days of irradiation. CFSE plots with large cells shown in red and small 
cells shown in blue for a) 1BR, b) CJ179, c) GOS5 and d) F96 cells 6 days after treatment 
with 0, 2 and 4 Gy y-radiation as indicated. The Artemis deficient CJ179 line and 
undefined GOS5 line were more prone to the induction of a population of large arrested 
cells compared to control cells. The undefined F96 line was slightly more susceptible to 
this endpoint compared to controls, but not as sensitive as the CJ179 and GOS5 lines.
Figure 4-8: A combination of early and late CFSE division experiments examined cell division 
within the first 10 days of irradiation, a) Early division experiments focused on 
proliferation between 0 and 6 days after irradiation, b) Late division experiments focused 
on proliferation between 5 and 10 days after irradiation.
Figure 4-9: Late division experiments with radiosensitive fibroblasts; Reduction in the
percentage of cells that have completed 5 divisions between days 5 and 10 after irradiation. 
Compared to control 1BR cells (blue bars) the patient line F96 (pale green bars) 
demonstrated a significant reduction in the percentage of cells that have completed 5 
divisions after the higher doses of 4 and 6 Gy y-radiation. This was similar to the Artemis 
deficient CJ179 line (cream bars). The A-T1BR line was severely affected at all doses 
(dark red bars). Error bars represent SEM.
Figure 4-10: Radiation induces distinct populations of arrested cells in radiosensitive fibroblast 
lines 10 days after irradiation. CFSE plots with large cells shown in red and small cells 
shown in blue for a) 1BR, b) CJ179 and c) F96 cells 10 days after treatment with 0, 2 and 
4Gy y-radiation as indicated. Cells were labeled with CFSE 5 days after irradiation. After 
2 Gy y-radiation small dividing cells that have completed 5 divisions dominated 1BR, 
CJ179 and F96 cultures at this late time point. After 4 Gy y-radiation the radiosensitive 
lines (CJ179 and F96) produced distinct populations of large (population 1) and small 
(population 2) arrested cells, along with a minor population of small dividing cells 
(population 3). CJ179 cells were more prone to a large cell arrest phenotype (population 
1), compared to F96 cultures that contained a substantial proportion of small arrested cells 
(population 2).
Figure 4-11: Affect of cell size on the incorporation of CFSE. CFSE plots with large cells shown 
in red and small cells shown in blue. F96 cultures were treated with 4Gy y-radiation,
incubated for 5 days and then labelled with CFSE. Cells were analysed by FACS either 
immediately (a) or after a further 5-day incubation (b). Larger cells incorporate slightly 
more CFSE than small cells (a), but this effect is substantially less than the difference 
between the arrested populations 1 and 2 after a further five-day incubation (b). Population 
2 is therefore a distinct population, and represents at least one additional division during 
the labelled incubation period. 132
Figure 4-12: Cellular morphology and SA-Pgal staining of the distinct populations induced by y- 
radiation in the control line 1BR and the radiosensitive line F96. Late division experiments 
were repeated for the control (1BR) and F96 lines, and cells were sorted according to their 
CFSE fluorescence level using the gates indicated, taking care to minimise any overlap 
between different populations. Sorted cells were incubated overnight in fibroblast growth 
medium, and cellular morphology was then examined (1BR top panel, F96 bottom panel).
At this time SA-0gal staining was also performed, and only population 1 cultures contained 
any SA-Pgal positive cells (shown in middle panel). In both lines the dividing population 3 
consisted of small cells with a young morphology and no cells were positive for SA-Pgal 
activity. The arrested cells in population 2 were also negative for SA-Pgal, although 1BR 
cells in this population displayed a modest increase in size. There was a relatively high 
level of cellular debris in population 2 cultures, and this was more pronounced in the F96 
line. For both lines the arrested population 1 consisted of large flattened cells with a 
senescent like morphology, and approximately 10-20 % of these stained positive for SA- 
Pgal activity at this time. 134
Figure 4-13: Levels of apoptosis in CFSE labelled cultures 10 days after exposure to 4Gy y- 
radiation. Late division experiments were repeated for the control (1BR, top panel) and the 
radiosensitive CJ179 (middle panel) and F96 (bottom panel) lines. CFSE labelled cells 
were co-stained with Annexin V-PE and 7AAD to identify cells that had initiated 
apoptosis. Although the increase in Annexin V positive cells was low in 1BR, CJ179 and 
F96 cultures 10 days after irradiation (1.4, 3 and 2.2 fold respectively), the majority of 
apoptotic cells arose from the small arrested cells in population 2. When this population 
was specifically gated, 3.7, 6 and 3 % of these small arrested cells were positive for 
AnnexinV staining in the 1BR, CJ179 and F96 lines respectively. This suggests that a 
small percentage of cells in population 2 are in the early stages of apoptosis, and since 
fibroblasts are resistant to this endpoint, a more widespread instability may be present in 
these cells. 136
Figure 5-1: F96 cells demonstrate normal Gl/S checkpoint function. Unirradiated cells (a) or 
cells incubated for 12 hrs (b) after exposure to 4Gy y-radiation were labelled for 30 minutes 
with BrdU, fixed and analysed by FACS. Control and F96 cells demonstrated efficient 
activation of a Gl/S checkpoint 12 hrs after irradiation with a ~90 % reduction of cells in 
S-phase. A-T1BR cells displayed abrogated activation of a Gl/S checkpoint with only a 47 
% reduction in the percentage of cells in S-phase 12 hrs after irradiation. 145
Figure 5-2. Northern blot of p21 mRNA induction in control, radiosensitive mutant and 
radiosensitive patient fibroblasts after exposure to 4Gy y-radiation. The fold induction of 
p21 mRNA (white figures) was assessed using a densitometer and normalised to the 
expression level of Glyceraldehyde Phosphate Dehydrogenase (GAPDH). Control (1BR), 
repair defective (CJ179 and 180BR) and RS patient (F96, GOS1, GOS5 and GOSH) 
fibroblasts demonstrated efficient induction of p21 mRNA after irradiation. A-T cells 
displayed abrogated induction of p21 after irradiation. 146
Figure 5-3a): Levels of unrepaired chromosome and chromatid breaks after irradiation of primary 
fibroblasts. The A-T1BR and CJ179 lines displayed significantly elevated levels of 
unrepaired breaks after irradiation compared to control (1BR) cells. For the A-T1BR line, 
this was mostly due to high levels of chromatid breaks. The GOS1, GOSH, and GOS5 
patient lines demonstrated normal levels of unrepaired breaks similar to the control line 
1BR. F96 cells exhibited significantly higher levels of unrepaired breaks after irradiation 
compared to controls, and this was similar in magnitude to that of CJ179 cells. This
suggests that the F96 line may have a defect in DSB repair. 149
Figure 5-3b: Representative metaphase spreads of unrepaired chromosome and chromatid breaks 
for the control line 1BR, the known mutant lines A-T1BR (ATM) and CJ179 (Artemis),
12
and the undefined radiosensitive lines F96 and GOS1. Examples of unrepaired damage are 
indicated by arrows. 150
Figure 5-4: Average number of y-H2AX foci counted in nuclei of control (1BR and 48BR), 
radiosensitive patient and radiosensitive mutant fibroblasts at indicated periods of repair 
time after irradiation with 2Gy. Whereas the ligase IV deficient 180BR line demonstrated 
a deficiency in the initial rate of foci removal, Artemis deficient cells (CJ179) 
demonstrated elevated levels of residual foci after 24 hours. Similar to this, the F96 line 
displayed higher levels of residual foci at 24 hours compared to control, and this may 
indicate comparable defect in DSB repair. GOS1 and GOS5 demonstrated a mild increase 
in residual foci, while the GOS21 line was similar to control cells. Error bars represent 
standard deviation (SD). 153
Figure 5-5: Average number of y-H2AX foci counted in nuclei of control (48BR), repair 
defective (180BR and CJ179) and undefined F96 fibroblasts at late time points after 
irradiation with 2Gy. Foci levels in 180 BR cells that have a slow initial rate of removal 
eventually return to pre-irradiation values 72 hours after irradiation. The high level of 
residual breaks in CJ179 cells at 24 hrs remains elevated even after 72 hrs of repair time.
F96 cells that have a normal initial rate of foci removal demonstrated elevated levels of 
foci 24 and 48 hours after irradiation compared to controls, but this decreased to control 
levels after 72 hours. Error bars represent SD. 155
Figure 6-1: Strategy for sequencing human XRCC4. PCR primers UX and LX were designed to 
amplify the entire coding sequence of XRCC4. These were first used to amplify XRCC4 
from cDNA, and then in conjunction with primers U l, U2, LI and L2, were again used to 
sequence the gel purified PCR product. 165
Figure 6-2: Strategy for sequencing human Ligase IV. PCR primers UB and LB were designed 
to amplify the 5' coding sequence of Ligase IV. These were first used to amplify the 5' 
region from cDNA, and then in conjunction with primers U2, U3, U4, LI and L2, were 
again used to sequence the gel purified PCR product. PCR primers UA and LA were 
designed to amplify the 3' coding sequence of Ligase IV. These were first used to amplify 
the 3' region from cDNA, and then in conjunction with primers U6, U7, L4 and L5, were 
again used to sequence the gel purified PCR product. The resulting sequence data was then 
pooled in order to construct the full coding sequence of Ligase IV for each primary cell 
line. 166
Figure 6-3: Strategy for sequencing human Artemis. PCR primers UA and LAI were designed to 
amplify the 5' coding sequence of Artemis. These were first used to amplify the 5' region 
from cDNA, and then in conjunction with primers U2, U3, L4 and L5, were again used to 
sequence the gel purified PCR product. PCR primers UA2 and LA were designed to 
amplify the 3' coding sequence of Artemis. These were first used to amplify the 3' region 
from cDNA, and then in conjunction with primers U4, U5, L2 and L3, were again used to 
sequence the gel purified PCR product. Whereas the 3' fragment produced high quality 
sequence data, the 5' fragment generated sequence that became confused toward the 5' end, 
and appeared as a smear when resolved for an extended time on a 1% agarose gel (b). The 
gel purified 5' fragment was therefore blunt end ligated into pZErO and clones were 
sequenced using the T7 (forward) and SP6 (reverse) sequencing primers. 167
Figure 6-4: Strategy for cloning the full coding region of Artemis. The Art-F and Art-R PCR 
primers were designed to amplify the entire coding region of Artemis, and incorporate a 
CACC motif exactly 5' to the ATG translation initiation codon. The gel purified PCR 
products could then be cloned directly into a gateway expression vector using the TOPO 
cloning system. Cloned inserts were sequence using a combination of the original PCR 
primers (Art-F and Art-R) and the sequencing primers described in figure 6-3. 170
Figure 6-5: The organisation of the 1BR Artemis gene and the sequence of exon lb. The exon-
intron organisation is depicted. The constitutive exons are shown as and the alternative 
exons are shown as . In addition to the previously described variants (Li et al, 2001a),
1BR cells expressed VI and V2 transcripts with deletion of exon 5 (1BR-V1A5 and 1BR- 
V2A5). One transcript (lBR-Vl+lb) was also identified that utilised a novel 134 bp 
alternative exon that lies between exon 1 and 2, designated exon lb. The sequence of exon
13
lb is displayed in bold upper case, and the intron sequence directly 5' and 3' is shown in 
lower case. No transcripts were found that involved alternative exons 2c, and 3b. 3 
differences to the published sequence were also present. T643C and C1809T are silent 
polymorphisms that are not expected to change the primary sequence of the Artemis 
protein, whereas G1678T results in a Valine560Leucine amino acid change. 171
Figure 6-6: The exon 9 alternative splice site involved in transcript F96-V9/11-G377A. 
Transcript F96-V9/11-G377A involved the splicing of exon 8 to an alternative splice site in 
the middle of exon 9. Exon 9 sequence is depicted in bold upper case, and intron sequence 
is shown in lower case. The 3' exon 9 sequence that was present in transcript F96-V9/11- 
G377A is depicted in blue bold upper case. The A728G polymorphism present on the 
G377A F96 allele is shown in red and therefore did not occur in transcript F96-V9/11- 
G377A. 172
Figure 6-7: The F96 line is a compound heterozygote for mutations in the Artemis gene. F96 
cells express 2 mutant Artemis alleles. Allele 1 harbors a GTT207-209 deletion in exon 3 
that is predicted to result in the deletion of Leucine 70. Allele 2 contains a G377A point 
mutation in exon 6 that results a Glycine 126Aspartic acid change in the Artemis protein.
All the other differences compared to the published Artemis mRNA sequence are likely to 
be polymorphisms, since they were found in control cells and the draft sequence of the 
human genome (italics). 173
Figure 6-8: The protein sequence coded for by Artemis variant transcript IBR-Vl+lb that 
involves inclusion of alternative exons lb and 2b. The novel sequence encoded by exon lb 
is shown in bold that when spliced to exon 2 results in a ffameshift and a severely truncated 
protein of 82 amino acids. 176
Figure 6-9: The protein sequence coded for by Artemis variant transcript F96-V9/11 that 
involves the use of an alternative splice site within exon 9 and deletion of exon 10. The 
novel 13 amino acid sequence introduced into the Artemis protein primary structure by use 
of the alternative splice site is shown in bold. 176
Figure 6-10: The Artemis protein can be divided into 3 regions. The metallo-P-lactamase 
homology domain, which contains four out of five conserved catalytic residues, spans the 
first 155 amino acids. This is followed by the J3-CASP region that is common to metallo- 
P-lactamases that act in nucleic acids. The last 307 amino acids has no homology to any 
known proteins. The novel F96 mutations identified lie within the metallo-P-lactamase 
domain. 178
Figure 6-11: Expression of wild type Artemis protein in 293T cells shows a nuclear localisation,
a) Western blot of Artemis expression. 293T cells were transiently transfected with 
pEXP3.2-Artemis-V5 and cell lysates prepared after a 24 hr incubation. Immunoblot 
analysis was performed using anti-V5 antibody, and a band of the correct size (83 kD) for 
V5-tagged Artemis was visualised. Actin expression levels were used as a loading control 
(bottom panel), b) 293 cells were transfected with pEXP47-Artemis-GFP and the sub- 
cellular localisation of GFP tagged Artemis was visualised by fluorescence microscopy 24 
hrs after transfection. Artemis expression was confined to the nucleus (excluding 
nucleoli), c) Expression levels of transfected GFP tagged Artemis compared with GFP 
alone as measured by FACS analysis. Compared to transfection with GFP alone, there 
were less GFP-tagged Artemis positive cells, and those that were positive displayed a 
lower level of fluorescence. 180
Figure 6-12: F96 mutant Artemis proteins are stable in the human carcinoma cell line HCT116.
HCT116 cells were transfected with pEXP3.2-V5 expression vectors coding for V5 tagged 
wild type Artemis (pEXP3.2-Art-V5), G126D mutant Artemis (pEXP3.2-ArtG126D-V5) 
or AL70 mutant Artemis (pEXP3.2-ArtAL70-V5). The two F96 mutants were also co­
transfected (F96mut Co-transfection). Mock and GFP (pGFP) transfected cells were used 
as controls. 24 hrs after transfection the cells were either treated with 1 Gy y-radiation (+y) 
or mock irradiated (-y), and cell lysates prepared after a further 4 hr incubation. The 
expression of the Artemis-V5 proteins, as detected by immunoblot analysis, is shown in the 
upper panel; non-specific binding is shown below. 181
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Figure 6-13: Analysis of Artemis protein sequence and the proposed active site, a) Artemis is 
composed of three identifiable regions, the metallo-P-lactamase homology domain (amino 
acids 1-155) coded by exons 1-6, the associated p-CASP domain (amino acids 156-385) 
coded by exons 7-13, and the COOH-terminal region (amino acids 386-692) coded by exon 
14. Five motifs (I-V) that compose the catalytic site of bacterial p-lactamases are 
conserved in Artemis. Two residues may constitute the fifth domain, since both residues 
are required for nuclease activity. A hydrophobic amino acid, such as valine, at position 
341 is typical of metallo-P-lactamases that act on DNA rather than RNA. The mutations 
identified in the F96 line resulting in AL70 and G126D changes to the Artemis protein are 
indicated, b) The catalytic site of Artemis proposed by Pannicke et al, 2004, involves the 
coordination of two metal ions by the conserved residues that constitute the metallo-P- 
lactamase/p-CASP active site. Residues thought to function in metal binding are shown in 
ball-and-stick representation (with yellow carbons, blue nitrogen, and red oxygen atoms).
Two metal ions (magenta spheres) are bound by Asp37 and histidines 33, 35, 38, 115 and 
319 and Asp 17, 136 and/or 165 may orient histidines 38 and 33 for efficient metal 
coordination (dashed lines). A putative water molecule might complete the coordination 
pocket (red sphere) and two coordination sites on the active site metals (green spheres) may 
bind the DNA substrate, (adapted from Pannicke et al, 2004) 185
Figure 6-14: Conservation of leucine 70 and glycine 126 in human, mouse and chicken Artemis
proteins. Homologous sequence is shown in blue, with residues proposed to function in 
metal binding shown in bold. Residues corresponding to leucine 70 and glycine 126 of 
human Artemis are shown in red, and differences to the human sequence are shown in 
green. The chicken Artemis protein sequence was predicted from partial mRNA sequence 
by automated computational analysis, and is therefore incomplete. Numbers in parenthesis 
are GenBank identifiers. 188
Figure 7-1: p53 isolated from F96 cells displays retarded migration and elevated levels of 
radiation-induced serine-15 phosphorylation compared to control. In control cells there 
was a marked increase in the level of p53 serine-15 phosphorylation 2 hours after 
irradiation, but this had decreased to near baseline levels after 8 hours. The F96 line 
demonstrated more pronounced phosphorylation of p53 serine-15 2 hours after irradiation, 
and compared to control cells this was maintained at a relatively high level up to 8 hours 
post-irradiation. The amount of total p53 demonstrated a modest increase 2 hours after 
irradiation in both lines, with a substantial amount of non-phosphorylated p53 being 
present before irradiation. F96 p53 migrated more slowly than p53 from the control cells, 
which may suggest the presence of additional post-translational modifications, or that p53 
may not be wild type in the F96 line 192
Figure 7-2: Phosphorylation and acetylation are not responsible for the slow migration of F96 
p53, but acetylation may facilitate p53 stabilisation and phosphorylation, a) Phosphatase 
treatment successfully removed p53 serine-15 phosphorylation in both the control and F96 
lines, but did not affect the slow migration of total p53 from F96 cells, b) Control (1BR) 
and F96 cells were pre-treated with the acetylation inhibitor Anacardic Acid (AA) for 2 or 
12 hrs, before irradiation with 1 Gy and a further 4 hr incubation. DMSO only controls 
were treated for 12 hours prior to irradiation and a further 4 hr incubation. Cell lysates 
were then prepared and western blotted. AA did not affect the slow migration of F96 p53, 
although levels of total p53 and serine 15 phosphorylation were reduced for both the 
control and F96 lines in a dose dependent manner. This western blot was analysed by 
densitometry and the relative levels of p53 serine-15 phosphorylation are shown. 193
Figure 7-3: Strategy for sequencing human p53 and the identification of codon 72 
polymorphisms in different fibroblast lines, a) PCR primers P5F and P7R were designed to 
amplify the entire coding sequence of p53. These were first used to amplify p53 from 
cDNA, and then in conjunction with primers P6F, P7F and P5R, were again used to 
sequence the gel purified PCR products, b) Chromatogram of anti-sense sequencing results 
for the region 205-225 bp from the ATG translation initiation codon that contains codon 
72. 1BR cells appeared to be homozygous for CGC codon 72 sequence, which codes for 
arginine in the p53 protein, whereas F96 cells were homozygous for CCC in this position, 
which codes for proline. GOS5 cells seem to be heterozygous for this polymorphism, 
illustrated by the double G/C peak for the middle base of codon 72 on the GOS5 sequence 
chromatogram. 195
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Figure 7-4: p53 status and radiation induced serine-15 phosphorylation in control and 
radiosensitive lines, a-b) Western blots of total p53 and serine-15 phosphorylation 4 hours 
after exposure to lGy y-radiation. The control lines 1BR, 48BR and 249BR all displayed 
only the fast migrating form of p53 indicative of p53Arg. The Ligase IV defective line 
180BR also contained only this form of p53, but the other radiosensitive lines GOS5 
(undefined), CJ179 (Artemis deficient), and A-T1BR (ATM deficient) all displayed a p53 
doublet indicative of heterozygosity for the codon 72 polymorphism. Only the 
radiosensitive line F96 was associated with a single, slow migrating p53 band consistent 
with the homozygous p53pro genotype of this line. These blots were analysed by 
densitometry and the normalised fold induction of p53 serine-15 phosphorylation is 
presented in graph form (c). This experiment was repeated at least 3 times for control and 
F96 cells; error bars represent 1 SD of the mean. All lines examined demonstrated 
radiation-induced p53 serine-15 phosphorylation except the A-T1BR line. Whilst F96 cells 
displayed significantly higher levels of radiation-induced serine-15 phosphorylation than 
the control line 1BR, all the remaining lines demonstrated normal induction of serine-15 
phosphorylation.
Figure 7-5: F96 cells display elevated levels of p21 induction after irradiation, a) Northern blot 
of p21 mRNA levels 4 hours after exposure to lGy y-radiation. b) Western blot of p21 
protein levels 4 hours after exposure to lGy y-radiation. For control and F96 cells these 
experiments were repeated at least twice and the normalised fold induction of p21 
calculated to give an average value, displayed in bar chart form underneath each 
representative blot. Error bars represent 1 SD of the mean. The F96 line displayed higher 
levels of p21 mRNA and protein induction after irradiation compared to control. The AT 
line A-T1BR demonstrated no significant induction of p21.
Figure 7-6: The presence of the F96 mutant Artemis proteins does not enhance radiation-induced 
p53 serine-15 phosphorylation in HCT116 cells, a) Western blot of HCT116 cells either 
mock transfected or transfected with V5-tagged EXP3.2 expression vectors coding for wild 
type Artemis (pArt), G126D Artemis (pArt-G126D), or AL70 Artemis (pArt-AL70). A co­
transfection with equal amounts of each Artemis mutant (Mut. Co-T) is also included, as 
well as transfection with GFP alone (pGFP). 24 hours after transfection cells were either 
mock irradiated (-y) or exposed to lGy y-radiation (+y) and total cellular protein isolated 
after a further 4-hour incubation. The final 2 lanes represent protein isolated from the 1BR 
and F96 primary fibroblast lines 4 hours after lGy irradiation. Similar to the 1BR line, 
HCT116 cells express only the fast migrating form of p53 (p53Aia)- The G126D Artemis 
mutant was expressed at a lower level compared to the other Artemis transfections, which 
produced comparable amounts of 83 kD V5 tagged protein. The presence of the F96 
Artemis mutants did not significantly affect radiation induced serine-15 phosphorylation,
b) HCT116 cells were transfected with either a GFP-tagged wild type Artemis EXP47 
expression vector (pArt-GFP) or co-transfected with equal amounts of each GFP-tagged 
F96 mutant (G126D and AL70) EXP47 expression vector (Mut Co-T-GFP). 24 hours after 
transfection, half of each sample was either mock irradiated (-y) or exposed to 1 Gy y- 
radiation (+y), and after a further 4-hour incubation cells were sorted into GFP negative 
(GFP-ve) and GFP positive (GFP+ve) populations. Total cellular protein was then isolated 
and a western blot of p53 serine-15 phosphorylation performed. Transfection with either 
wild type Artemis or the F96 mutants resulted in a significant increase in p53 serine-15 
phosphorylation in untreated cells, and irradiation only marginally increased this 
modification. The expression of the F96 mutant Artemis proteins did not result in the 
specific amplification of radiation-induced p53 serine-15 phosphorylation compared to that 
with wild type Artemis.
Figure 7-7: Distribution of normalised intensity for each of the 12 U133A microarrays used for 
analysis of radiation-induced gene expression
Figure 7-8: 13,168 transcripts detected in at least 2 out of 12 samples. Expression levels were 
compared between F96 (left) and 1BR (right) cells in any condition. Each line compares 
the mean expression level of a transcript in F96 to that in 1BR (n=6).
Figure 7-9: 51 genes differentially expressed in F96 (left) and 1BR (right) cells irrespective of 
irradiation.
Figure 7-10: 80 genes were upregulated in the F96 line. Whilst many of the genes upregulated 
by IR in the F96 line did not show a similar pattern of expression in 1BR cells (top panel), 
many of the F96 upregulated genes increased only to a level similar to that in 1BR cells 
before irradiation (highlighted in black, bottom panel). A small group of genes were 
elevated after IR in F96 cells above that of 1BR irradiated levels (blue genes, bottom 
panel).
Figure 7-11:7 p53 target genes elevated by IR in F96 cells but not in 1BR cells after exposure to 
lGy y-radiation. p21 was the only p53 target gene to be induced in both lines after 
irradiation, although this was considerably reduced in 1BR cells. Lines connect the mean 
values of triplicate measurements at the 2 doses.
Figure 7-12: Selection of p53 target genes induced in 1BR and F96 cells after exposure to 6 Gy 
y-radiation measured using Affymetrix U95A microarrays. Gene order is Cyclin G, Bax, 
Fas, PCNA, Fas (alt splice), Bax, DDB2, Bax (alt splice), PLK, GADD45, p21, IGFBP4, 
IGFBP3
Figure 8-1: Mechanisms that may lead to distinct cell fates of lymphocytes in vivo and fibroblasts 
in vitro after DSB induction in Artemis deficient cells.
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Chapter 1: Introduction
The preservation of genomic integrity is crucial for cell survival since cellular functions 
depend on the quality of information stored within genomic DNA. DNA damage 
therefore poses a serious threat to living organisms. Lesions in genomic DNA can 
result in the introduction of permanent mutations that lead to abnormal cellular function, 
cell death and genomic instability. Consequently, cells have evolved complex 
mechanisms to recognise DNA damage, instigate cell cycle arrest and activate repair 
mechanisms (Jackson, 2001). Whilst this provides some protection from the deleterious 
effects on cell viability, in metazoans DNA damage is also a precursor o f cancer 
(Elledge, 1996). In this situation cells must not only repair the lethal effects o f DNA 
damage, but also guard against the accumulation o f mutations that may lead to a loss of 
cell cycle control and threaten organism survival. This is achieved by the induction of 
permanent arrest or apoptosis in cells that have received a high level o f damage.
1.1 Sources of DNA damage
Genomic DNA is constantly exposed to a wide array of DNA damaging agents. These 
can arise from endogenous sources as products of normal cellular metabolism in 
consequence to hydrolysis, lipid peroxidation events and the formation o f small reactive 
oxygen species (ROS) (Cooke et al, 2003). Electron transport chains all posses the 
potential to leak electrons to oxygen resulting in superoxide formation, which is a 
precursor to various other ROS. These ROS then have the potential to attack DNA 
resulting in many forms of DNA damage including base damage (Cooke et al, 2003) 
and one of the most lethal forms of DNA damage, the double strand break (DSB) (Prise 
et al, 1989). Indeed, the process of DNA replication itself can lead to the production of 
DSBs when replication forks collapse (Cox, 2002) and it has been suggested that about 
10 replication forks collapse in a human cell replication cycle (Haber, 1999).
Although DNA DSBs pose a major threat to genome integrity, they are sometimes 
generated deliberately as intermediates during normal physiological processes.
Probably the best-characterised example of this in higher eukaryotes is the pathway of 
Variable (Diversity) Joining (V(D)J) recombination, which occurs in developing B- and 
T-lymphocytes to provide the basis for the antigen-binding diversity o f the
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immunoglobulin and T-cell receptor proteins (reviewed in Bassing et al, 2002a).
During this process lymphocytes assemble functional antigen receptor genes by the 
ordered rearrangement of component variable (V), diversity (D) and joining (J) gene 
segments, which involves the induction and repair o f DNA DSBs. DSBs also arise as 
intermediates during meiotic recombination (Keeney et al, 2001), which generates the 
genetic variability during sexual reproduction upon which natural selection can act.
Whilst cells must be able to cope with these endogenous sources o f DNA damage, there 
are also many genotoxic agents that arise from exogenous sources such as UV light, 
ionising radiation (IR) and chemical mutagens. A plethora o f different chemical 
mutagens can produce a wide variety of lesions in DNA, such as base damage, 
interstrand/intrastrand cross-links and single and double strand breaks. One o f the most 
abundant lesions induced by Ultraviolet (UV) radiation is the cyclobutane-pyrimidine 
dimer (CPD), which involves the covalent linking o f two adjacent pyrimidine bases 
within the DNA double helix. Exposure o f cellular DNA to IR can also result in base 
damage, along with single strand breaks and double strand breaks. The latter are 
thought to be the primary lethal lesion induced by IR. DSBs are potent inducers of 
mutations and cell death. Inmetazoa, just one DSB can kill a cell if  it leads to the 
inactivation of an essential gene or, more frequently, triggers apoptosis (Rich et al, 
2000). Furthermore, there is experimental evidence for a causal link between the 
generation of DSBs and the induction of mutations and chromosomal translocations 
with tumourigenic potential (Vamvakas et al, 1997) (Richardson et al, 2000) (Ferguson 
et al, 2001) (Khanna and Jackson, 2001). It is therefore vitally important that living 
organisms are able to detect and repair DSBs efficiently once they arise.
1.2 The cellular response to DNA DSBs
The cellular response to DNA DSBs can be divided into three levels o f organisation 
depending on the function of its components (figure 1 -1). Initially the pathway must be 
activated by the presence of DNA damage and this requires putative sensor proteins that 
are activated by DSBs. The sensors stimulate the activation of a transducer system that 
amplifies and diversifies the signal by targeting a series o f downstream effectors. These 
effectors then regulate various aspects of cellular function such as cell cycle arrest, 
apoptosis and the regulation of DNA repair mechanisms. The components o f this 
damage response network need to be exquisitely sensitive and selective since they must
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be triggered efficiently by low numbers of, and possibly just one, chromosomal DNA 
DSB, yet remain inactive under other conditions.
IR
Detection of DNA damage
Activation of cellular 
responses to DNA damage
Gene transcription
Cell cycle control Apoptosis
Sensors
Transducers
Effectors
DSB repair
Figure 1-1: Organisation of the metazoan DNA damage response netw ork
1.3 DSB Detection and response initiation
Although the exact mechanism of DSB detection remains unclear, many putative sensor 
proteins have been proposed to function in this role. ATM (AT Mutated), encoded by 
the gene that is mutated in individuals with the neurodegenerative syndrome Ataxia 
Telangiectasia (AT), is activated early after DNA damage induction and could serve as 
a sensor, as well as an initiator, of the ensuing cellular genotoxic response. ATM is a 
member of the phosphatidylinositol 3-kinase (PI-3K) superfamily that includes ATR 
(ATM and Rad3-related). While ATR responds to UV damage or stalled replication 
forks, ATM reacts primarily to DSBs induced by IR (Guo et al, 2000) (Hekmat-Nejad
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et al, 2000) (Pandita et al, 2000) (Abraham et al, 2001). Once activated ATM 
phosphorylates various downstream protein targets o f the damage response, including 
p53, the checkpoint kinase (Chk) 2, Breast cancer 1 gene product (BRCA1) and 
Mutated in Nijmegen breakage syndrome 1 (Nbsl), leading to a variety o f effects on 
DNA repair, cell cycle progression and apoptosis (Abraham 2001) (Shiloh, 2001). 
Reports have suggested that ATM can bind to and is activated by DSBs (Smith et al, 
1999) (Suzuki et al 1999) (Andegeko et al, 2001), which may implicate ATM as a DSB 
sensor. Recent data has demonstrated that ATM exists as an inactive dimer that 
undergoes autophosphorylation on serine-1981 after DNA damage to release kinase 
active monomers (Bakkenist and Kastan, 2003). This was rapidly triggered by changes 
in chromatin structure, even under conditions that are not likely to induce DSBs, which 
suggests a more indirect mechanism for ATM activation. This may involve the 
association of ATM with other DNA damage mediator proteins that co-localise with 
ATM at sites of DSBs.
Many proteins have been implicated in the recruitment o f DSB response proteins to 
damaged chromatin. y-H2AX is the phosphorylated form of the Histone 2AX (H2AX) 
variant and has been proposed to recruit several damage response proteins to DSB sites 
such as Rad 50, Rad 51 (Pauli et al, 2000), p53 binding protein 1 (53BP1) (Femandez- 
Capetillo et al, 2002) Mediator of DNA damage checkpoint protein 1 (M dcl) (Stewart 
et al, 2003) BRCA1 (Bassing et al, 2002b) and Nbsl (Celeste et al, 2002). y-H2AX 
foci form over large chromatin domains surrounding damaged DNA (Rogakou et al, 
1999). This phosphorylation is reported to be performed by ATM (Burma et al, 2001) 
and its PI-3K homologue DNA dependent protein kinase (DNA-PK) in a redundant, 
overlapping manner (Stiff et al, 2004a). Whilst the phosphorylation o f H2AX is 
important for the recruitment of some damage response proteins, this event is likely to 
occur downstream of DSB recognition and ATM activation. Recent reports suggest that 
although this modification is important for the retention of damage response proteins 
within nuclear foci, the initial recognition of DSBs occurs in the absence o f H2AX 
phosphorylation (Celeste et al, 2003).
A protein complex that is a good candidate for a DSB sensor that is able to stimulate 
ATM activity is the Mrel 1 complex, which consists o f Mrel 1, Rad50 and N b sl. This 
trimeric complex is recruited to DSB sites rapidly (Mirzoeva and Petrini, 2001), and 
examination at early timepoints after irradiation revealed this was unaffected by ATM
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deficiency (Mirzoeva and Petrini, 2001) and caffeine treatment to inhibit ATM, ATR 
and DNA-PK (Mirzoeva and Petrini, 2003). Furthermore, the initial recruitment o f the 
Mrel 1 complex to DSBs 8 minutes after irradiation is not affected by H2AX deficiency 
(Celeste et al, 2003). This is consistent with the lack o f checkpoint deficiency observed 
in H2AX deficient cells (Celeste et al, 2002), and although Nbsl foci formation was 
impaired in this study, early timepoints when DSBs are first recognised were not 
examined. The Mrel 1 complex has also been shown to be required for the activation of 
ATM dependent pathways (Uziel et al, 2003), which is consistent with its role upstream 
of ATM as a sensor, but Nbsl has also been shown to be phosphorylated by ATM after 
irradiation (Lim et al, 2000). These results suggest an intriguing situation, where the 
DNA damage sensor is also a target for the transducing kinase.
Recent work showing that the Mrel 1 complex binds to ATM and increases its affinity 
towards substrates demonstrated that Nbsl phosphorylation enhances this activity (Lee 
and Pauli, 2004a). But this phosphorylation is not required for Nbsl recruitment to 
damage sites, as shown by the proficient radiation-induced foci formation in Nbsl 
S343A cells (Kobayashi et al, 2002). Similarly, early Mrel 1 foci are formed by a 
mechanism independent of ATM, ATR and DNA-PKcs (Petrini et al, 2003).
Furthermore ATM activation and binding to sites o f DNA damage requires a functional 
Mrel 1 complex (Uziel et al, 2003). Together these findings suggest that ATM, initially 
recruited to DNA damage by the Mrel 1 complex, phosphorylates H2AX, and this 
H2AX phosphorylation in turn is required for the recruitment and retention o f additional 
Nbsl and other damage response proteins at DSB sites. This consequently leads to an 
amplification of this cascade, initiating a chain reaction involving ATM and these 
damage response proteins (Figure 1-2).
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Figure 1-2: Detection of DSBs leads to the recru itm ent of damage response proteins into 
sub-nuclear foci, and the activation of ATM  dependent signaling pathways. DSBs are 
detected by the Mrel 1 complex which then activates the ATM protein kinase, although this is 
probably not the only mechanism of ATM activation. ATM can phosphorylate Nbsl which 
amplifies the signal leading to the enhanced phosphorylation of ATM substrates such as H2AX. 
Phosphorylated H2AX (y-H2AX) is able to retain the Mdcl, Brcal and 53bpl adaptor proteins 
in nuclear foci along with additional Mrel 1 complexes, and together these are able to facilitate 
the phosphorylation of downstream ATM targets that function in DNA repair, cell cycle arrest 
and apoptosis.
Mdcl and 53bpl are two of the damage response proteins that are recruited to sites of 
DSBs after irradiation (Schultz et al, 2000) (Anderson et al, 2001) (Goldberg et al,
2003) (Lou et al, 2003a), (Stewart et al, 2003) and it has been suggested that similarly 
to the Mrel 1 complex these proteins may also function in the activation of ATM 
(Mochan et al, 2003). Mochan et al demonstrated that the suppression of Mdcl by 
siRNA inhibited ATM activation and phosphorylation of various ATM substrates.
Mdcl is known to interact with Nbsl (Goldberg et al, 2003) and a recent study 
indicated this protein may function as a H2AX-dependent interaction platform enabling 
a switch from transient, Mdcl independent recruitment of Nbsl to DSBs towards 
sustained, Mdcl-dependent interactions with the surrounding chromosomal 
microenvironment (Lukas et al, 2004). Also, in cells with defective Nbsl, suppression 
of 53bpl was shown to further abrogate ATM activation (Mochan et al, 2003). The 
Mrel 1 complex may therefore require other damage response proteins for the sustained 
activation of ATM, and this may not be the only mechanism of DSB detection.
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Mdcl and 53bpl both contain 2 BRCT (BRCA1 C-terminal) domains (Mochan et al,
2004) (Stucki et al, 2004) that are found in DNA repair proteins from yeast to 
mammals, and as the name suggests are also present in the BRCA1 protein. BRCT 
domains behave as phosphopeptide binding motifs ideal for protein targeting (Manke et 
al, 2003) (Yu et al, 2003), and BRCA1 is also recruited to sites of DSBs (Zhong et al,
1999) by a mechanism that is dependent on Mdcl (Lou et al, 2003b). Although BRCA 
1 does not appear to be essential for the activation of ATM, it was shown to be required 
for IR induced phosphorylation o f some ATM substrates, including p53, Chk2 and 
Nbsl (Foray et al, 2003) (Fabbro et al, 2004). These results suggested that BRCA1 
might act as a scaffold protein that facilitates the ability of ATM to phosphorylate some 
downstream targets. BRCA1 has been identified as part of a larger protein complex, the 
BRCA 1-associated genome surveillance complex (BASC), which contains ATM, the 
Mrel 1 complex and many other DNA damage response proteins (Wang et al, 2000). 
Since ATM phosphorylates BRCA1 (Cortez et al, 1999) (Gatei et al, 2000), Mdcl 
(Goldberg et al, 2003), and 53bpl (Mochan et al, 2004) this could regulate the 
formation of large aggregates of damage response proteins at DSB sites. These proteins 
may then act as adaptors to allow ATM to signal to other downstream targets in the 
damage response that effect DNA repair, cell cycle arrest and apoptosis.
1.4 Signal transduction and effector function: the p53 response
After the detection of DSBs the active ATM protein kinase phosphorylates transducer 
proteins that can signal the presence of DNA damage to the cell cycle and apoptotic 
machinery. The p53 tumour suppressor protein plays a key role in this part o f the DNA 
damage response, and acts as a node or hub for the incoming stress signals it receives. 
ATM can directly and indirectly facilitate an accumulation and activation o f the p53 
tumour suppressor, the function of which largely depends on its transcriptional activator 
properties. ATM directly phosphorylates p53 on serine-15 (Banin et al, 1998) (Canman 
et al, 1998) (Khanna et al, 1998) (Nakagawa et al, 1999), which seems to enhance its 
transcriptional activator function (Lambert et al, 1998) (Dumaz and Meek, 1999). 
Serine-15 phosphorylation is then thought to nucleate a series of subsequent post- 
translational modifications on p53 that contribute to both its stabilisation and 
biochemical activation (as many as 17 sites in p53 undergo phosphorylation or 
acetylation) (Appella and Anderson, 2001).
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ATM can indirectly induce phosphorylation of p53 at serine 20 through activation of 
Chk2 (Chehab et al, 2000) (Shieh et al, 2000), a modification that appears to increase 
p53 stability by interference with p53’s association with its inhibitor, murine double 
minute 2 (mdm2) (Chehab et al, 1999) (Unger et al, 1999). mdm2 is a prime mediator 
of p53’s degradation, serving as the E3 ligase, which mediates both the ubiquitylation 
and proteasome dependent degradation o f p53 (Michael et al, 2003). Another facet to 
our understanding of ATM mediated induction of p53 came with the finding that ATM 
phosphorylates mdm2 in response to DSBs (Khosravi et al, 1999) (de Toledo et al,
2000) and that this attenuates the p53-inhibitory potential of mdm2 (Maya et al, 2001). 
Other work suggested that ATM might also inhibit mdm2 by the phosphorylation and 
induction of E2F1 transcription factor (Lin et al, 2001). This would allow the 
subsequent induction o f ARF, a negative regulator o f mdm2.
Coupled with the stabilization o f p53, phosphorylation o f serine-15, threonine 18 and 
serine-20 also stimulates the recruitment o f transcription factors including p300, CBP 
(both transcriptional co-activators and histone acetyl-transferases [HATs]) and P/CAF 
(a p300/CBP-associated HAT) (Appella and Anderson, 2001). These factors not only 
stimulate transcription from p5 3-responsive promoters but also promote acetylation o f a 
cluster of C-terminal lysine residues in p53 that are normally targets for ubiquitylation 
(Li et al, 2002b). Phosphorylation o f serine 15 and serine 20 may also block export of  
p53 mediated by mediated by a nuclear export signal (NES) present in this region of the 
N-terminus (Zhang et al, 2001b).
1.4.1 Checkpoint Activation
A major consequence o f ATM activation after DNA damage is therefore the induction 
of p53 dependent gene transcription. One of the first effects of p53 induction in nearly 
all cell types is cell cycle arrest. Cell cycle checkpoints function at a number o f critical 
points in the cell cycle, including the Gl/S and G2/M boundaries and during S-phase 
(Nyberg et al, 2002) (figure 1-3). These checkpoints are triggered by a mixture o f p53 
dependent and p53 independent pathways, and may initially prevent cells from 
conducting DNA replication or mitosis in the presence of unrepaired damage, allowing 
time for repair processes to complete their function. A wealth of evidence confirms that 
p53 is required for proper G1 arrest after DNA damage (Kastan et al, 1991) (Kuerbitz et 
al, 1992) (Donehower and Bradley, 1993) (Ko and Prives, 1996), and this is triggered
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largely through the transactivation o fp21Wc^  by p53, which inhibits G1 cyclin 
dependent kinases such as Cyclin dependent kinase (Cdk) 2 and Cdk4 (El-Deiry et al, 
1993) (Harper et al, 1993). This results in the maintenance o f the Rb-E2F complex to 
consequently prevent S-phase entry (Gottlieb and Oren, 1996) (Ko and Prives, 1996) 
and inactivated Cdk2 accumulates and cannot phosphorylate Cdc45 to initiate 
replication. This p53 dependent pathway is thought to be responsible for the 
maintenance o f G1 arrest, but another more rapid pathway involving CDC25A may 
induce an initial, transient arrest in G1 that lasts for only several hours and involves the 
inhibition of Cdk2 within 20-30 min (Bartek and Lukas, 2001). This pathway also 
functions in the S-phase checkpoint response and is described below.
Over 2 decades ago it was observed that irradiation o f cells results in delayed 
progression during the S-phase o f the cell cycle, and a defect in this process was noticed 
in cells with defective ATM function that displayed Radioresistant DNA Synthesis 
(RDS), a characteristic o f cells derived from patients with AT and Nijmegen Breakage 
Syndrome (NBS) (Painter and Young, 1980). The extent of RDS in NBS cells is milder 
than that in cells deficient in ATM, suggesting that the S-phase checkpoint is regulated 
by two parallel branches that are triggered by ATM (Falck et al, 2002) (figure 1-3).
One branch is the ATM-Chk2-CDC25A pathway and the other requires N b sl. In the 
ATM-Chk2-CDC25A pathway ATM activates Chk2, which then phosphorylates the 
cell cycle regulator CDC25A, leading to its degradation by polyubiquitination-mediated 
hydrolysis, and thus maintaining the inhibitory phosphorylation on Cdk2 that is 
consequently unable to initiate DNA synthesis through Cdc45. This prompt cell cycle 
delay is independent o f p53 mediated transcription and may serve the purpose of  
temporarily slowing down cell cycle progression to provide more time for DNA repair. 
The other pathway places Nbsl, BRCA1 and SMC1 in a complex where all are 
phosphorylated by ATM and directly or indirectly affect Cdk2 activity. Both pathways 
do not exclude each other, since Nbsl may facilitate the phosphorylation o f CDC25A 
and lead to its degradation (Falck et al, 2002).
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Figure 1-3: Ionising radiation induced DNA damage checkpoints in m am m alian cells.
After a cell has completed DNA replication there is a second growth phase of the cell 
cycle (G2) before mitosis is initiated. This transition is also subject to a DNA damage 
checkpoint; the G2/M checkpoint. It has been reported that there are two distinct G2/M 
checkpoint pathways. Whereas one is ATM dependent, IR-dose independent and of 
rapid response, the other is a prolonged response, ATM independent and IR dose 
sensitive (Xu et al, 2002). The prolonged G2/M delay has not been thoroughly 
investigated. It appears to be partly the result of a loss of DNA damage induced S- 
phase checkpoint response and represents an accumulation of cells that were damaged 
during DNA replication (Xu et al, 2002). The rapid response pathway involves the 
activation of ATM, which then activates the downstream transducing kinase Chkl 
(Gatei et al, 2003) (figure 1-3). Subsequently, Chkl phosphorylates CDC25 family 
members promoting their sequestration by 14-3-3 protein(s). Originally Cdc25C was 
though to be the effector of the G2/M checkpoint (Peng et al, 1997), but it was 
subsequently found that mouse Cdc25C (-/-) cells have normal G2/M checkpoint (Chen
et al, 2001). In contrast, disruption o f the Chkl-Cdc25A pathway abrogates ionizing 
radiation-induced S and G2 checkpoints (Zhao et al, 2002), indicating that the Cdc25A 
phosphatase is the main effector o f the G2/M checkpoint. As long as the pathway is 
activated, CDC25A remains inaccessible, CDC2-cyclin B heterodimers remain inactive 
and the cell remains in G2. p53 also appears to contribute to the G2/M checkpoint, 
since its downstream target gene 14-3-3 a  can sequester the cyclin B1 and CDC2 
proteins that initiate mitosis and prevent them from entering the nucleus (Chan et al,
1999), and another p53 target gene GADD45 can destabilize CDC2/cyclin B complexes 
(Zhan et al, 1999) (Jin et al, 2002). p53 also suppresses the promoters o f CDC2 and 
cyclin B, which is thought to be important for the maintenance o f G2/M arrest. 
(Passalaris etal, 1999)
1.4.2 Genetic damage assessment and survival effector genes
Concomitant with the activation o f the transient cell cycle checkpoints described above, 
metazoan cells enter a period of damage assessment after irradiation involving p53 
dependent gene transcription. At this stage, depending on the severity o f damage and 
cell type, one of three survival outcomes may occur (figure 1-4): -
1) Survival
Independent of p53 activation, ATM activates signalling pathways that enhance cell 
survival. ATM is required for activation of NF-kB after DNA damage (Lee et al, 
1998b) (Piret et al, 1999) (Panta et al, 2004), and this response may induce a 
transcriptional program that promotes cell survival after irradiation (Stankovic et al, 
2004). Additionally, ATM has also been shown to facilitate escape from terminal 
growth arrest induced by a complex genotoxin such as Chromium (VI) (Ha et al, 2003). 
Some p53 target genes have been described that enhance cell survival. The p53 induced 
gene Heparin-Binding EGF-like growth factor (HB-EGF) (Fang et al, 2001) has been 
shown to promote cell survival through the activation of Mitogen activated protein 
kinases (MAPKs) and Cyclooxygenase 2 (Cox-2) (Han et al, 2002). This constitutes a 
rare, pro-survival example of a p53 target gene, since most are involved in the induction 
of apoptosis or cell cycle arrest.
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2) Permanent arrest
The cell may enter permanent cell cycle arrest, a senescent like state that involves 
prolonged expression of the p53 targets p21 and GADD45, followed by the delayed 
induction of another Cdk inhibitor, p i6 (Robles and Adami, 1998). DNA damage o f  
normal human fibroblasts induces terminal growth arrest, which is accompanied by 
phenotypic changes that bear a striking resemblance to cells that undergo replicative 
senescence (Di Leonardo et al, 1994) (Robles and Adami, 1998) and is now termed 
Stress induced premature senescence (SIPS) (Toussaint et al, 2000). This effectively 
removes highly damaged cells from the replicative population and therefore functions as 
a protective mechanism against the propagation o f genomic instability in multicellular 
organisms (Linke et al, 1997).
3) Apoptosis
In other cell types such as lymphocytes DNA damage may induce apoptosis and unlike 
permanent cell cycle arrest, which seems to involve just a few genes, this appears to 
result from the co-ordinated induction o f a wide variety of apoptotic p53 target genes 
(Vousden and Lu, 2002) (Sax et al, 2002). These genes contribute to induction o f both 
the mitochondrial and death-receptor pathways of apoptosis. For example many o f 
these proapoptotic gene products such as Bax, Puma, Noxa and p53AIPl localise to the 
mitochondria and promote the loss of mitochondrial membrane potential and 
cytochrome c release, resulting in the formation o f the apoptosome complex with Apafl 
and caspase 9 (Oda et al, 2000), (Nakano and Vousden, 2001), (Yu et al, 2001), 
(Matsuda et al, 2002). ROS produced by PIGs (p53-induced genes) can also cause 
damage to the mitochondria and initiate apoptosis (Polyak et al, 1997). In contrast, the 
proapoptotic gene products such as Fas, TNF-related apoptosis-inducing ligand receptor 
(TRAILR)/DR5 and PIDD are components of the death receptor-mediated cell death 
pathway (Owen-Schaub et al, 1995) (Lin et al, 2000) (Takimoto and El-Deiry, 2000) 
(Wu et al, 2000). In this instance caspase 8 is activated at the cell membrane following 
the clustering of death receptors that occurs following their occupation by factors such 
as TRAIL or the Fas ligand. The activation of the caspase family o f cysteine proteases 
in both the mitochondrial and death receptor pathways then results in cleavage of 
cellular substrates and production of the apoptotic phenotype. Another p53 induced 
gene, HTRA2, is a serine protease that cleaves CIAP, a mammalian homologue o f  
Drosophila Inhibitor of Apoptosis Proteins (LAPs), during p53 induced apoptosis to
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Figure 1-4. p53 genetic damage assessment, survival effector genes and mechanisms of 
p53 induced apoptosis. (Modified from Hofseth et al, 2004)
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remove the inhibitory effect o f CIAP on executioner caspases and promote apoptosis 
(Jin et al, 2003). p53 may also induce apoptosis via an ER-dependent mechanism by 
transactivating the expression o f Scotin and SCN3B, proteins that appear to be localised 
to the ER (Bourdon et al, 2002) (Adachi et al, 2004).
In addition to the transactivation o f genes directly involved in apoptotic pathways, p53 
can activate the expression o f genes that inhibit survival signalling, e.g. Insulin-like 
growth factor binding protein (IGF-BP) (Buckbinder et al, 1995), and therefore promote 
cell death indirectly. p53 has also been reported to promote apoptosis independent of 
transcriptional activation (Caelles et al, 1994), for example by caspase activation (Ding 
et al, 1998), enhancing the transport o f Fas from the Golgi to the cell membrane 
(Bennett et al, 1998) and transcriptional repression o f survival promoting genes 
(Murphy et al, 1996). Recent reports have demonstrated the direct localisation o f p53 
to the mitochondria following DNA damage, where p53 can interact with both pro- and 
anti-apoptotic proteins such as Bcl2, B cIX l and Bak. p53 was found to form complexes 
with the protective Bcl2 and B cIXl proteins, resulting in cytochrome c release (Mihara 
et al, 2003). The interaction of p53 with proapoptotic Bak caused oligomerisation of 
Bak and release of cytochrome c from mitochondria, and the formation o f the p53-Bak 
complex coincided with loss o f an interaction between Bak and the anti-apoptotic Bcl2- 
family member Mcll (Leu et al, 2004). This suggests that the action o f p53 as a 
transcription factor may not be a requirement for it to induce death. The ability o f p53 
to locate to the mitochondria is also associated with one polymorphic form of p53. It 
has been reported that p53 with arginine at position 72 (p53Arg) induces apoptosis more 
efficiently than p53 with proline at position 72 (p53pr0), and part of the explanation for 
this was that more p53Arg than p53pro is located in the mitochondria (Dumont et al,
2003). Therefore p53 may translocate to the mitochondria and contribute directly to 
apoptotic signalling and the release of cytochrome c.
1.4.3 Cell fate decision
The final cellular response to DNA damage therefore depends on the combined effect of 
a wide variety of p53-induced genes, in conjunction with certain non-transactivating 
properties of p53 and independent pro-survival signalling through ATM. In cells 
capable o f p53-dependent apoptosis, low levels of DNA damage generally induce cell 
cycle arrest whereas high levels of p53 are required for apoptosis (Chen et al, 1996). 
Some evidence suggests this could be due to the presence of high- and low-affinity p53
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binding sites in the promoters o f cell cycle arrest and apoptotic genes (Szak et al, 2001) 
(Kaeser ad Iggo, 2002). Therefore, increased levels or activity of p53, governed by the 
type and/or intensity o f the signal, can lead to the onset o f apoptosis once a certain 
threshold level is achieved. A model for the differential control for p53-dependent gene 
transcription was proposed by a recent study that involves the composition of 
transcription initiation complexes at the core promoters o f p53 responsive genes 
(Espinosa et al, 2003). Basal levels o f p53, binding to cognate sites upstream of the 
core promoter region, mediate assembly o f a poised RNA Polymerase II initiation 
complex on the core promoters o f genes involved in the growth arrest response 
(including p21 and GADD45). Following DNA damage, the paused polll complex is 
permitted to engage the elongation phase o f transcription. This preloading o f the 
transcriptional machinery lowers the threshold for p53 activation, and therefore small 
increases in p53 activity give rise to a rapid induction of target gene expression. 
Conversely, for proapoptotic genes there is a significantly lower level o f bound 
initiation complex compared to growth arrest genes prior to a stress stimulus. In this 
instance, after a stress stimulus the induction o f gene expression requires a higher level 
of p53 activation and proceeds with much slower kinetics. A failure to terminate the 
p53 response, for example due to the persistence o f DNA DSBs, may therefore provide 
time for the accumulation o f sufficient levels o f the appropriate apoptotic gene products 
to initiate an apoptotic response (figure 1-5).
The threshold for p53-mediated apoptosis may be set at different levels in different cell 
types, since this response has been shown to vary between tissues. For example, 
thymocytes and splenocytes undergo p53-dependent apoptosis in vivo in response to 
ionising radiation, whereas fibroblasts arrest in a p53-dependent manner. These 
different cell types may therefore exhibit low and high thresholds, respectively, for the 
onset of apoptosis. The currently accepted model for the choice between arrest and 
apoptosis is based principally on the idea that p53 is able to differentially transactivate 
promoters of growth arrest and apoptosis genes depending on the cellular context. This 
is reflected in our personal observation that lymphoid human cancer cell lines that 
undergo apoptosis following irradiation induce PUMA, while primary fibroblasts that 
are resistant to apoptosis do not. Built into this idea are many factors that influence the 
extent to which p53 can favour a given class of promoters, including the presence o f  
pro-apoptotic proteins that govern promoter selectivity, and the concerted action of  
apoptosis-related pathways that shift the balance of p53 induction in favour of
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apoptosis. (modified from Meek et al, 2004)
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cell death, either by influencing the cellular environment or by impinging directly on 
the ability of stress signals to induce a p53 response (Gudkov and Komarova, 2003) 
(Vousden and Lu, 2002).
One factor that may affect the ability o f p53 to bind to target genes in different cell 
types is the presence o f certain post-translational modifications. Phosphorylation of p53 
on serine-46 has been shown to be important for the induction of the pro-apoptotic gene 
p53AIP, but not mediators o f cell cycle arrest such as p21 (Bulavin et al, 1999) (Oda et 
al, 2000b). Furthermore, a novel p53-responsive gene, p53DINPl, is thought to 
mediate the stimulation of serine-46 phosphorylation and apoptosis, possibly by a 
mechanism involving interaction o f p53DINPl with a serine-46 kinase (Okamura et al,
2001). This may represent a positive feedback loop for the induction of apoptosis, and 
demonstrates that the presence o f certain proteins may promote specific covalent 
modifications o f p53 to influence the final cellular outcome. Another form of control 
may be the presence of cell-type specific co-activators o f p53. JMY for example has 
been shown to co-operate with the p53 binding protein p300 to enhance the ability of 
p53 to induce expression o f genes such as Bax, without significantly influencing the 
induction of p21 (Shikama et al, 1999). More recently ASPP1 and 2 have been shown 
to enhance the interaction o f p53 with the promoters of apoptotic genes such as Bax, 
and inhibition o f ASPP expression was shown to selectively block the apoptotic 
response to p53 (Samuels-Lev, 2001). iASPP is also a member of the ASPP family of 
proteins and behaves as an inhibitor o f its larger siblings. Whereas ASPP1 and 2 
enhance p5 3-mediated transcription of proapoptotic genes, iASPP antagonises this 
elevation in gene expression, and by extension iASPP also suppresses p53-mediated 
death (Bergamaschi et al, 2003). Other p53 family members may also contribute to this 
level of control, since p63 and p73 were shown to be required for p53-dependent 
apoptosis (Flores et al, 2002). The presence of certain co-factors may therefore prime a 
cell to respond to p53 activation in a particular fashion once a specific threshold of 
DNA damage is achieved (figure 1-5).
Factors that influence the p53-mdm2 loop are likely to play a significant role in setting 
the threshold for p53 activation and consequently apoptosis. mdm2 is the target o f the 
AKT protein kinase that mediates many survival signals that are transduced through the 
PI3-kinase pathway (Mayo et al, 2001) (Ogawara et al, 2002). AKT mediated 
phosphorylation o f mdm2 has been reported to stimulate nuclear import o f mdm2 and
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mdm2 mediated p53 degradation. Removal o f survival signaling blocks this 
phosphorylation o f mdm2, and the basal level o f p53 is increased, effectively lowering 
the threshold needed to initiate p53 induction in response to other factors. Under these 
circumstances p53 induction becomes acutely sensitive to DNA damaging agents in a 
manner that favours apoptosis (Gottlieb et al, 2002). Conversely, mutation of the PTEN 
tumour suppressor gene, whose product inhibits survival signals propagated by AKT, 
can lead to a constitutively high level o f mdm2 activity in tumour cells, which increases 
the threshold required for p53-mediated apoptosis (Mayo et al, 2002). ARF, the protein 
inhibitor of mdm2 that is induced by hyper-proliferative signals, may also contribute to 
regulating the threshold level for p53 induction, since murine fibroblasts lacking this 
protein show a weakened induction o f p53 and consequently p21 in response to DNA 
damage (de Stanchina et al, 1998) (Khan et al, 2000). ARF has also been shown to be a 
component of the DNA damage response in primary human fibroblasts (Khan et al, 
2004). ARF may therefore contribute to setting the threshold for p53 induction through 
its interaction with mdm2 in a manner that may reflect the proliferative status o f the 
cell.
1.5 Double Strand Break (DSB) Repair
Concurrent with the activation o f the p53 response to DNA damage, the presence of 
DNA DSBs leads to the activation o f proteins that function to repair this potentially 
lethal lesion. Two major pathways exist for the repair o f DSBs, Non-homologous end 
joining (NHEJ) and Homologous recombination (HR) (Valerie and Povirk, 2003). 
Homologous recombination requires that the cell be diploid for the region that requires 
repair and in vertebrate organisms is restricted to late S and G2 phases o f the cell cycle 
(Johnson and Jasin, 2000) (Takata et al, 1998). The NHEJ pathway o f DSB repair is 
active throughout the cell cycle, including late S and G2 (Takata et al, 1998). Hence 
NHEJ is thought to repair the majority of DSBs in mammalian cells.
1.5.1 Homologous Recombination (HR)
HR involves the use of a homologous, undamaged partner molecule, for example a 
sister chromatid, and is therefore relatively error free. The DNA transactions o f HR can 
be divided into three basic steps: 1) pre-synapsis, preparation of a recombination 
proficient DNA end; 2) synapsis, formation of a joint molecule between the
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recombination proficient DNA end and a double-stranded homologous template; 3) 
post-synapsis and resolution, repair o f DNA strands and separation o f the recombined 
DNA molecules (figure 1 -6).
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Figure 1-6: Schematic representation of Homologous Recombination (HR) repair of a 
DSB. Duplex DNAs are indicated by ladders with the rungs representing base pairs. Pre­
synapsis consists of stages A-C. The damaged DNA molecule is nucleolytically processed to 
result in 3' single-stranded tails. The white duplex DNA molecule represents a homologous 
DNA molecule such as a sister chromatid. Synapsis, comprised o f stages D and E, involves the 
formation o f a joint molecule between the processed broken DNA and the intact homologous 
template using the strand invasion and exchange properties o f the Rad51 protein. Post-synapsis, 
stages E-G. Base pairs between the joint molecule and second DNA end are established, DNA 
is re-synthesised, and Holiday junctions are resolved by structure specific endonucleases. 
(Modified from Wyman et al, 2004)
The first event to occur in HR repair is the nucleolytic resection o f the DNA DSB in the 
5' to 3' direction during pre-synapsis. The efficiency o f this reaction relies upon, and 
probably involves, the Mrel 1 complex (comprised o f Mrel 1, Nbsl and Rad50). Even 
though in vitro this complex has 3' to 5' exonuclease activity, the kinetics o f the 
appearance of recombinogenic single-stranded DNA with a 3' end is significantly lower 
in Mrel 1 mutant yeast cells (Lee et al, 1998a). Nbsl was also shown to be required for
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HR in higher vertebrate cells, and the rare recombinants observed suggested the Mrel 1 
complex might be required to process recombination intermediates (Tauchi et al, 2002).
After the resection o f the DSB, the ensuing 3' single stranded tails are then bound by 
Rad51 to promote synapsing and strand invasion. This process is influenced by a range 
of other proteins, including replication protein A (RPA), Rad52 and Rad54. The RPA 
protein binds to the 3' single stranded overhang and prevents secondary structures from 
forming that might inhibit downstream repair events (Bauman et al, 1997) (Sugiyama et 
al, 1997). A side effect o f RPA binding to the overhang that needs to be overcome is 
that it hinders Rad51 from interacting with the single-stranded DNA (Sung et al, 1997). 
There is evidence that the Rad52 protein, which is able to bind both single and double 
stranded ends of DNA, overcomes this inhibitory effect, possibly by direct interaction 
with Rad51 (Benson et al, 1998) (New et al, 1998) (Parsons et al, 2000) (Sung et al, 
1997). Notably, Rad52 has been shown to preferentially bind to DSBs, leading to the 
model whereby competition between Rad52 and the NHEJ protein Ku for DNA ends 
determines which of the two DSB repair pathways is employed (Van Dyck et al, 1999). 
Therefore it is plausible that Rad52 binds to resected DNA ends, whilst RPA binds 
along the 3' single stranded overhangs. Once these initial interactions are complete, 
Rad52 then recruits and facilitates Rad51 binding to the overhang. Five Rad51 
paralogs, X-ray cross complementing (XRCC) 2, XRCC3, Rad51B, Rad51C and 
Rad51D found in vertebrates, that dimerise to form distinct complexes, have also been 
proposed as mediators o f presynaptic filament assembly, and are likely to have a role in 
the delivery of Rad51 to recombination substrates (Sung et al, 2003). In addition, the 
results o f diverse in vitro assays can support roles for Rad54 at all three stages o f HR, 
including presynaptic filament assembly.
The Rad51 nucleoprotein filament then interacts with an undamaged DNA molecule 
and, when a homologous region has been located, Rad51 catalises strand-exchange 
events in which the damaged molecule invades the other DNA duplex, displacing one 
strand as a D-loop (figure 1-6, stage D). Rad54 appears to be crucial for this step. 
Although Rad 51 has only a modest ability to make a D-loop, addition o f a catalytic 
amount o f Rad54 renders D-loop formation highly robust (Symington et al, 2002) 
(Krejci et al, 2003) (Petukhova et al, 1998). Rad54 uses the free energy from ATP 
hydrolysis to fuel its translocation along duplex DNA, leading to the transient opening 
of DNA strands (Van Komen et al, 2000). It is thought this facilitates the location of
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homologous sequences and the extension o f heteroduplex DNA in the joint molecule. 
At this point the 3' terminus of the damaged DNA molecule is extended by a DNA 
polymerase that copies information from the undamaged partner, and the ends are 
ligated by DNA ligase I.
Table 1-1: Proteins implicated in the different stages of HR
Stage of HR Process mediated Proteins
Pre-synapsis (A-C) Endprocessing M rell complex
Negotiating single stranded DNA RPA
Recombinase loading Rad52, Rad51 paralogs,
Rad54
Synapsis (D, E) Joint molecule formation by strand invasion Rad51, Rad54
Post-synapsis (F, G) Branch migration Rad54
Resolution of crossed DNA ends Not defined
Repair of DSBs by homologous recombination is not complete until the product DNA 
molecules are separated. Because DNA structures with crossed strands (Holliday 
junctions) are an unavoidable consequence o f homologous recombination (figure 1-6 D- 
F) they need to be resolved by structure-specific endonucleases. In the prokaryote E. 
coli the RuvA and RuvB proteins are involved in branch migration whereas the RuvC 
protein performs the resolution o f Holliday junctions (reviewed in West, 1996). These 
proteins are also capable o f performing branch migration and resolution in vitro 
(Eggleston et al, 1997). More recently, a mammalian protein complex was identified, 
which is able to perform both branch migration and resolution of Holliday junctions in a 
manner that is homologous to the RuvABC system of E. coli (Constantinou et al, 2001). 
Further work is required to establish the identities o f the components o f this complex, 
and to investigate whether it is required for HR.
Strong links have been established between HR and the breast cancer susceptibility 
proteins, BRCA1 and BRCA2 in mammalian cells. Cells that are deficient for either 
BRCA1 or BRCA2 have compromised HR suggesting a role for these proteins in this 
repair process (Moynahan et al, 1999) (Snouwaert et al, 1999) (Moynahan et al, 2001) 
(Xia et al, 2001). The function of BRCA 1 and BRCA2 might be mediated via 
interactions with Mrel 1-Rad50-Nbsl andRad51 proteins. BRCA1 interacts directly 
with Rad50 and is found in the same foci as the Mrel 1 complex following treatment
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with ionising radiation, and both BRCA1 and BRCA2 associate with Rad51 in vivo 
(Chen et al, 1998) (Scully et al, 1997) (Zhong et al, 1999). Indeed, it has been shown 
that, through its BRCT motifs, BRCA2 directly interacts with Rad51 thereby affecting 
both the nuclear localisation and DNA binding properties of Rad51 (Davies et al, 2001) 
and permitting Rad51 to form foci at sites o f DNA damage within the cell (Scully et al,
2000) (Chen et al, 1999a) (Yuan et al, 1999) BRCA1 and BRCA2 may therefore 
function in HR as protein scaffolds to co-ordinate the HR machinery, or as modulators 
of chromatin structure (Bochar et al, 2000)
There is evidence that proteins that are involved in the signaling o f DNA damage might 
regulate HR by means of Rad51. For example, work in the chicken DT40 system has 
shown genetically that ATM functions, at least in part, by affecting the HR pathway 
(Morrison et al, 2000). One mechanism by which this regulation might take place is 
through the protein kinase c-Abl. In response to ionising radiation, ATM interacts with, 
and activates c-Abl (Baskaran et al, 1997) (Shafman et al, 1997). Once activated, c-Abl 
phosphorylates Rad51, a modification that enhances Rad51-Rad52 interaction (Chen et 
al, 1999b). The Rad51 and Rad52 interaction following treatment with ionising 
radiation is impaired in both ATM and c-Abl deficient cells, and in human cells the 
ATM, c-Abl and Rad51 can be co-immunoprecipitated (Chen et al, 1999b). These 
findings suggest that following DNA damage by ionising radiation, the ATM protein 
activates c-Abl, which in turn, facilitates Rad51-Rad52 interaction by phosphorylating 
Rad51. In addition ATM directly phosphorylates Nbsl (Lim et al, 2000) and BRCA1 
(Cortez et al, 1999) (Gatei et al, 2000) in response to DSBs, modifications that may be 
important for the regulation o f HR, and the phosphorylation of H2AX by ATM (Burma 
et al, 2001) is thought to modulate chromatin structure to allow access o f both the HR 
and NHEJ repair complexes.
1.5.2 Non Homologous End Joining (NHEJ)
As mentioned above NHEJ is the predominant repair pathway for DNA DSBs in higher 
eukaryotes. Since the chemical configuration of both pathologic and physiologic DNA 
DSBs is highly diverse, this key vertebrate repair pathway needs to be able to handle the 
varied chemical nature of these lesions. This is achieved because the proteins and 
enzymes involved in NHEJ recognise DNA ends based on their structure rather than on 
their sequence. This theme is illustrated throughout the mechanistic steps o f NHEJ 
(figure 1-7).
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Figure 1-7: Non Homologous End Joining (NHEJ), the predom inant DSB repair pathway 
in vertebrate cells. DSB ends are first recognised by the Ku heterodimer, which then recruits 
the DNA-PK-Artemis complex. To allow subsequent repair steps to proceed the two ends must 
be held in close proximity. This step is referred to as synapsis and evidence suggests this is 
performed by two DNA-PKcs molecules. For complex (incompatible) DNA ends, as would be 
generated by ionising radiation, there is often need for nucleolytic processing. This is carried 
out by the Artemis-DNAPKcs complex, and the P-lactamase domain of Artemis is essential for 
this nuclease activity. End processing may also involve the filling in of gaps by polymerases. 
Ligation is the final step in NHEJ, and is performed by the XRCC4-ligase IV complex. A 
simpler pathway that involves only Ku and the XRCC4-LigaseIV complex may occur at blunt 
or compatible ends that do not require a nuclease or polymerase. (Modified from Lieber et al,
2004)
The first stage in NHEJ repair is therefore recognition of the DNA break. Although the 
identity of the initial sensor protein that functions to activate ATM at DSB sites in the 
signaling response is only just beginning to emerge, the initial sensor for NHEJ repair 
has been known for some time. The Ku protein is central to NHEJ in organisms from 
yeast to man, and binds to the two DNA ends of a DSB. Ku is a heterodimer of two 
subunits called Ku70 (~69 kDa in man) and Ku80 (~83 kDa in man, also called Ku86) 
(Critchlow and Jackson, 1998) (Lieber, 1999) (Smith and Jackson, 1999). It has been 
established that Ku binds to DNA in a non-sequence-dependent manner that relies on 
DNA DSBs (Dynan et al, 1998). Once loaded onto a DNA terminus, Ku can diffuse to 
internal positions (de Vries et al, 1989) (Yaneva et al, 1997). The crystal structure for 
Ku reveals a form that is ideally suited to its function and biochemical properties 
(Walker et al, 2001). A 20 A hole through the center of Ku seems to permit it to thread
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onto any DNA end in a sequence independent manner, and this toroidal structure 
explains why Ku cannot dissociate from a linear DNA molecule that has been 
circularized, since the Ku protein dose not have an end at which to exit. Functional 
studies suggest that long single-stranded arms projecting off both strands at the DNA 
end (a pseudo-Y) are not an impediment to Ku (Falzon et al, 1993). It may therefore be 
the case that Ku threads onto only one of the strands of such a pseudo-Y DNA end, and 
this may be understandable considering the action of the nuclease that functions to 
process DSB termini before ligation.
In vertebrates, Ku serves as the DNA targeting subunit of the DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs), which together with Ku forms the DNA-PK 
holoenzyme (Smith and Jackson, 1999). DNA-PKcs is a 469 kDa polypeptide, the c- 
terminal region of which has homology to the catalytic domains of proteins o f the PI-3 
kinase family, such as the ATM protein kinase described earlier (Hartley et al, 1995). It 
is believed that Ku first binds to the DNA end, translocates inwards by one helical turn, 
and then recruits DNA-PKcs and stabilises its binding to DNA. Once bound to DNA 
ends, DNA-PKcs itself can tether the broken DNA ends together in a synaptic complex 
containing two DNA-PKcs molecules (Cary et al, 1997) (DeFazio et al, 2002). 
Therefore, one function o f DNA-PK in DSB repair may be to bridge the broken ends to 
facilitate rejoining. The other function o f DNA-PK is to recruit, and, perhaps, activate 
proteins involved in DNA-end processing and ligation. This is likely to involve the 
kinase activity of DNA-PK, which appears to be activated by an interaction with a 
single stranded region derived from a DSB that may arise from ‘breathing’ o f the DNA 
end (Hammarsten et al, 2000) (Martensson et al, 2002).
Pathological and physiological DSBs usually result in incompatible ends, therefore 
rejoining typically requires nuclease activity to remove several nucleotides prior to 
rejoining. This is believed to be performed by the Artemis protein (Moshous et al,
2001), which is a target for phosphorylation by DNA-PK (Ma et al, 2002). Within 
eukaryotic cells, some fraction of Artemis and DNA-PKcs molecules are bound to each 
other in a very stable complex, and therefore Artemis is presumably localised to DSB 
sites along with DNA-PKcs. Artemis has nuclease activity that is limited to 5' 
exonuclease activity in the absence of DNA-PKcs. However, once bound to a DNA 
end, DNA-PKcs phosphorylates itself and Artemis (Ma et al, 2002), and one o f these 
targets (or perhaps both) permits the Artemis-DNA-PK complex to function as an
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endonuclease, allowing it to cleave both 5' and 3' overhangs of any length (Ma et al,
2002). Since mutations of Artemis in its p-lactamase fold abolish endonuclease 
activity, this region may be at least partly responsible for the nuclease activity. The 
Artemis-DNA-PKcs complex is also very efficient at opening DNA hairpins, which is 
extremely important in the context o f V(D)J recombination during lymphocyte 
development. Blunt or compatible DNA ends, such as the signal ends generated during 
V(D)J recombination, may not require nuclease processing and could therefore be 
repaired independently o f Artemis-DNA-PK. Given that pathologic sources o f DSBs 
(such as ionising radiation) are thought to induce multiple local sites o f oxidative 
damage to bases and sugar moieties (Nikjoo et al, 2001), it is assumed that the nuclease 
activity of Artemis-DNA-PK is required for the repair of a significant amount these 
lesions. Consistent with this model, recent work has confirmed that Artemis deficient 
cells are unable to repair a subset o f radiation-induced DSBs, and this defect is 
enhanced by agents that induce relatively high levels of complex DSBs (Riballo et al,
2004). Furthermore, ATM was shown to phosphorylate Artemis and function in a 
common DSB repair pathway, which may explain the elevated level o f residual DSBs 
observed in AT cells after irradiation (Comforth and Bedford, 1985) (Foray et al, 1997). 
H2AX, 53BP1 and the Mrel 1 complex were also required for this ATM dependent 
rejoining (Riballo et al, 2004) suggesting these proteins may have important adaptor 
functions in certain NHEJ events.
Recent work has suggested that certain polymerases may function at this stage o f NHEJ 
to allow gaps to be filled in where microhomologies exist between the two DNA ends. 
However, NHEJ mechanistic schemes that do not require a polymerase for at least some 
NHEJ events could be proposed. For example, the Artemis-DNA-PK nuclease activity 
could simply resect the two DNA ends until they were compatible as blunt ends or with 
one- or two-nucleotide compatible overhangs. One study in mammalian cells has 
shown that when Ku and the XRCC4-Ligase IV complex, which performs the final 
ligation step of NHEJ (Li et al, 1995) (Critchlow et al, 1997) (Grawunder et al, 1997), 
are bound at a DNA end, then polymerase p is recruited (Mahajan et al, 2002).
Although the polymerase p knockout mouse and cells from it are not sensitive to IR 
(Bertocci et al, 2002), slightly shortened coding ends at the kappa light chain junctions 
were observed in lymphocytes suggesting somewhat abnormal V(D)J recombination 
(Bertocci et al, 2003). Immunodepletion of polymerase X from human crude extracts 
has been used in support of the possibility that this polymerase is also involved in NHEJ
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(Lee et al, 2004b). Recently, NHEJ reactions reconstituted in vitro have shown that 
polymerases p and X can bind Ku and function in certain NHEJ events (Ma et al, 2004). 
Some NHEJ reactions are therefore likely to use a polymerase prior to ligation where 
appropriate, but this does not to appear to be essential for NHEJ per se.
Once the DSB has been processed into a form suitable for rejoining, Artemis-DNA- 
PKcs may dissociate from the Ku-DNA complex to permit the ligation step o f NHEJ by 
the XRCC4-Ligase IV complex. This rearrangement process may involve 
autophosphorylation o f DNA-PKcs, since there is evidence that this modification 
regulates its binding to DNA, and this activity is required for DSB rejoining (Chan et al, 
1996) (Merkle et al, 2002) (Ding et al, 2003) (Block et al, 2004) (Reddy et al, 2004). 
Recently, Mdcl was implicated in NHEJ since it was shown to regulate DNA-PK 
autophosphorylation activity (Lou et al, 2004). DNA-PK also phosphorylates XRCC4 
in vitro and IR induced phosphorylation o f XRCC4 is dependent on DNA-PKcs in vivo 
(Leber et al, 1998) (Matsumoto et al, 2000), although it is not clear what significance 
this modification has since it does not seem to be required for efficient rejoining 
(Mizuta et al, 1997) (Grawunder et al, 1998) (Leber et al, 1998). Although the 
XRCC4-Ligase IV complex does not seem to form a stable complex with DNA, it does 
so with a Ku-DNA complex (Chen et al, 2000). The Ku protein has been shown to load 
the XRCC4-Ligase IV complex onto DNA ends and stimulate DNA end ligation 
(Ramsden and Gellert, 1998) (Nick McElhinny et al, 2000). Endogenously the 
XRCC4-Ligase IV complex exists in a pre-adenylated form. Recruitment o f the 
XRCC4-Ligase IV complex causes inward translocation of Ku, allowing the AMP 
moiety of the ligase-adenylate complex to transiently attach to the DNA end promoting 
ligation (Kysela et al, 2003). The XRCC4 protein appears to function by stabilising and 
enhancing the activity o f Ligase IV (Grawunder et al, 1997) (Grawunder et al, 1998), 
and evidence exists in lower eukaryotes that XRCC4 may also help target Ligase IV to 
DSB sites (Teo et al, 2000). Recently the high molecular weight protein AHNAK, that 
is under-expressed in many radiosensitive neuroblastoma cell lines, was shown to 
interact with the XRCC4-Ligase IV complex and stimulate DNA end joining (Stiff et al, 
2004b). AHNAK was also able to link two DNA molecules, suggesting that this protein 
may have a role in the synapsis of DNA ends during the ligation phase o f NHEJ.
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1.5.3 Regulation of DSB repair
Whereas HR is restricted to the certain phases of the cell cycle and may be regulated by 
cellular signalling mechanisms (described above), the NHEJ system is ideally 
configured to be the constitutive pathway of DSB repair. If the density o f Ku protein in 
a typical nucleus is calculated and a random distribution is assumed, then the average 
distance between two Ku molecules is only 4-6 times the Ku diameter (Lieber et al,
2003). Any Ku molecule is therefore only 4-6 diameters from any potential DSB, so 
early DSB detection by Ku is unlikely to be a rate-limiting step, especially given the 
high affinity of Ku for DNA ends. Elimination of Ku has been reported to result in 
increased HR, which suggested that there was competition between these two pathways 
(Adachi et al, 2001) (Fukushima et al, 2001) (Pierce et al, 2001). In this situation 
defects in the XRCC4-Ligase IV complex should not stimulate HR since Ku would still 
be able to recruit DSBs for NHEJ, but HR was found to be increased in mammalian 
cells with mutations in XRCC4 (Delacote et al, 2002). This has led to the proposal that 
NHEJ is the initial pathway that is attempted and, if  this fails, HR might take over. This 
process would be restricted to the late S- or G2-phases of the cell cycle, when HR is 
active.
1.5.4 V(D)J recombination and DSB repair
In vertebrates the adaptive immune system depends on the generation o f a vast 
repertoire of soluble and membrane bound antigen receptors expressed in B 
lymphocytes and T lymphocytes respectively. The variable regions o f immunoglobulin 
(Ig) and T-cell receptor (TCR) chains directly bind foreign antigen, and are encoded by 
a modest number of gene segments. During early B and T lymphocyte development 
immunological diversity is achieved through a series o f programmed DNA 
rearrangements, termed V(D)J recombination, where germline variable (V), diversity 
(D) and joining (J) gene segments are rearranged to code for a highly diverse repertoire 
of Ig and TCR variable regions (reviewed in Bassing et al, 2002a). TCR P and 5 chain 
and Ig heavy chain (IgH) variable region exons are assembled from V, D and J 
segments, while TCR a  and y chains and Ig light chain variable region exons are 
assembled from just V and J segments. This developmental process involves the 
programmed induction of DSBs between V, D and J (coding) sequences and flanking 
recombination signal sequences (RSS) by the recombination activating gene (RAG) 1 
and RAG2 proteins. RAG proteins are expressed only in lymphoid progenitors and the
47
cell cycle expression profile of RAG2 serves to restrict introduction o f RAG generated 
DSBs to the G1 phase o f the cell cycle (Lee et al, 1999). The RAG generated ends are 
then joined in a new configuration by the NHEJ DSB repair proteins to complete V(D)J 
recombination.
The molecular steps through which RAG introduces DSBs between coding and RSS 
have been extensively characterised in vitro (reviewed in Fugmann et al, 2000) (Gellert 
et al, 2002). The DNA cleavage phase begins when the RAG-1, RAG-2 and HMG1 
proteins form a complex that binds at the RSS (depicted as triangles, figure 1-8) 
adjacent to each V, D or J element (depicted as rectangles). The RAG complex nicks 
the DNA at each o f the RSS. RSS are composed o f highly conserved heptamers and 
nonamers separated by either 12 or 23 bp spacers. One nicked 12-signal (next to a V 
segment, for example, at the kappa light chain gene locus) and one nicked 23-signal 
(next to a J segment at the J segment o f the kappa light chain locus) are brought into 
synapsis by the RAG complex (figure 1-8). In a subsequent reaction step, RAG then 
catalyses a trans-esterification reaction in which the coding strand 3'OH attacks the 
opposite coding strand to form sealed DNA hairpin coding ends and recombination 
signal (RS) ends in the form of blunt, 5' phosphorylated DSBs (McBlane et al, 1995) 
(van Gent et al, 1995).
The four RAG liberated DNA ends remain associated with RAG in a stable 
postcleavage synaptic complex (PSC), and RAG, in the context o f this complex, appears 
be important for directing the joining phase o f the reaction (Qiu et al, 2001) (Yamell 
Schultz et al, 2001) (Tsai et al, 2002). At this stage the RAG proteins may be involved 
in recruiting NHEJ factors and in holding the broken ends in close proximity. The Ku 
protein is presumed to bind some or all o f the four DNA ends, perhaps thereby 
displacing the RAG complex to allow DNA repair proteins to gain access, since 
retention of signal sequences within the signal complex has been shown to prevent their 
joining by the XRCC4-Ligase IV complex (Jones and Gellert, 2001). The Artemis- 
DNA-PKcs complex, recruited to the coding ends by Ku, opens the hairpinned V, D or J 
ends (Ma et al, 2002). The Artemis-DNA-PK complex then acts as an endonuclease 
(and perhaps Artemis acts as an exonuclease) to trim the V, D or J ends to variable 
extents, thereby contributing to junctional diversity (Ma et al, 2002). A template 
dependent polymerase, such as polymerase p, may then fill in the gaps. At this stage 
terminal deoxynucleotide transferase (TdT), which is expressed in B- and T- cell
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lymphoid progenitors, is recruited to coding ends in a process that probably involves Ku 
(Purugganan et al, 2001) (Sandor et al, 2004). TdT is then responsible for template- 
independent DNA synthesis, which markedly contributes to the junctional diversity at 
the coding end. Finally, the XRCC4-Ligase IV complex carries out the ligation of the 
two ends (Figure 1 -8).
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Figure 1-8: Mechanism of the V(D)J recom bination reaction. RAG1, RAG2, and HMG1 
form a complex that binds recombination signal sequences (RSS). The RAG complex creates a 
nick adjacent to the coding end side of each RSS, and the two nicked species are brought into 
synapsis. The RAG complex then catalyses a trans-esterification reaction to create hairpinned 
coding ends at the end of the V, D or J ends. Ku binds to the coding ends and recruits Artemis- 
DNA-PKcs which opens the hairpins. TdT then conducts template-independent DNA synthesis 
to increase coding join diversity. Ku also binds to signal ends, and the XRCC4-Ligase 4 
complex is recruited to complete the end joining reaction for both coding and signal ends. 
(Modified from Bassing and Alt, 2004)
The signal ends are also rejoined by the XRCC4-Ligase IV complex (Bassing et al, 
2002a), and whereas Ku is absolutely required for this, possibly to recruit the ligase 
complex, DNA-PKcs-Artemis is dispensable for this reaction. Thus, while DNA-PKcs 
mice are essentially completely defective for ability to join coding ends, they are 
relatively unimpaired in their ability to generate signal joins (Gao et al, 1998) (Taccioli 
et al, 1998). This may be because blunt ends do not require nucleolytic processing and,
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hence, Ku and XRCC4-Ligase IV may be sufficient. Consistent with this model, 
Artemis deficient mice and humans display a similar molecular phenotype to DNA- 
PKcs mutants, being blocked for coding joint formation, but showing normal signal 
joining (Moshous et al, 2001) (Rooney et al, 2002). However, while Artemis appears to 
have no role in signal end joining, DNA-PKcs deficiency does have variable effects on 
this reaction, particularly with respect to fidelity (Bogue et al, 1998) (Fukumura et al,
2000) indicating a non-Artemis dependent role for DNA-PKcs in V(D)J end joining.
As discussed above this may involve tethering the broken DNA ends together (Cary et 
al, 1997) (DeFazio et al, 2002). Overall, the roles of Ku, XRCC4 and Ligase IV 
compared to DNA-PKcs and Artemis in V(D)J recombination are consistent with the 
model that the latter two proteins function, at least predominantly, in the subset o f  
NHEJ reactions that require DSB end processing.
1.6 DNA damage response defects and human 
immunodeficiency
The fact that DSBs arise as intermediates during immune development and damage 
response mechanisms, particularly the NHEJ pathway, are exploited to effect 
rearrangements at the break sites suggests that defects in these mechanisms may 
contribute to human immunodeficiency. Cells from such an individual would be 
sensitive to IR since the repair o f exogenous DSBs would also be compromised.
Indeed, immunodeficient patients that display cellular radiosensitivity have been 
described with mutations in proteins that function in the NHEJ pathway o f DSB repair. 
As expected, cells from these patients were also impaired in their ability to perform 
V(D)J recombination. Other DNA damage response defects do not necessarily impinge 
on the ability to conduct V(D)J recombination (Table 1-2). Ataxia telangiectasia (AT), 
resulting from mutations in the ATM transducing kinase, is an autosomal recessive 
disorder characterised by diverse clinical symptoms including immunodeficiency.
Whilst AT patients are proficient in V(D)J recombination, cells from these patients are 
severely radiosensitive and have defects in checkpoint activation. Similar to AT, 
Nijmegen Breakage Syndrome (NBS) and AT like disorder (ATLD), resulting from 
defects in the Mrel 1 complex, are also disorders that do not directly affect V(D)J 
recombination, but result in clinical immunodeficiency and cellular radiosensitivity 
associated with checkpoint defects. In addition to the described defects in NHEJ and 
DSB signaling, other individuals have been described that do not appear to fall into
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either category. Despite being immunodeficient and radiosensitive, these patients 
display normal levels o f V(D)J recombination and activate checkpoints efficiently. 
These patients may have defects that affect the DNA damage assessment process, where 
an inappropriate cell survival outcome, such as permanent arrest or apoptosis, results 
from only a modest level o f damage (Table 1-2).
Table 1-2: Proposed DNA DSB response defects that result in immunodeficiency
Human
Disorder
Mutant
protein
Immune phenotype Defective DSB 
Response
Cellular phenotype
AT ATM Variable
immunodeficiency
DSB signalling 
& repair
Checkpoint and repair defects
NBS
ATLD
Nbsl
Mrell
Variable
immunodeficiency 
Mild variable 
immunodeficiency
DSB signalling 
& repair Checkpoint and repair defects
LIG4 syndrome 
Artemis defect
Ligase IV 
Artemis
Pancytopenia
SCID
NHEJ repair Repair defect, checkpoints normal
Not classified Survival
effector
Pancytopenia Survival
assessment
Increased senescence, apoptosis. 
Normal repair
1.6.1 Ataxia Telangiectasia (AT)
Ataxia telangiectasia (AT) was one o f the first recognised disorders in which 
immunodeficiency was associated with an abnormal response to DNA damage (Taylor 
et al, 1975). AT is characterized by diverse clinical features including 
immunodeficiency, progressive cerebellar ataxia, oculocutaneous telangiectasies, 
clinical radiosensitivity, chromosome instability and elevated risk o f lymphoid 
malignancy (Jorgensen et al, 1996) (Taylor et al, 1996). The immunodeficiency 
associated with AT involves cellular and humoral impairment, but clinical 
manifestations are extremely variable ranging from normal to profoundly reduced 
responses to bacterial antigens (Shiloh et al, 1997). Sinopulmonary infection is 
common and lymphopaenia has been described. Low or absent IgA, IgE or IgG 
subclasses are also commonly observed suggesting an impairment o f B cell maturation.
The mutations found in ATM patients are frequently truncations resulting in 
inactivation of protein function (Savitsky et a l, 1995). The wide range o f clinical
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characteristics associated with AT is reflected at the cellular level with a pleiotropic 
phenotype (Jorgensen et al, 1996) (Taylor et al, 1996) (Rotman and Shiloh, 1998). AT 
cells display severe y-radiation sensitivity associated with defects in cell cycle 
checkpoint control including an inability to arrest at the Gl/S and S-phase checkpoints 
and, for cells in G2 at the time o f irradiation, an impaired G2/M arrest (Beamish and 
Lavin, 1994) (Houldsworth and Lavin, 1980) (Kastan et al, 1992) (Painter et al, 1980). 
Furthermore AT cells fail to stabilise p53 after radiation exposure (Khanna et al, 1995) 
(Lu and Lane, 1993) an event that is required for efficient Gl/S arrest. The severe 
radiosensitivity observed in AT cell lines had thus been attributed to the failure to arrest 
the cell cycle in the face o f high levels of DNA damage, but the fact that p53 defective 
cells lines, which are also unable to arrest at the G1 checkpoint, are radioresistant rather 
than radiosensitive suggests that absence o f this checkpoint, at least, does not confer 
radiosensitivity (Slichenmyer et al, 1993). Radio sensitivity has also been observed in 
non-dividing AT cells (Thacker et al, 1994) which indicates that defective checkpoints 
are not solely responsible for this radiosensitive phenotype.
There is increasing evidence that AT cells also harbor a significant defect in DSB repair 
and this contributes to the radiosensitive phenotype. It has long been known that 
although the initial rate at which arrested AT cells repair radiation induced-DSBs is 
normal, they retain a higher level o f residual breaks than control cells (Comforth and 
Bedford, 1985) (Foray et al, 1997). This finding was confirmed by monitoring the 
removal o f y-H2AX foci, a marker o f DSBs, and at prolonged repair times the defect in 
AT cells was more pronounced than that o f Ligase IV mutant cells (Kuhne et al, 2004) 
(Riballo et al, 2004). This suggests that, similar to Artemis, ATM is required for the 
repair of a subset of DSBs. Other work has shown that ATM is important for the 
control of HR DSB repair (Morrison et al, 2000), and a recent study using glioma cells 
indicates that this regulation occurs throughout the cell cycle (Golding et al, 2004). 
Defects in HR may therefore contribute to the inherent chromosomal instability 
associated with AT.
AT cells are able to carry out V(D)J recombination using a cell based assay (Hsieh et al, 
1993). Nevertheless, AT patients show frequent translocations that involve the V(D)J 
loci (Shiloh et al, 1997). One explanation for this may be that although the efficiency 
of DSB rejoining is only marginally affected, the fidelity of repair is significantly 
compromised. Consistent with this are findings that AT cells are impaired in the
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fidelity of DSB rejoining (Cox et al, 1986) (North et al, 1990). This function may be 
coupled to the recently described role o f ATM in the routine surveillance o f  
intermediates o f V(D)J recombination (Perkins et al, 2002), which may help to suppress 
potentially oncogenic translocations when repair fails. It has also been suggested ATM 
may be required to halt the cell cycle in G1 until V(D)J recombination is complete 
(Rotman and Shiloh, 1998). Therefore, although the heterogeneous immunodeficiency 
observed in AT does not appear to result from a specific defect in V(D)J recombination, 
ATM may have an ill defined regulatory role that could influence DSB repair to some 
extent.
1.6.2 AT-Like Disorder (ATLD) and Nijmegen Breakage Syndrome (NBS)
AT-Like Disorder (ATLD) and Nijmegen Breakage Syndrome (NBS) are conditions 
resulting from defects in the Mrel 1 complex, caused by mutations in the Mrel 1 and 
Nbsl proteins respectively. The clinical features o f patients with ATLD are very 
comparable to those o f AT, with the clearest similarity being the progressive cerebellar 
ataxia shown in both cases. In contrast to AT, however, ATLD patients show no 
telangiectasia, and the slower progression o f the disorder gives the overall appearance 
of a milder condition than AT (Taylor et al, 2004). These similarities suggest that the 
Mrel 1 complex and ATM function in the same pathway, but NBS patients have very 
different clinical features involving pronounced developmental delay in contrast to the 
progressive neurological impairment seen in AT and ATLD (Shiloh et al, 1997)
(Stewart et al, 1999). Both ATLD and NBS patients show a measurable 
immunodeficiency, although NBS is more comparable to AT in this respect, displaying 
humoral and cellular abnormalities associated with a more severe immunodeficient 
phenotype than observed in ATLD (Jeggo and Concannon, 2001).
An explanation for the different clinical symptoms observed in NBS compared to 
ATLD may be the result of the mutational change in the respective proteins, or could be 
that the components of the Mrel 1 complex have some distinct functions. The roles of  
the individual Mrel 1 complex proteins is difficult to decipher since the mutations in 
NBS and ATLD cells result in global effects on the Mrel 1 complex. However, a recent 
study using Mrel 1/Rad50 that is able to locate to the nucleus in the absence o f Nbsl 
(nuclear localisation of the Mrel 1 complex is thought to be one o f the main functions of 
Nbsl) has suggested some distinct roles for Mrel 1 complex components. Whereas only
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Mrel 1 and Rad50 were required for ATM activation early after low doses o f irradiation, 
the entire Mrel 1 complex is required for certain ATM-dependent phosphorylation 
events later after irradiation (Cerosaletti et al, 2004). At the cellular level both disorders 
exhibit hypersensitivity to ionising radiation, measured chromosomally and by cell 
survival (Stewart et al, 1999) (Varon et al, 1998). Radiation-induced 
autophosphorylation o f ATM, which is a measure of ATM activation, is impaired in 
both cases (Delia et al, 2004) (Horejsi et al, 2004), possibly reflecting mutations that 
affect the entire Mrel 1 complex. The downstream radiation-induced phosphorylation 
of p53 has been reported as both normal (Jongmans et al, 1997) (Stewart et al, 1999) 
(Lim et al, 2000) and defective (Delia et al, 2004), but theses discrepancies may be due 
to different dosing regimes. After higher levels o f irradiation other DSB responsive 
pathways may compensate for the underlying defects. Indeed, a dose dependent Gl/S  
checkpoint defect has been defined in NBS cells after low doses of radiation (Girard et 
al, 2002), and ATLD cells have also been associated with an abrogated G1 arrest (Delia 
et al, 2004). Cells from patients with both disorders are certainly defective in S-phase 
checkpoint arrest, and display RDS (Painter and Young, 1980) (Stewart et al, 1999) 
although this is not as severe as that observed in AT cells, because o f a parallel ATM- 
dependent, Nbsl-independent S-phase checkpoint pathway (Falck et al, 2002).
Comparable to AT cells, the radiosensitivity of NBS cells does not consistently 
correlate with checkpoint deficiencies, and may involve a defect in DSB repair. An 
immortalized NBS fibroblast line (347BR) with near normal checkpoints demonstrated 
severe sensitivity to radiation (Girard et al, 2000), and this line displayed an elevated 
level of residual breaks similar to that observed in AT cells. This repair defect does not 
affect the overall rate o f DSB repair in human cells (Kraakman-van der Zwet, et al 
1999), but may impair the resolution o f a subset o f DSBs (Riballo et al, 2004). Since 
the Mrel 1 complex is required for efficient HR repair (Yamaguchi-Iwai, et al, 1999), a 
defect in this pathway may contribute to the repair deficiency of this line. NBS cells are 
proficient in V(D)J recombination (Yeo et al, 2000), suggesting the Mrel 1 complex is 
not essential for V(D)J recombination associated DSB repair. This may not be the case 
for other immune specific processes involving NHEJ repair. Class Switch 
Recombination (CSR) is a process whereby B-lymphocytes replace the immunoglobulin 
Cp constant region with the constant region of another immunoglobulin, and involves 
the NHEJ pathway of DSB repair. Whereas CSR involves Ku (Manis et al, 1998), 
DNA-PKcs does not appear to be essential (Bosma et al, 2002). The immunodeficiency
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observed in NBS patients has recently been linked to a defect CSR (van Engelen et al,
2001), and a recent study suggests a similar deficit exists in ATLD patients 
(Lahdesmaki et al, 2004). Since ATM has also been implicated in CSR (Pan et al,
2002) (Lahdesmaki et al, 2004), ATM and the Mrel 1 complex may be involved in 
NHEJ during CSR, a process that is independent o f DNA-PKcs. Defective CSR may 
therefore contribute to the immunodeficient phenotypes of AT, ATLD and NBS.
1.6.3 LIG4 syndrome
Mutations in the Ligase IV DSB repair gene have been reported in five patients. One 
patient, designated 180BR, was clinically normal but developed leukaemia at age 14 
and dramatically over-responded to subsequent chemotherapy (Riballo et al, 1999).
The remaining patients all displayed pancytopenia as well as additional features that 
include microcephaly and developmental delay (O’Driscoll et al, 2001). The patients 
also show facial features that have been described as “bird-like”, “Seckel-like” or more 
simply “characteristic facial features” (O’Driscoll et al, 2004), and 2 o f the patients 
displayed telangiectasies, a clinical feature that overlaps with AT.
Given that Ligase IV is essential for V(D)J recombination, a T-B- Severe Combined 
Immunodeficient (SCID) phenotype may be expected in patients with Ligase IV 
defects, but these patients display a milder form of pancytopenia reminiscent o f NBS. 
Mice with inactivating mutations in Ligase IV are embryonic lethal (Barnes et al, 1998) 
(Frank et al, 2000). Thus, the mutations identified in Ligase IV patients are anticipated 
to be hypomorphic, generating expressed proteins that retain some residual function. 
Indeed, the mutations identified were either missense mutations or small truncations. 
The published Ligase IV mutations include a R278H substitution in the catalytic site 
and a G469E missense as well as two nonsense mutations (R580X and R814X) (Riballo 
et al, 1999) (O’Driscoll et al, 2001). These mutations lead to C-terminus truncation of 
the protein in the region containing the two BRCT motifs, previously shown to be 
required for the proper interaction with XRCC4 (Grawunder et al, 1998) (Sibanda et al,
2001). The severity o f clinical features may reflect the impact o f the mutational change 
on protein function. Consistent with this concept, in vitro expressed Ligase IV 
harbouring the R278H mutation, identified in the clinically normal patient 180BR, 
retains a higher level of residual activity relative to proteins harbouring other mutational 
changes identified in the more severe patients (O’Driscoll et al, 2004). Another patient
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with the R278H mutation had more severe clinical features, and this was attributed to 
the presence o f 2 additional linked polymorphisms that when combined with the 
otherwise mild R278H mutation, reduced Ligase IV activity to a level observed in the 
more severely affected patients displaying immunodeficiency (Girard et al, 2004). 
Analysis o f V(D)J recombination in cells from Ligase IV patients showed that while the 
frequency of rejoining was only marginally reduced, the fidelity o f rejoining was 
dramatically impaired (O’Driscoll et al, 2001). This partially functional V(D)J 
recombination pathway may therefore be sufficiently ‘leaky’ to allow a limited amount 
of immune development to occur in these patients. The effect o f the 180BR mutation is 
apparently mild enough to allow relatively normal lymphocyte development, but the 
deficit in joining fidelity could have predisposed this patient to the development o f 
leukaemia.
In contrast to the leaky immune phenotype observed in Ligase IV syndrome, cells from 
these patients, including 180BR, show dramatic radiosensitivity and a DSB repair defect 
that is not substantially different from that observed in fully inactivated rodent cell 
lines. This may be explained if  the residual activity o f the mutant Ligase IV proteins is 
sufficient to handle the small number o f breaks that arise during V(D)J recombination 
but is insufficient to repair the much larger number o f breaks arising from exposure to 
IR. This defect in DSB repair does not impinge on checkpoint signaling pathways, 
since Ligase IV defective lines were shown to have normal Gl/S, S- and G2/M 
checkpoint function (O’Driscoll et al, 2001). Thus the radiosensitivity o f Ligase IV 
defective cells is attributed to impaired NHEJ.
1.6.4 Defects in Artemis
Amongst T-B- SCID patients identified are some who have very significant defects in 
coding joint formation but little or no impairment in the ability to join signal ends 
(Moshous et al, 2000). Immunophenotyping of bone marrow samples from 2 patients 
showed the absence of complete Vh-Jh gene rearrangements and consequently a 
complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint (Noordzij et 
al, 2003). Cells from these patients also display radiosensitivity (Nicolas et al, 1998), 
and this condition is therefore referred to as Radiosensitive (RS)-SCID. A similar T-B- 
SCID condition (referred to as SCID A) occurs with a very high incidence in inbred 
populations of Athabascan-speaking Native Americans, including Navajos and
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Apaches, and the V(D)J recombination defect in SCIDA and RS-SCID was found to be 
identical (Moshous et al, 2000). This phenotype is comparable to that described for cell 
lines defective in DNA-PKcs, raising this as a potential candidate gene. Linkage 
analysis from affected families, however, mapped the gene to a location distinct from 
DNA-PKcs on chromosome 10 (Li et al, 1998) (Moshous et al, 2000). Based on this 
localisation, the Artemis gene, the defect o f which is responsible for RS-SCID, was 
identified and cloned through in silico gene search (Moshous et al, 2001). Functional 
complementation studies and mutation analysis then confirmed that Artemis was indeed 
responsible for RS-SCID and SCIDA (Moshous et al, 2001) (Li et al, 2002a)
Most of the Artemis mutations identified in RS-SCID patients seem to represent null 
alleles, which result from genomic deletions covering several of the 5' exons or involve 
the production of severely truncated proteins (Moshous et al, 2001). These truncations 
are caused by genomic deletions or insertions, nonsense mutations in the coding region, 
or mutations in splice sites. The founder mutation identified in Athabascan-speaking 
Native Americans is a nonsense mutation predicted to result in prematurely truncated 
protein (Li et al, 2002a). Another founder mutation identified in Japanese families 
results in deletion of exon 3 (Kobayashi et al, 2003). All o f these mutations affect the 
NH2 half of Artemis encompassing the metallo-P-lactamase homology domain, which 
is thought to define the core catalytic region o f the protein (Poinsignon et al, 2004). In 
addition four missense mutations that affect this region have been described; S32C (Le 
Deist et al, 2004), G118V, G135E (Noordzij et al, 2003), and D165N (Ma et al, 2002). 
Overall these results indicate that Artemis is not essential for viability, unlike Ligase IV 
and XRCC4. Indeed, Artemis KO mice are viable and present the same phenotype of 
RS-SCID (Rooney et al, 2002).
Significantly, four patients with hypomorphic mutations in Artemis have been identified 
(Moshous et al, 2003). All of them presented with partial T and B lymphocyte 
immunodeficiency, low serum IgG, absent IgA and developed recurrent pulmonary and 
respiratory infections soon after birth. These patients exhibited truncations o f Artemis 
within the last exon, thereby leaving the metallo-P-lactamase domain intact, and this 
appeared to confer residual V(D)J recombination activity (Moshous et al, 2003).
Hence, some B and T lymphocytes could be generated. Interestingly, these patients 
have an elevated frequency o f EBV positive B cell lymphomas, which is highly 
reminiscent of the emergence o f pro-B-cell lymphomas described in NHEJ deficient
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mice when crossed onto a p53'7' background (Difilippantonio et al, 2000) (Ferguson et 
al, 2000) (Zhu et al, 2002). Artemis deficiency may therefore confer elevated cancer 
predisposition, raising the possibility that Artemis is a genome caretaker. In this context 
it is noteworthy that fibroblasts derived from Artemis deficient mice also display 
elevated chromosome instability (Rooney et al, 2002).
Although Artemis has been found to open the DNA hairpin structures that arise as 
intermediates during V(D)J recombination (Ma et al, 2002), (which explains the 
immunodeficiency observed in RS-SCID patients), the role of Artemis in the repair of 
radiation induced DSBs is less well defined. DNA hairpins are not generated by 
exposure to y-radiation or treatment with radiomimetic drugs, such as bleomycin. The 
increased radiosensitivity o f Artemis-deficient cells may be explained if  Artemis was 
required for the processing o f other types o f DNA end structures present at radiation 
induced DNA breaks. This function could include the specific 5' and 3' single stranded 
overhang nuclease activity o f Artemis in the presence o f DNA-PKcs (Ma et al, 2002), 
which could produce blunt ends, removing any associated base damage in the process, 
ready for ligation by the XRCC4-Ligase IV complex. The model whereby Artemis is 
required for the repair o f a subset o f radiation-induced DSBs has been reinforced by the 
observation that although Artemis deficient cells demonstrate a normal initial rate of 
DSB repair, an elevated level o f residual breaks is demonstrated (Riballo et al, 2004). 
The repair of simple breaks may therefore proceed unimpaired through ligation by the 
XRCC4-Ligase IV complex conferring a normal initial rate of repair, but complex 
breaks that require processing persist and hinder survival. This model is consistent with 
the unaffected formation o f signal ends during V(D)J recombination (Nicolas et al, 
1998), and one may argue that Artemis is dispensable for the DNA repair o f 5' 
phosphorylated blunt DNA termini.
1.6.5 Uncharacterised immunodeficiency -  damage assessment defects
There are a significant number o f undefined immunodeficient patients where defects in 
genes likely to be involved in damage response mechanisms are associated with some 
form of immunodeficiency, albeit frequently ill defined. Such examples include a 
patient defective in DNA ligase I (Barnes et al, 1992), a patient that appears to have a 
defect in an as yet unidentified component of the NHEJ repair machinery (Dai et al,
2003), and some uncharacterised examples that may not involve a deficiency in DNA
58
repair. Severe immunodeficiency associated with lymphopaenia that was progressive 
with age was described in two siblings, one of which (designated F96) was examined in 
more detail (Peake et al, 1999). Although, unlike other combined immunodeficiencies, 
the T cells that were present seemed to be functionally normal, they displayed increased 
levels o f spontaneous apoptosis in vitro. This prompted the investigators to examine 
factors know to promote apoptosis in lymphocytes, such as decreased expression o f the 
anti-apoptotic protein Bcl2 and abnormal death receptor signaling, but these pathways 
appeared to be functionally normal.
It then became apparent that the underlying defect did not only affect lymphocyte 
survival, but had more widespread implications. Examination of the patient’s 
fibroblasts demonstrated that although these cells did not show an increased 
susceptibility to apoptosis, they did display elevated sensitivity to y-radiation. This 
suggested that there may be defects in the response to DNA DSBs, but no deficiencies 
in DSB repair or the induction o f cell cycle checkpoints (at least one feature o f which is 
displayed by the characterised radiosensitive immunodeficient disorders described 
above) could be identified in this patient’s fibroblasts. This prompted the investigators 
to postulate this fibroblast line represented a new radiation-sensitive phenotype, in 
which radiation sensitivity is not associated with a cell cycle checkpoint defect nor a 
V(D)J recombination defect, and is not a chromosome breakage disorder.
The mutation in this patient seems to lie in a gene that influences both radiosensitivity 
and a mechanism that commits to apoptosis. A defect in the DNA damage assessment 
process involving p53 may not necessarily affect a cell’s ability to repair damage or 
initiate cell cycle checkpoints, but may still result in an inappropriate cell survival 
outcome. Lymphocytes, which are highly sensitive to DNA damage induced apoptosis, 
may be particularly influenced by this defect. This could confer an immunodeficient 
phenotype through the impaired survival of developing lymphocytes. Since fibroblasts 
are notoriously resistant to apoptosis (Dikomey et al, 1998) (Chung et al, 1998) 
(Kawabe et al, 2001) (Zhang et al, 2001a), the radiosensitivity observed in these cells 
may be conferred through a distinct mechanism. Thus, in both cell lineages there could 
be a commitment to an inappropriate cell survival outcome, and depending on cell type 
this may be apoptosis or another less well-defined mechanism such as permanent cell 
cycle arrest. Some undefined immunodeficient patients may therefore have similar
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defects in the survival assessment process after DNA damage, and further investigation 
is required characterise these potential disorders.
1.7 Statement of the problem and project strategy
The examination of cells from patients with radiosensitive immunodeficiency has 
proved to be a valuable method o f research in learning more about the DNA damage 
response and the factors that affect cell survival after irradiation. This work has 
improved our understanding o f the processes that function to promote genomic stability 
and restrain the accumulation o f mutations, cellular characteristics that are pivotal in the 
suppression of malignant transformation. A subset of undefined immunodeficient 
patients may have novel defects in the DNA damage response network similar to those 
described above and we sought to investigate this possibility. Patients were selected 
that displayed varying degrees o f pancytopenia o f unknown origin, which should 
include patients with potential DNA repair and/or survival assessment defects. Cellular 
radiosensitivity is generally determined with fibroblasts irradiated in vitro using a 
colony forming assay (Arlett et al, 1988) (Peake et al, 1999) (O’Driscoll et al, 2001) 
(Dai et al, 2003) (Kobayashi et al, 2003) (Noordzij et al, 2003). Fibroblast lines 
generated from patient skin biopsies were examined in this way in order to identify 
patients with potential radiosensitive disorders.
The generation of primary fibroblast lines and subsequent colony forming assays is a 
procedure that can take several months to complete from the initial receipt o f the skin 
biopsy. In an attempt to identify radiosensitive patients more rapidly, we also aimed to 
develop novel assays for cellular radiosensitivity that might speed up this process. 
Lymphocytes are easily isolated from whole blood, a tissue more readily obtained from 
patients than skin biopsies, and these cells display radiation-induced apoptosis after a 
matter of days (Camplejohn et al, 1995) (Hertveldt et al, 1997). We therefore 
investigated whether this endpoint could be used as a measure of intrinsic 
radiosensitivity, and where possible compared this to fibroblast radiosensitivity results. 
Another limitation of fibroblast colony forming assays is that they give no insight into 
the mechanisms that may be responsible for a radiosensitive phenotype. We were 
interested in developing novel methodology that could examine the fate o f cells that 
survive the initial genotoxic insult, but do not return to cycle to form colonies. We 
therefore investigated fibroblast division within the first week o f irradiation in normal
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and radiosensitive lines. Using this technique we further characterised the 
radiosensitive phenotype to delineate how damaged cells may be removed from the 
proliferative population, and if particular defects in the DNA damage response are 
associated with certain cell fates.
Undefined radiosensitive lines may have defects in the repair o f DNA damage and/or 
the survival assessment process. We further investigated these crucial aspects o f the 
damage response to determine if  such deficiencies were apparent in the selected 
radiosensitive lines. Examination o f chromosome damage and DNA repair after 
irradiation, in parallel with the analysis o f p53 dependent processes, concentrated our 
search for the underlying defects, which could then be related to the cell fate observed 
after irradiation. The approach taken in this study was to investigate undefined 
immunodeficient patients for potential radiosensitive disorders, and develop new 
methodologies to achieve this whilst learning more about the processes concerned. 
Through the characterisation o f radiosensitive lines we hoped to gain insight into the 
mechanisms involved in cellular radiosensitivity, identify the mutant genes responsible 
and study the wider implications o f certain defects on the cellular response to DNA 
damage.
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Chapter 2: Materials and methods
2.1 Patient selection criteria
Patients with low T and B lymphocyte function o f unknown origin and variable Natural 
Killer (NK) cell counts were selected by medical staff at Great Ormond Street Hospital. 
The decision to further investigate patients for radiosensitivity was based on expert 
clinical and scientific judgment provided by the medical staff at Great Ormond Street 
Hospital and the academic staff at the Institute o f Child Health. This involved the 
assessment of clinical parameters to decide whether the observed immunodeficiency 
was likely to result from a radiosensitive disorder based on previous experience 
described in the literature. This was intended to identify patients with either DNA 
repair or survival defects.
2.2 Generation of fibroblast cell lines and culture
Primary fibroblast lines were generated from skin biopsies from the patients. These 
were sent to the unit in the fibroblast culture medium described below. On arrival, each 
biopsy was placed in a 6 cm tissue culture dish with 1ml of fibroblast culture medium. 
As much of the fat and dermal layer was removed as possible using a scalpel, and if  
large enough the biopsy was cut in half to allow one piece to be cryo-preserved. The 
remaining tissue was cut into small fragments (lmm/2mm square) with a scalpel using a 
downward cutting action to prevent shearing o f the tissue. 5 ml of fibroblast culture 
medium was added to 2 x 25 cm2 tissue culture flasks making sure the surface area was 
completely wet, and the small pieces o f skin were transferred to the top half o f the flask 
in a slanted position so that the explants were free o f the medium. Flasks were left in 
this slanted position for approximately 48 hours in a humidified 5 % CO2 atmosphere at 
37 °C to allow the skin fragments to adhere. The flasks were then gently lowered to 
allow the medium to cover the explants, and left until there was a 1 cm diameter of cells 
around some pieces. Cells were then trypsinised, expanded and cryo-preserved.
In addition to the undefined primary fibroblast lines examined, this project utilised a 
series control and known mutant primary fibroblast lines for comparison (table 2-1).
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Table 2-1: Control and known mutant fibroblast lines used for comparison
Primary line 1BR 48BR 249BR A-T1BR CJ179 180BR
Defect Control Control Control ATM Artemis Ligase IV
Fibroblast lines were cultured in Minimal Essential Medium (Gibco Invitrogen) 
supplemented with 15% Fetal Bovine Serum (FBS) (Sigma), 0.2% sodium bicarbonate 
(Gibco Invitrogen), 2mM L-glutamine (Gibco Invitrogen), 100 U ml'1 penicillin G 
sodium and 100 pg ml'1 streptomycin sulphate using standard methods (Arlett et al, 
1983). Fibroblasts were routinely cultured in 75 cm tissue culture flasks and incubated 
in a humidified atmosphere at 37°C, 5 % CO2. Cells were split using 1 x trypsin-EDTA 
(Gibco Invitrogen) and washed in 1 x PBS (Gibco Invitrogen).
2.3 Fibroblast radiosensitivity survival assays
Fibroblasts below passage 15 in the exponentially growing phase were trypsinised, 
washed in PBS and counted using a haemocytometer followed by serial dilution. Cells 
were then subsequently irradiated with a 137Cs y-ray source at a dose rate of 0.09 Gy 
sec*1 and plated into 6 cm tissue culture dishes as described in table 2-2 in 
quadruplicate. In control and patient lines that displayed mild radiosensitivity doses up 
to 6 Gy were initially employed to extend the dose response curve, further reduce 
survival and possibly aid in classification. During this time we found doses up to 4 Gy 
were sufficient to classify radiosensitivity and this dose range was therefore used 
routinely to screen undefined patients for cellular radiosensitivity. Due to the poor 
plating efficiency of GOS5 cells, the number of cells plated for each dose was doubled 
when using this line in order to obtain a reasonable amount of colonies on the mock- 
irradiated plates.
Table 2-2: Plating numbers for the radiosensitivity survival assay
Dose (Gy) Number of cells plated per 6cm dish
0 200
1 400
2 800
4 1600
6 1600
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The cells were then incubated at 37 °C, 5 % CO2 until colonies were visible to the 
naked eye (14-21 days). 2.5 ml 1 % Methylene Blue (Sigma) staining solution was then 
added carefully to the culture medium of each plate. After 30 minutes the staining 
solution was poured off and the plates were placed upside down and dried overnight. 
The following day the plates were carefully washed in H2 O before visible colonies were 
counted. The colonies counted were well defined and contained more than 50 cells. 
Smaller, ill defined colonies were also observed that are likely to represent cells that 
ceased to divide after a certain number o f divisions. This endpoint was regarded as a 
form of clonogenic death, therefore these colonies were not included in the count o f  
surviving colonies. The plates with the mock-irradiated cells were used as a standard to 
derive plating efficiency. The cell survival was then calculated and plotted on log 
graphs.
2.4 Case reports of 10 undefined immunodeficient patients with 
cellular radiosensitivity
The case reports o f 10 undefined immunodeficient patients that demonstrated cellular 
radiosensitivity using the fibroblast survival assay are shown below.
Table 2-3: Phenotype of 10 radiosensitive patients’ lymphocytes (Data from  
clinical reports)
Patient Lymphocytes 
x109 cells/litre CD3+
Phenotype of lymphocytes % 
CD19+ CD16/56+ CD4+ CD8+
F96 1.1 54 32 58 14 38
GOS1 3.74 86 5 4 50 37
GOS3 5.32 99 0.5 0.5 75 26
GOS4 0.62 40 29 19 27 9
GOS5 1.07 70 8 10 45 21
GOS10 0.25 0.5 0.7 85 0.5 0
GOS14 0.77 54 25 20 41 12
GOS17* 0.5 72 11 20 13 59
GOS21* 1.4 78 15 6 39 39
GOS23 0.62 39 18 37 19 10
Normal Range (Child) 2-6 50-80 10-20 1-30 35-65 15-35
Normal Range (Adult) 1-3 50-80 5-20 5-30 35-65 15-35
* These patients were adults
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Case reports
F96
This patient was previously described (Peake et al, 1999). Briefly, a 4 year old boy was 
found to have Combined Immunodeficiency (CID) with recurrent infections. He was 
lymphopaenic (1.1 xlO9 cells/litre) and hypogammaglobulinaemic [IgG, 4.1 g/1 (NR for 
age, 5.3-10.1); IgA, <0.2 g/1 (NR, 0.34-0.78); IgM, 0.85 g/1 (NR, 0.54-1.06)] with no 
specific antibody responses. Lymphocyte cultures exposed to 1 Gy y-radiation showed 
30 lesions/50cells (0.6 per cell) compared with 16 lesions/40cells in control cells (0.4 
per cell).
GOS1
This patient was a 1-year-old female that presented with CID, repeated severe Varicella 
Zoster Virus (VZV) infection and later developed Hodgkin’s lymphoma. There was no 
specific response to purified protein derivative o f tuberculin and Haemophilus 
influenzae type b (Hib) vaccine. She was hypogammaglobulinaemic [IgG 2.87 g/1 (NR, 
3.1-13.8); IgA 0.27 g/1 (NR, 0.3-1.2); IgM 0.43 g/1 (NR, 0.5-2.2)] and T-cell mitogenic 
responses to phytohemagglutin (PHA) were poor. Lymphocyte numbers were normal 
(3.74 xlO9 cells/litre).
GOS3
This male infant was 2 months old at the time of this study. He had normal levels o f T- 
lymphocytes with CD4 and CD8 cells in appropriate proportions. B-lymphocytes and 
NK cells were absent. He was Hypogammaglobulinaemic [IgA 0.39 g/1 (NR, 0.7-2.5); 
IgM 0.43 (NR, 0.5-1.8)] and T-cell mitogenic responses to PHA were normal.
GOS4
This patient was a 5-month-old female who presented with severe lymphopaenia (0.62 
xlO9 cells/litre). T-cell responses to PHA were absent and immunoglobulin levels were 
normal or just below the normal range [IgG 1.46 g/1 (NR, 3.1-13.8); IgA 0.24 g/1 (NR, 
0.7-2.5); IgM 0.57 g/1 (NR, 0.5-1.8)].
GOS5
This patient was a 10-year-old boy that was diagnosed with CID. He was lymphopaenic 
(0.95 xlO9 cells/litre) and had a poor vaccine response. Immunoglobulin levels were
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not lower than normal but suggested IgA dysregulation [IgG 9.16 g/1 (NR, 3.1-13.8);
IgA 5.88 g/1 (NR, 0.7-2.5); IgM 0.53 g/1 (NR, 0.5-1.8)]. T cell mitogenic responses to 
PHA were poor. The patient subsequently had a bad response to chemotherapy used for 
pre-Bone Marrow Transplant (BMT) conditioning.
GOSIO
This patient was a 4-month-old boy from a consanguineous family who presented with a 
severe T-B-NK+ immunodeficiency. He was hypogammaglobulinaemic [IgA 0.06 g/1 
(NR, 0.7-2.5); IgM 0.05 (NR, 0.5-1.8)] and there were insufficient numbers o f T-cells to 
perform a PHA activation assay. This patient was subsequently found to have a 
homozygous Y589X mutation in the RAG1 protein.
GOS14
This patient was a 9-year-old girl that presented with CID and Cryptosporidium. She 
was severely lymphopaenic (0.45 xlO9 cells/litre), with a particular deficiency in 
Cytotoxic T Lymphocytes (CTLs) (table 4-2). There was no specific response to 
vaccine. She was hypogammaglobulinaemic with a particular deficit in IgM [IgA 0.54 
g/1 (NR, 0.7-2.5); IgM 0.06 (NR, 0.5-1.8)]. T cell mitogenic responses to PHA were 
variable.
GOS17
This patient was a dysmorphic 43-year-old male with lymphopaenia [0.5 xlO9 cells/litre 
(NR 1-3)]. He had normal levels o f immunoglobulin and suffered from extensive warts.
GOS21
This patient was a dysmorphic 20 year old male with extensive warts. Although 
absolute numbers of lymphocytes were normal, there was a low ratio o f CD4/CD8 cells. 
Immunoglobulin levels were normal.
GOS23
This patient was a 7-year-old girl diagnosed with CID. She was severely lymphopaenic 
(0.62 xlO9 cells/litre) with low T-cell numbers and exhibited developmental delay. She 
was severely hypogammaglobulinaemic [IgA 0.06 g/1 (NR, 0.5-2.7); IgM 0.08 g/1 (NR, 
0.5-1.8)] and T-cell mitogenic responses to PHA were poor. Metaphase analysis of 
chromosomes demonstrated an elevated level o f random chromosome breakage.
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Similarities amongst radiosensitive patients
Most of the patients that were found to be radiosensitive had combined 
immunodeficiency with poor responses to vaccine. Lymphopaenia was present in all 
patients that demonstrated intermediate levels of sensitivity (F96, GOS5 and GOS23), 
and four mildly sensitive patients (GOS4, GOSIO, GOS14 and GOS17). Since patient 
GOSIO was subsequently found to have a homozygous Y589X mutation in the RAG1 
protein, and this is not expected to confer a radiosensitive phenotype, the patients that 
demonstrated borderline-mild radiosensitivity may in fact represent the lower end o f the 
normal range. A severe lack o f immunoglobulin levels or function coupled with 
lymphopaenia (but normal NK cell levels) may therefore be a good biological marker of  
patients with radiosensitive immune disorders, but may also select patients with RAG 
disorders.
2.5 Lymphocyte Apoptosis
Primary blood lymphocytes (PBLs) were isolated from heparinised blood by density 
gradient centrifugation using Lymphoprep (Nycomed Pharma, Oslo, Norway). Where 
possible a control blood sample from a healthy volunteer under 30 years o f age was 
transported with the patient’s blood. An equal volume o f Phosphate buffered saline 
(PBS) was first added to fresh heparinised blood and mixed well. 2 ml o f lymphoprep 
(Nycomed) per 10 ml of blood/PBS mixture was then slowly layered underneath the 
blood/PBS mixture by placing the tip of the pipette containing the lymphoprep at the 
bottom of the sample tube. The sample was then centrifuged at 2000 rpm with no 
brake. The white cell layer containing the PBLs was then removed by pipetting, and the 
cells were added to 8 -  10 ml o f RPMI medium (Gibco Invitrogen) supplemented with 5 
% FBS (Sigma). The cells were then washed and resuspended in 1 ml o f RPMI, 5 % 
FBS. Cells were counted, diluted to 1 x 106 cells/ml and cumulatively treated with a 
137Cs y-ray at a dose rate o f 0.09 Gy sec'1 until each of the required doses was reached, 
then a 1 ml aliquot of cells was removed and transferred to a 24 well tissue culture plate. 
Cells were then incubated at 37 °C, 5 % CO2 for 24 hours, after which 100 pi o f each 
dose was transferred to FACS tubes in triplicate and cells were washed with 1 ml of ice 
cold PBS. Lymphocytes were stained for apoptosis using the Annexin V-Fluorescein 
isothiocyanate (FITC) apoptosis detection kit (Pharmingen) by first resuspending in 100
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pi of binding buffer. 5 pi of Annexin V-FITC antibody solution and 5 jal o f 1 mg ml"1 
7-aminoactinomycin-D (7AAD) (Sigma) was then added to each sample, gently mixed 
and incubated for 15 minutes at room temperature in the dark. A further 400 pi o f 1 x 
binding buffer was then added to each tube, and cells were analysed for apoptosis 
(AnnexinV positive) by flow cytometry immediately on a Coulter EPICS XL Analyser 
using 10,000 events/sample, unless otherwise stated.
2.6 CFSE cell division analysis
2.6.1 Early and late division experiments
Carboxy-fluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Leiden, 
Netherlands) was dissolved in dimethylsulphoxide (DMSO) at a concentration o f 5 mM 
as a stock solution and kept at -20°C until further use. Fibroblasts to be assayed were 
seeded at a density o f 5 x 104 in 10 cm tissue culture plates and incubated overnight to 
allow them to adhere. Duplicate plates were prepared for each dose and time point.
Cells were washed once with 5 ml Opti-MEM (Gibco Invitrogen), CFSE stock was 
diluted 1/1000 in Opti-MEM (5 pM final concentration) and 5 ml of this was added to 
label each cell culture. Cells were incubated with CFSE for 10 min at 37°C, 5 % CO2 , 
washed twice with 5 ml Opti-MEM, followed by the addition o f fibroblast culture 
medium. Cells were then irradiated with a 137Cs y-ray source at a dose rate o f 0.09 Gy 
sec'1 and incubated at 37°C, 5 % CO2 for the appropriate time. FACS analysis was then 
performed counting 15,000 events per sample.
For each experiment 1 plate was used as a 0 day labelling control. These cells were 
trypsinised immediately after labelling, fixed in 1 % paraformaldehyde (PFA) and 
stored at 4 °C until the day FACS analysis was performed. These cells were then used 
to set the zero division level in order to account for any differences in labelling that may 
have occurred between each cell line and experiment. In early division experiments 5 x 
104 cells per sample were labelled as described above and then treated with 0, 1,2, or 
4Gy y-radiation on day 0. FACS analysis was then performed on these cultures after a 6 
day incubation at 37°C, 5 % CO2 . For late division experiments, 5 x 104 cells per 
sample were treated with 0, 1, 2, 4 or 6 Gy y-radiation on day zero and incubated for 5 
days at 37 °C, 5 % CO2 . Labelling was then performed as described above and cultures
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were incubated for a further five days at 37 °C, 5 % CO2 . During this period if  the 
unirradiated or low dose cultures approached confluence, they were split either 1:4 or 
1:8 to keep them at a sub-confluent density that is optimal for cell division. FACS 
analysis was then performed on day 10 after irradiation.
2.6.2 CFSE cell sorting
5 x 104 1BR or F96 cells were seeded into ten 10 cm tissue culture plates and left 
overnight to adhere. The following day 8 plates from each line were exposed to 4Gy y- 
radiation and the remaining 2 were mock irradiated. After a 5 day incubation, the cells 
were labelled with CFSE and one plate was harvested and fixed in 1 % PFA to serve as 
a 0 day labelling control. The remaining 9 plates were incubated for a further 5 days 
(10 days after irradiation) similar to the late division experiments previously described. 
These cells were than harvested for cell sorting. The 0 day labelling control was used to 
set the highest level o f CFSE fluorescence, and the mock irradiated sample represented 
cells that had divided normally in this time frame. Cells from the 8 irradiated plates 
were pooled together and sorted into high, medium and low CFSE fluorescence 
populations according to the gates shown in figure 4-12 using a Coulter EPICS ALTRA 
cell sorter. Approximately 5 x l 0 4 - 1 . 5 x l 0 5 cells were sorted for each population. 
Cells were then plated out in fresh growth medium and left overnight to adhere. Cell 
morphology and senescence associated P-galactosidase (SA-pgal) activity was 
examined. Photographs were taken using a Nikon-F70 camera in conjunction with a 
Nikon TMS-F microscope at lOOx magnification.
2.6.3 Senescence Associated p-Galactosidase (SA-pgal) staining of CFSE 
labeled cells
Cells were washed once with PBS and fixed in tissue cultures plates with 3 % 
formaldehyde. Fixed cells were then washed 3 times with PBS and incubated at 37 °C 
overnight with SA-pgal staining solution (40 mM Citric Acid, 12 mM Sodium 
Phosphate, 5 mM K3Fe(CN)6, 5 mM K4 Fe(CN)6, 150 mM NaCl, 2 mM MgCl2, lmg ml' 
1 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal)).
2.6.4 Apoptosis detection with CFSE labeled cells
Late CFSE division experiments were performed as described above. Before FACS 
analysis cells were stained with AnnexinV-Phycoerythrin (PE) and 7AAD using the
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AnnexinV-PE Apoptosis Detection Kit (Pharmingen) according to the manufacturer's 
instructions. Briefly, cells were washed twice with cold PBS and resuspended in 100 pi 
of binding buffer. 5 pi o f Annexin V-PE and 5 pi o f 1 mg ml"1 7AAD was then added 
to each sample, followed by a 15-minute incubation at room temperature in the dark.
400 pi of binding buffer was then added and the amount o f apoptosis at different CFSE 
fluorescence levels was examined by FACS. Unstained cells and cells stained with 
Annexin-PE and 7AAD alone served as controls.
2.7 BrdU cell cycle analysis
Cells were seeded into 6 cm tissue culture plates at least 24 hrs prior to irradiation at 
densities to prevent contact inhibition. Cultures were then either mock irradiated or 
exposed to a 137Cs y-ray source at a dose rate o f 0.09 Gy sec'1 to give a total dose o f 4 
Gy. 12 hrs after irradiation cultures were pulse-labeled with 10 pM bromodeoxyuridine 
(BrdU) (Pharmingen) for 30 min, harvested by trypsinisation, and resuspended in 0.6 ml 
PBS. The cells were then added drop wise to 10 ml of ice-cold 70 % ethanol and 
incubated on ice for at least 1 hr. The fixed cells were then centrifuged at 2150 rpm for 
7 min, resuspended in 1 ml chilled 0.1M HC1, 0.5 % Triton-X 100 (TX100) and 
incubated on ice for 10 min in order to extract histone proteins. Following the addition 
of 5 ml H2O, cells were centrifuged at 1200 rpm for 10 min, and resuspended in 1.5 ml 
H2O. At this stage samples were transferred to 1.5 ml eppendorf tubes, and incubated 
for 10 min at 100 °C to denature cellular DNA. Cells were then incubated on ice for 3 
min, centrifuged at 13,000 rpm for 3 mins and washed once in 1 ml PBS, 0.5 % TX100. 
Cells were resuspended in 100 pi of 5pg ml'1 Anti-BrdU-fluorescein solution (Roche) 
diluted in PBS, 0.1 % Bovine serum albumin (BSA), 0.1 % TX100 and incubated for 30 
min at room temperature in the dark. Cells were then washed once with PBS, and 
resuspended in 500 pi PBS. 27 pi RNase A (10 mg ml'1) and 20 pi propidium iodide 
(PI) solution (50 pg ml'1) was then added to each sample followed by a 30 min 
incubation at room temperature in the dark. Subsequently FACS analysis was 
performed. Cellular debris and fixation artifacts were gated out and the fraction o f cells 
in S-phase (BrdU positive) was quantified.
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2.8 Preparation of RNA and northern analysis
Total RNA was prepared from irradiated or unirradiated cells for use on northern blots 
and the preparation of cDNA. Cells were lysed in situ using Trizol reagent (Invitrogen) 
following the protocol supplied by the manufacturer. For northern blots mRNA was 
then isolated from total RNA with Oligotex beads (Qiagen) according to the 
manufacturer's instructions and quantified using the Agilent Bioanalyser system. RNase 
free H2O (Qiagen) was used for all RNA work. Northern blots were performed using a 
modified version of the GeneScreen protocol (NEN Life Science Products). Briefly, 2- 
5 pg of mRNA was resuspended in 1 x MOPS (40 mM Morpholinopropanesulfonic 
acid, 10 mM Sodium acetate-3H2O, 1 mM ethylenediaminetetraacetic acid (EDTA)- 
Na2-2H20, pH 7.2), 3.5 pi Formaldehyde (Sigma) and 10 pi Formamide (Amresco).
The volume was adjusted to 20 pi using RNase free H2O. The secondary structure of  
the mRNA was denatured by heating to 65 °C for 15 minutes, followed by chilling on 
ice whilst loading dye was added to each sample. The mRNA samples were then 
separated on a 1.2 % agarose gel containing 10 % Formaldehyde using 90 V for 2 
hours. The gel was then soaked in ddH20 for 3 x 10 minutes and transferred overnight 
to GeneScreen membrane in 10 x SSC. The membrane was then washed briefly in 2 x 
SSC to remove residual agarose, UV auto-crosslinked and baked at 80 °C for 2 hours.
2.9 Probing northern blots
The membrane was incubated for 1 hour in a rotating hybridisation bottle filled with 5 
ml pre-hybridisation solution (For 200 ml pre-hybridisation mix 20 g Dextran Sulphate 
(Sigma), 40 ml 20 x SSC, 20 ml 50 x Denhardts Solution (Sigma) 130 ml ddH20 and 10 
ml 10 % SSC were mixed) containing 100 pg ml'1 denatured sheared salmon sperm 
DNA (Sigma).
A p21 probe was generated by reverse transcription-polymerase chain reaction (RT- 
PCR) using cDNA prepared from irradiated 1BR fibroblasts as a template. Primers 
p21-U and p21-L were designed to generate a 598 bp fragment from the 3' non-coding 
region of p21 mRNA using an annealing temperature of 65 °C.
Sequence of p21 PCR primers: -
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p21-U:
p21-L:
S'-GCTACTTCCTCCTCCCCACTTG-S'
5'-TCCCTTCCCCTTCCAGTCCATTG-3'
The p21 PCR product was run on an ethidium bromide stained 1 % agarose gel, gel 
purified and run on another ethidium bromide stained 1 % agarose gel to assess the 
concentration of the probe template.
Labelling o f probe templates was carried out by mixing 25-50 ng probe template DNA  
with ddH20  to a final volume o f 10 pi. The sample was denatured by heating to 95 °C 
for 6 minutes and then immediately placed on ice. On ice 5 pi 20 ng pi"1 random 
primers (6-mers to 9-mers in ddH20 ), 5 pi 5 x 9LB reaction buffer (10 ml 9LB buffer is 
prepared by mixing 4.55 ml ddH20 , 50 pi p-mercaptoethanol (Sigma), 100 pi each o f  
100 mM dATP, 100 mM dGTP and 100 mM d TTP and 5 ml 0.5 M Na phosphate 
buffer, pH 7.4. 200 ml 0.5 M Na phosphate buffer, pH 7.4 was prepared by mixing 22.6 
ml 1 M NaH2P 04, 77.4 ml 1M Na2H P04 and 100 pi H20 ), 1 pi of 0.5 M MgCl2/10 pg 
nl'1 BSA solution, 3 nl a 32P-dCTP (>3000 Ci mM’1 ICN), and 1 nl 5 U jjl-1 Klenow 
fragment (Promega). The reaction was subsequently incubated at 37 °C for 30 minutes. 
Following primer extension 80 pi TE -  0.1 % sodium dodecyl sulphate (SDS) was 
added and the sample transferred to a spin column containing sephadex G-50 
(Pharmacia) and centrifuged into a fresh eppendorf tube containing 33 pi 1M NaOH.
To the denatured, labelled probe template was then added 135 pi 2M Tris 
(Tris(hydroxymethyl) aminomethane), pH8. The probe was then transferred to the 
hybridisation bottle and incubated in a rotating hybridisation oven at 65°C overnight.
The following morning, the pre-hybridisation mix with the probe template was 
discarded and the membrane washed in 2 x SSC, 0.1 % SDS for 5 minutes at room 
temperature. The membrane was then washed twice in 2 x SSC, 0.1 % SDS at 55 °C for 
10-15 minutes. The membrane was then wrapped in saran wrap and monitored with 
the probe of a Gieger counter. If the monitor detected large amounts o f background 
emitted from the membrane, as identified by strong signals in places where the probe 
was not expected to hybridise, e.g. the edges o f the membrane, additional washes were 
performed using 2 x SSC, 0.1 % SDS until the background emission had washed off.
The membrane was then wrapped in saran wrap, placed in a cassette and exposed to 
photographic film (Kodak) at -70  °C. Following exposure the film was developed and 
the autorad examined for signal.
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2.10 Chromosome break analysis
For chromosome break analysis cells were grown in 75 cm2 tissue culture flasks with 15 
ml of fibroblast growth medium. Cells in the exponentially growing phase were mock 
irradiated or irradiated with a 137Cs y-ray source at a dose rate o f 0.09 Gy sec'1 to give a 
final dose of 3 Gy. After an incubation period o f 8 hrs, 150 pi o f Colcemid solution (10 
pg ml"1, Gibco BRL) was added to each tissue culture flask and incubated overnight. 
Cells arrested at metaphase were harvested by partial trypsinisation for 2 min at room 
temperature, taking care to collect any floating cells present in the growth medium or 
PBS during washing steps. Cells were then resuspended in 5 ml preheated (37 °C) 1 % 
sodium citrate and incubated at 37 °C for 15 minutes to allow adequate cell swelling. 
Samples were then centrifuged at 1200 rpm for 5 min and carefully resuspended in 10 
ml of fix solution (3:1 ,  methanol: acetic acid). To minimise clumping the first 1 ml of 
fix was added as the centrifuge tube was flicked, and the sample was subsequently 
vortexed. This process was repeated for addition of the first 3 ml o f fix, and the last 7 
ml was added together. Cells were then washed 3 times in 5 ml o f fix solution and 
resuspended in 1 ml of fix solution. Using a Pasteur pipette, fixed cells were then 
dropped onto clean glass slides held at arms length. Slides were allowed to dry, stained 
with giemsa for 10 min, washed twice and propped up to dry. After the application of 
cover slips, metaphase spreads were visualised by light microscopy at lOOOx 
magnification using a Zeiss Axioskop microscope (Photometries, Tucson, Ariz) and the 
number o f unrepaired chromosome and chromatid breaks were counted per metaphase. 
Chromosome breaks were defined as acentric chromosome fragments and chromatid 
breaks were defined as chromatid gaps (larger than a chromatid width) or fragments.
We also noted the number o f dicentric chromosomes observed. Metaphase spreads 
were prepared from at least 2 separate experiments for each primary line.
2.11 Candidate repair gene sequencing
Total RNA, extracted from control and patient fibroblasts, was used to synthesise 
cDNA using random hexamer primers and SUPERSCRIPT II reverse transcriptase 
according to the manufacturer’s instructions (Invitrogen). PCR of cDNA with Pfx 
polymerase (Invitrogen) was performed with sense (U) and antisense (L) primers for the 
coding sequence of the gene in question. All primers were designed with DNASTAR
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PrimerSelect and MacVector software using sequences retrieved on the NCBI database 
at:
www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide 
Details of primers and cycling conditions are listed below: - 
XRCC4
These primers target XRCC4 transcript variant 3 (NM 022550), which includes the 3' 
portion of non-coding exon 1 that is missing in the other two known variants (1 and 2). 
The protein-coding region o f transcript 3 is the same as that of variant 1.
Primers
Ux: 5'-GGAAGTAGAGTCACGGAGAGGT-3'
Lx: 5*-T G CC AGT GT CAT CAT C AAAT CGT A-3'
Amplified fragment size, 1283bp
PCR reaction
These primers were used in a 50 pi PCR reaction consisting o f 5 pi 10 x Pfx 
amplification buffer (Invitrogen), 5 pi 10 x Pfx enhancer solution (Invitrogen),
1.5 nl 10 mM dNTPs, 1 pi 50 mM M gS04, 1 pi UX (100 pmol p i 1), 1 pi LX 
(100 pmol pi'1), 34 pi ddlfcO, 0.5 pi Pfx (Invitrogen) and lp l cDNA.
Cycling conditions
94 °C for 2 min 
94 °C for 15 sec 
Annealing temp 61 °C for 30 sec
68 °C for 1 min 30 sec 
68 °C for 10 min 
Hold at 4 °C
>-35 cycles
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L igase IV
PCR o f the coding region was performed using two separate reactions. The amplified 
fragments overlapped within the coding region, and extended into the 5' untranslated 
region (UTR) (5' fragment) or the 3' UTR (3' fragment).
5' fragment
Primers
UB: 5'-ATGGCTGCCTCACAAACTTC-3'
LB: S'-GGGGCTTCTCTGCTACTGC-y
Amplified fragment size, 1473bp 
PCR reaction and cycling conditions
As with XRCC4, except for annealing temp of 53 °C
3' fragment
Primers
UA: 5'-ACGGGGT GG AAT GAT GTCTC-3'
LA: S'-CTTGGCTTTGGGCTATTGTCT-S'
Amplified fragment size, 1496bp 
PCR reaction and cycling conditions
As with XRCC4, except for annealing temp of 53 °C
Artemis
PCR o f the coding region was performed using two separate reactions. The amplified 
fragments overlapped within the coding region, and extended into the 5' UTR (5' 
fragment) or the 3' UTR (3' fragment).
5' fragment
Primers
UA: 5'-GATCGGCGGCGCTATGAGTT-3'
LA1: 5'-GGT G AACT GTTCT AG CT CT C-3'
Amplified fragment size, 1160bp 
PCR reaction and cycling conditions
As with XRCC4, except for annealing temp of 54°C
75
3' fragment
Primers
UA2: 5'-CCTCCTACAGTGAGATTAAA-3'
LA: 5'-TGTCATCTCTGTGCAGGTT-3'
Amplified fragment size, 1177bp 
PCR reaction and cycling conditions
As with XRCC4, except for annealing temp o f 51 °C
Each fragment was amplified three times in separate PCR reactions, and the resulting 
products were sequenced in both directions. This was intended to generate adequate 
sequence data for analysis that could account for errors that may occur during the PCR 
reaction.
Double-stranded PCR products were gel purified and sequenced using ABI BigDye 
Terminator Cycle Sequencing Kit Vl . l  (Applied Biosystems, Foster City, CA). 
Sequencing reactions contained 6 pi Big Dye terminator, 2.4-3.2 pmol sequencing 
primer and 30 -  90 ng of purified PCR product, with the reaction made up to 15 pi with 
PCR-grade water. Cycling conditions were as follows; 96 °C for 1 minute, followed by 
25 cycles o f 96 °C for 10 seconds, 50 ° C for 5 seconds, 60 °C for 4 minutes and then 
hold at 4 °C. DNA was then precipitated by adding 50 pi absolute ethanol and 3 pi 3 M 
Sodium Acetate pH4.6 and incubating at -2 0  °C for 30-45 minutes. Precipitated DNA 
was then washed twice with 70 % ethanol and stored as a dry pellet at -20  °C until 
analysis. The oligonucleotides employed in the initial PCR reactions were used in 
combination with the following sense (U) and anti-sense (L) primers in order to fully 
sequence the amplified products (depicted in section 6.2): -
XRCC4 sequencing primers
U1: 5'-TCTCATTCAGACTTGGTTCC-3'
U2: 5'-AAAGGAGACAGCGAATGC-3'
L1: 5'-TGCTCCTGACAACAATGC-3'
L2: 5'-GT CT CCTTTTT CT ACTT G GTGC-3'
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Ligase IV sequencing primers
5' fragment
U2
U3
U4
L1
L2
5'-G ATGG AAAAG AT GCCCT C-3* 
5'-GAAAAAGTCTGTAGGCAACTGC-3' 
5'-CAGACAAAAGAGGTGAAGGG-3' 
5'-AGTTCCAGTGGGTGTTCTG-3' 
5'-GGGT AAG AG AACCTT CAGT AGG-3'
3' fragment
U6: 5'-AGTGGAACAGATAGCCAGCC-3'
U7: 5'-ATGAGGGGACAAGGTTAGC-3'
L4: 5'-TCTTCATCTTTGGGGCAG-3'
L5: 5'-TTCTTCAGGAGTCTGCTCG-3'
Artemis sequencing primers
5' fragment
U2: 5'-AGGAGACTTCAGATTGGCG-3'
U3: 5'-TGGTTTGGAGAAAGGAGC-3'
L4: 5'-TGCTGATTATGTGGAGTGG-3'
L5: 5'-T CTTCCTT CT CT CCT GATGC-3'
y  fragment
U4: 5'-TGAGACAAACCCCAGGATG-3'
U5: 5'-CCCG AGG AAAAAAGTTT GC-3'
L2: 5'-GG AGT AAGT ATCCTTTGGGC-3'
L3: 5'-TCTCAGTTTTTCAGGCTGC-3'
Extension products were run on an Applied Biosystems Prism 377 automatic sequencer 
and the resulting data was analysed using EditView (ABI) and DNASTAR software.
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2.12 Artemis cloning
2.12.1 Cloning of the 5* half of F96 Artemis
The sequence data produced from the 5' fragment o f Artemis isolated from the 
radiosensitive F96 line suggested the presence o f mutations, but this was difficult to 
confirm because o f the poor quality o f sequence data produced in this region. Since the 
5' region of Artemis has previously been reported to undergo many alternative splicing 
events in other radiosensitive cells (Li et al, 2001), we decided to clone and sequence 
the 5' fragment of F96 Artemis. This was performed using the pZErO cloning system 
(Invitrogen), which allows the efficient cloning o f blunt ended PCR products.
2 of the 5' fragments o f F96 Artemis generated in separate PCR amplifications in 
section 2.10 were used in ligation reactions with pZErO, which had been previously cut 
with EcoRV and gel purified. This was performed at a ratio o f 10:1 (insert:vector), and 
each reaction contained 1 pi o f pZErO (lOng pi’1), 1 pi 10 x ligase buffer (NEB), 0.5 pi 
gel purified F96 5' Artemis fragment (70 ng pi’1) and 6.5 pi ddFLO. A vector only 
negative control was also prepared that contained everything except the F96 Artemis 
insert. 1 pi of 400 U pi"1 T4 DNA ligase (NEB) was then added to each ligation mix 
and the reactions were incubated at 16 °C for 1 hour. The ligations were then 
transformed into chemically competent DH5a E.coli (Invitrogen). The transformations 
were carried out by mixing 2 pi o f each ligation with 50 pi o f competent DH5a E.coli, 
and incubating the mixtures on ice for 20 minutes. The transformation mix was then 
heated to 42 °C for 90 seconds and then chilled on ice for 2 minutes. In order to allow 
time for expression of the Zeocin resistance gene present in pZErO, 350 pi o f L-Broth 
(10 g Bacto Tryptone (Becton Dickenson), 7 g Bacto Yeast extract (BD), 10 g NaCl, in 
1 litre) was added to each transformation, which was then incubated in a shaking 
incubator (37 °C, 225 rpm) for 1 hour. The transformations were then plated on low 
salt LB agar plates (1 % tryptone, 0.5 % yeast extract, 0.5 % NaCl, 1.5 % agar, pH 7.5) 
containing Zeocin (50 pg ml"1) and incubated overnight at 37 °C. Using sterile pipette 
tips 3 clones from each transformation were picked and cultured overnight in 5 ml low 
salt L-Broth supplemented with 50 pg ml"1 Zeocin and miniprepped using the Qiaprep 
Miniprep protocol (Qiagen). To test for the presence o f Artemis inserts, miniprep DNA 
was digested with EcoRl and Xhol restriction endonucleases that cut either side o f the
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insert, with EcoRl also cutting once within the wild type Artemis sequence. This 
should produce 3 bands o f 2775, 861 and 332 bp when the digests are run on an 
ethidium bromide stained 0.8 % agarose gel, and potential Artemis clones were 
sequenced using T7 and SP6 primers with ABI Dyedeoxy Terminator Cycle Sequencing 
apparatus (Applied Biosystems, Foster City, CA).
2.12.2 Cloning of full length Artemis into the gateway system
By cloning the 5' half o f Artemis isolated from F96 cells we discovered the presence of 
alternatively spliced variants together with the full length transcript. Sequencing results 
also indicated the presence o f potential mutations in the F96 Artemis gene that appeared 
to be mutually exclusive and therefore present on separate alleles. In order to fully 
characterise the variety o f alternatively spliced transcripts expressed in human 
fibroblasts and confirm the presence o f mutations in the F96 Artemis gene, full length 
Artemis from wild type and F96 cells was cloned into the gateway cloning system 
(Invitrogen). Full length Artemis coding sequence was first obtained by PCR using 
cDNA as a template with primers ArtFl and ArtRl.
ArtF1: 5'-CACCATGAGTTCTTTCGAGGG-3'
ArtRl: 5'-CC AGGT AT CT AAG AGT G AGC-3'
Primer ArtFl consisted o f the ATG translation initiation codon followed by the first 14 
bases of the Artemis coding sequence. 5' to the ATG start codon we inserted a CACC 
motif in order to allow efficient directional cloning into a TOPO gateway expression 
vector (Invitrogen). The primer ArtRl was designed to modify the translation stop 
codon of Artemis to code for tryptophan, and this was achieved by incorporating a CCA 
codon at the 5' end of this anti-sense primer that will modify the TAA stop codon to 
TGG in the amplified product. This would allow the Artemis coding sequence to be 
cloned in frame with a C-terminal protein tag, which could be useful in any later 
expression studies since there was not a reliable Artemis antibody available at the time 
of this study. These primers were used in a 50 pi PCR reaction consisting o f 5 pi 10 x 
Pfx amplification buffer (Invitrogen), 5 pi 10 x Pfx enhancer solution (Invitrogen), 1.5 
pi 10 mM dNTPs, 1 pi 50 mM MgS0 4 , 1 pi ArtFl (100 pmol p f1), 1 pi ArtRl (100 
pmol p f1), 34 pi ddHiO, 0.5 pi Pfx and lp l cDNA. The following cycling conditions 
were found to be optimal for this amplification reaction.
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Cycling conditions
94 °C for 2 min 
94 °C for 15 sec 
Annealing temp 50 °C for 30 sec
68 °C for 2 min 15 sec 
68 °C for 10 min 
Hold at 4 °C
^35 cycles
After amplification the PCR reaction was loaded onto an ethidium stained 1 % agarose 
gel and the 2083 bp Artemis product was visualised, then gel-purified using the Qiagen 
spin column protocol (Qiagen).
The full length coding sequence o f Artemis amplified from either control (1BR) or F96 
cDNA was cloned into the pcDNA3.2/V5/GW/D-TOPO vector (Invitrogen) according 
to the manufacturer’s instructions. Briefly, 20 ng o f Artemis insert was combined with 
1 pi TOPO salt solution (Invitrogen), 1 pi o f pcDNA3.2/V5/GW/D-TOPO and made up 
to 5 pi with ddH20. A vector only control reaction was also prepared, which consisted 
o f everything except the Artemis insert. The reactions were mixed gently and incubated 
at room temperature for 30 minutes. 2 pi of each cloning reaction was then transformed 
into One Shot TOP 10 competent cells (Invitrogen) using the protocol described in 
section 2.11.1, plated on LB agar plates (1 % tryptone, 0.5 % yeast extract, 1 % NaCl,
1.5 % agar, pH 7) containing Ampicillin (100 pg ml"1) and incubated overnight at 37 
°C. For both the 1BR and F96 transformations, 26 clones were picked using sterile 
pipette tips, cultured overnight in 5 ml L-Broth supplemented with 100 pg ml"1 
Ampicillin and miniprepped using the Qiaprep Miniprep protocol (Qiagen). To test for 
the presence of Artemis inserts, miniprep DNA was digested with EcoRV and Hindlll 
restriction endonucleases that both cut once within the full length Artemis coding 
sequence. This approach also allowed us to identify the presence o f certain previously 
described alternative transcripts (Li et al, 2002), since together these enzymes are 
predicted to generate distinct fragments for some variants. Digestion o f full length, 
SCIDA-V1 and SCIDA-V2 Artemis transcripts releases a 1280 bp fragment from the 
recombinant plasmid. SCIDA-V3 and SCIDA-V4 both release a 1224 bp fragment, and 
digestion o f the latter also liberates a 119 bp fragment due to the presence o f an 
additional Hindlll site. These subtle differences were apparent after careful
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examination on an ethidium stained 0.8 % agarose gel. Cloned SCIDA-V5 and SCIDA- 
V6 were both predicted to generate fragments o f 1280bp and 30bp, and consistent with 
sequencing results we did not observe this signature in any o f the clones examined. 25 
1BR clones and 23 F96 clones that demonstrated the presence o f an Artemis insert after 
restriction digestion were then sequenced using T7 (forward) and TK (reverse) primers. 
The additional sequencing primers U2, U3, U4, U5, L2, L3, L4, and L5 described in 
section 2.10 were then used to generate comprehensive sequence data for the full-length 
1BR, F96 AGTT207-209 and F96 G377A transcripts.
2.12.3 Artemis recombination reactions using the Gateway cloning system
We had cloned full-length wild type and F96 mutant Artemis coding sequences into the 
pcDNA3.2/V5/GW/D-TOPO gateway vector that allows expression o f V5 tagged 
Artemis in mammalian cells. At this point we were also interested in expressing 
Artemis using a system that produces green fluorescent protein (GFP)-tagged 
recombinant protein. The gateway cloning system enables the rapid and highly efficient 
transfer o f DNA sequences into multiple vector systems while maintaining orientation 
and reading frame using the bacteriophage lambda site-specific recombination process. 
We therefore utilised this system to transfer the Artemis coding sequence from the 
pcDNA3.2/V5/GW/D-TOPO vector to the pDEST47 (Invitrogen) destination vector 
that incorporates a C-terminal GFP tag. In order to achieve this, 2 successive gateway 
recombination reactions were required. The first recombines the Artemis gene (Art) 
cloned into pcDNA3.2/V5/GW/D-TOPO with a gateway donor vector (pDONR221) in 
a BP clonase reaction to produce an entry clone (pENTR221-Art) (Figure 2-1). This 
entry clone can then be used in an LR recombination reaction with a destination vector 
(pDEST47) to produce an expression clone (pEXP47-Art). This process was completed 
for the full length wild type, F96 AGTT207-209 and F96 G377A Artemis alleles.
BP recombination reaction
BP recombination reactions were performed according to the manufacturer's 
instructions. Briefly, 500 ng (-100 fmol) of pcDN A3.2/V5/GW vector containing the 
Artemis gene was used in a BP recombination reaction consisting of 2 pi pDONR221 
(150 ng pi'1, -100 fmol), 4 pi 5X BP Clonase Reaction Buffer, 4 pi BP Clonase enzyme 
mix, and made up to 20 pi with TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). This 
reaction was incubated at room temperature for at least 2 hours. 2 pi Proteinase K
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Figure 2-1: Strategy for the tran sferra l of Artem is from  the pcDNA3.2/V5/GW cloning 
vector to the destination vector pDEST47 using gateway recom bination reactions. The
Artemis genes cloned into pcDNA3.2/V5/GW were first transferred to the donor vector 
pDONR221 in a BP clonase reaction to produce pENTR221-Art entry clones. The pENTR221- 
Art entry clones were then recombined with the destination vector pDEST47 in LR reactions to 
produce pEXP47-Art expression clones, which code for GFP-tagged Artemis recombinant 
proteins.
solution (Invitrogen) was then added followed by a 10 minute incubation at 37 °C. 1 pi 
of the BP reaction was then transformed into Library Efficiency DH5a Chemically 
Competent E. coli using the previously described transformation protocol. The 
transformations were then plated on agar plates containing Kanamycin (50 pg ml"1) and 
incubated overnight to select for pENTR221-Art vectors, which have a Kanamycin 
resistance gene but have also recombined with the Artemis insert to lose the toxic ccdB 
gene. The following day 3 colonies from each transformation were picked and grown 
using sterile pipette tips, cultured overnight in 5 ml L-Broth supplemented with 50 pg 
ml'1 Kanamycin and miniprepped using the Qiaprep Miniprep protocol (Qiagen). Test 
digests were performed with EcoRV that should cut once within the Artemis coding 
region and once within the pDONR221 sequence to produce bands of 1930 and 2729 bp 
after ethidium bromide-stained agarose gel electrophoresis. Glycerol stocks of DH5a 
E. coli clones containing the pENTR221-Artemis entry clone were prepared my mixing 
850 pi of exponentially growing culture in Kanamycin containing L-Broth with 150 pi 
of glycerol and freezing at -80 °C.
LR Recombination Reactions
Once we had obtained pENTR221 - Artemis entry clones for the wild type and F96 
mutant Artemis alleles, these were used in LR recombination reactions with the 
pDEST47 destination vector. LR recombination reactions were performed according to 
the manufacturer's instructions. Briefly, 200 ng (~60 fmol) o f pENTR221-Artemis 
miniprep DNA was used in a LR recombination reaction consisting o f 2 pi pDEST47 
(150 ng pi'1, ~60 fmol), 4 pi 5X LR Clonase Reaction Buffer, 4 pi LR Clonase enzyme 
mix, and made up to 20 pi with TE buffer, pH 8.0. This reaction was incubated at room 
temperature for at least 2 hours. 2 pi Proteinase K solution (Invitrogen) was then added 
followed by a 10 minute incubation at 37 °C. 1 pi o f the LR reaction was then 
transformed into Library Efficiency DH5a Chemically Competent E. coli using the 
previously described transformation protocol. The transformations were then plated on 
agar plates containing Ampicillin (100 pg ml'1) and incubated overnight to select for 
pEXP47-Artemis vectors, which have an Ampicillin resistance gene but have also 
recombined with the Artemis insert to lose the toxic ccdB gene. The following day 3 
colonies from each transformation were picked and grown using sterile pipette tips, 
cultured overnight in 5 ml L-Broth supplemented with 100 pg ml'1 Ampicillin and 
miniprepped using the Qiaprep Miniprep protocol (Qiagen). Test digests were 
performed with Hindlll that should cut once within the Artemis coding region and twice 
within the pDONR221 sequence to produce bands o f 696, 1617 and 5931 bp after 
ethidium bromide-stained agarose gel electrophoresis. Glycerol stocks of DH5a E. coli 
clones containing the pEXP47-Artemis expression clone were prepared my mixing 850 
pi of exponentially growing culture in Ampicillin containing L-Broth with 150 pi of 
glycerol and freezing at -8 0  °C.
To obtain large amounts of DNA for use in transfections, pEXP47-Artemis DH5a E. 
coli clones were grown up in 300 ml Ampicillin (100 pg ul’1) containing L-Broth for 16 
hours, the culture was then split in half and 2 HiSpeed Plasmid Maxipreps (Qiagen) 
were performed. Plasmid DNA was eluted in 500 pi TE buffer and recombined to give 
1000 pi of high concentration (>1 pg pi"1) pEXP47-Artemis plasmid DNA. This was 
also performed for the pcDNA3 .2/V5-Artemis expression clone.
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2.13 Expression of Artemis recombinant protein in cell lines
2.13.1 Transfection of 293T and HCT116 cells
We were unable to express recombinant Artemis protein in human fibroblasts using 
integrin mediated transfection (Estruch et al, 2001) despite achieving a transfection 
efficiency of ~50 % using a GFP only vector (pGFP). This suggested that human 
fibroblasts are sensitive to high levels o f Artemis protein. We therefore transfected 
Artemis into the 293T and HCT116 cell lines, which are known to express recombinant 
proteins more readily.
293T cells were grown in DMEM (Gibco Invitrogen), 10 % FCS, 2 mM L-glutamine 
(Gibco Invitrogen), 100 U ml"1 penicillin G sodium and 100 pg ml"1 streptomycin 
sulphate (Gibco Invitrogen). HCT116 cells were grown in McCoys 5A medium (Gibco 
Invitrogen) 10 % FCS, 2mM L-glutamine (Gibco Invitrogen), 100 U ml'1 penicillin G 
sodium and 100 pg ml'1 streptomycin sulphate (Gibco Invitrogen). This protocol was 
used to transfect cells at 80 % confluence in a 6 well plate, but was scaled up 
accordingly to transfect larger amounts o f cells. In one 5 ml universal tube 1 pg o f  
plasmid DNA (0.5 pg of each construct for co-transfection) was diluted to 100 pi with 
Opti-MEM (Invitrogen). In another 5 ml universal, 5 pi Lipofectamine (lm g ml"1, for 
293T cells) or Lipofectamine 2000 (lm g ml"1, for HCT116 cells) was diluted to 100 pi 
with Opti-MEM. The diluted DNA was then added drop wise to the diluted 
Lipofectamine reagent, and incubated for 20 minutes at room temperature to allow the 
formation o f lipid-DNA complexes. The cells were then washed once with Opti-MEM, 
and 800 pi of Opti-MEM was replaced in each well. The DNA complexes (200 pi) 
were then added drop wise to each well and the cells were incubated at 37 °C, 5 % CO2  
for 4 hours, after which 500 pi of growth medium was added and the cells were 
incubated overnight. The next morning fresh medium was replaced in each well, and 
the cells returned to incubation. Depending on the particular experiment the transfected 
cells were then treated accordingly 24 hours after the initial addition o f DNA-lipid 
complexes. Expression levels o f V5 tagged protein were ascertained by western blot. 
The levels and localization o f GFP tagged protein were visualised using a Zeiss 
Axiovent SI00 fluorescent microscope at 400x magnification and/or FACS analysis.
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2.13.2 Cell sorting of Artemis-GFP positive HCT116 cells
Four 10 cm tissue culture plates containing HCT116 cells at 80 % confluence were 
transfected with wild type Artemis-GFP or co transfected with G126D and AL70 
Artemis-GFP expression constructs. 24 hours later 2 plates from each transfection were 
exposed to lGy y-radiation, while the remainder was mock irradiated. After a further 4 
hour incubation cells were sorted on a Coulter EPICS ALTRA sorter into GFP positive 
and negative populations. Approximately 5 x 105 cells were sorted for each population 
and cell lysate was immediately prepared for analysis o f p53 status by western blot.
2.14 Protein methodology
2.14.1 Protein lysates
To prepare protein lysate cells were trypsinised, washed once in PBS, resuspended in 1 
ml PBS and transferred to a 1.5 ml eppendorf tube. Each sample was then centrifuged 
at 1800 rpm for 5 minutes in a microfuge and resuspended in 50-100 pi o f cell lysis 
buffer (125 mM Tris/HCl, 32 mM dithiothreitol (DTT), 2 % SDS, 1 complete mini 
protease inhibitor cocktail tablet (Roche), in 10 ml total solution). The lysate was then 
placed in a heating block at 100 °C for 10 minutes, and centrifuged at top speed (13200 
rpm) in a microfuge for 10 minutes. The supernatant containing total cellular protein 
was transferred to a fresh eppendorf tube and stored at -80  °C until required.
2.14.2 Estimation of protein concentration
The protein concentration in each sample was measured using the BCA Protein Assay 
Kit (Pierce) according to the manufacturer's instructions. This method is based on the 
absorbance of protein samples at 562 nm. A standard curve using known 
concentrations o f BSA was first completed (figure 2-2), and this allowed us to calculate 
the concentration of total cellular protein in our samples using the relationship 
Absorbance x 0.0012"1 = Protein concentration (pg ml'1). Protein samples to be assayed 
were first diluted 1:100 with water, and this dilution factor was taken into account when 
calculating protein concentration.
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Figure 2-2: Standard curve for measurement of protein concentration using the BCA 
Protein Assay Kit. The absorbance o f known concentrations of BSA allowed the relationship 
Absorbance = Protein concentration (pg m l'1) x 0.0012'1 to be calculated from the line o f best 
fit, R2 = 0.9976.
2.14.3 Western blotting
20-40 pg of protein was diluted to 10 pi with lysis buffer and mixed with 5 pi o f 3X 
Red Reducing SDS Loading Buffer (NEB). The samples, along with 15 pi o f Broad 
Range Prestained Protein Marker (NEB), were then denatured by heating to 100 °C for 
5 minutes, and centrifuged at top speed (13000 rpm) in a microfuge for 3 minutes.
For examination of p53 and Artemis proteins the samples were loaded onto a large 10 % 
SDS-PAGE gel prepared in a Hoefer Sturdier SE400 vertical unit (Amersham 
Pharmacia Biotech). The gel was made by first preparing the 10 % resolving gel by 
mixing 15.8 ml H2O, 13.3 ml ProtoGel 30 % w/v Acrylamide (National diagnostics), 10 
ml 1.5 M Tris pH 8.8, 400 pi 10 % SDS, 400 pi freshly made 10 % Ammonium 
Persulfate (APS) and 16 pi N,N,N',N'-Tetramethylethylenediamine (TEMED). The 
stacking gel was then prepared by mixing 1.7 ml H2O with 1.7 ml ProtoGel 30 % w/v 
Acrylamide, 1.25 ml 1 M Tris pH 6.8, 100 pi 10 % SDS, 100 pi freshly made 10 %
APS and 10 pi TEMED. The gel was run in 1 x running buffer (3.03 g Tris base, 14.4 g 
Glycine, 10 ml 10 % SDS, made up to 1 litre with H2O) overnight at 50 V ensuring 
adequate resolution of the 47.5, 62 and 83 kDa markers. The gel was then transferred 
overnight onto a Hybond-C extra nitrocellulose membrane (Amersham) in 1 x transfer 
buffer (Transfer buffer was prepared by mixing 3.03 g Tris base, 14.4 g glycine with 1
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litre o f H2O, adding 400 ml methanol, then making the solution up to 2 litres with H20 )  
at 300 mA.
For examination of p21, samples were loaded onto 12 % SDS-PAGE gels prepared 
using BioRad MiniGel apparatus. A 12 % gel comprised o f 6.6 ml H20 , 8 ml ProtoGel 
30 % w/v Acrylamide (National diagnostics), 5 ml 1.5 M Tris pH 8.8, 200 pi 10 %
SDS, 200 pi freshly made 10 % Ammonium Persulfate (APS) and 8 pi TEMED. The 
stacking gel and running buffer was the same as described above. These gels were run 
at 80 V for approximately 2 hours until the loading dye reached the bottom of the gel. 
The gel was then transferred in 1 x transfer buffer at 60 V for 1 hour 30 minutes.
After the transfer was complete the sandwich was dismantled and protein transfer 
examined using Ponceau S solution (Sigma). The membrane was then blocked in TBS- 
T (To make 1 litre TBS-T mix 12.5 ml 1M Tris pH 7.6, 30 ml 5M NaCl, 1 ml Tween-20 
and make up to 1 litre with H20 )  with 5 % marvel (milk powder) on a rocking platform 
either for 1 hour at room temperature or overnight at 4 °C. The membrane was then 
washed once in a large volume o f TBS-T, and incubated with primary antibody diluted 
1:1000 in TBS-T with 0.5 % marvel on a rocking platform, either for 1 hour at room 
temperature or overnight at 4 °C. The primary antibody was then removed by washing 
twice in a large volume o f TBS-T, 10 minutes each time. The washing solution was 
then discarded and replaced by secondary antibody (Santa Cruz), which was diluted 
1:2500 in TBS-T with 0.5 % marvel and incubated on a rocking platform for 1 hour.
The secondary antibody was then discarded and the membrane was washed 3 times in 
large volumes of TBS-T, 15 minutes each time. The signal on the membrane was 
visualised using ECL reagents (Amersham) according to the manufacturer's 
instructions, and autoradiographic film was exposed to the membrane for various 
periods of time depending on this intensity of the bands. Where applicable, bands were 
quantified using a BioRad Densitometer.
Primary antibodies used were as follows: -
• Anti-V5 mouse monoclonal (Invitrogen)
• Phospho-p53 (Seri 5) rabbit polyclonal (Cell Signaling Technology)
• p53 (FL-393) goat polyclonal (Santa Cruz)
• p21 (C-19) rabbit polyclonal (Santa Cruz)
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2.14.4 Phosphatase treatment of cell lysate
200 pg of total cellular protein isolated using standard lysis buffer was diluted to 100 pi 
with 50 mM Tris, ImM MgCl2. 10 pi o f Calf intestinal alkaline phosphatase (CIAP) (1 
unit pi'1, Promega) was then added to each sample and incubated at 37 °C for 30 
minutes. To stop the reaction 50 pi o f 3X Red Reducing SDS Loading Buffer (NEB) 
was added to each sample, and 30 pi (40 pg) was loaded onto a standard 10 % SDS- 
PAGE gel. The remainder was frozen at -80 °C until required.
2.14.5 Inhibition of p53 protein acetylation using Anacardic Acid
Anacardic acid (AA) (Calbiochem) is a non-competitive inhibitor o f the p300 and 
P/CAF acetyltransferases that are known to target p53. This compound was dissolved 
in DMSO at a concentration o f 10 mg ml'1 and stored as a stock solution at -20°C. For 
both the 1BR and F96 lines, 6 cell cultures were grown in 3.5 cm tissue culture plates to 
80 % confluence. 6 pi o f DMSO or 6 pi o f AA (10 mg ml'1) was then added to 2 plates 
from each line and incubated for 12 hours prior to irradiation. 2 hours prior to 
irradiation 6 pi AA solution was then added to the 2 remaining plates o f each line. 1 
plate from each treatment regime (12 hrs DMSO, 12 hrs AA and 2 hrs AA) was then 
exposed to 1 Gy y-radiation while the other was mock irradiated, and all were incubated 
for a further 4 hours. Total cellular protein was then isolated and p53 status 
investigated by western blot as previously described.
2.15 Sequencing of p53
A 1426 bp fragment encompassing the entire coding region o f p53 was amplified from 
cDNA using primers P5F and P7F described below: -
Primers
P5F: 5*-T CCGGGG AC ACTTT GCGTT C-3'
P7R: 5'-AGCCCCGGGACAAGCAA-3'
Amplified fragment size, 1426 bp
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PCR reaction
These primers were used in a 50 pi PCR reaction consisting o f 5 pi 10 x Pfx 
amplification buffer (Invitrogen), 1.5 pi 10 mM dNTPs, 1 pi 50 mM M gS04, 1 
pi P5F (100 pmol pi'1), 1 pi P7R (100 pmol pi"1), 38.5 pi ddH20 , 1 pi Pfx 
(Invitrogen) and 1 pi cDNA.
-n
Cycling conditions
94 °C for 2 min 
94 °C for 15 sec 
Annealing temp 57 °C for 30 sec )>- 35 cycles 
68 °C for 2 min 
68 °C for 10 min 
Hold at 4 °C
The double-stranded PCR product was gel purified and sequenced using ABI Dyedeoxy 
Terminator Cycle Sequencing apparatus with a Prism 377 automatic sequencer (Applied 
Biosystems, Foster City, CA). For each line the p53 fragment was amplified three times 
in separate PCR reactions, and the resulting products were sequenced in both directions. 
The oligonucleotides employed in the initial PCR reaction were used in combination 
with the following forward (F) and reverse (R) primers in order to fully sequence the 
amplified products (depicted in figure 7-3): -
p53 sequencing primers
P6F: 5*-CT CCTGGCCCCT GT CAT CTT-3' 
P7F: 5'-AGTGTGGTGGTGCCCTATGA-3'
P6R: S'-ATGTGCTGTGACTGCTTGTAG-S'
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2.16 Affymetrix GeneChip analysis
The F96 line displayed enhanced levels o f p53 phosphorylation after DNA damage, and 
this appears to result in the abnormally high induction o f the Cdk inhibitor p21, a p53 
target gene. We were interested in further investigating radiation-induced gene 
expression in the F96 line to determine whether this enhanced response was restricted to 
the induction o f p21, or if other damage response genes were induced at similarly high 
levels in these mutant cells. This was achieved using Affymetrix GeneChip analysis, 
which allows the researcher to simultaneously monitor the activities o f thousands of 
genes and compare this between experimental samples.
Affymetrix GeneChips are fixed oligonucleotide arrays with complementary probes for 
each gene in specific locations on the chip. Each feature on a chip consists o f millions 
o f copies of a 25mer oligonucleotide, and each gene is represented by 11-16 pairs of 
such oligos, designed to non-conserved regions at the 3' end o f the gene (often in the 3' 
untranslated regions). Each pair of oligos consists o f  a perfect match (PM) to the probe 
sequence and a mismatch (MM) oligo that differs in  only one position (13 o f 25), and 
acts as a cross hybridisation control. High quality total RNA prepared from the test 
sample is first reverse transcribed into cDNA using a primer that incorporates a T7 
promoter at its 5' end, which then serves as a template for an in vitro transcription (IVT) 
labeling reaction that produces many copies o f complementary RNA (cRNA) that has 
incorporated biotinylated nucleotides. Biotin labeled cRNA is then fragmented, 
hybridized to the GeneChip and stained with a fluorescent marker directed against the 
biotin tag. The relative levels o f gene expression are determined by analysing 
fluorescence intensities at particular locations (figure 2-3).
90
Total RNA
AAAA 
AAAA 
• AAAA
cONA
S 'J
I
K
OwwCNp
BtottevlatwKd
cRNA
In Vitro
-B
Fragmentation
Fragmented.
Btodn labeled r  \  
cRNA ■ A
sr*  \
C rB > ^  S '
>* \ S \  *-» ^
X
Figure 2-3: S tandard  eukaryotic gene expression assay using Affymetrix GeneChips. The
basic concept behind the use of GeneChip arrays for gene expression. Labelled cRNA targets 
derived from the mRNA of an experimental sample are hybridised to nucleic acid probes 
attached to the solid support. By monitoring the amount of label associated with each DNA 
location, it is possible to infer the abundance of each mRNA species represented. Taken from 
the Affymetrix website, www.affymetrix.com.
2.16.1 Preparation of target cRNA
Analysis o f total RNA quality and concentration
Total RNA was isolated from 1BR and F96 cells 4 hours after exposure to either 0 or 
lGy y-radiation using Trizol reagent (Invitrogen) according to the manufacturer's 
instructions. This procedure was completed 3 times in separate experiments, which 
generated triplicate RNA samples for each cell line before and after irradiation. The 
quality and concentration of each Total RNA sample was then assessed using an Agilent 
2100 Bioanalyser (figure 2-4).
Double Stranded cDNA Synthesis
cDNA synthesis was performed with the Microarray cDNA Synthesis Kit (Roche). For 
each sample 8 pg of total RNA was mixed with 2 jal of T7-OHgo(dT) Primer (200 pmol) 
and made up to 21.5 jal with RNase free H2O.
T7-Oligo(dT) Primer:
5'-GGCCAGTGAATTGTAATTGTAATACGACTCACTATAGGGAGGCGG-(dT)24-3'
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Figure 2-4: Analysis of total RNA quality and concentration using an Agilent 2100 
Bioanalyser, a) Agilent 2100 Bioanalyser gel image of all 12 total RNA samples isolated from 
primary fibroblasts to be analysed by gene chip analysis. A, B and C refers RNA obtained from 
3 separate expriments. b) Electropherogram (from Agilent 2100 Bioanalyser) of a representitve 
total RNA sample (1BR lGy B, lane 6). For a high quality RNA sample, two well defined 
peaks corresponding to the 18S and 28S ribosomal RNAs should be observed, with ratios 
approaching 2:1 for the 28S: 18S bands.
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The T7-01igo(dT) Primer was hybridised to poly-A RNA by incubating the mixture at 
70 °C for 10 minutes, spinning down and placing the mixture on ice. 8 pi o f 5 x 
Reverse Transcriptase Buffer, 4 pi 0.1 M DTT, 2.5 pi Reverse Transcriptase Enzyme 
Mix (20 U p i'1) and 4pl o f dNTP mix (10 mM each) was then added to the mixture and 
the reaction was incubated for an hour at 42 °C (total reaction volume 40 pi).
The first strand cDNA sysnthesis reactions were then placed on ice ready for second 
strand syntheis. This was perfomed by adding 72 pi RNase free H2 O, 30 pi 5 x Second- 
strand Synthesis Buffer, 1.5 pi dNTP mix (10 mM each), 6.5 pi Second-strand 
Synthesis Enzyme Mix (containing E. coli DNA Ligase, DNA Polymerase I and RNase 
H) (total reaction volume 150 pi). The reaction was incubated at 16 °C for 2 hours, 
followed by the addition o f 20 pi o f T4 DNA Polymerase (20 U), and a further 5 minute 
incubation at 16 0 C. The reaction was stopped by the addition o f 17 pi 0.2 M EDTA 
pH 8. Residual RNA was removed by the addition o f 1.5 pi RNase I (15 U) and a 30 
minute incubation at 37 °C. Samples were then purified using the GeneChip Sample 
Cleanup Module (Affymetrix) according to the manufacturers instructions for cDNA 
purfication.
In Vitro Transcription (IVT) labeling reaction
Each cDNA sample was used as a template for an IVT reaction using the GeneChip IVT 
Labeling Kit (Affymetrix). To 12 pi o f cDNA, we added the following components; 8 
pi RNase free H2 0 , 4 pi 10 x IVT Labeling Buffer, 12 pi IVT Labeling NTP Mix, 4 pi 
IVT Labeling Enzyme Mix (total reaction volume 40 pi). The reactions were incubated 
at 37 °C for 16 hours and cRNA was purified using the Sample Cleanup Module 
(Affymetrix) according to the manufacturers instructions for cRNA purification. The 
quality and concentration o f the biotin-labeled cRNA was then analysed using an 
Agilent 2100 Bioanalyser (figure 2-5)
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Figure 2-5: Analysis of cRNA samples after in vitro transcrip tion  using an Agilent 2100 
Bioanalyser, a) Agilent 2100 Bioanalyser gel image of the 12 labeled cRNA samples generated 
by in vitro transcription to be used for GeneChip analysis. B) Electropherogram (from Agilent 
2100 Bioanalyser) of a representitve cRNA sample (1BR OGy B, lane 6).
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Fragmentation o f RNA
The full length cRNA was fragmented to 35 to 200 base fragments using the 
Fragmentation Buffer supplied with the Sample Cleanup Module (Affymetrix). 20 pg of 
test cRNA was mixed with 8 pi 5 x Fragmentation Buffer and made up to a total volume 
of 40 pi with RNase free H2O. The mixture was incubated at 94 °C for 35 minutes and 
then placed on ice.
2.16.2 Target Hybridisation
Hybridisation of cRNA to HG-U133A GeneChips was performed according to the 
manufacturer's instructions. Briefly, 15 pg o f fragmented cRNA was mixed with 5 pi 
of Control Oligonucleotide B2, 15 pi 20 X Eukaryotic Hybridisation controls (bioB, 
bioC, bioD, ere), 3 pi Herring Sperm DNA (10 mg ml'1), 3 pi BSA (50 mg ml"1), 30 pi 
DMSO, 150 pi 2 X Hybridisation Buffer (100 mM 2-[Morpholino] ethanesulphonic 
acid (MES), 1M [Na+], 20 mM EDTA, 0.01 % Tween-20) and made up to a final 
volume o f 300 pi with H2O. This hybridization cocktail was heated to 99 °C for 5 
minutes, followed by a 5-minute incubation at 45 °C. Meanwhile, HG-U133A 
GeneChips were filled with 1 X Hybridisation Buffer and incubated at 45 °C for 10 
minutes with rotation. The GeneChips were then filled with the appropriate 
hybridization cocktail and incubated for 16 hours at 45 °C with rotation.
2.16.3 Washing, Staining and Scanning
After hybridisation, the chips were stained with a fluorescent molecule, streptavidin- 
phycoerythrin (SAPE), which binds to biotin. The staining protocol includes a signal 
amplification step that employs anti-Streptavidin antibody (goat) and biotinylated goat 
IgG antibody (Figure 2-6). The series of washes and stains with these reagents binds 
the biotin and provides an amplified flour that will emit light when the chip is scanned 
with a confocal laser. SAPE mix was prepared by mixing 600 pi 2 X Stain Buffer (100 
mM MES, 1 M [Na+], 0.05 % Tween-20), 48 BSA (50 mg ml'1), 12 nl SAPE (lm g  
ml'1), 540 nl H20 .
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Figure 2-6: Fluorescent staining of the hybridised G eneChip arrays incorporates a signal 
amplification step involving SAPE, A nti-Streptavidin (goat) and biotinylated G oat IgG.
Biotin antibody solution mix was prepared by mixing 300 pi 2 X Stain Buffer, 24 pi 
BSA (50 mg ml'1), 6 pi 10 mg m l'1 Goat IgG (10 mg m l'1), 3.6 pi biotinylated antibody 
(0.5 mg ml'1) and 266.4 pi H2O. The hybridised GeneChip arrays were washed and 
stained using a Fluidics Station 400 operated by Microarray Suite 5 (Affymetrix). The 
fluidics station was set to run the Affymetrix wash and stain script EukGE-WS2v4 
(table 2-4)
EukGE-WS2v4*
Post Hyb 
Wash#1
10 cycfes o f  2 m ixesfcycfe w ith W ash  
Buffer A at 25*C
Post Hyb 
Wash #2
4 cycfes of 15 m ixes/cycle with W ash  
Buffer B at 50*C
Stain Stain th e probe- array for 10 m in utes in SAPE solution at 25*C
Post Stain 
Wash
10 cycfes o f  4  m ixes/cycle  with W ash  
Buffer A at 25*C
2nd Stain Stain th e probe array for 10 m in utes in antibody solution at 25*C
3rd Stain Stain th e probe array for 10 m in utes in SAPE solution at 25*C
Final
Wash
15 cycfes of 4  m ixes/cycle with W ash  
Buffer A at 30*C. The holding 
tem perature is 25°C
•  W ish  Buffer A = non-stringent w a sh  buffer
•  W ash Buffer B =  stringent w ash buffer
Wash Buffer A
Non-Stringent Wash Buffer 1000 ml
300 ml 20 X SSPE
(3M NaCl, 0.2M NaH2P 0 4, 0.02M  EDTA)
1.0 ml 10 % Tween-20 
699 ml H20
Wash Buffer B
Stringent Wash Buffer 1000 ml
83.3 ml 12 X MES Stock Buffer 
5.2 ml 5 M NaCl
1.0 ml 10 % Tween-20 
910.5 ml H20
Table 2-4: Fluidics protocol EukGE-WSv4 and wash buffers used for antibody 
amplification of eukaryotic targets
The stained microarrays were then scanned with an Affymetrix GeneChip Scanner 3000 
controlled by Microarray Suite 5. The Microarray Suite 5 (MAS5) statistical algorithm 
was used to calculate signal intensities and make significance calls for the resulting 
data, which was exported to GeneSpring 6.0 for comparative analysis.
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Chapter 3: Development of novel assays for cellular 
radiosensitivity
3.1 Background
One of the main aims of this project was to develop new methods o f assessing and 
investigating cellular radiosensitivity. Fibroblast survival assays have been widely used 
to identify patients with radiosensitive disorders (Arlett et al, 1988) (Cavazzana-Calvo 
et al, 1993) (Nicolas et al 1996) (Nicolas et al 1998) (Peake et al, 1999) (Riballo et al, 
1999) (O’Driscoll et al, 2001) (Dai et al, 2003) (Kobayashi et al, 2003) (Noordzij et al, 
2003) but once a skin biopsy is received it takes approximately 2 months before a 
primary line is generated and the survival assays completed. We therefore investigated 
whether radiation induced lymphocyte apoptosis, an endpoint that can be measured after 
a matter of days, could be used as a more rapid screen for cellular radiosensitivity. 
Lymphocytes are also easily separated from whole blood, a tissue that is more readily 
obtained from patients than skin biopsies. This assay could therefore improve the speed 
and ease with which we identified radiosensitive patients.
Radiation induced lymphocyte apoptosis is an end point that can be accurately 
measured using Annexin V staining and subsequent FACS analysis (Hertveldt et al, 
1997), but the relative fraction o f primary human fibroblasts that initiate apoptosis in 
response to radiation has been reported as very low or nearly null (Chung et al, 1998) 
(Dikomey et al, 1998) (Kawabe et al, 2001) (Zhang et al, 2001a). In contrast, there is 
increasing evidence that after irradiation a substantial fraction of human cells, in 
particular primary fibroblasts, are inactivated by a permanent growth arrest (Little et al, 
1985) (Di Leonardo et al, 1994) (Yount et al, 1996) (Linke et al, 1997) (Williams et al, 
1997) (Boyle et al, 1999) (Azzam et al, 2000). Since survival assays focus on colony 
formation after 2-3 weeks, they give no insight into the fate of cells that survive the 
initial genotoxic insult, but ultimately fail to proliferate and form colonies. We 
therefore developed a novel assay to look at the proliferation o f fibroblast cultures 
within days of irradiation. This was performed using CFSE cell division analysis, and 
allowed us to identify important differences between control and radiosensitive cells in 
relation to cell fate after irradiation.
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3.2 Lymphocyte apoptosis as a measure of cellular 
radiosensitivity
14 patients were investigated for abnormal responses to DNA damage using the 
Annexin V-FITC lymphocyte apoptosis assay. Where possible, blood was obtained 
from a healthy adult donor (below 30 years) in parallel with patient blood, and both 
samples were transported together to the Institute o f Child Health (ICH).
3.2.1 FACS analysis
The sample was first evaluated with respect to cell size and granularity, allowing the 
elimination of any debris during data acquisition (figure 3-1 a-b). The gated 
lymphocytes were then analysed for Annexin V and 7AAD fluorescence using 10,000 
events/sample, unless otherwise stated (figure 3-lc-d). Annexin V binds to 
phosphatidylserine (PS) residues that translocate from the inner leaflet o f the plasma 
membrane to the outer leaflet in the early stages o f apoptosis. This exposes PS to the 
external environment and allows the percentage o f cells undergoing apoptosis to be 
quantified. Lymphocytes were also counterstained with 7AAD, which is a DNA 
binding dye and identifies necrosis and the later stages o f apoptosis, when the plasma 
membrane becomes highly permeable.
Radiation induced apoptosis was first investigated in a control sample in order to select 
the criterion to be used for data analysis. We decided to use a 24 hour incubation period 
from a preliminary time course experiment (data not shown) of 24, 48 and 72 hours 
because radiation induced apoptosis was well defined, and there was minimum death 
resulting from cell culture conditions. After 3 Gy o f y-radiation the percentage of 
Annexin V positive cells (green dots) increased by approximately 10 %, and the 
percentage of 7AAD positive cells (blue dots) increased by approximately 4 %. This 
increase in Annexin V and 7AAD staining corresponds to cells that have entered the 
early (figure 3-1 d, arrow 1) and late (figure 3-Id, arrow 2) stages o f apoptosis 
respectively, in response to y-irradiation. Total Annexin-V positive cells (figure 3-lc-d, 
green and blue dots) was used as a measure o f radiation-induced apoptosis since this 
displayed the most consistent dose response relationship (data not shown). An increase 
in apoptosis of approximately 15 % was observed in total Annexin-V positive cells after 
3 Gy y-radiation at 24 hours (figure 3-le-f).
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Figure 3-1: Selection of criterion  for da ta  analysis from  a control of average rad iation  
response, (a-b) Dot plots of cell size versus cell granularity 24 h after (a) 0- and (b) 3-Gy y- 
radiation. The cells in the gated areas are lymphocytes, (c-d) Dot plots of Annexin V staining 
versus 7AAD staining showing lymphocytes (selected from the previous gated areas) 24 h after 
(c) 0- and (d) 3-Gy y-radiation. Red dots are unstained cells, green are both annexin V positive 
and 7AAD negative and blue are both Annexin V and 7AAD positive. Their percentage is 
given, (e-f) Histograms of annexin V staining of lymphocytes 24 h after (e) 0- and (f) 3-Gy y- 
radiation. The percentage of cells stained with annexin V is given (these data are from a control 
donor of average radiation response)
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Evaluating a sample with respect to cell size and granularity is important in order to 
gate out any debris during data acquisition. This process also identified two distinct 
populations of lymphocytes. Population X (figure 3-2a) corresponded to resting (non­
cycling) lymphocytes, and population Y, with increased cell size and granularity, 
represented activated lymphocytes. Activated lymphocytes display high levels of 
spontaneous apoptosis and the percentage o f activated cells varied greatly between 
control and patient samples (data not shown), which could obscure any correlation of 
radiation-induced death. Immunodeficient patients may also have defects in 
lymphocyte activation, showing a failure to activate cells or excessive Activation 
Induced Cell Death (AICD). We therefore investigated the effect o f gating out activated 
lymphocytes, and focusing on non-cycling cells.
In response to 3 Gy y-radiation a patient o f average radiation response showed 37.7 % 
apoptosis when all lymphocytes were gated (figure 3-2a & c). When the same data was 
re-analysed to gate out the activated lymphocytes (population Y, figure 3-2a) and focus 
on the resting cells (population X, figure 3-2b) the apoptotic response was reduced by 
approximately 5 % (figure 3-2d). This may be expected considering the high levels o f 
apoptosis present in activated lymphocytes. When all lymphocytes were gated in 
(figure 3-2c) there were higher levels o f intermediary cells that fell between the two 
major populations. Gating out activated lymphocytes reduced this noise significantly, 
and produced two distinct populations o f cells, i.e. viable cells with low annexin-V 
staining, and apoptotic cells with high annexin-V staining. This allowed a more specific 
measurement of lymphocytes that had instigated apoptosis due to y-radiation induced 
DNA damage. Therefore, measurements o f apoptosis were taken from only resting 
lymphocytes.
3.2.2 Radiation induced PBL apoptosis
We performed the lymphocyte apoptosis assay on 14 control and 18 patient samples. 
PBLs isolated from whole blood were treated with increasing doses o f radiation from 0 
to 3 Gy, and incubated for 24 hours. Levels o f apoptosis increased with radiation. In 
order to establish a measure o f radiosensitivity, we evaluated levels o f spontaneous 
apoptosis, what constitutes a control response, and what criteria define a difference from 
this control response. Where possible we compared patient lymphocyte apoptosis 
results to those obtained using the fibroblast survival assay.
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Figure 3-2: Effect of gating out activated lymphocytes for a patien t of average rad ia tion  
response, (a-b) Dot plots of cell size versus cell granularity 24 h after 3-Gy y-radiation. (a) All 
lymphocytes gated (Population X (resting) and Y (activated)), (b) Resting cells gated (Population X ). (c- 
d) Histograms of annexin-V staining of lymphocytes 24 h after 3-Gy y-radiation (selected from 
the previous gated areas), (c) All lymphocytes gated (Population X (resting) and Y  (activated)), (d) 
Resting cells gated (Population X ). The percentage of cells stained with annexin-V is given (these 
data are from a patient of average radiation response). Note the clearer peak separation when 
resting cells are gated.
Spontaneous Apoptosis
The spontaneous (0 Gy) levels of apoptosis appeared to be highly variable between 
patient samples, ranging from below 5 % to approximately 30 % (figure 3-3). This 
range was reduced in control samples, from below 5 % to approximately 15 %. This 
high degree of variability between patient samples did not appear to be indicative of 
radiation sensitivity. Therefore, in order to identify differences in radiation-induced
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apoptosis, we modified this raw data by first subtracting the spontaneous (0 Gy) levels 
of apoptosis from each response. This process would also be expected to reduce any 
variability due to differences in handling o f the samples before they arrived at the 
Institute of Child Health.
Establishment o f a mean control response
All of the control samples demonstrated radiation induced apoptosis (figure 3-4a). The 
majority (9/14) of control samples exhibited radiation induced apoptosis of 
approximately 10 - 18 % at 3 Gy o f radiation (figure 3-4a. solid lines). The other 5 
control samples fell outside this range and appeared to have abnormal levels o f radiation 
induced apoptosis (figure 3-4a, dashed lines). Differences in sensitivity between 
individual controls were accounted for by taking an average of all (14) the control 
responses and calculating the standard deviation. This gave a normal radiation response 
region with which to compare patient samples (figure 3-4b).
Patient dose response curves
The patient lymphocytes all demonstrated increased apoptosis after irradiation (figure 3- 
5, red lines), and could be classified into 3 categories according to the extent of 
apoptosis induced. 7 o f the patient samples exhibited high levels o f apoptosis compared 
to the mean control region (figure 3-5, high group). These responses were comparable 
to those observed for the abnormally high control responses (figure 3-4a). 9 o f the 
patient samples fell in the mean control range and were therefore classified as normal 
(figure 3-5, medium group). 2 o f the patient samples demonstrated low radiation 
induced apoptosis compared to the mean control region (figure 3-5, low group). These 
responses were comparable to the abnormally low control responses (figure 3-4a)
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Figure 3-3: Spontaneous (0 Gy) levels of apoptosis for control and patient samples
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Figure 3-4: Establishm ent of a m ean control response, (a) Radiation induced apoptosis of 
control lymphocytes. The majority (9/14) of control samples demonstrated radiation induced 
apoptosis of approximately 10 -  18 % at 3 Gy (solid lines). 5 control samples deviated from 
this and appeared to have abnormal levels of radiation induced apoptosis (dashed lines), (b) 
Mean of the 14 control responses. Grey shaded area represents one standard deviation from the 
mean.
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Figure 3-5: Patient dose response curves com pared to the m ean control region. Dose 
response curves of radiation induced apoptosis for patient lymphocytes (red lines). Shaded area 
represents the normal control region. Patient responses fell into 3 categories; high responses 
compared to control (7), medium responses comparable to control (9) and low responses 
compared to control (2).
Individual Patient Radiation Sensitivity
After subtraction of spontaneous apoptosis the lymphocyte apoptotic response of 18 
patient samples exposed to 3 Gy y-radiation was expressed as the percentage of the 
mean control response (figure 3-6). 4 of these samples represented repeat experiments. 
Patients NG1 and 455BR displayed an abnormally low induction of apoptosis in 
response to radiation compared to control (figure 3-6, grey bars). This may represent a 
defect in these patients’ lymphocytes that prevents them from mounting a normal 
physiological response to radiation induced DNA damage. Patients NG2, GOS13, 
GOS14, GOS7, GOS11 and GOS12 (2 experiments) all show apoptotic responses to 
radiation within the control region (figure 3-6, clear bars). 2 patients displayed an 
elevated apoptotic response in the first experiment (figure 3-6, l)GOS5 and 1)SMM1), 
but a normal response in the repeat (figure 3-6, 2)GOS5 and 2)SMM1).
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Figure 3-6: Bar chart of patient lymphocyte apoptosis 24 h after 3 Gy y-radiation. Values 
are expressed as % of the mean of 14 control responses to 3 Gy y-radiation. Error bars represent 
standard deviation. 9 responses fell within (clear bars), 2 below (grey bars) and 7 above (red 
bars) the normal range. 1) and 2) represent first and repeat experiments respectively.
This made it difficult to determine whether these patients were truly radiosensitive. 
There may be a factor (e.g. treatment, progression of disease) influencing the radiation 
response of lymphocytes from these patients that has changed between experiments, and 
due to the nature of studies using clinical samples we have been unable to control for 
this. GOS1, NG3 and GOS9 displayed elevated levels of apoptosis in response to 
radiation after one experiment. Further studies would be required to verify this result in 
light of the variability between experiments that has been observed. Patient GOS9 was 
being treated with dexamethasone at the time of this study, which may have affected the 
lymphocyte apoptotic response. Patient ACX034 is the only patient to show clearly
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elevated apoptosis in response to radiation in two experiments (figure 3-6, 1)ACX034 
and 2)ACX034). This may demonstrate a defect in this patient’s cells, where the DNA 
damage response network induces higher levels o f apoptosis due to abnormal repair 
and/or survival pathways.
Comparison with fibroblast survival assays
It was possible to use the fibroblast survival assay to determine radiation sensitivity for 
5 of the patients also investigated for abnormal lymphocyte apoptosis, and the results 
from both assays were compared (table 3-1).
Table 3-1: Lymphocyte apoptosis and fibroblast survival assay results
Patient Lymphocyte Apoptosis Fibroblast Sensitivity
ACX034 Elevated (2 experiments)) Mild radiosensitivity*
GOS1 Mildly Elevated Mild radiosensitivity
GOS5 Elevated (1st experiment) Normal (2nd experiment) Radiosensitive
GOS7 Normal Normal*
GOS14 Normal Mild radiosensitivity
Results are for patients with a known result in both assays (Section 4.2 and results from collaborators). 
*Results from collaborators (Laboratory of P. Jeggo, University of Sussex).
ACX034 and GOS1 both had mildly sensitive fibroblasts and displayed elevated levels 
of radiation induced lymphocyte apoptosis. GOS7 also had comparable results in both 
assays, demonstrating normal fibroblast and lymphocyte sensitivities. Conversely, 
GOS14 displayed elevated fibroblast sensitivity to radiation, but normal levels of 
radiation-induced lymphocyte apoptosis. GOS5 exhibited radiosensitive fibroblasts but 
had variable lymphocyte apoptosis results, with elevated levels of radiation induced 
apoptosis in one experiment but normal levels in the repeat. These results demonstrate 
that a patient with radiosensitive fibroblasts can have a normal result in the lymphocyte 
apoptosis assay, and suggest that radiation induced lymphocyte apoptosis is not always 
a consistent measure o f fibroblast sensitivity. Patients with radiosensitive fibroblasts 
generally displayed elevated levels o f radiation induced lymphocyte apoptosis, but on 
two occasions this was not the case. Lymphocyte radiosensitivity therefore showed 
some correlation with fibroblast radiosensitivity, but does not appear reliable enough to 
use as a predictive assay.
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3.3 Analysis of fibroblast radiosensitivity using CFSE
Colony forming assays have been widely used to identify patients with radiosensitive 
disorders and are the most reliable method o f determining cellular radiosensitivity.
These assays evaluate the relative survival o f different fibroblast lines 2-3 weeks after 
irradiation, but give no insight into what happens to cells that survive the initial 
genotoxic insult but fail to proliferate and form colonies. We therefore developed a 
novel assay to look at what happens to fibroblasts during the course o f a radiosensitivity 
survival assay, and what mechanisms may be influencing these cell fate decisions.
Since there is increasing evidence that fibroblasts do not initiate apoptosis in response to 
radiation (Chung et al, 1998) (Dikomey et al, 1998) (Kawabe et al, 2001) (Zhang et al, 
2001), we focused on cell division using the fluorescent dye CFSE.
CFSE is used for analysing cell division by monitoring serial dilution o f the dye in 
labeled cells. CFSE consists o f a fluorescein molecule containing two acetate moieties 
and a succinimidyl ester functional group. In this form, it is membrane permeate and 
non-fluorescent. After diffusion into the intracellular environment, endogenous 
esterases remove the acetate groups, rendering the molecule highly fluorescent and non- 
permeate to the cell. In addition, the succinimidyl ester reacts with free amine groups of 
intracellular proteins, forming covalent dye-protein adducts. Upon cell division CFSE 
is partitioned between daughter cells with remarkable fidelity.
3.3.1 Examination of fibroblast cell division using CFSE
There are no studies in the literature reporting the use o f CFSE to monitor cell division 
in primary fibroblasts. Preliminary experiments therefore addressed whether this 
technique could be used for this purpose. Control cells harvested and fixed immediately 
after labeling with CFSE displayed a high level o f fluorescence (figure 3-7, blue line). 
When the cells were incubated for 6 days this fluorescence decreased to a level that 
corresponded to 5-8 divisions in the majority o f cells (figure 3-7, red line). The CFSE 
profile o f  dividing fibroblasts did not consist o f well-defined peaks that represent each 
cell division as is the case with lymphocytes (Lyons, 2000). This may be explained by 
the greater heterogeneity in size between individual fibroblast cells compared to 
lymphocytes. Fibroblasts o f a certain division number had a wider range o f CFSE 
fluorescence, and therefore the corresponding peaks merged into a profile with poorer 
resolution compared to lymphocytes. In order to calculate the percentage o f cells that
107
had achieved a certain number of divisions, the fluorescence level at the peak of the 
zero division control population was used as a baseline. This value was sequentially 
halved to calculate the fluorescence intensity that corresponded to cells of any 
subsequent division number.
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Figure 3-7. CFSE profile of control fibroblast division after 6 days. Cells were labelled 
with CFSE and fixed in Paraformaldehyde immediately (blue line) or incubated for 6 days (red 
line). Cells were then analysed by flow cytometry
3.3.2 Examination of control fibroblast division early after irradiation
After we demonstrated that CFSE could be used to monitor primary fibroblast division, 
we then investigated the effect of y-radiation on the cell division profiles of control 
cells. Initial experiments involved labeling and irradiating cells on day 0, incubating the 
cultures for 3 and 6 days and then performing FACS analysis. Irradiated cells were 
compared to untreated cultures, and cells that were harvested and fixed immediately 
after labeling again served as 0 day controls. After a 3 day incubation the majority of 
cells in irradiated cultures had arrested after only 1 division whereas most of the 
unirradiated cells had completed 3 divisions (figure 3-8). This is consistent with the 
initiation of DNA damage checkpoints and the induction of cell cycle arrest. After a 6 
day incubation, whereas the majority of unirradiated cells had completed 5 divisions, 
irradiation induced two distinct populations of cells. Whilst the majority of cells 
remained arrested after only 1-3 divisions, a minor population of cells had emerged to 
complete 5 divisions similar to the majority of unirradiated cells (figure 3-8). We 
hypothesised that these dividing cells may represent the surviving fraction of cells that
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would proliferate to form colonies in clonogenic survival assays. We therefore went on 
to investigate whether this fraction of dividing cells could be used as a measure of 
radiosensitivity, and compare this endpoint between control cells and a line we knew to 
be radiosensitive, the Artemis deficient CJ179 line.
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Divisions
3 days
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Figure 3-8: Effect of 4Gy y-radiation on CFSE cell division profiles of control cells 
incubated for (a) 3 and (b) 6 days. Control 1BR cells were labeled with CFSE and then either 
mock irradiated (-y) or exposed to 4Gy y-radiation (+y) on day 0. Cells were then incubated for 
(a) 3 or (b) 6 days after which FACS analysis was performed, (a) 3 days after irradiation the 
majority of cells had arrested after only 1 division (+y), whereas mock irradiated cells had 
divided 3 times (-y). (b) 6 days after irradiation although the majority of cells remained arrested 
after only 1-3 divisions, a minor population of cells had divided 5 times similar to mock 
irradiated cells.
3.3.3 Comparison of early post-irradiation division in control and 
radiosensitive cells
Control cells were labeled with CFSE and treated with increasing doses of y-radiation 
up to 4Gy. Since preliminary experiments suggested that a 6 day incubation may be 
optimal to distinguish dividing from arrested cells (figure 3-8), this time point was used 
to asses the relative level of division after irradiation. This was taken as the percentage 
of cells that completed at least 5 divisions during the 6-day timeframe. In each 
experiment cells that were harvested and fixed immediately after labeling were used to 
set the 0 day level of CFSE fluorescence. This accounted for any variation in labeling 
between individual experiments and different cell lines.
As the dose of radiation increased the percentage of control (1BR) cells that completed 
5 divisions decreased, from 85% in unirradiated cultures, to 33% in cells treated with 
4Gy y-radiation (figure 3-9a). This coincided with an equivalent increase in the amount
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Figure 3-9: CFSE profiles of a) 1BR and b) CJ179 fibroblasts 6 days after irradiation.
With increasing doses of radiation more cells arrested after only 1-3 divisions, and the 
percentage of cells that have completed 5 divisions decreased. This effect was more severe in 
the radiosensitive CJ179 line (b) than in control cells (a).
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of cells arrested after only 1-3 cell divisions. When the same experiment was performed 
with the radiosensitive CJ179 line, this effect was more severe (figure 3-9b). The 
percentage of CJ179 cells that completed 5 divisions decreased from 75% in 
unirradiated cultures, to only 6% in cells treated with 4 Gy y-radiation.
We repeated early division experiments for the control 1BR and repair defective CJ179 
lines a minimum of 3 times. In order to account for any differences in cell doubling 
time between different lines, the amount of cells that completed 5 divisions after 
irradiation was expressed as a percentage of that in unirradiated cells. This allowed us 
to focus on radiation-induced changes in cell division. Compared to control 1BR cells, 
the radiosensitive CJ179 line demonstrated a significant reduction in the perecentage of 
cells that had completed 5 divisions after irradiation (figure 3-10). This was evident 
even at the lowest dose investigated. After 1 Gy of y-radiation only 48 % of cells had 
completed 5 divisions in the CJ179 line, compared to 91 % in control cells.
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Figure 3-10: Fibroblast division early after irradiation in a control and radiosensitive 
line; reduction in the percentage of cells that have completed 5 divisions within the first 6 
days of irradiation. Compared to control 1BR cells (blue bars) the radiosenstive line CJ179 
(red bars) demonstrated a signgificant reduction in the percentage of cells that have completed 5 
divisions. This was evident even at the lowest dose of 1 Gy. Error bars represent SEM 
(standard error of the mean).
During these early division experiments we noticed there was a consistent increase in 
the proportion of large cells within fibroblast cultures after irradiation, and this was 
evident in forward scatter (FS) side scatter (SS) plots (figure 3-11). This population of
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large cells corresponded to those that had arrested after only 1-3 divisions. The 
remaining smaller cells within the culture corresponded to dividing cells that had 
completed at least 5 divisions (figure 3-11, blue cells). Since these cells were labeled 
with CFSE before irradiation, any increase in large cells with high CFSE fluorescence 
(i.e. arrested cells) after irradiation can be attributed to the genotoxic treatment, and not 
that larger cells simply incorporate more CFSE. This is consistent with the induction of 
a senescent like phenotype, which has been previously described to occur in primary 
fibroblasts after irradiation (Toussaint et al, 2000) and has been monitored using flow 
cytometry (Gorbunova et al, 2003).
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Figure 3-11: Increase in a population of large arrested cells in control fibroblasts 6 days 
after irradiation, (a-c) Forward scatter, side scatter plots with small cells shown in blue, and 
large cells shown in red 6 days after (a) OGy (b) 2Gy and (c) 4Gy y-radiation. Percentage of 
large and small cells is shown, (d-e) Corresponding CFSE plots with large cells shown in red 
and small cells shown in blue 6 days after (d) OGy, (e) 2Gy and (f) 4Gy y-radiation.
In early division experiments the Artemis deficient C J179 line demonstrated a 
significant reduction in the percentage of cells that had completed 5 divisions after 
irradiation compared to control (figure 3-10). After further analysis we found that this 
line was much more prone to a radiation-induced population of large arrested cells, and 
this accounted for the significant reduction in cell division observed compared to the 
control line (figure 3-12).
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Figure 3-12: The CJ179 line is m ore p rone to the induction  of an a rre s ted  population  of 
large cells w ithin 6 days of irrad ia tion . CFSE plots with large cells shown in red and small 
cells shown in blue for a) 1BR and b) CJ179 cells 6 days after treatment with 0, 2 and 4Gy y- 
radiation as indicated. The Artemis deficient CJ179 line was more prone to the induction of a 
population of large arrested cells compared to control cells.
CFSE cell division analysis can therefore be used to monitor primary fibroblast division 
early after irradiation, i.e. within the first few days. We were able to determine that the 
induction of an arrested population of cells occurred in a dose dependent manner, and 
since primary fibroblasts are resistant to radiation-induced apoptosis, this is likely to be 
an important endpoint in determining cellular radiosensitivity. Consistent with this 
hypothesis, we were able to identify differences between control and radiosensitivie 
cells, and discover that the repair defective CJ179 line is more prone to the induction of 
an arrested population of cells. This resulted in a significant reduction in the 
proliferation of CJ179 cultures compared to controls after irradiation, and cell cycle 
arrest may therefore be a key mechanism by which the clonogenic potential of 
radiosensitive fibroblasts is affected. After irradiation we also observed an increase in 
the proportion of large cells within fibroblasts cultures, and these cells corresponded to 
those that had arrested after only 1 -3 divisons. The C J179 line was more prone to this 
large cell arrest phenotype than control cells, and this suggests that DNA repair defects 
have a substantial influence on cell survival outcome after irradiation. This assay 
should allow the further investigation of what happens to fibroblasts during the course 
of a clonogenic survival assay, and allow a better understanding of what factors may be 
influencing these cell fate decisions.
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3.4 Discussion
Fibroblast survivals assess the clonogenic potential o f cells treated with ionizing 
radiation and have been extensively used to identify patients with radiosensitive 
disorders (Arlett et al, 1988) (Cavazzana-Calvo et al, 1993) (Nicolas et al 1996)
(Nicolas et al 1998) (Peake et al, 1999) (Riballo et al, 1999) (O’Driscoll et al, 2001) 
(Dai et al, 2003) (Kobayashi et al, 2003) (Noordzij et al, 2003). This process involves 
the generation of primary fibroblast lines from skin biopsies and the subsequent analysis 
of radiosensitivity using a colony-forming assay. This entire process takes 
approximately 2 months to complete and therefore restricts the speed with which the 
researcher can identify patients with radiosensitive disorders. The development o f a 
more rapid screen for cellular radiosensitivity would therefore be beneficial to both the 
clinician and scientist in the investigation o f patients with potential DNA damage 
response defects.
We investigated whether radiation-induced lymphocyte apoptosis could be used to 
identify radiosensitive patients more rapidly and less intrusively than the fibroblast 
survival assay. We found there was a high degree o f inter-control variability in 
radiation induced lymphocyte apoptosis, and 2 patients displayed conflicting results 
between repeat experiments. This suggested there were external factors we could not 
control for, such as the subject’s current state o f health or treatment, which were 
influencing the apoptotic response o f lymphocytes. Lymphocyte cell types have been 
shown to vary in their apoptotic response to DNA damage (Crompton et al, 2001) 
(Wilkins et al, 2002) (Schmitz et al, 2003), and differences in cell populations may have 
contributed the observed variability. Another problem encountered was that most o f the 
patients described are children, and obtaining control samples from healthy children of a 
similar age is difficult. The lymphocyte apoptotic response has been shown to both 
decrease (6.5 % less apoptosis with each 10 years o f life, Crompton et al, 2001) and 
increase (Schmitz et al, 2003) with age using two different experimental designs. 
Although we tried to obtain control blood from adults under 30, comparing samples 
from subjects o f different ages is not ideal, and may have contributed to inter-control 
variability.
Patients with radiosensitive fibroblasts generally displayed elevated levels o f radiation 
induced lymphocyte apoptosis, but on two occasions this was not the case. Previous
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studies have failed to identify a robust correlation between fibroblast and lymphocyte 
radiosensitivity (Cole et al, 1988) (Geara et al, 1992), and it was suggested that tissue- 
specific characteristics, such as differentiation status, might variably modulate 
radiosensitivity. We investigated undefined immunodeficient patients that are likely to 
have abnormal blocks in lymphocyte development. The limited number o f lymphocytes 
that remain in these patients were investigated for radiosensitivity, and may have given 
varied apoptotic responses depending on their differentiation status, and not just the 
intrinsic sensitivity of the patient. This may explain some o f the observed discrepancies 
between radiation-induced lymphocyte apoptosis, and radiosensitivity in fibroblast 
lines; cells that should be o f similar differentiation status between different patients.
Since radiation-induced lymphocyte apoptosis can be measured within 24 hours of 
irradiation, this was a good candidate system to use as a predictive assay for intrinsic 
cellular radiosensitivity. Despite showing some correlation with fibroblast survival 
assays, we found that radiation-induced lymphocyte apoptosis can be variable between 
repeat experiments, and certain control samples from apparently normal individuals 
may give an elevated response. Therefore, although this assay may have an application 
in the investigation of a predetermined radiosensitive phenotype, it does not appear 
reliable enough to use as a pre-screening assay for fibroblast radiosensitivity.
Whilst fibroblast survival assays take a relatively long time to perform, they also give 
no insight into the fate o f cells that survive the initial genotoxic insult, but then fail to 
proliferate and form colonies. Many reports suggest that primary fibroblasts are not 
prone to the induction o f apoptosis after irradiation (Chung et al, 1998) (Dikomey et al, 
1998) (Kawabe et al, 2001) (Zhang et al, 2001a), but there is increasing evidence that a 
substantial fraction of primary fibroblasts are inactivated by a permanent growth arrest 
(Little et al, 1985) (Di Leonardo et al, 1994) (Yount et al, 1996) (Linke et al, 1997) 
(Williams et al, 1997) (Boyle et al, 1999) (Azzam et al, 2000). We therefore decided to 
examine the proliferation o f primary fibroblasts after irradiation using CFSE cell 
division analysis. This allowed us to study the early effects o f radiation on fibroblast 
growth, within the first few days o f DNA damage.
Early division experiments demonstrated that 3 days after irradiation the majority of 
control cells had arrested after only 1 division, compared to unirradiated cultures where 
most cells had completed three cell divisions. This is consistent with the induction o f
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DNA damage checkpoints and the initiation o f cell cycle arrest. 6 days after irradiation 
whilst the majority of cells remained arrested after only 1 -3 divisions, a minor 
population of cells had emerged to complete 5 divisions similar to the majority o f  
unirradiated cells. These dividing cells may represent the surviving fraction that 
proliferates to form colonies during clonogenic survival assays. A similar effect of 
radiation on cell division has been described in colon carcinoma cells, where although a 
strong damage-induced growth arrest occurred 3 days after treatment with 
chemotherapeutic agents, a substantial fraction o f dividing cells emerged by day 6 after 
release from the drug (Chang et al, 1999b). The extent o f this growth arrest was greatly 
diminished in the absence o f p21, and partially reduced on a p53 null background 
(Chang et al, 1999a). A large proportion o f the radiation induced growth arrest we have 
observed in primary fibroblasts is therefore likely to result form the induction o f p21, 
via both p53 dependent and possibly p53 independent pathways.
We next demonstrated that the DSB repair defective CJ179 line is more prone to the 
induction o f an arrested population o f cells after irradiation compared to control cells, 
and this resulted in a reduced amount o f cells that completed 5 divisions. An elevated 
level of radiation-induced chromosome damage has been previously observed in NHEJ 
defective cells (Badie et al, 1995a) (Badie et al, 1995b) (Evans et al, 1996) (Rooney et 
al, 2003). This could have led to an enhanced activation o f the p53 pathway and a 
higher induction of growth arrested cells. A similar situation was previously described 
in NHEJ deficient cells undergoing V(D)J recombination, where the persistence o f  
DSBs led to the enhanced activation o f p53 and elevated levels o f apoptosis (Guidos et 
al, 1996). The persistence o f chromosomal damage after V(D)J recombination in 
lymphocytes or radiation exposure of fibroblasts may therefore lead to an enhanced 
activation of p53. Since fibroblasts are resistant to apoptosis, this manifests as elevated 
levels of growth arrest in this system.
Another possibility for enhanced growth arrest in the CJ179 line after DNA damage 
may be inactivation due to abnormal mitotic events. This involves the induction of 
chromosome aberrations that lead to the loss o f DNA during mitosis in the form of 
micronuclei 2-3 divisions after irradiation (Joshi et al, 1982a) (Joshi et al, 1982b) (Joshi 
et al, 1982c) (Savage et al, 1989) (Comforth and Goodwin, 1991). This mode o f cell 
inactivation was shown to be associated with non- or slow- growing fibroblast colonies 
after irradiation, and would be expected to be more prevalent in Artemis deficient cells
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due to the elevated levels of persistent radiation-induced chromosome damage 
frequently observed in radiosensitive lines (Badie et al, 1995a) (Badie et al, 1995b) 
(Evans et al, 1996) (Kawata et al, 2003) (Rooney et al, 2003).
We also observed an increase in the proportion o f large cells within irradiated cultures, 
and these cells corresponded to those that had arrested after only 1-3 divisions. This is 
consistent with the induction of a senescent like phenotype that has been observed after 
exposure to radiation (Di Leonardo et al, 1994) (Oh et al, 2001), and previous reports 
have described a similar increase in forward scatter when analysing senescent 
fibroblasts by flow cytometry (Gorbunova et al, 2003). The repair defective CJ179 line 
was more prone to this endpoint than control cells, and due to the high level o f residual 
chromosome damage described above may be more prone to the induction o f a stress 
induced premature senescence (Toussaint et al, 2000). This is consistent with a model 
proposed by Naka et al (2004) in which DNA damage initially triggers the G l/S  
checkpoint by the activation o f p53 by ATM. If DNA damage cannot be repaired 
within a few days o f irradiation, then the cells undergo SIPS to prevent accumulation of 
genetic mutations. Since CJ179 cells are defective in DSB repair, this line is unable to 
deal with the same level o f damage as controls and is therefore more prone to the 
induction of SIPS. This mechanism may be an important determinant o f cellular 
radiosensitivity since a significant correlation has been observed between radiation- 
induced differentiation and fibroblast survival (Lara et al, 1996).
Since this analysis focused on the live cells that remained 6 days after irradiation, these 
experiments would not detect any differences in mitotic death associated with lethal 
chromosome damage that had occurred within the first few days o f irradiation. This 
mode of cell inactivation was thought to be the most important process leading to a loss 
of proliferative capacity in irradiated cells (Comforth and Bedford, 1987), but recent 
results have suggested that p53 dependent arrest accounts for at least half o f the 
inactivation in irradiated primary fibroblasts (Borgmann et al, 2004). Analysis o f cell 
division would be expected to identify arrested cells resulting from both p53 dependent 
processes and gross chromosomal damage, but may not account for any cells that were 
killed by mitotic death. Whilst this caveat may result in an underestimation of 
radiosensitivity, this assay was able to identify major differences in post radiation cell 
division between a wild type and NHEJ deficient line. This suggests that in primary 
fibroblasts growth arrest is one o f the major cell fates after irradiation and is an
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important determinant of cellular radiosensitivity. Further analysis o f the distinct 
populations of dividing and growth arrested cells after irradiation may improve our 
understanding of the factors that influence cell fate decisions in response to DNA 
damage.
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Chapter 4: Identification of radiosensitive patients and 
further investigation
4.1 Background
A main aim of this project was to identify undefined immunodeficient patients that 
demonstrated cellular radiosensitivity. Fibroblast survival assays have been widely 
used for this purpose (Arlett et al, 1988) (Cavazzana-Calvo et al, 1993) (Nicolas et al 
1996) (Nicolas et al 1998) (Peake et al, 1999) (Riballo et al, 1999) (O’Driscoll et al, 
2001) (Dai et al, 2003) (Kobayashi et al, 2003) (Noordzij et al, 2003) and involve the 
generation of primary fibroblast lines. We took skin biopsies from undefined patients 
with low T- and B- lymphocyte function and established primary fibroblast lines, which 
were then assessed for radiosensitivity using a colony-forming assay. Primary 
fibroblasts were treated with increasing doses o f y-radiation and incubated for 2-3 
weeks until surviving colonies were visible to the naked eye. Colonies were then 
stained and counted which allowed the relative survival after irradiation to be 
calculated. Patient lines were compared to control cells and known radiosensitive 
mutants in order to classify radiosensitivity. This allowed the identification of a group 
of patients that demonstrated significant radiosensitivity compared to controls.
Section 3.2 described the development o f a novel radiosensitivity assay that focused on 
cell division with the first few days o f irradiation. Using CFSE we were able to monitor 
cell division early after irradiation and identified differences between control and 
radiosensitive cells in relation to survival outcome. This assay has the potential to 
investigate undefined radiosensitive lines and identify what happens to cells that survive 
the initial genotoxic insult but do not grow to form colonies in survival assays. Cell 
division analysis was therefore applied to the two undefined lines that demonstrated the 
most pronounced radiosensitivity in survival assays in order to gain some insight into 
the fate of these radiosensitive cells after irradiation.
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4.2 Identification of radiosensitive patients
4.2.1 Generation of primary fibroblasts
Primary skin fibroblast lines were established from 19 undefined immunodeficient 
patients. All of these lines grew well with a similar doubling time to that o f control 
cells except the GOS5 line. This line displayed poor growth and premature senescence 
at passage 9.
4.2.2 Fibroblast radiosensitivity survival assays
Primary fibroblast lines were investigated for radiosensitivity using the fibroblast 
survival assay described in section 2. This assay focuses on surviving colony formation 
after an incubation period o f 2-3 weeks post irradiation. Two control lines (1BR and 
48BR) demonstrated normal levels o f survival after exposure to ionising radiation 
(figure 4-1). A typical AT cell line (A-T1BR) demonstrated severe radiosensitivity 
similar to that previously described (Taylor et al, 1975). CJ179 is a line derived from a 
patient with a large genomic deletion in the Artemis DSB repair gene that results in the 
absence of transcript and protein. These cells can therefore be considered as Artemis 
null (P. Jeggo, personal communication), and this line demonstrated an intermediate 
level of radiosensitivity (figure 4-1).
F96 cells are from an undefined immunodeficient patient and were previously shown to 
be radiosensitive (Peake et al, 1999). These cells demonstrated intermediate levels of 
radiosensitivity similar to the repair defective CJ179 cells. 2BN cells, from another 
undefined immunodeficient patient, are known to be extremely sensitive to ionising 
radiation and defective in DSB repair (Dai et al, 2003). This line demonstrated severe 
radiosensitivity that was more pronounced than AT cells (figure 4-1)
20 undefined immunodeficient patients were investigated for damage response defects 
using the fibroblast survival assay. As a population this group o f 20 immunodeficient 
patients was not significantly more radiosensitive than the control population (p=0.1). 
This suggests that undefined immunodeficient patients do not represent a distinct 
population compared with normal individuals with respect to radiosensitivity.
Moreover, patients demonstrated a variety o f sensitivities ranging from normal to
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Figure 4-1 Sensitivity of control, mutant and patient fibroblasts to ionising radiation.
Exponentially growing fibroblasts were treated with y-radiation and plated immediately. Patient 
cells were compared to normal controls (1BR and 48BR), a typical AT cell line (A-T1BR), and 
a DSB repair deficient line (CJ179). Cells demonstrated normal, mild, intermediate or severe 
levels of radiosensitivity. Error bars represent SEM.
clearly radiosensitive. Subtle genetic differences and polymorphisms are likely to 
account for mild differences in radiosensitivity near to the control range, whilst more 
pronounced radiosensitivity is more likely to result from mutations that impair damage 
response protein function. On an individual level, we attempted to identify such 
patients by comparing the survival of each patient line to that of control cells after 
exposure to 4 Gy y-radiation using a student t-test to see if the survival levels observed 
were statistically significant. Using this criterion, 10 patient lines demonstrated normal 
levels of sensitivity that were not significantly different from control cells after 4 Gy y- 
radiation (figures 4-2 and 4-3).
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Figure 4-2: Survival curves for 10 patients that demonstrated normal radiosensitivity. 10
patient lines (light blue lines) demonstrated normal levels of sensitivity similar to control cells 
(blue line). AT cells demonstrated severe radiosensitivity (green line) and CJ179 cells 
displayed intermediate sensitivity (red line). Lines represent the mean o f at least 2 experiments.
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Figure 4-3: Bar chart of relative survival after 4 Gy y-radiation for 10 patients that 
demonstrated normal radiosensitivity: 10 patients demonstrated normal sensitivity (light
blue bars) that was not significantly different from controls (blue bars). CJ179 cells (red bar) 
displayed significantly less survival compared to the control lines. Error bars represent SEM.
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Figure 4-4: Survival curves for 10 patients that demonstrated significant radiosensitivity.
7 patient lines demonstrated mild radiosensitivity (light purple lines) and 3 patient lines 
displayed intermediate sensitivity (dark purple lines) compared to control cells (blue line). AT 
cells demonstrated severe radiosensitivity (green line) and CJ179 cells displayed intermediate 
sensitivity (red line). Lines represent the mean of at least 2 experiments.
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Figure 4-5: Bar chart of relative survival after 4 Gy y-radiation for 10 patients that 
demonstrated significant radiosensitivity: 7 patients demonstrated mild radiosensitivity (light 
purple bars, p<0.05) and 3 patients displayed intermediate radiosensitivity (-dark purple bars, 
p<0.01) compared to control cells (blue bars). CJ179 cells (red bar) displayed intermediate 
levels of radiosensitivity (red bar, p<0.01). No patients demonstrated severe radiosensitivity 
similar to that of the A-T1BR line. Error bars represent SEM.
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10 patient lines demonstrated significant radiosensitivity compared to control cells 
(figures 4-4 and 4-5). This effect ranged from a mild sensitivity that was significantly 
different to control cells after 4Gy y-radiation, to a more pronounced phenotype 
comparable to the Artemis defective CJ179 line. These radiosensitive patient lines were 
grouped into two categories o f sensitivity according to the severity o f this phenotype. 7 
patients were defined as mildly radiosensitive compared to control cells (figures 4-4 and 
4-5, light purple series, p<0.05) and 3 patients, with a more pronounced phenotype, 
were classified as displaying intermediate sensitivity (dark purple series, p<0.01) that 
was similar to that of the CJ1791ine. No patients demonstrated a severe radiosensitivity 
that was observed in the A-T1BR line.
Using the fibroblast survival assay we have identified a group o f 10 undefined 
immunodeficient patients that demonstrated cellular radiosensitivity (table 4-1). These 
patients may therefore have defects in the response to DNA damage. The severity o f 
radiosensitivity observed may reflect the extent to which the underlying mutation 
affects the repair and/or survival processes initiated by ionising radiation.
Table 4-1: Radiosensitivity of 20 undefined immunodeficient patients
Radiosensitivity No. of patients Comparablemutant Cell line example
Normal 10 Controls 1BR, 48BR
Mild + 7 - G OSl,GOS14
Intermediate ++ 3 Artemis GOS5, F96
Severe +++ 0 ATM -
4.3 Investigation of radiosensitive fibroblasts using CFSE cell 
division analysis
In chapter 3 we described the development of a novel assay for assessing the 
radiosensitivity of primary fibroblasts that focused on cell division within the first few 
days of irradiation. This technique allowed us to gain some insight into what may be 
happening to fibroblasts during the course o f a clonogenic survival assay, and what 
happens to a large proportion of cells that do not survive to form colonies in 
radiosensitive lines. In order to further investigate the radiosensitive phenotype o f the 
identified patient lines, we subjected these cells to CFSE cell division analysis after
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irradiation. This was performed for the two undefined lines that demonstrated the most 
pronounced radiosensitivity, F96 and GOS5. Results for these patient lines were 
compared to the previously characterised CJ179 line, and the AT line A-T1BR.
4.3.1 Investigation of early cell division after irradiation
As described previously, cells were labelled with CFSE and irradiated on day 0, then 
analysed by FACS after a 6-day incubation. Compared to control 1BR cells, the 
radiosensitive CJ179 and A-T1BR lines demonstrated a significant reduction in the 
perecentage of cells that completed 5 divisions after irradiation (figure 4-6). The 
magnitude of this effect was similar between the two radiosensitive lines, which is in 
contrast to survial results where AT cells were considerbly more sensitive than the 
CJ179 line. The GOS5 line also demonstrated a reduced amount o f cells that completed 
5 divisions compared to controls. This effect was slightly less than that observed for the 
CJ179 line, and this is in agreement with survival results where the GOS5 line was 
slightly less radiosensitive than CJ179 cells (figure 4-5).
In fibroblast survival assays the F96 line demonstrated the most severe radiosensitivity 
compared to all other undefined patient lines (figure 4-5). Conversely, analysis o f early 
cell division demonstrated only a modest reduction in the percentage o f F96 cells that 
had completed 5 divisions after irradiation (figure 4-6). This mild reduction was 
significantly less than that observed for the CJ179 line at doses o f 1 (CJ179 48%, F96 
81% cells >5 divisions) and 2 Gy (CJ179 16%, F96 49% cells >5 divisions), and 
suggested that F96 cultures were initially able to recover from low doses o f radiation 
relatively well.
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Figure 4-6: Early division experim ents w ith radiosensitive fibroblasts; R eduction in the 
percentage of cells that have completed 5 divisions w ithin the firs t 6 days of irrad ia tion .
CJ179 (cream bars) and A-T1BR (dark red bars) cells demonstrated an abnormal block on 
proliferation that was similar in magnitude between the two lines. GOS5 cells (purple) were 
also sensitive to this endpoint, although this effect was slightly less pronounced than that of the 
known mutant lines. F96 cells (pale green) demonstrated only a modest reduction in the 
percentage cells that have completed 5 divisions compared to controls. Error bars represent 
SEM.
In early division experiments with the CJ179 line, the significant reduction in the 
percentage of cells that had completed 5 divisions compared to controls was associated 
the induction of a population of large arrested cells (figure 3-12). This accounted for 
the significant reduction in cell division observed, and is consistent with the induction 
of a Stress Induced Premature Senescence (SIPS) that has been described in cells 
following irradiation (Toussaint et al, 2000) and has been monitored using FACS 
(Gorbunova et al, 2003). The GOS5 line was similar to the CJ179 line in this respect, 
and demonstrated a similar tendency for this radiation-induced population of large 
arrested cells (figure 4-7). In contrast, the F96 line displayed a more modest reduction 
in early cell division than the CJ179 (figure 4-6), and was not as prone to the induction 
of a population of large arrested cells (figure 4-7)
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Figure 4-7: Radiosensitive lines are m ore prone to the induction of an a rre s te d  population  
of large cells within 6 days of irrad iation . CFSE plots with large cells shown in red and small 
cells shown in blue for a) 1BR, b) CJ179, c) GOS5 and d) F96 cells 6 days after treatment with 
0, 2 and 4 Gy y-radiation as indicated. The Artemis deficient CJ179 line and undefined GOS5 
line were more prone to the induction of a population of large arrested cells compared to control 
cells. The undefined F96 line was slightly more susceptible to this endpoint compared to 
controls, but not as sensitive as the CJ179 and GOS5 lines.
4.3.2 Investigation of late cell division after irradiation
Since we knew F96 cells were radiosensitive but observed only a modest reduction in 
early cell division compared to control, we went on to examine late cell division. This 
was intended to identify any abnormal blocks on cell division that occurred after the 0-6 
day timeframe already examined. Late division experiments therefore focused on a
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subsequent timeframe, between 5 and 10 days after irradiation. This involved 
irradiating cells on day 0, labeling the cultures on day 5, and then performing FACS 
analysis on day 10 (figure 4-8). This was designed to account for the fact that you can 
only monitor cell division with CFSE for up to 8-10 divisions, after this the fluorescent 
signal becomes weak and unreliable.
Colony formation -  3 weeks 
 ►
a) Early division experiments
Cell division 0-6 days after damage
Day 0 Day 6
t  t
CFSE & Irradiate Analyse
b) Late division experiments
Cell division 5-10 days after damage
DayO Day 5 Day 10
t  t  t
Irradiate CFSE Analyse
Figure 4-8: A combination of early and late CFSE division experim ents exam ined cell 
division within the first 10 days of irrad iation , a) Early division experiments focused on 
proliferation between 0 and 6 days after irradiation, b) Late division experiments focused on 
proliferation between 5 and 10 days after irradiation.
In late division experiments A-T1BR cells displayed a significant reduction in the 
percentage of cells that had completed 5 divisions at all doses compared to the control 
line 1BR (figure 4-9). At the lower doses of 1 and 2 Gy of y-radiation CJ179 cells were 
able to recover from showing a significant reduction in proliferation in early division 
experiments (figure 4-6) to near control levels of division in this later timeframe. This 
demonstrates that unlike AT cells, CJ179 cultures are able to recover from low doses of 
radiation, and is compatible with survival assay results where they demonstrated a less 
severe phenotype than the A-Tl BR line. At higher doses the CJ179 line was unable to
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recover with only 2% of cells that had completed 5 divisions after 6 Gy y-radiation 
compared to 33% in control cells.
OGy 1 Gy 2Gy 4Gy 6Gy
Figure 4-9: Late division experim ents w ith radiosensitive fibroblasts; R eduction in the 
percentage of cells tha t have completed 5 divisions between days 5 and  10 a fter 
irradiation. Compared to control 1BR cells (blue bars) the patient line F96 (pale green bars) 
demonstrated a significant reduction in the percentage of cells that have completed 5 divisions 
after the higher doses of 4 and 6 Gy y-radiation. This was similar to the Artemis deficient 
CJ179 line (cream bars). The A-T1BR line was severely affected at all doses (dark red bars). 
Error bars represent SEM.
Similar to CJ179 cells the F96 line was able to recover to control levels of proliferation 
after 1 and 2 Gy y-radiation in this later timeframe (figure 4-9). At the higher doses of 
4 and 6 Gy y-radiation there was a significant reduction in the percentage of cells that 
had completed 5 divisions compared to controls (1BR 4 Gy; 66%, 6 Gy; 33%. F96 4 
Gy; 21%, 6 Gy; 1% cells >5 divisions), and this was comparable to that for the CJ179 
line (CJ179 4 Gy; 13%, 2 Gy; CJ179 2% cells >5 divisions). F96 cells were therefore 
similar to the CJ179 line in this late division timeframe, recovering well from low doses 
of y-radiation but meeting with a significant block on proliferation at higher doses.
These results suggested that although F96 cells can cope relatively well with the early 
effects of low doses of radiation, once a certain threshold is reached these cells are 
ultimately unable to recover. When we examined the morphological phenotype of cells 
in late division experiments we found that whereas at 4 Gy y-radiation control cells 
recovered and produced a major population of small dividing cells, the CJ179 cultures
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were still dominated at this point by large arrested cells (figure 4-10, population 1). We 
also noted a minor population of small cells that had ceased to divide after 
approximately one division (population 2), along with another minor population of 
small dividing cells (population 3) that corresponded to the dominant proliferating 
population in the control line.
a) OGy 2Gy 4Gy
1BR
b)
CJ179
c)
F96
CFSE Arrested
cells
Figure 4-10: Radiation induces distinct populations of a rrested  cells in radiosensitive 
fibroblast lines 10 days after irrad iation . CFSE plots with large cells shown in red and small 
cells shown in blue for a) 1BR, b) CJ179 and c) F96 cells 10 days after treatment with 0, 2 and 
4Gy y-radiation as indicated. Cells were labeled with CFSE 5 days after irradiation. After 2 Gy 
y-radiation small dividing cells that have completed 5 divisions dominated 1BR, CJ179 and F96 
cultures at this late time point. After 4 Gy y-radiation the radiosensitive lines (CJ179 and F96) 
produced distinct populations of large (population 1) and small (population 2) arrested cells, 
along with a minor population of small dividing cells (population 3). CJ179 cells were more 
prone to a large cell arrest phenotype (population 1), compared to F96 cultures that contained a 
substantial proportion of small arrested cells (population 2).
Although the late division profile of the F96 line also contained 3 distinct populations of 
cells after 4 Gy y-radiation (figure 4-10); large arrested (population 1), small arrested 
(population 2) and small dividing (population 3), there were reproducible differences in 
the proportion of these populations compared to CJ179 cells. The small arrested
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population (population 2) was much more prominent in F96 cultures, and constituted a 
major proportion of the total arrested cells, whereas the majority o f arrested CJ179 cells 
were of the large cell phenotype. Therefore, although the F96 line was not as sensitive 
as CJ179 to the earlier induction o f a large arrested cell phenotype, at higher doses there 
was a subsequent arrest that occurred within the remaining population o f small cells. 
This accounted for the significant reduction in the percentage o f cells that had 
completed 5 divisions compared to control cultures (figure 4-9), which were mainly 
composed of small proliferating cells at this time (figure 4-10).
We have observed what appears to be the induction o f distinct populations o f arrested 
cells in radiosensitive fibroblast lines using CFSE analysis. An important question in 
this regard is whether these populations, that are present at different CFSE fluorescence 
levels, represent different numbers of cell division or whether this is just an artefact o f  
larger cells incorporating higher amounts o f CFSE. This was less o f an issue with early 
division experiments since CFSE labelling was performed before there were any 
radiation-induced changes in cell size. In late division experiments we labelled cells 
with CFSE 5 days after irradiation, when there are sure to be changes in cell size that 
have occurred in response to this insult. In order to address this point, we labelled 
cultures of F96 cells with CFSE 5 days after exposure to 4 Gy y-radiation just as in late 
division experiments, but then analysed the culture by FACS immediately afterwards. 
The difference in CFSE fluorescence between large and small cells in this culture was 
found to be relatively small compared to that between the large arrested (population 3) 
and small arrested (population 2) populations in cultures incubated for a further 5 days 
(figure 4-11). We therefore concluded that the difference between populations 2 and 3 
in late division experiments was more than just an artefact o f cell size, and represented 
at least one additional division which population 2 had completed before arresting in 
this time frame.
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Figure 4-11: Affect of cell size on the incorporation of CFSE. CFSE plots with large cells 
shown in red and small cells shown in blue. F96 cultures were treated with 4Gy y-radiation, 
incubated for 5 days and then labelled with CFSE. Cells were analysed by FACS either 
immediately (a) or after a further 5-day incubation (b). Larger cells incorporate slightly more 
CFSE than small cells (a), but this effect is substantially less than the difference between the 
arrested populations 1 and 2 after a further five-day incubation (b). Population 2 is therefore a 
distinct population, and represents at least one additional division during the labelled incubation 
period.
4.3.3 Investigation of the phenotype of arrested cells in radiosensitive 
lines
We were interested in identifying what mechanisms may be responsible for the 
induction of the different populations o f arrested cells in the CJ179 and F96 lines 5-10 
days after irradiation. Normal human fibroblasts have been reported to undergo SIPS in 
response to ionising radiation that involves the induction of a permanent G1 growth 
arrest, an increase in cell size and the expression of senescent markers. We investigated 
whether the different arrested populations observed in the F96 line after irradiation 
corresponded to the induction of SIPS. Late division experiments were repeated and 
cells were sorted into 3 populations according to their CFSE fluorescence. As described 
above, population 1 consisted of small dividing cells, population 2 of small arrested 
cells, and population 3 of large arrested cells. The 3 sorted populations were then 
seeded into tissue culture plates overnight, cell morphology was examined and cultures 
were stained for the senescence marker SA-Pgal. This was performed for the control 
line 1BR and the undefined radiosensitive line F96.
132
1BR3 1BR1
1BR 
10 days
F96
10 days
F96 3
SA-(3gal
F96 1
For both the 1BR and F96 lines, population 1 consisted o f cells that had a large, 
flattened, senescent like morphology, and 10-20% o f these cells stained positive for SA- 
Pgal (figure 4-12). This suggested that these large arrested cells resulted from the 
induction of a senescent like state. A longer incubation period after cell sorting may 
have increased the percentage o f SA-Pgal positive cells. In both lines the dividing 
population 3 consisted of small cells with a young morphology and no cells were 
positive for SA-pgal activity. The arrested cells in population 2 were also negative for 
SA-pgal, although 1BR cells at this level o f CFSE fluorescence displayed a modest 
increase in size. There was also a relatively high level o f cellular debris in population 2 
cultures, and this was more pronounced in the F96 line.
From these results we concluded that the radiation-induced population o f large arrested 
cells (population 1) corresponded to the induction o f SIPS, and the small dividing cells 
in population 3, which were identical in morphology to cells that grow to form colonies 
in survival assays, represented the clonogenic surviving fraction. Indeed, when these 
two populations were further incubated, population 3 grew to confluence rapidly, 
whereas population 1 cells did not reach confluence after a two-week incubation. It was 
less clear what the small arrested cells in population 2, that were negative for SA-pgal 
and prominent in the F96 line, represented. Although these cells eventually reached 
confluence during a further two-week incubation, this growth was relatively slow and 
may have resulted from contamination with the dividing cells o f population 3. The 
relatively high level o f cellular debris in population 2 cultures suggested that these cells 
might be undergoing some form o f death. We therefore investigated whether there were 
any detectable levels o f apoptosis in this population.
Figure 4-12: Cellular morphology and SA-Pgal staining of the distinct populations
induced by y-radiation in the control line 1BR and the radiosensitive line F96. Late 
division experiments were repeated for the control (1BR) and F96 lines, and cells were sorted 
according to their CFSE fluorescence level using the gates indicated, taking care to minimise 
any overlap between different populations. Sorted cells were incubated overnight in fibroblast 
growth medium, and cellular morphology was then examined (1BR top panel, F96 bottom 
panel). At this time SA-Pgal staining was also performed, and only population 1 cultures 
contained any SA-Pgal positive cells (shown in middle panel). In both lines the dividing 
population 3 consisted of small cells with a young morphology and no cells were positive for 
SA-pgal activity. The arrested cells in population 2 were also negative for SA-Pgal, although 
1BR cells in this population displayed a modest increase in size. There was a relatively high 
level of cellular debris in population 2 cultures, and this was more pronounced in the F96 line. 
For both lines the arrested population 1 consisted of large flattened cells with a senescent like 
morphology, and approximately 10-20 % of these stained positive for SA-Pgal activity at this 
time.
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Late division experiments with CFSE were repeated and cells were co-stained with 
Annexin V-PE and 7AAD. Annexin V binds to phosphatidylserine (PS) residues that 
translocate from the inner leaflet o f the plasma membrane to the outer leaflet in the 
early stages of apoptosis. This exposes PS to the external environment and allows the 
percentage of cells undergoing apoptosis to be quantified. 7AAD is a DNA binding dye 
and identifies necrosis and the later stages o f  apoptosis, when the plasma membrane 
becomes highly permeable. These CFSE-Apoptosis experiments were performed for 
the control line 1BR, the Artemis deficient line CJ179 and the undefined radiosensitive 
line F96.
The total amount of Annexin V-PE positive cells for control (1BR) cells 10 days after 
4Gy y-radiation was 1.4 % compared to 1% for unirradiated cultures, which represented 
a 1.4 fold increase in apoptosis (figure 4-13). This is consistent with the low levels of  
radiation-induced apoptosis reported for primary fibroblast lines. We also noted that 
this small increase in apoptosis arose in cells with a medium level o f CFSE 
fluorescence, corresponding to the population o f small arrested cells identified in the 
radiosensitive CJ179 and F96 lines (figure 4-10), and gating on this population revealed 
that 3.7 % of these cells were apoptotic. This effect was more pronounced in the CJ179 
line, which displayed a 3 fold increase in the total levels o f apoptosis after irradiation. 
Similar to the 1BR line, the majority o f the apoptotic CJ179 cells were in population 2, 
and when this population was gated 6.2 % o f these cells had initiated apoptosis. This 
represents a relatively high proportion considering this analysis was performed 10 days 
after irradiation, and that primary fibroblasts are notoriously resistant to radiation- 
induced apoptosis. The F96 line demonstrated a 2.2 fold increase in apoptosis after 
irradiation, which comparable to the CJ179 line arose from cells within population 2. 
When this population was specifically gated, 3 % of these cells were positive for 
AnnexinV. Therefore, although primary fibroblasts do not display substantial levels of 
radiation-induced apoptosis 10 days after irradiation, the small increases that were 
observed were restricted to population 2. This may signify a delayed form o f genomic 
instability that leads to the activation o f p53 dependent pathways, resulting in growth 
arrest and a low level o f apoptosis. The F96 line was exceptionally prone to this cell 
fate, which may reflect the nature o f the underlying mutation.
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Figure 4-13: Levels of apoptosis in CFSE labelled cultures 10 days after exposure to 4Gy y-radiation. Late division experiments were repeated for the control 
(1BR, top panel) and the radiosensitive CJ179 (middle panel) and F96 (bottom panel) lines. CFSE labelled cells were co-stained with Annexin V-PE and 7AAD to 
identify cells that had initiated apoptosis. Although the increase in Annexin V positive cells was low in 1BR, CJ179 and F96 cultures 10 days after irradiation (1.4, 3 
and 2.2 fold respectively), the majority of apoptotic cells arose from the small arrested cells in population 2. When this population was specifically gated, 3.7, 6 and 
3 % of these small arrested cells were positive for AnnexinV staining in the 1BR, CJ179 and F96 lines respectively. This suggests that a small percentage of cells in 
population 2 are in the early stages of apoptosis, and since fibroblasts are resistant to this endpoint, a more widespread instability may be present in these cells.
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4.4 Discussion
Fibroblast survival assays assess the clonogenic potential o f cells treated with ionizing 
radiation and have been extensively used to identity patients with radiosensitive 
disorders (Arlett et al, 1988) (Cavazzana-Calvo et al, 1993) (Nicolas et al, 1996) 
(Nicolas et al, 1998) (Peake et al, 1999) (Riballo et al, 1999) (O’Driscoll et al, 2001) 
(Dai et al, 2003) (Kobayashi et al, 2003) (Noordzij et al, 2003). Using this assay we 
identified a group o f 10 patients that demonstrated significant cellular radiosensitivity 
compared to control cells. This ranged from a mild sensitivity that was marginally 
significant compared to controls, to a more pronounced phenotype that was similar to 
that of the repair defective CJ179 line. As a population, the group o f undefined 
immunodeficient patients examined did not display a cellular radiosensitivity that was 
significantly different from the control group. This suggests that these patients do not 
represent a distinct population with respect to radiosensitivity. These results more 
likely reflect a range o f sensitivities ensuing from subtle genetic differences and 
polymorphisms (that may be present in the normal population) at the more 
radioresistant end of the scale, to a more pronounced radiosensitivity that may result 
from mutations in damage response genes that impair protein function. Since only a 
few (3 out of 20) patients displayed this more pronounced phenotype, the incidence o f  
radiosensitivity amongst undefined immunodeficient patients appears to be low 
(~10 %). This indicates that only a small proportion o f undefined immunodeficient 
patients have disorders that affect cellular radiosensitivity.
Fibroblast lines derived from patients with distinct immunodeficient disorders have 
previously been shown to display different sensitivities to ionising radiation. The most 
sensitive line reported to date is 2BN, which is thought to have a defect in an 
unidentified component o f the NHEJ pathway (Dai et al, 2003). Consistent with 
previous reports, 2BN cells were the most sensitive line examined in this study, and 
demonstrated a profound sensitivity that was greater than AT cells, which are among 
the most exquisitely radiosensitive lines described. A-T1BR cells demonstrated a 
severe radiosensitivity that was not observed in any o f the undefined lines, and none of 
theses immunodeficient patients displayed any other symptoms common to AT patients. 
This suggests that the observed radiosensitive phenotypes do not result from defects in 
the ATM protein.
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F96, GOS5 and GOS23 cells were among the most radiosensitive o f all the undefined 
lines examined, and were classified as displaying an intermediate sensitivity that was 
slightly less pronounced than that o f the Artemis deficient CJ179 line. These cells are 
therefore good candidate lines for defects in the NHEJ pathway, although the inherent 
mutations may not be as extreme as an Artemis null mutation, and may allow somewhat 
superior repair to marginally increase radioresistance. This would also be consistent 
with the limited number o f T- and B- lymphocytes that were detected in these patients 
that could result from a partially functional V(D)J recombination pathway, compared to 
the more severe immunodeficient phenotype associated with inactivating mutations in 
Artemis (O’Driscoll et al, 2004).
Fibroblast lines derived from different normal individuals have previously been shown 
to display a broad variation in radiosensitivity, and this was attributed to genetic 
differences (Little et al, 1988) (Deschavanne and Fertil, 1996) (Dikomey et al, 2003). 
Although the two control lines used in this study demonstrated almost identical levels of 
survival after irradiation (1BR; 9.4% after 4 Gy, 48BR, 9.9% after 4 Gy), it was 
difficult to assess to what extent random genetic differences affected radiosensitivity 
with only 2 normal lines at our disposal. This issue became o f particular relevance 
when examining lines that demonstrated a mild radiosensitivity that was on the 
borderline of significance.
We grouped 7 patient lines into a mild category o f radiosensitivity based on their 
reduced survival after 4 Gy y-radiation that was not as pronounced as that o f the three 
intermediate radiosensitive lines (F96, GOS5, GOS23). Although this mild level o f 
radiosensitivity was significantly different from 2 control lines, it was difficult to 
determine whether this represented a distinct pathological phenotype, or if  this was the 
result of random genetic variation affecting sensitivity. Later in this study a patient that 
demonstrated borderline significance radiosensitivity (GOSIO) was found to have a 
homozygous Y589X mutation in the RAG1 gene. Although this almost certainly 
accounts for the severe immunodeficiency observed in this patient, this protein is not 
thought to function in general DSB repair (Gellert et al, 2002) and RAG mutations have 
not been reported that affect radiosensitivity. This suggests that although patients that 
were borderline radiosensitive, such as GOS3, GOS17, GOSIO and GOS4, 
demonstrated a significant difference compared to controls, this mild phenotype may be 
the result of other genetic differences that do not directly affect DNA damage response
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pathways. A similar borderline radiosensitivity has been reported in fibroblasts derived 
from a patient with Adenine Deaminase (ADA) deficiency after low dose rate 
irradiation (Sproston et al, 1997). ADA deficiency, the first known cause o f a severe 
combined immunodeficient disorder (Giblett et al, 1972), is thought to result from 
abnormal purine metabolism during lymphocyte development (Aldrich et al, 2000) and 
is not implicated in the general response to DNA damage. This would further suggest 
that the marginal radiosensitivity observed in some SCID patients might be the result of 
global genetic variation and not mutations in specific damage response pathways. 
Further characterisation therefore concentrated on the lines that displayed intermediate 
radiosensitivity that may reflect pathological defects in the response to DNA damage.
In section 3.3 we described the development o f a novel assay for cellular 
radiosensitivity using the fluorescent dye CFSE that focuses on cell division within the 
first week of irradiation. This system allowed us to identify differences in post­
radiation division between control cells and a radiosensitive line (CJ179) with a null 
mutation in the Artemis DSB repair gene. We observed that a lower percentage of 
repair defective cells were able to complete five divisions after irradiation compared to 
controls, and this coincided with the induction o f a population o f large arrested cells, 
consistent with the initiation o f Stress Induced Premature Senescence (SIPS). We next 
employed this test system to further characterise the GOS5 and F96 lines, which 
demonstrated intermediate radio sensitivity in clonogenic survival assays. The GOS5 
line was more prone to the induction o f a population o f large arrested cells compared to 
controls, and hence significantly fewer cells completed 5 divisions. This suggests that 
similar to the CJ179 line, the radiosensitivity observed in GOS5 cells is conferred, at 
least in part, through the induction o f abnormally high levels o f radiation induced 
growth arrest within 6 days. This could result from a similar mechanism to that in 
CJ179 cells, involving deficient DSB repair, or a defect in the damage assessment 
process that leads to elevated levels o f SIPS after irradiation. Since the GOS5 line also 
displayed premature senescence at passage 9 o f normal tissue culture, deregulation of 
this tumour suppressor mechanism may be inherent to these cells. Further investigation 
was therefore required to determine whether a defect in DNA repair is associated with 
the GOS5 line (section 5).
Despite showing a similar radiosensitivity to that o f the GOS5 and CJ179 lines in 
clonogenic survival assays, the F96 line displayed only a modest reduction in cell
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division within the first 6 days o f  irradiation. This was especially evident after low 
doses of y-radiation, which suggested that F96 cells are able to deal with the early 
effects of low doses relatively well. In order to further investigate this discrepancy 
between clonogenic survival and early cell division results, we decided to examine cell 
division at a later timeframe, between days 5 and 10 after irradiation. At the lower 
doses of 1 and 2 Gy the F96 line continued to divide well, and CJ179 cultures were also 
able to recover to produce a substantial proportion o f dividing cells. This was in 
contrast to the A-T1BR line, which displayed low levels o f division at all doses, 
consistent with the severe radiosensitivity o f this line. After the higher doses o f 4 and 6 
Gy both the F96 and CJ179 lines met with a severe block on late cell division compared 
to controls. Whilst in the CJ179 line this was generally due to the continued presence of 
a population of large cells that had not divided in this timeframe, the F96 line displayed 
a high proportion of cells that had arrested after 1 -2 additional divisions. These data 
suggest that unlike the CJ179 and AT-1BR lines, the F96 line is able to deal with low 
doses of y-radiation relatively well, but once a certain threshold is reached these cells 
meet with a delayed block on proliferation.
There have been many reports on the delayed effects o f ionising radiation on cultured 
cells. This has been documented as delayed chromosomal instability in surviving cells 
manifested as multiple rearrangements several generations after exposure to X rays 
(Marder and Morgan, 1993), and a high frequency o f chromosome bridge formation and 
delayed reproductive death in the progeny o f human embryonic cells surviving similar 
treatment (Suzuki et al, 1998). This delayed chromosomal instability was reduced by 
delayed plating, which allows more time for repair and suggests that the potentiality of 
genetic instability is determined by the repair process o f the initial radiation damage 
(Roy et al, 1999). Therefore, the F96 line may harbour a subtle defect in the damage 
response that initially allows a normal rate o f DNA repair and proliferation, but after a 
certain number of divisions high levels o f delayed genetic instability and/or reactivation 
of growth arrest pathways impair clonogenic survival.
Delayed chromosomal instability has also been described as delayed induction o f y- 
H2AX foci, corresponding to a 0.5 — 1 Gy equivalent dose, which was observed in cells 
30-50 population doublings post irradiation (Suzuki et al, 2003a). Since y-H2AX foci 
are thought to represent sites o f DNA DSBs (Rogakou et al, 1999) this may be expected 
to initiate a secondary p53 response. Consistent with this hypothesis, these studies
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demonstrated the delayed activation o f p53 in a significant number o f colonies 
surviving the initial genotoxic insult (Suzuki et al, 2003b). Whilst these effects were 
seen in cells 30-50 population doublings after irradiation, a similar phenomenon has 
been described in human fibroblasts 5 days after irradiation, which is within the 
timeframe that the F96 line demonstrated a significant block on cell division. X- 
irradiation was shown to cause a primary transient induction o f p53 followed by a 
reinduction of p53 5 days after irradiation (Rugo et al, 2002). This reinduction 
persisted for 2 days and coincided with the largest induction o f apoptosis. The F96 line 
may therefore display high levels o f delayed growth arrest due to the abnormal 
reinduction of p53, but this does not seem to be associated with high levels o f apoptosis. 
Co-staining of CFSE labelled cells with Annexin V-PE revealed that although any 
limited increase in apoptosis was restricted to cells that had initiated a delayed growth 
arrest, less than 10 % o f these cells were apoptotic. Levels o f apoptosis in human 
fibroblasts have previously been reported to be maximal at about 5 days after 
irradiation, although this was evident in only a small proportion o f cells (Belyakov et al,
1999). The same study observed that a larger proportion o f cells were micronucleated, 
and this response peaked at around 5 days after irradiation. Micronuclei are formed in 
cells manifesting chromosome aberrations during cell division and result from nuclear 
membrane encapsulation o f chromatin and chromosomal fragments that fail to properly 
segregate after mitosis (Muller et al, 1996). If the F96 line was prone to a form of 
delayed chromosome instability, which may involve the induction o f secondary DSBs, 
micronuclei may be induced after several further divisions. Since p53 activation and 
cell cycle arrest have been shown to occur in response to micronuclei (Sablina et al, 
1998), this may account for the delayed arrest observed in F96 cells.
Although the cells that demonstrated a delayed arrest in treated F96 cultures did not 
show signs of premature senescence, the radiation-induced populations o f large arrested 
cells contained cells with a senescent-like, flattened morphology that were positive for 
the senescence marker SA-Pgal. This is consistent with previous studies that separated 
dividing and growth retarded colon carcinoma cells after treatment with 
chemotherapeutic agents. The arrested population was shown to contain a high 
percentage of cells with increased granularity that stained positive for SA-pgal 
compared to the dividing population (Chang et al, 1999b). Of the few colonies that 
grew out of this growth retarded population, none stained positive for SA-Pgal, 
suggesting that the senescent-like cells lost their long-term proliferative capacity. This
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mechanism may therefore function as a means o f  inducing proliferative death in cells 
such as primary fibroblasts that are resistant to apoptosis but have persistent DSBs after 
irradiation, as suggested by Naka et al, 2004. In colon carcinoma cells this arrest was 
substantially dependent on p21, and partly dependent on p53 (Chang et al, 1999a) and 
was associated with inhibition o f  genes involved in cell proliferation and coinduction of  
multiple intracellular and secreted growth inhibitors (Chang et al, 2002). The induction 
of high levels of p21 has also been shown to be detrimental to growth-arrested cells that 
evade premature senescence and return to cycle. After release from growth arrest 
mediated by p21 over-expression from an inducible promoter, human fibrosarcoma cells 
failed to from colonies due to abnormal mitosis o f  the recovering cells (Chang et al,
2000). This was attributed to the p21-induced depletion o f cellular pools o f mitosis- 
control proteins, followed by the asynchronous resynthesis o f such proteins after release 
from p21. Genetic destabilisation o f cells recovering from p21 -induced growth arrest 
may therefore contribute to the delayed effects o f  ionising radiation in the F96 line.
We have shown that a significant amount o f primary fibroblasts initiate a senescent like 
growth retardation within the first 6 days o f irradiation, and the repair defective line 
CJ179 is more prone to this endpoint than control cells. This suggests that unrepaired 
radiation-induced DSBs may promote growth retardation and the induction o f  
premature senescence. Whilst GOS5 cells displayed a similar propensity for this 
endpoint, the F96 line was more disposed to a delayed arrest after higher doses o f y- 
radiation, which did not involve the induction o f  premature senescence at this time.
Since there were also minimal levels o f apoptosis in these cells, this may reflect a 
delayed instability that that promotes abnormal mitotic events and/or the reinduction of 
growth arrest pathways. These data suggest that the underlying mutation in this line 
allows for proliferation early after irradiation but promotes a delayed instability that is 
detrimental to long-term survival. In order to delineate the nature o f the defects in these 
undefined radiosensitive lines, further characterisation was required in relation to p53 
responses and DNA repair.
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Chapter 5: Characterisation of radiosensitive fibroblast 
lines
5.1 Background
In the previous chapter we described a group o f  undefined immunodeficient patients 
that demonstrated cellular radiosensitivity in primary fibroblasts. These patients may 
have defects in the damage response network that impairs their ability to respond 
efficiently to radiation-induced DSBs. This could manifest as a failure to initiate 
appropriate cell cycle checkpoints through the activation o f p53, and this phenotype has 
been described in AT cells that are defective in this process (Houldsworth and Lavin, 
1980) (Kastan et al, 1992) (Lu and Lane, 1993) (Beamish and Lavin, 1994) (Khanna et 
al, 1995). Since these cells are unable to efficiently arrest the cell cycle after DNA 
damage, cells that have incurred high levels o f damage are allowed to progress into S- 
phase. This is believed to exacerbate the damage sustained and induce a high level o f  
genomic instability that ultimately impairs cell survival. The G l/S cell cycle 
checkpoint was therefore investigated in the most radiosensitive undefined line, F96, 
using BrdU cell cycle analysis. The efficient and sustained activation o f the G l/S  
checkpoint depends on the induction o f the Cdk inhibitor p21, a target gene o f p53 
(Waldman et al, 1995) (Brugarolas et al, 1999). We also examined whether p21 mRNA 
was induced normally in undefined radiosensitive lines using northern blot analysis. 
These responses were compared to those from control cells and the ATM deficient line 
A-T1BR.
Concurrent with the activation o f  cell cycle checkpoints, cells also initiate pathways that 
function to repair DNA damage and promote survival. This is an important aspect of 
the damage response, since the persistence o f DNA DSBs after irradiation has been 
correlated with cellular radiosensitivity (Wurm et al, 1994) (Kiltie et al, 1997)
(Dikomey et al, 1998) (Sarkaria et al, 1998) (Zhou et al, 1998) (Dikomey et al, 2000a) 
(Dikomey et al, 2000b). Radiosensitivity may therefore result from defects in DSB 
repair pathways, and this has been previously described in some patients with 
radiosensitive immunodeficiency (Moshous et al, 2001) (O’Driscoll et al, 2001) (Li et 
al, 2002a) (Kobayashi et al, 2003) (Noordzij et al, 2003). In order to investigate DSB 
repair in undefined radiosensitive lines we took two approaches. We first analysed
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unrepaired chromosome breaks after irradiation by preparing metaphase spreads after a 
suitable incubation time for repair processes to function. This was complemented by 
work from our collaborators that examined the phosphorylated form o f H2AX (y- 
H2AX) after irradiation. Since this modification is believed to mark the site o f DSBs, 
depreciation of y-H2AX foci within cell nuclei can be used as a marker o f DSB repair. 
These assays allowed us to gain an indication as to the presence o f defective repair in 
undefined lines.
5.2 Initial checkpoint function in F96 cells
AT cells have defects in initial checkpoint function and this is likely to contribute to 
their poor survival after irradiation. To confirm that F96 cells are proficient in 
activating a Gl/S checkpoint within hours o f irradiation, we performed 
Bromodeoxyuridine (BrdU) cell cycle analysis before and after exposure to 4Gy y- 
radiation. BrdU is a thymidine analogue and is specifically incorporated into DNA 
during DNA synthesis when incubated with cycling cells. Anti-bromodeoxyuridine 
monoclonal antibody can then be used to identify cells that have incorporated BrdU 
during S-phase. Co-staining with propidium iodide (PI) also allows the discrimination 
of G1 and G2 phases o f the cell cycle.
In unirradiated control cultures 19 % o f  cells incorporated BrdU during a 30-minute 
incubation period and were considered to be in S-phase (Figure 5-1). When these cells 
were treated with 4 Gy o f y-radiation the amount o f BrdU positive cells diminished to 
2% 12 hrs after irradiation, which represented a 90 % reduction in the percentage of  
cells in S-phase and is consistent with the efficient activation o f a G l/S DNA damage 
checkpoint. F96 cells demonstrated a similar reduction in DNA synthesis after 
irradiation, with 28 % o f BrdU positive cells in unirradiated cultures diminishing to 2 % 
in cells 12hrs after exposure to 4Gy y-radiation. This represented a 93 % reduction in 
the percentage of cells in S-phase and suggested that F96 cells are proficient in 
activation of an initial G l/S DNA damage checkpoint.
AT cells have defects in initial checkpoint function and consistent with this the A-T1BR 
line displayed only a 47 % reduction in the percentage o f cells in S-phase 12 hrs after 
irradiation compared to 90 % in control cells. This is consistent with previous reports 
that document the failure o f AT cells to efficiently activate a G l/S checkpoint after
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radiation exposure (Beamish et al, 1994). Although some cells were able to initiate cell 
cycle arrest, many progressed into S-phase despite the genotoxic insult that was 
sustained.
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Figure 5-1: F96 cells demonstrate normal Gl/S checkpoint function. Unirradiated cells (a) 
or cells incubated for 12 hrs (b) after exposure to 4Gy y-radiation were labelled for 30 minutes 
with BrdU, fixed and analysed by FACS. Control and F96 cells demonstrated efficient 
activation of a Gl/S checkpoint 12 hrs after irradiation with a ~90 % reduction of cells in S- 
phase. A-T1BR cells displayed abrogated activation of a Gl/S checkpoint with only a 47 % 
reduction in the percentage of cells in S-phase 12 hrs after irradiation.
5.3 p53 dependent gene transcription in radiosensitive lines
In response to radiation induced DSBs, p53-dependent gene transcription is an 
important factor in the activation of DNA damage checkpoints and the induction of  
apoptosis (Vogelstein et al, 2000). p21 is a target gene of p53 and functions to arrest 
the cell cycle by inhibiting Cdks. This protein is crucial for the efficient and sustained
145
1BR
12 48
CJ179 
0 12 48
GOS14 
0 12 48
GAPDH
180BR 
0 12 48 hrs
GAPDH
GOS1
0 12 48 hrs
GAPDH
F96
12 48
GOS5 
0 12 48 hrs
p 2 1
GAPDH
2.0 2.0
Figure 5-2. Northern blot of p21 mRNA induction in control, radiosensitive mutant and 
radiosensitive patient fibroblasts after exposure to 4Gy y-radiation. The fold induction of 
p21 mRNA (white figures) was assessed using a densitometer and normalised to the expression 
level of Glyceraldehyde Phosphate Dehydrogenase (GAPDH). Control (1BR), repair defective 
(CJ179 and 180BR) and RS patient (F96, GOS1, GOS5 and GOS14) fibroblasts demonstrated 
efficient induction of p21 mRNA after irradiation. A-T cells displayed abrogated induction of 
p21 after irradiation.
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activation of checkpoints that function at both the G l/S  (Waldman et al, 1995) 
(Brugarolas et al, 1999) and G2 (Bunz et al, 1998) phases o f the cell cycle. The 
integrity of these arrest pathways is critical to the ability o f cells to repair mutations that 
otherwise might compromise viability or contribute to deregulation o f cellular growth 
and proliferation. In this situation the genomic instability that results after DNA 
damage is likely to contribute to the extreme radiosensitivity o f A-T cell lines, which 
are defective in signaling to p53. We therefore investigated whether this response 
occurred normally in undefined radiosensitive patient fibroblasts by northern blot 
analysis of p21 mRNA induction. The fold induction o f p21 mRNA was assessed using 
a densitometer and normalised to the expression level o f Glyceraldehyde Phosphate 
Dehydrogenase (GAPDH), which served as a loading control.
Induction of p21 transcription occurred 12 hours after exposure to 4Gy y-radiation in the 
control cell line 1BR (2.1 fold, figure 5-2), and had further increased after 48 hrs (3.5 
fold). Conversely, AT cells displayed abrogated induction o f p21 transcription 12 and 
48 hrs after irradiation (1.3fold). This may be expected considering ATM is the 
primary kinase responsible for signaling the presence o f DSBs to p53. CJ179 and 
180BR are DSB repair defective lines, and these cells demonstrated normal induction of 
p21 transcription 12 hrs (2 and 2.4 fold respectively) and 48 hrs (2.4 and 2.8 fold 
respectively) after irradiation. This suggests that although these cells are deficient in 
DSB repair, they retain normal checkpoint function. Radiosensitive patient cell lines 
F96, GOS1, GOS5 and GOS14 all demonstrated a normal 2-3 fold induction o f p21 12 
hrs after irradiation (figure 5-2). After 48 hours this increase was either maintained 
(GOS5) or declined slightly (F96, GOS1 and GOSH). This demonstrates that unlike 
the A-T1BR line, these undefined lines are able to efficiently induce p21 mRNA after 
irradiation, and that this arm o f the damage response network is not impaired after a 
dose of 4Gy y-radiation. Although there appeared to be distinct kinetics o f p21 
induction that could have resulted from different co-regulation o f the p21 promoter in 
the different cell lines, there was not enough data to convincingly demonstrate these 
differences. The differences in p21 induction between 12 and 48 hrs after irradiation 
were small, and the number o f replicates too low to know what variability is associated 
with these measurements, hence these differences may only reflect normal variation.
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5.4 Analysis of double-strand break repair in radiosensitive 
lines
Primary immunodeficiency combined with cellular radiosensitivity has previously been 
described in patients with mutations in genes that function in DSB repair (Moshous et 
al, 2001) (O’Driscoll et al, 2001) (Li et al, 2002a) (Kobayashi et al, 2003) (Noordzij et 
al, 2003). These patients have defects in the NHEJ pathway o f DSB repair, and are 
inefficient at performing V(D)J recombination during lymphocyte development and 
resolving DSBs induced by ionising radiation. Failure to efficiently repair DNA 
damage after irradiation is detrimental to cell survival and the number o f residual DSBs 
have been found to be correlated with cellular radiosensitivity (Wurm et al, 1994)
(Kiltie et al, 1997) (Dikomey et al, 1998) (Sarkaria et al, 1998) (Zhou et al, 1998) 
(Dikomey et al, 2000a) (Dikomey et al, 2000b). We therefore investigated whether a 
defect in repair could be observed in the identified radiosensitive patient lines. This was 
performed by examining unrepaired chromosome breaks after irradiation, and the 
disappearance of y-H2AX foci in similarly treated cells. These assays may give an 
indication as to the presence o f defective repair.
5.4.1 Analysis of chromosome breakage after irradiation
Radiation induced chromosome damage can be assessed by preparing metaphase 
spreads and examining individual cells for abnormal structures. This was performed 
with the identified radiosensitive lines, with particular reference to unrepaired 
chromosome and chromatid breaks after irradiation. Exponentially growing cells were 
treated with 3 Gy y-radiation and given time to repair the damage (8 hours) after which 
the addition of colcemid arrested cells at metaphase. Metaphase spreads were then 
prepared and the number o f unrepaired breaks was assessed for each cell line (figure 5- 
3a and b). Chromosome breaks were defined as acentric chromosome fragments that 
may have formed by irradiation in G1 or early S-phases o f the cell cycle. Chromatid 
breaks were defined as chromatid gaps or fragments that may have arisen by irradiation 
during late S- or G2 phases o f the cell cycle, or by other poorly defined mechanisms 
(Bryant et al, 2004)
Considering both chromosome and chromatid breaks together, the control line 1BR 
demonstrated the normal level o f un-repaired breakage after irradiation (1.65 breaks per 
cell, figure 5-3a). CJ179 cells are defective in the Artemis DSB repair protein and
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Figure 5-3a): Levels of un repa ired  chrom osom e and chrom atid  breaks a fte r irrad ia tion  of 
prim ary fibroblasts. The A-T1BR and CJ179 lines displayed significantly elevated levels of 
unrepaired breaks after irradiation compared to control (1BR) cells. For the A-T1BR line, this 
was mostly due to high levels of chromatid breaks. The GOS1, GOS14, and GOS5 patient lines 
demonstrated normal levels of unrepaired breaks similar to the control line 1BR. F96 cells 
exhibited significantly higher levels of unrepaired breaks after irradiation compared to controls, 
and this was similar in magnitude to that of CJ179 cells. This suggests that the F96 line may 
have a defect in DSB repair.
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Figure 5-3b: Representative m etaphase spreads of un rep a ired  chrom osom e and  chrom atid 
breaks for the control line 1BR, the know n m u tan t lines A-T1BR (ATM ) and CJ179 
(Artemis), and the undefined radiosensitive lines F96 and  GOS1. Examples of unrepaired 
damage are indicated by arrows.
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demonstrated a significantly higher level o f total unrepaired breaks compared to control 
cells (2.7 breaks per cell, p<0.05). This result is consistent with the presence o f a defect 
in DSB repair. AT cells are defective in checkpoint activation (Houldsworth and Lavin, 
1980) (Painter and Young, 1980) (Beamish and Lavin, 1994) (Jorgensen and Shiloh,
1996) and have displayed a high level o f residual DSBs after irradiation suggesting a 
defect in repair (Comforth and Bedford, 1985) (Sasai et al, 1994) (Foray et al, 1995), 
(Foray et al, 1997) (Khune et al, 2004). These effects combine to produce a high level 
of genomic instability in irradiated AT cells, and the A-T1BR line therefore exhibited 
significantly higher levels o f unrepaired breaks after irradiation compared to control 
cells (15.1 breaks per cell, p<0.001). The level o f unrepaired breaks in AT cells was 
substantially higher than that observed in repair defective CJ179 cells, but the majority 
of these breaks were chromatid aberrations, which have previously been observed at 
high levels in AT cells after irradiation (Taylor et al, 1976) (Nagasawa et al, 1985) 
(Virsik-Kopp et al, 2004). Some o f these Chromatid breaks may have formed in cells 
that were in late S- and G2 phases o f the cell cycle at the time o f irradiation and reflect a 
specific defect in DNA repair at these points in the cell cycle. Another mechanism may 
involve the persistence o f DSBs induced in G1 into the late S- and G2- phases o f the 
cell cycle since AT cells are unable to efficiently activate cell cycle checkpoints. These 
persistent chromosome breaks may then initiate the delayed formation o f chromatid 
breaks.
Patient cell lines GOS1 and GOSH displayed normal levels o f unrepaired chromosome 
breaks (1.7 and 1.6 breaks per cell respectively) similar to control cells. Although 
GOS5 cells demonstrated a slightly elevated level o f unrepaired breaks (2 breaks per 
cell) compared to the control line, this difference was not significant. Therefore no 
evidence was found to suggest the presence o f a repair defect in the GOS1, GOS5 or 
GOSH cell lines. In contrast, F96 cells displayed a significantly higher level o f  
unrepaired breaks after irradiation (2.9 breaks per cell) compared to control cells, and 
this was similar in magnitude to that o f the CJ179 line (2.7 breaks per cell). This 
suggests that the F96 line may harbour a defect in DSB repair that has similar effects on 
the residual level of chromosome damage as that which occurs in the absence o f the 
Artemis repair protein.
Dicentric chromosomes are reciprocal translocations between two different 
chromosomes that are believed to be formed by the aberrant repair o f one or two DNA
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DSBs (Pfeiffer et al, 2000). In order to investigate potential mis-rejoining o f radiation- 
induced DSBs in radiosensitive lines, we counted the number o f dicentric chromosomes 
present in each metaphase spread (table 5-1). Whilst the control line 1BR and the 
mildly radiosensitive line GOS1 displayed low levels o f dicentric chromosomes (5 and 
0 % of metaphases respectively contained at least one dicentric chromosome), the 
GOSH, CJ179 and A-T1BR lines demonstrated a slightly elevated level o f this 
aberration (10, 10 and 11 % o f metaphases respectively) that may suggest a subtle 
tendency for mis-rejoining. The radiosensitive lines F96 and GOS5 displayed relatively 
high levels of dicentric chromosomes (21 and 23 % o f metaphases respectively), which 
may indicate that DSBs mis-rejoining is inherent to these lines.
Table 5-1: Frequency of dicentric chromosomes in primary fibroblast metaphase 
spreads
Primary cell line
Metaphases
scored Total dicentrics
Metaphases with 
a dicentric
% Metaphases 
with a dicentric
1BR 40 2 2 5 %
F96 53 12 11 21 %
GOS5 30 9 7 2 3 %
GOS1 30 0 0 0 %
G O SH 30 3 3 10%
CJ179 30 4 3 10%
A-T1BR 19 2 2 11 %
5.4.2 Results from our collaborators: y-H2AX enumeration
Using a fluorescent antibody specific for the phosphorylated form o f H2AX (y-H2AX), 
discrete nuclear foci can be visualised at sites o f DSBs induced by exogenous agents 
such as IR (Rogakou et al, 1999) (Burma et al, 2001), and the number o f y-H2AX foci 
were found to be closely correlated with the number o f DSBs (Sedelnikova et al, 2002). 
Recent studies have demonstrated that enumerating y-H2AX foci at various time points 
after irradiation can be used to measure the repair o f DSBs in primary human fibroblasts 
(Rothkamm and Lobrich, 2003) (Khune et al, 2004) and Chinese hamster ovary cells 
(Rothkamm et al, 2003). This method is a more sensitive than Pulse Field Gel 
Electrophoresis (PFGE), which is limited to a dose o f 10 Gy and has been widely used 
to measure DSB repair in the past. Using y-H2AX foci analysis our collaborators 
(laboratory of P. Jeggo, University o f Sussex) were able to assess DSB repair in 
response to more physiologically relevant doses o f y-radiation. Also, fewer cells are
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required to perform this assay than PFGE and no radioactivity is involved apart from 
the dosing of cells. In order to analyse the rate of foci disappearance in undefined 
radiosensitive lines, fibroblasts were exposed to 2Gy y-radiation, and incubated directly 
afterwards in tresh medium for 3 minutes, 15 minutes, 2 hrs, 6 hrs or 24 hrs repair time. 
After immunostaining with y-H2AX antibodies, the number of initially induced foci, 
and residual foci, were counted.
About 30-40 foci/nucleus on average were present 3 minutes post irradiation and this 
number peaked at 40-60 after 15 minutes (not shown). Following this induction period 
foci levels continuously fell, until after 24 hours there was only 2.6 and 2.4 foci per cell 
present in the control lines 1BR and 48BR respectively (figure 5-4).
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Figure 5-4: Average n u m b er of y-H2AX foci counted in nuclei of control (1BR and 48BR), 
radiosensitive patien t and  rad iosensitive  m u tan t fib roblasts a t indicated  periods of repair 
time after irrad ia tion  w ith  2Gy. Whereas the ligase IV deficient 180BR line demonstrated a 
deficiency in the initial rate of foci removal, Artemis deficient cells (CJ179) demonstrated 
elevated levels of residual foci after 24 hours. Similar to this, the F96 line displayed higher 
levels of residual foci at 24 hours compared to control, and this may indicate comparable defect 
in DSB repair. GOS1 and GOS5 demonstrated a mild increase in residual foci, while the 
GOS21 line was similar to control cells. Error bars represent standard deviation (SD).
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180BR is a primary line derived from a patient with mutations in the Ligase IV DSB 
repair gene (Riballo et al, 1999), and as expected these cells demonstrated a slower rate 
of foci removal compared to control cells, with 12 foci per cell remaining after 24 hrs. 
CJ179 is a primary fibroblast line with a null mutation in the Artemis DSB repair 
protein, and although these cells displayed a relatively normal rate o f foci removal up to 
6 hrs after irradiation, at 24 hrs they had an elevated level o f residual foci (9 foci per 
cell) that was comparable to that o f  the 180BR line. This is consistent with the notion 
that Artemis is required for the resolution o f  a subset o f DSBs. Although these cells can 
rapidly repair the majority o f  breaks, a percentage remains that is refractory to repair in 
the absence o f Artemis.
The undefined radiosensitive lines GOS1, GOS5 and GOS21 all demonstrated an initial 
rate of foci removal that was similar to the control lines 1BR and 48BR. 24 hrs after 
irradiation GOS21 cells had a level o f  residual foci (2.08 foci per cell) comparable to 
that in control cells (2.4 foci per cell), which suggests this line is proficient in DSB 
repair. GOS1 and GOS5 cells displayed approximately double the control level of 
residual foci at 24 hrs (4.9 foci per cell for both lines) and this may indicate a mild 
defect in repair. Earlier in this chapter F96 cells demonstrated an abnormally high level 
of unrepaired chromosome breaks after irradiation and consistent with this we detected 
an elevated level o f residual y-H2AX foci 24 hrs after irradiation (8 foci per cell). This 
represented a 3 fold increase in residual foci compared to control cells. Similar to the 
Artemis deficient lines, there was no apparent deficit in the initial rate o f foci removal in 
F96 cells, which may suggest a similar defect in DSB repair.
In order to further investigate residual levels o f foci in F96 cells, the later time points of 
48 and 72 hrs were examined and compared to control and DSB repair defective cells.
In the control lines 1BR and 48BR the number o f foci had returned to near unirradiated 
levels (~1 foci per cell) by 48 hrs after irradiation (figure 5-5). Although the 180BR 
line displayed a slower rate o f  foci removal, the number o f foci eventually returned to 
baseline 72 hrs after irradiation, and this is consistent with the presence o f a 
hypomorphic mutation in ligase IV that produces a partially functional protein (Riballo 
et al, 2001). CJ179 do not express Artemis and may be considered null for this DSB 
repair protein. These cells demonstrated an elevated level o f residual foci 24 hrs after 
irradiation (10.6 foci per cell) similar to the 180BR line, but unlike 180BR cells the 
number of foci did not decrease substantially by 72 hrs and remained high (5 foci per
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cell). This suggests that a certain number o f breaks are not repaired in CJ179 cells and 
is consistent with the role o f Artemis in repairing a subset of DSBs. Since these cells 
have no functional Artemis protein, these complex breaks persist for extended periods 
beyond 72 hrs (Riballo et al, 2004).
Similar to the CJ179 line, F96 cells demonstrated elevated levels of residual foci 24 
hours after irradiation. Although still exceeding the control value at 48 hrs, foci levels 
continued to decrease until they were similar to control cells at 72 hours post irradiation. 
F96 cells were therefore characterised by a normal initial rate of foci removal (figure 5- 
4) until 24 hrs when there was an elevated level o f residual breaks, but this had returned 
to normal after 72 hours (figure 5-5).
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Figure 5-5: Average number of y-H2AX foci counted in nuclei of control (48BR), repair 
defective (180BR and CJ179) and undefined F96 fibroblasts at late time points after 
irradiation with 2Gy. Foci levels in 180 BR cells that have a slow initial rate of removal 
eventually return to pre-irradiation values 72 hours after irradiation. The high level of residual 
breaks in CJ179 cells at 24 hrs remains elevated even after 72 hrs of repair time. F96 cells that 
have a normal initial rate of foci removal demonstrated elevated levels of foci 24 and 48 hours 
after irradiation compared to controls, but this decreased to control levels after 72 hours. Error 
bars represent SD.
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These results indicate that although F96 cells may harbour a defect in the repair o f a 
subset o f DSBs, unlike CJ179 cells these are eventually resolved with delayed kinetics. 
The underlying mutation therefore does not affect the repair o f all DSBs as proposed for 
Ligase IV deficiency, and is not as severe as an Artemis null mutation regarding the 
persistence of residual breaks.
Using a combination o f chromosome break analysis and y-H2AX foci enumeration we 
have been able to gain an indication o f whether a defect in the repair o f radiation- 
induced DSBs is present in undefined radiosensitive lines. Although GOS5 cells 
demonstrated slightly elevated levels o f residual damage in both assays compared to 
controls, this was not significant enough to suggest any substantial defect in repair. F96 
cells demonstrated significantly elevated levels o f residual damage in both assays 
indicating defective repair, and this connotation was considered in subsequent 
investigations of this undefined line.
5.5 Discussion
Concurrent with the activation o f repair processes DNA damage activates cell-signaling 
cascades that function to arrest the cell cycle. In the first instance this is thought to 
allow time for repair to occur before the initiation o f DNA synthesis (G l/S checkpoint), 
resumption of DNA synthesis (S-phase checkpoint) or the initiation o f mitosis (G2/M 
checkpoint) (Nyberg et al, 2002). Failure to efficiently activate cell cycle checkpoints 
after the induction o f DNA damage is associated with high levels o f genomic instability 
and cellular radiosensitivity, characteristics that are exemplified by cells with mutations 
in the ATM transducing kinase (Houldsworth and Lavin, 1980) (Painter and Young, 
1980) (Kastan et al, 1992) (Beamish et al, 1994). Consistent with this data, the A- 
T1BR line displayed a deficiency in G l/S  checkpoint activation compared to control 
cells as shown by BrdU cell cycle analysis. In contrast, the F96 line demonstrated 
efficient G1 arrest after irradiation and, apart from immunodeficiency, the F96 patient 
did not show any of the clinical characteristics o f A-T. This suggests that the F96 line 
does not have defects in ATM that confer checkpoint deficiency. These results are 
consistent with previous investigations into the F96 line that described normal 
checkpoint function (Peake et al, 1999).
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AT cells fail to efficiently stabilise p53 after exposure to ionising radiation (Lu and 
Lane, 1993) (Khanna et al, 1995) an event that is required for efficient G l/S  arrest. In 
order to determine whether the undefined radiosensitive lines identified in section 4 are 
deficient in the activation o f p53, we examined the induction o f p21, a p53 target gene 
that is required for efficient G l/S  arrest after exposure to y-radiation. Consistent with 
BrdU cell cycle analysis results, the A-T1BR line demonstrated a deficiency in the 
induction of p21 mRNA after irradiation compared to control. The minimal increase 
(1.3 fold) in p21 mRNA levels that was observed may result from activation o f ATR, 
which has been proposed as a compensatory mechanism for the delayed activation of 
p53 in the absence o f ATM (Abraham, 2001). In contrast, the repair defective lines 
180BR and CJ179, which have mutations in the Ligase IV and Artemis DSB repair 
genes respectively, displayed a normal induction o f p21 mRNA after irradiation. This is 
consistent with previous reports that have described the efficient initiation o f a Gl/S  
checkpoint and induction o f p21 after irradiation in NHEJ defective cells (Badie et al,
1997) (Jhappen et al, 2000). Therefore, although wild type Ligase IV and Artemis are 
required for normal levels o f survival after irradiation, these defects are not associated 
with impaired checkpoint signaling regarding the induction o f p21 after irradiation. 
Similar to the repair defective lines examined, the undefined radiosensitive lines GOS1, 
GOS5, GOS14 and F96 all demonstrated a robust induction o f p21 mRNA after 
irradiation. This may be expected for the F96 line, considering the efficient activation 
of a Gl/S checkpoint as shown by BrdU analysis, and since p21 protein induction after 
irradiation was previously found to be normal in F96 cells (Peake et al, 1999). Thus, in 
contrast to AT cells, these undefined radiosensitive lines do not show any evidence of 
an attenuated p53 response. Since none o f these patients presented with the 
characteristic clinical symptoms o f AT, it is unlikely that the observed radiosensitive 
phenotypes result from defects in the ATM protein associated with impaired p53 
signaling.
Whilst the undefined radiosensitive lines have demonstrated robust activation o f the p53 
signaling pathway, this was also observed in DSB repair defective lines. In this 
situation, concurrent with the activation o f DNA damage checkpoints, these mutant 
lines initiate repair pathways that are insufficient to effectively repair DNA damage.
This can result in an increased number o f residual DSBs after irradiation (Borgmann 
and Dikomey, 1997) (Dikomey et al, 1998) (Wachsberger et al, 1999), and since this 
endpoint has been associated with poor survival after irradiation (Wurm et al, 1994)
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(Kiltie et al, 1997) (Dikomey et al, 1998) (Sarkaria et al, 1998) (Zhou et al, 1998) 
(Dikomey et al, 2000a) (Dikomey et al, 2000b), we investigated whether any o f the 
undefined radiosensitive lines showed any evidence o f defective repair. This was 
initially performed by examining levels o f unrepaired chromosome and chromatid 
breaks after irradiation.
AT cells have previously demonstrated a high level o f unrepaired chromatin breaks after 
irradiation (Taylor et al, 1976) (Sasai et al, 1994) or treatment with a radio-mimetic 
drug (Shaham et al, 1983), which may lead to increased levels o f chromosomal 
deletions (Comforth and Bedford, 1985) (Mozdarani and Bryant, 1989) (Martin et al,
2003). Consistent with these previous findings, the A-T1BR line demonstrated 
significantly higher levels o f unrepaired breaks compared to control cells. Whilst the A- 
T1BR line displayed an elevated level o f residual breaks that was approximately ten­
fold higher than that that o f control cells, the Artemis deficient CJ179 line demonstrated 
only a two-fold increase. This difference in chromosomal radiosensitivity is consistent 
with results obtained for cellular radiosensitivity using these lines, in which the A- 
T1BR line was found to be considerably more radiosensitive that the CJ179 line 
(section 4).
The majority o f unrepaired breaks observed in the A-T1BR line after irradiation 
corresponded to chromatid breaks, in contrast to other lines that displayed 
approximately equal numbers o f  chromosome and chromatid breaks. AT cells have 
previously been shown to convert more DSBs into chromatid deletions than do normal 
cells (Mozdarani and Bryant, 1989). Whereas chromosome breaks are thought to arise 
from DSBs induced in G l, chromatid breaks are initiated by an undetermined 
mechanism involving DSBs induced in late S- or G2 phases o f the cell cycle (Bryant,
2004). Since there appears to be no correlation between Gl chromosomal 
radiosensitivity and G2 chromatid radio sensitivity (Scott et al, 1999) different 
mechanisms are thought to convert DSBs into chromosomal aberrations at different 
stages of the cell cycle. The high levels o f chromatid breaks observed in A-T cells may 
therefore result from a specific defect in DSB repair in G2. Since Homologous 
Recombination (HR) DSB repair is restricted to the late S- and G2 phases o f the cell 
cycle (Takata et al, 1998) (Johnson and Jansin, 2000), and ATM has been implicated in 
this pathway (Chen et al, 1999b) (Morrison et al, 2000), the high levels o f chromatid 
breaks observed in AT cells may reflect a specific defect in HR DSB repair. High
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levels of chromatid breaks may also result from the lack o f checkpoint function 
associated with AT cells (Houldsworth and Lavin, 1980) (Painter and Young, 1980) 
(Kastan et al, 1992) (Beamish et al, 1994) (section 5.3). Recent work has supported the 
notion that chromatid breaks result from a signaling pathway initiated by the presence 
of a DSB in a distinct loci, which involves either intra- or inter- chromatid 
recombination (Bryant et al, 2004). Since DSBs induced in Gl are expected to persist 
into the later stages o f the cell cycle in A-T cells due checkpoint deficiency, this effect 
may promote chromatid break formation at this time.
The CJ179 line displayed significantly higher levels o f unrepaired chromatin breaks 
compared to control cells. This is consistent with the complete lack o f functional 
Artemis protein in this line (P. Jeggo, personal communication). Previous studies on 
murine cells have demonstrated increased levels o f  chromosomal instability in the 
absence of Artemis protein (Rooney et al, 2002), and this effect was enhanced in ES 
cells by treatment with ionising radiation (Rooney et al, 2003). Our results confirm that 
Artemis deficiency leads to increased chromosomal instability in human cells after 
irradiation, and may suggest a genome caretaker role for this protein in humans. The 
higher levels of chromatin breaks observed are likely to reflect the DSB repair defect 
associated with Artemis deficient cells as shown using the H2AX DSB repair assay 
(section 5.6.2) and pulse field gel electrophoresis to measure DSB rejoining (Riballo et 
al, 2004). The mildly radiosensitive lines GOS1 and GOSH demonstrated a normal 
level of unrepaired chromatin breaks after irradiation, and although GOS5 cells had 
slightly elevated levels compared to control, this difference was not significant. This 
suggests that these cells are able to rejoin DNA DSBs efficiently and argues against the 
presence of a major defect in DSB repair. Conversely, the F96 line demonstrated 
significantly higher levels o f unrepaired chromatin breaks compared to controls and this 
was to a similar extent as that observed in the Artemis deficient CJ179 line. These 
results indicated that the F96 line may harbour a similar defect in DSB repair, and we 
were able to further investigate this eventuality using the H2AX DSB repair assay.
Recent studies have demonstrated that enumerating y-H2AX foci at various time points 
after irradiation can be used to measure the repair o f DNA DSBs in primary human 
fibroblasts (Rothkamm and Lobrich, 2003) (Khune et al, 2004) and Chinese hamster 
ovary cells (Rothkamm et al, 2003). This method can also be employed at more 
physiologically relevant doses o f  ionising radiation compared to the more established
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DSB repair assay involving PFGE (Badie et al, 1995a), which is restricted to doses of at 
least 10 Gy therefore limiting sensitivity. Compared to control cells, the radiosensitive 
180BR line that harbours a hypomorphic mutation in the Ligase IV DSB repair gene 
(Riballo et al, 1999) (Riballo et al, 2001) displayed a slower initial rate o f  DSB repair. 
The number o f foci returned to pre-treatment levels 48 hours after irradiation, while 
control cells achieved this within 24 hours. This is consistent with a hypomorphic 
mutation in Ligase IV that limits the initial rate o f DSB rejoining but eventually, and 
with slower kinetics, is able to reduce the level o f residual DSBs to pre-treatment levels. 
A slower initial rate o f DSB repair has previously been reported in the 180BR line that 
was associated with reduced, but not abolished, double stranded DNA end ligation 
(Riballo et al, 2001). Since DNA end ligation is likely to be required for all NHEJ 
reactions, this should affect the repair o f most, i f  not all, o f the DSBs induced by 
ionising radiation.
In contrast the Artemis null CJ179 line displayed an initial rate o f DSB rejoining that 
was similar to control cells until 24 hours after irradiation, when an elevated level o f  
residual breaks remained. This elevated level o f residual breaks did not dissipate 
significantly up to 72 hours after irradiation, suggesting a defect in DSB repair distinct 
from that observed in the Ligase IV defective 180BR line. This may indicate that while 
the Artemis protein is not required for the repair o f the majority o f radiation induced 
DSBs that occurs within the first 24 hours o f radiation, a subset o f breaks persist and are 
refractory to repair. This is consistent with the notion that Artemis is required for the 
repair of complex DSBs, i.e. those with base lesions and single strand breakage in the 
proximity of the DSB that require processing before ligation (Jeggo an O’Neil, 2002). 
From biophysical simulations, the proportion o f IR induced DSBs that are complex is 
significant and may represent 30-40 % for sparsely ionising radiations such as y-rays, 
rising to ~95 % for densely ionising a-radiation (Nikjoo et al, 2001). A consequence of  
the increased complexity o f DSB is seen as a decrease in the proportion o f DSB 
rejoined in mammalian cells on increasing ionisation density o f the radiation (Jenner et 
al, 1993). Therefore, a fraction o f complex breaks may require nucleolytic processing 
before ligation, and this does not occur in the absence o f Artemis and leads to cell 
inactivation. Previous studies that report normal DSB repair in Artemis deficient cells 
utilising doses o f 20-60 Gy followed by PFGE (Nicolas et al, 1996) (Zhang et al, 2004) 
may not be able to detect this residual fraction o f unrepaired DSBs due to the poor 
sensitivity of this assay. In addition, the Zhang et al, 2004 study did not examine the
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residual level of DSBs beyond 4 hours after irradiation, when the elevated level of 
residual DSBs is most apparent in the Artemis null CJ179 line. Indeed, recent work 
examining extended time points after irradiation confirmed that Artemis deficient cells 
are unable to repair a subset o f DSBs, and this defect is enhanced by agents that induce 
relatively high levels o f  complex DSBs (Riballo et al, 2004).
Similar to the Artemis null CJ179 line, although the F96 line displayed a normal initial 
rate of DSB repair, an elevated level o f residual H2AX foci remained 24 hours after 
irradiation. This is consistent with chromosome breakage results, which demonstrated 
an elevated level o f chromatin breaks after irradiation in F96 cells. Whilst an elevated 
level of foci was still present at 48 hours, this had returned to control levels 72 hours 
after irradiation, in contrast to the Artemis null CJ179 line that retained elevated levels 
of foci at this late time point. These results indicate that whilst the F96 line may 
harbour a similar defect to that o f CJ179 cells in the repair o f a subset o f DSBs, this 
deficiency may not be as severe since the level o f foci eventually returned to normal. 
The underlying mutation may therefore confer enough residual function to repair 
complex breaks with reduced kinetics and/or fidelity, but the extended persistence 
and/or poor stability o f such rejoined breaks may lead to cell inactivation. This would 
be consistent with the high level o f dicentric chromosomes observed in the F96 that 
may result from mis-rejoining o f radiation induced DSBs (Pfeiffer et al, 2000) and have 
been observed at high levels after irradiation in DNA-PK deficient cells (Evans et al, 
1996). Indeed dicentric chromosomes have been proposed as a surrogate maker for the 
quality of DSB repair and were reduced by stimulation o f DNA-PK activity (Dittmann 
et al, 2003). Our results suggest that a high level o f misrepair occurs in the F96 line 
after irradiation.
A previous investigation into DSB repair in the F96 line described a fast rate o f initial 
rejoining with normal levels o f residual breaks 24 hours after exposure to y-radiation 
(Peake et al, 1999). This was performed using the relatively insensitive PFGE 
technique after a dose o f 30 Gy. Although these results disagree with our findings, the 
observed defect in DSB repair is subtle and only detectable within a restricted 
timeframe after irradiation. The poor sensitivity associated with PFGE and large doses 
of y-radiation employed may have masked this subtle defect in DSB repair. Indeed, the 
fact that PFGE was unable to detect any defects in DSB repair in Artemis deficient cells 
similar to the CJ179 line (Nicolas et al, 1996) (Zhang et al, 2004) would suggest that
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the less severe deficiency inherent to F96 cells would go undetected using this 
technique. The results from our chromosome breakage study further support the notion 
of defective repair in the F96 line.
The radiosensitive GOS1 and GOS5 lines demonstrated a normal rate o f initial DSB 
repair as shown by y-H2AX foci enumeration, and although there were slightly elevated 
levels of residual breaks 24 hours after irradiation, this effect was not significant 
compared to controls. The GOS5 line also demonstrated a slightly elevated level o f  
unrepaired chromosome breaks compared to control that was not significant, and 
therefore displayed comparable results in both test systems. Although these results 
suggest no overt defect in repair is associated with the GOS1 and GOS5 lines, GOS5 
cells did display a high level o f dicentric chromosomes that could result from poor DSB 
repair fidelity. The radiosensitive GOS1 line was found to be comparable to control 
cells in both the chromosome breakage and y-H2AX enumeration assays systems, 
therefore a defect in DSB repair is unlikely to be responsible for the observed 
radiosensitivity o f this line.
These results indicate that unlike AT cells, the radiosensitive lines examined are able to 
efficiently activate p53 dependent gene transcription. The observed radiosensitivity of 
these lines is therefore not expected to be associated with defective G l/S checkpoint 
activation. Whilst all o f the GOS lines have shown no convincing evidence o f a defect 
in DSB repair, the F96 line is a good candidate to have a mild defect in this aspect of 
the damage response similar, but not as severe, to that observed in the Artemis null 
CJ179 line. The repair deficiency observed in F96 cells may also be associated with a 
high level of DSB misrejoining.
Chapter 6: Analysis of candidate genes associated with 
radiosensitive immunodeficiency
6.1 Background
We have identified a group o f undefined immunodeficient patients that have 
demonstrated cellular radiosensitivity in fibroblast survival assays. After further 
investigation, one radiosensitive line (F96) displayed evidence o f defective DNA repair. 
Defects in DNA repair have been previously described in radiosensitive 
immunodeficient patients with mutations in the Ligase IV (O’Driscoll et al, 2001) and 
Artemis (Moshous et al, 2001) (Li et al, 2002a) (Kobayashi et al, 2003) (Moshous et al, 
2003) (Noordzij et al, 2003) DSB repair genes. Such deficiencies impair the ability to 
perform V(D)J recombination during lymphocyte development and result in poor 
cellular survival after radiation-induced DSBs.
To investigate the possibility that the radiosensitive patients identified in this project 
have similar mutations in DSB repair genes, we analysed the coding region o f candidate 
genes obtained by RT-PCR o f primary fibroblast cDNA. This was performed for the 
Artemis, Ligase IV and XRCC4 DSB repair genes. The Artemis protein is a nuclease 
that is thought to remove several end nucleotides prior to DSB rejoining, since 
pathological and physiological DSBs usually result in incompatible ends (Moshous et 
al, 2001) (Jeggo and O’Neill, 2002). The XRCC4/Ligase IV complex then functions in 
the final ligation stage o f NHEJ, where the XRCC4 protein appears to stabilise and 
enhance the activity o f Ligase IV in the rejoining o f DSBs (Grawunder et al, 1997) 
(Grawunder et al, 1998). Although patients with mutations in XRCC4 have not been 
previously described, such defects would be expected to result in a similar human 
disorder to Ligase IV syndrome since the proteins function in the same step o f NHEJ 
and their interaction is required for V(D)J recombination and DSB repair (Grawunder et 
al, 1998).
The sequencing o f candidate genes can be a laborious process depending on the size o f 
the coding region in question. We therefore restricted our efforts to 3 genes with a 
coding region of reasonable size (less than 3 kb) that was amenable to RT-PCR 
followed by DNA sequencing. We also focused on the F96, GOS5 and GOS23
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undefined lines that displayed intermediate radiosensitivity in section 4.2.2., since it is 
more likely these patients have mutations in specific DNA repair genes compared to the 
patients that demonstrated a mild radiosensitivity, which could possibly result from 
random genetic variation. Consistently, no data was found for a defect in DNA repair in 
lines that demonstrated mild radiosensitivity (section 5.4), whereas one line with 
intermediate radiosensitivity (F96) displayed evidence o f defective repair. Hence, this 
line in particular was a strong candidate to harbour a mutation in the repair genes under 
investigation.
6.2 Sequencing of candidate DNA repair genes
6.2.1 XRCC4 sequencing
A pair of PCR primers (UX and LX) was designed to amplify a 1283 bp fragment that 
spans the entire human XRCC4 coding sequence using cDNA as a template (figure 6- 
1). These primers target XRCC4 transcript variant 3 (GenBank identifier NM 022550), 
which includes the 3’ portion o f non-coding exon 1 that is missing in the other two 
known variants (1 and 2). The protein-coding region o f transcript 3 is the same as that 
of variant 1, coding for full length XRCC4. Transcript 3 was sequenced here since the 
optimal design o f PCR primers was easily achieved using this transcript as a template. 
PCR conditions were optimised to generate a clear 1283 bp band after gel 
electrophoresis on a 1 % agarose gel (figure 6-1), and the amplified product was then 
gel purified to be used as a template for DNA sequencing. The original PCR primers 
(UX and LX) were used in conjunction with sequencing primers located at 
approximately 500 bp intervals along the amplified product (U1 and U2; upper strand,
LI and L2; lower strand, figure 6-1) in order to sequence the coding region. This was 
performed in both directions for 3 templates generated in separate PCR reactions, after 
which the sequence data was pooled for analysis in each cell line. This process was 
completed for the control line 48BR and the radiosensitive patient lines F96, GOS5 and 
GOS23. All of these lines had wild type XRCC4 coding sequence identical to the 
published sequence.
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Figure 6-1: Strategy for sequencing human XRCC4. PCR primers UX and LX were 
designed to amplify the entire coding sequence of XRCC4. These were first used to amplify 
XRCC4 from cDNA, and then in conjunction with primers Ul, U2, LI and L2, were again used 
to sequence the gel purified PCR product.
6.2.2 Ligase IV sequencing
The Ligase IV coding region is 2734 bp long and was amplified in two overlapping 
sections. Primers UB and LB were designed to amplify a 1473 bp fragment that 
encompassed the 5' half of the coding region (figure 6-2). These PCR primers were 
then used in conjunction with primers U2, U3, U4 (upper strand), LI and L2 (lower 
strand) in order to sequence the gel purified product in both directions. The 3' half of 
the coding region was amplified using primers UA and LA, which produce a 1496 bp 
PCR product (figure 6-2). These primers were then used in conjunction with primers 
U6, U7 (upper strand) L4 and L5 (lower strand) in order to sequence the gel purified 
PCR product in both directions. For both the 5' and 3' fragment, 3 templates produced in 
separate PCR reactions were sequenced in both directions, and the resulting sequence 
data pooled to construct the full coding sequence for each cell line. This process was 
completed for the control line 48BR and the radiosensitive patient lines GOS5 and 
GOS23. All of these lines had wild type Ligase IV coding sequence identical to the 
published sequence.
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Figure 6-2: Strategy for sequencing human Ligase IV. PCR primers UB and LB were 
designed to amplify the 5' coding sequence of Ligase IV. These were first used to amplify the 5 
region from cDNA, and then in conjunction with primers U2, U3, U4, LI and L2, were again 
used to sequence the gel purified PCR product. PCR primers UA and LA were designed to 
amplify the 3' coding sequence of Ligase IV. These were first used to amplify the 3 region 
from cDNA, and then in conjunction with primers U6, U7, L4 and L5, were again used to 
sequence the gel purified PCR product. The resulting sequence data was then pooled in order to 
construct the full coding sequence of Ligase IV for each primary cell line.
6.2.3 Artemis sequencing
The Artemis coding region is over 2000 bp long, and similar to the strategy used to 
sequence Ligase IV, this gene was initially amplified to two sections. Primers UA and 
LAI were designed to amplify a 1160 bp fragment that encompassed the 5’ half of the 
coding region (figure 6-3). These PCR primers were then used in conjunction with 
primers U2, U3, (upper strand), L4 and L5 (lower strand) in order to sequence the gel 
purified product in both directions. The 3’ half of the coding region was amplified using 
primers UA2 and LA, which produce a 1177 bp PCR product (figure 6-3).
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Figure 6-3: Strategy for sequencing human Artemis. PCR primers UA and LAI were 
designed to amplify the 5' coding sequence of Artemis. These were first used to amplify the 5' 
region from cDNA, and then in conjunction with primers U2, U3, L4 and L5, were again used 
to sequence the gel purified PCR product. PCR primers UA2 and LA were designed to amplify 
the 3' coding sequence of Artemis. These were first used to amplify the 3' region from cDNA, 
and then in conjunction with primers U4, U5, L2 and L3, were again used to sequence the gel 
purified PCR product. Whereas the 3' fragment produced high quality sequence data, the 5' 
fragment generated sequence that became confused toward the 5' end, and appeared as a smear 
when resolved for an extended time on a 1% agarose gel (b). The gel purified 5' fragment was 
therefore blunt end ligated into pZErO and clones were sequenced using the T7 (forward) and 
SP6 (reverse) sequencing primers.
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These primers were then used in conjunction with primers U4, U5 (upper strand) L2 and 
L3 (lower strand) in order to sequence the gel purified PCR product in both directions. 
This was initially performed for the control line 1BR and the patient line F96, but 
whereas the 3' fragment in each case produced high quality sequence data, the 5' 
fragment displayed a sequence that became confused toward the 5’ end. This made it 
difficult to identify any potential mutations, and when this 5' fragment was resolved for 
an extended time on a 1 % agarose gel, the 1160 bp product appeared as a smear that 
consisted of at least two distinct bands. The Artemis gene consists o f 14 constitutive 
exons (Moshous et al, 2001) and several alternative splicing events have been reported 
involving the skipping o f exon 2 and/or exon 5, and the in-splicing o f alternative exons 
2b, 2c and 3b, all o f which occur in the 5' region o f  the coding sequence (Li et al,
2002a). This may have accounted for the convoluted sequence we obtained from the 5’ 
PCR product o f Artemis, since the 5’ primer used in this PCR (UA) is located in exon 1 
and would be expected to amplify all alternatively spliced transcripts. We therefore 
decide to ligate this fragment into pZErO, a vector that can be used to clone blunt ended 
PCR products for sequencing, in order to further study this region.
Plasmid DNA was isolated from 6 clones transformed with pZErO containing the 5' half 
of the Artemis coding region from the radiosensitive F96 line. Inserts were sequenced 
using the T7 (upper) and SP6 (lower) sequencing primers and this revealed the presence 
of several alternatively spliced transcripts. O f the 6 clones sequenced, 2 were full- 
length transcripts (2 x F96-G377A), 2 involved the in-splicing o f alternative exon 2b 
(F96-V1-G377A and F96-V1-AGTT, equivalent to SCIDA-V1 reported in Li et al, 
2002a), 1 involved the skipping o f exon 5 (F96-V3-AGTT, equivalent to SCIDA-V3, Li 
et al, 2002a) and 1 novel splice variant was identified that skips exon 9 (F96-V9- 
G377A) (table 6-1).
Table 6-1: Range of alternatively spliced transcripts and potential mutations in 
cloned F96 Artemis 5* fragment (Numberedfrom translation initiation codon)
Transcript Exon deletion Alternative
exons
Frequency Changes to 
published sequence
F96-G377A _ - 2/6 G377A, A728G
F96-V1-G377A - 2b 1/6 G377A, A728G
F96-V1-AGTT - 2b 1/6 AGTT207-9, T643C
F96-V3-AGTT 5 - 1/6 AGTT207-9, T643C
F96-V9-G377A 9 - 1/6 G377A, A728G
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In addition, there were 4 potential mutations present in the F96 Artemis gene that 
occurred in pairs that seemed to be mutually exclusive. This suggested that 2 Artemis 
alleles were represented in F96 cDNA, each o f which contained two mutations. One 
allele contained G377A and A728G (numbered from the translation initiation codon) 
point mutations, whilst the other harboured a GTT207-209 codon deletion and a T681C 
point mutation (table 6-1).
6.2.4 Cloning of full length Artemis cDNA and confirmation of F96 Artemis 
mutations.
In order to confirm the potential Artemis mutations identified in the F96 line and fully 
characterise the range o f transcripts expressed, we attempted to clone the entire Artemis 
coding region from control (1BR) and F96 cells. This was achieved using the gateway 
cloning system (Invitrogen). A pair o f  PCR primers (Art-F and Art-R) was designed to 
amplify the entire Artemis coding region and incorporate a CACC motif exactly 5' to 
the ATG translation initiation codon. The sequence o f the forward primer was therefore 
CACC ATG GTT CTT TCG AGG G. After a successful amplification reaction the 
CACC motif would allow the PCR product to be cloned directly into a Gateway TOPO 
directional cloning vector. The reverse primer was designed to anneal at the translation 
stop codon and modify this to code for tryptophan. This would allow the Artemis 
protein to be tagged at the C-terminus for later expression studies.
After optimisation o f PCR conditions, primers Art-F and Art-R produced a band o f the 
correct size (2083 bp) using both control (1BR) and F96 cDNA as a template (figure 6- 
4). The fragments produced using a PCR reaction containing ImM MgCk were cloned 
into pcDNA3.2/V5/GW/D-TOPO (Invitrogen) using the TOPO cloning system, 
whereby a GTGG overhang in the vector anneals to the CACC tagged PCR product, and 
Vaccinia virus topoisomerase I present at the cloning site recombines the two DNA 
molecules to clone the insert in the correct orientation. The T7 (forward) and TKR 
(reverse) primers where then used in combination with the Artemis sequencing primers 
described earlier (figure 6-3) to sequence the cloned inserts.
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Figure 6-4: Strategy for cloning the full coding region of A rtem is. The Art-F and Art-R 
PCR primers were designed to amplify the entire coding region of Artemis, and incorporate a 
CACC motif exactly 5' to the ATG translation initiation codon. The gel purified PCR products 
could then be cloned directly into a gateway expression vector using the TOPO cloning system. 
Cloned inserts were sequence using a combination of the original PCR primers (Art-F and Art- 
R) and the sequencing primers described in figure 6-3.
In order to gain sufficient insight into the range of Artemis transcripts expressed in 
normal primary fibroblasts, 25 clones derived from 1BR cDNA and 22 clones derived 
from F96 cDNA were sequenced. Consistent with the preliminary results described 
above, along with the primary Artemis transcript there were many alternatively spliced 
products present in the F96 line, and this was also reflected in 1BR cells. Similar 
alternatively spliced transcripts have been described in SCID patients of Athabascan­
speaking native Americans harbouring a common founder mutation (Y192X) (Li et al, 
2002a), and since a single point mutation is unlikely to cause all splicing events, these 
alternative transcripts may also be expected in wild type cells. In addition to these 
previously characterised splice events, we also identified 3 novel variant transcripts in 
the 1BR line (table 6-2). These either involved the skipping of exon five, or the in­
splicing of a previously uncharacterised 134 bp alternative exon that lies between exon 
1 and 2, designated exon lb (figure 6-5).
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Table 6-2: Range of alternatively spliced transcripts and polymorphisms in cloned 
full length Artemis from 1BR cells (Numberedfrom translation initiation codon)
Transcript Exon
deletion
Alternative
exons
Frequency Differences to published 
sequence
1BR - - 7/25 T643C, G1678T, C1809T
1BR-V1 - 2b 7/25 T643C, G1678T, C1809T
1BR-V1A5* 5 2b 3/25 T643C, G1678T, C1809T
1BR-V2A5* 5 2c 2/25 T643C, G1678T, C1809T
1BR-V3 5 - 2/25 T643C, G1678T, C1809T
1BR-V4 2 ,5 - 3/25 T643C, G1678T, C1809T
1BR-V1+1b* 1b, 2b 1/25 T643C, G1678T, C1809T
* Previously undescribed splice variants
The organisation of the 1BR Artemis gene
T643C G1678T C1809T
NC V560L NC
Sequence of exon lb
5'ggagtcagccaccatgcctagctaatgtttgtatttttattattattttgagGTGGAGTCTCCATCACCCTGG
AGTGCAGTGGCGTGATCTCTGTTCACTGCAACCTCCGCCTCCTGGGTTCAAGCG
ATTCTCGTGCCTCAGCCTCCCAAGTAGCTGGAGTTACAGGCACGCACCACCACA
CCCAGgtaatttttgtgtttttagtagagatgatgtttcacc3'
Figure 6-5: The organisation of the 1BR Artemis gene and the sequence of exon lb. The
exon-intron organisation is depicted. The constitutive exons are shown as [H and the alternative 
exons are shown as ^  . In addition to the previously described variants (Li et al, 2001a), 1BR 
cells expressed VI and V2 transcripts with deletion of exon 5 (1BR-V1A5 and 1BR-V2A5). One 
transcript (IBR-Vl+lb) was also identified that utilised a novel 134 bp alternative exon that lies 
between exon 1 and 2, designated exon lb. The sequence of exon lb is displayed in bold upper 
case, and the intron sequence directly 5' and 3' is shown in lower case. No transcripts were 
found that involved alternative exons 2c, and 3b. 3 differences to the published sequence were 
also present. T643C and C1809T are silent polymorphisms that are not expected to change the 
primary sequence of the Artemis protein, whereas G1678T results in a Valine560Leucine amino 
acid change.
The 1BR Artemis gene also had 3 differences to the published wild type sequence. 
T643C and C1809T in exons 8 and 14 respectively were classed as silent 
polymorphisms since these changes do not affect the predicted amino acid sequence of 
the Artemis protein. Conversely, the G1678T difference identified in exon 14 results in 
a V560L amino acid change in the Artemis protein. Since this represents the exchange 
of one hydrophobic amino acid for another, and the 1BR line is derived from a normal
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individual, this change in sequence was considered to be a polymorphism that is 
unlikely to have any significant affect on Artemis protein function.
Novel Artemis splice variants were also expressed in the F96 line (table 6-3), one 
resulting from the in-splicing o f alternative exon 2b as well as 2c, and the other 
involving the use o f an alternative splice site in the middle o f exon 9 and deletion o f  
exon 11 (figure 6-6). All o f the F96 Artemis clones contained the C1678T and C1809T 
polymorphisms characterised previously in the control line 1BR.
Table 6-3: Range of alternatively spliced transcripts and mutations in cloned full 
length Artemis from F96 cells (Numbered from translation initiation codon)
Transcript Exon
deletion
Alternative
exons
Frequency Differences to published 
sequence
F96-AGTT - - 4/22 AGTT207-209, T643C,
G1678T, C1809T
F96-V1-AGTT - 2b 4/22 AGTT207-209, T643C,
G1678T, C1809T
F96-V3-AGTT 5 - 1/22 A G T T 2 0 7 -2 0 9 , T643C,
G1678T, C1809T
F96-V2bc-AGTT* 5 2b, 2c 1/22 AGTT207-209, T643C,
G1678T, C1809T
F96-G377A - - 8/22 G377A, A728G,
G1678T, C1809T
F96-V1-G377A - 2b 2/22 G377A, A728G,
G1678T, C1809T
F96-V3-G377A 5 - 1/22 G377A, A728G,
G1678T, C1809T
F96-V9/11-G377A* 9# 11 - 1/22 G377A
G1678T, C1809T
* Previously undescribed splice variants, # Deletion o f  the 5 'half o f  exon 9
Exon 9 alternative splice site
5'atttcacataatttgcatgtatgtattatttgccttagGTTCATGTGAATAAGCTAGACATGTTTAGGA
ACATGCCTGAGATCCTTCATCGTCTCACAACAGACCGCAACACTCAGATCCATG
CATGCCGGCATCCCAAGgtacgtgtgcaagtgattcctctcgtattgtttgtgtaa3'
Figure 6-6: The exon 9 alternative splice site involved in transcript F96-V9/11-G377A.
Transcript F96-V9/11-G377A involved the splicing of exon 8 to an alternative splice site in the 
middle of exon 9. Exon 9 sequence is depicted in bold upper case, and intron sequence is 
shown in lower case. The 3' exon 9 sequence that was present in transcript F96-V9/11-G377A 
is depicted in blue bold upper case. The A728G polymorphism present on the G377A F96 
allele is shown in red and therefore did not occur in transcript F96-V9/11-G377A.
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The organisation of F96 Artemis alleles
F96 Allele 1 AGTT207-209
I
T643C
F96 sequence 199-212
GAGTT GTT AACGAG
I
G1678T C1809T
Deletion of Leucine 70
1BR sequence 199-215
GAGTTGTTGTT AACGAG
1
Leucine 70 COO' 
+H3N—C—H 
Chfc 
CH
HzC/  'ci-fc
F96 Allele 2 G377A
i
A728G
I
G 7 6 7 8 7  C 7 8 0 9 7
I  I
F96 sequence 369- 386
ATTTCAGGACAAT AAT GG
I
Aspartic Acid 126 coo' 
+H3N— C—H 
Cl-fc 
Cl-t 
CO O ‘
1BR sequence 369- 386
ATTT CAGGGCAAT AAT GG
i
Glycine 126 OOO'
I
H3N— C — H
I
H
Figure 6-7: The F96 line is a compound heterozygote for mutations in the Artemis gene.
F96 cells express 2 mutant Artemis alleles. Allele 1 harbors a GTT207-209 deletion in exon 3 
that is predicted to result in the deletion of Leucine 70. Allele 2 contains a G377A point 
mutation in exon 6 that results a Glycine 126Aspartic acid change in the Artemis protein. All 
the other differences compared to the published Artemis mRNA sequence are likely to be 
polymorphisms, since they were found in control cells and the draft sequence of the human 
genome (italics).
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The T643C silent polymorphism identified in 1BR cells was also present in the F96 line 
but this only occurred in approximately half o f the transcripts sequenced (10/22), which 
suggested the expression o f 2 distinct Artemis alleles. Consistent with the results 
obtained from cloning the 5' half o f F96 Artemis, the T643C polymorphism only 
occurred in parallel with a GTT207-209 codon deletion in exon 3 that was specific to 
the F96 line. The remaining 13 transcripts contained a G377A point mutation, and this 
was accompanied by an A728G base change in all but one instance. The G377A 
mutation appeared without the A728G base change in transcript F96-V9/11-G377A 
(table 6-3), but this transcript involved the deletion o f the 5' half o f exon 9 where A728 
is situated (figure 6-6).
From these sequencing results we concluded that the F96 line expressed 2 distinct 
Artemis alleles that contained novel mutations that were not present in the 1BR line 
(figure 6-7). Allele 1 contained a GTT207-209 codon deletion in exon 3 that is 
expected to result in the deletion o f Leucine 70. Allele 2 comprised G3777A and 
A728G point mutations that result in G126D and H243A changes in the Artemis protein 
respectively. The A728G change is present in the draft sequence o f the human genome 
and was also identified in another primary fibroblast control line (48BR) that was 
sequenced for Artemis, and this is therefore likely to represent a polymorphism. The 
G377A and AGTT207-209 mutations were not present in this other control line. We 
also cloned and sequenced Artemis from the radiosensitive GOS5 line. Whilst GOS5 
Artemis contained 3 o f  the polymorphisms already identified (T643C, G1678T and 
C1809T), no other changes to the published Artemis mRNA sequence were identified.
6.2.5 Analysis of Artemis splice variants
The Artemis gene is composed o f 14 constitutive exons with sizes ranging from 52 to 
1160 bp (Moshous et al, 2001), and exon 14 spans the entire C-terminal half o f the 
protein. Several alternative splicing events have been reported involving the skipping 
of exon 2 and/or exon 5, and the in-splicing o f alternative exons 2b, 2c and 3b, all of 
which occur in the 5' region o f the coding sequence (Li et al, 2002). These alternative 
splicing events were reported in a group o f Athabascan speaking Native Americans that 
harboured a common founder nonsense mutation (Y 192X) that is unlikely to be 
responsible for all splicing events. Consistent with these previous findings, amongst the 
control (1BR) clones sequenced, we identified transcripts with deletions involving
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exons 2 and 5, and inclusions o f exon 2b or 2c (Table 6-4). These alternative transcripts 
code for severely truncated Artemis proteins, since the splicing-out o f  exons 2 or 5 as 
well as the addition o f exons 2b or 2c, leads to a frameshift.
Table 6-4: Analysis of alternative Artemis transcripts identified in 1BR and F96 
cells in sections 6.2.3 and 6.2.4
Transcript Exon
deletion
Alternative
exon s
Frequency 
(rel) <%)
Frameshift 
after exon
Protein 
length (res)
1BR - - 7/25 28 - 692
1BR-V1 - 2b 7/25 28 2 54
1BR-V1A5* 5 2b 3/25 12 2 54
1BR-V2A5* 5 2c 2/25 8 2 56
1BR-V3 5 - 2/25 8 4 108
1BR-V4 2, 5 - 3/25 12 1 38
1BR-V1+1b* 1b, 2b 1/25 4 1b 82
F96
(G377A or AGTT)
- - 14/28 50 - 692 or 691
F96-V1 
(G377A or AGTT)
- 2b 8/28 29 2 54
F96-V2bc*
(AGTT)
5 2b, 2c 1/28 3.3 2 54
F96-V3 
(G377A or AGTT)
5 - 3/28 11 4 108 or 107
F96-V9*
(G377A)
9 - 1/28 3.3 - 658
F96-V9/11 * 
(G377A)
9# 11 - 1/28 3.3 “ 625
* Previously undescribed splice variants, # Deletion o f  the 5 'half o f  exon 9
We also described the sequence o f the novel alternative exon lb, identified in a wild 
type variant that also incorporated exon 2b. Whilst the inclusion o f exon lb leads to the 
incorporation o f 45 additional amino acids in the Artemis protein sequence, this leads to 
a frameshift when spliced to exon 2 and codes for a severely truncated protein o f 82 
amino acids (figure 6-8).
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MSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKGGVSITLECSGVISVHCNLRLLGSSDSR
ASASQVAGVTGTHHHTQIT. 82 Amino acids
Figure 6-8: The protein sequence coded for by Artemis variant transcript 1BR-Vl+Ib that 
involves inclusion of alternative exons lb  and 2b. The novel sequence encoded by exon lb is 
shown in bold that when spliced to exon 2 results in a frameshift and a severely truncated 
protein of 82 amino acids.
Similar to the control line 1BR, F96 cells expressed alternatively spliced Artemis 
transcripts that involved deletions o f  exon 5, and additions o f exons 2b and 2c. These 
variants contained either a G377A point mutation or a AGTT 207-9 codon deletion, and 
code for severely truncated proteins. There were also 2 transcripts expressed in the F96 
line that contained the G377A point mutation and involved deletions o f exon 9. F96-V9 
involved deletion o f exon 9 and codes for an Artemis protein with a 34 amino acid 
internal deletion in the metallo-B-lactamase-associated CPSF Artemis SNM1/PS02 (p- 
CASP) domain. F96-V9/11 involved the use o f an alternative splice site within exon 9 
and the deletion o f exon 10. Whilst the use o f this alternative splice site leads to a 
frameshift, the deletion o f exon 10 brings the sequence back into frame and codes for an 
Artemis protein o f 625 amino acids, which incorporates 13 amino acids o f novel 
sequence within the P-CASP domain o f Artemis (figure 6-9).
MSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPV 
TKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIWTLLPAGHCPGSVMFLFQGNN 
GTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRS 
WITRSPYHWWLNCKAAYGYEYLFTNLSEELGVQTATLRSMHAGIPRTGESSYRACFSFHSSYS 
EIKDFLSYLCPVNAYPNVIPVGTTMDKWEILKPLCRSSQSTEPKYKPLGKLKRARTVHRDSEE 
EDDYLFDDPLPIPLRHKVPYPETFHPEVFSMTAVSEKQPEKLRQTPGCCRAECMQSSRFTNFVD 
CEESNSESEEEVGIPASLQGDLGSVLHLQKADGDVPQWEVFFKRNDEITDESLENFPSSTVAGG 
SQSPKLFSDSDGESTHISSQNSSQSTHITEQGSQGWDSQSDTVLVSSQERNSGDITSLDKADYR 
PTIKENIPASLMEQNVICPKDTYSDLKSRDKDVTIVPSTGEPTTLSSETHIPEEKSLLNLSTNA 
DSQSSSDFEVPSTPEAELPKREHLQYLYEKLATGESIAVKKRKCSLLDT. 625 Amino
acids
Figure 6-9: The protein sequence coded for by Artemis variant transcript F96-V9/11 that 
involves the use of an alternative splice site within exon 9 and deletion of exon 10. The
novel 13 amino acid sequence introduced into the Artemis protein primary structure by use of 
the alternative splice site is shown in bold.
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In control (1BR) and F96 cells the full length Artemis transcript was found in 28 % and 
50 % of sequenced plasmids respectively. Although PCR can distort the proportions of 
particular transcripts in a mixed population, these results suggest that the full length 
transcript, possibly followed by variant 1 transcript, are the dominant species o f Artemis 
mRNA expressed in these primary human fibroblasts. Most o f the alternatively spliced 
transcripts, involving deletion o f  exons 2 and 5 or the addition o f alternative exons lb, 
2b and 2c, result in a frameshift and code for severely truncated Artemis proteins. Only 
two alternative splicing modes identified amongst the F96 transcripts, F96-V9 and F96- 
V9/11, produce non-truncated proteins that may retain some residual function. These 
transcripts were found in only one o f  the sequenced plasmids in each case (3.3 %), and 
may therefore represent only a small fraction o f  the total complement o f Artemis 
transcripts expressed by the F96 line.
6.2.6 Summary of candidate gene sequencing results
We have investigated 3 undefined radiosensitive lines for evidence o f mutations in 
candidate genes associated with radiosensitive immunodeficiency. A summary o f the 
results from these experiments is displayed in table 6-5.
Table 6-5: Summary o f candidate gene sequencing results
Line XRCC4 Artemis Ligase IV
GOS5 W T W T WT
F96 W T
AGTT207-209,
G377A*
ND
GOS23 W T ND WT
WT Wild type, ND Not done, * Compound heterozygote
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6.3 Expression of wild type and mutant Artemis proteins in
human cells
We have identified two novel mutations in the Artemis gene of a radiosensitive line 
derived from an undefined immunodeficient patient. The Artemis protein can be 
divided into three regions. The first 155 amino acids of Artemis have marked 
homology to proteins of the metallo-p-lactamase family, which were first described in 
bacteria mediating the cleavage o f p-lactam antibiotics (Aravind, 1999). This analogy 
was the first indication that Artemis probably has some kind of enzyme activity. The 
metallo-P-lactamase domain is followed by the P-CASP region (up to amino acid 385), 
which defines a family of metallo-P-lactamases that act on nucleic acids (Callebaut et 
al, 2002). Finally the last 307 amino acids of Artemis do not have any marked 
homology to other known proteins.
Figure 6-10: The Artemis protein can be divided into 3 regions. The metallo-P-lactamase 
homology domain, which contains four out of five conserved catalytic residues, spans the first 
155 amino acids. This is followed by the p-CASP region that is common to metallo-p- 
lactamases that act in nucleic acids. The last 307 amino acids has no homology to any known 
proteins. The novel F96 mutations identified lie within the metallo-P-lactamase domain.
The AL70 and G126D mutations identified in F96 cells lie within the metallo-P- 
lactamase domain (figure 6-10), which contains four out of five of the conserved 
residues that define the catalytic site of these enzymes. Although the F96 mutations do 
not alter these residues directly, their presence may impair the catalytic activity and/or 
stability of this protein.
6.3.1 Expression of wild type Artemis in human cells
In order to assess the stability of the F96 mutant Artemis proteins in human cells, we 
first attempted to transfect cells with an expression vector containing the coding region 
of wild type Artemis isolated from 1BR cells. This was performed using 1BR Artemis 
that was cloned into the pcDNA/V5/GW/D-TOPO gateway vector for sequencing in 
section 6.2.4. A clone containing full length 1BR Artemis transcript was selected. The
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AL70 G126D
N Metallo-fl- 
J lactamase
385
Carboxyl terminus c
692
TOPO system used to clone this fragment ensured that the insert was cloned in-frame 
with a C-terminal V5 tag, which can then be used to monitor expression with an anti-V5 
antibody.
Initial attempts to transfect Artemis into primary human fibroblasts and human 
fibroblasts immortalised by stable expression o f human telomerase (F96-hTERT) were 
unsuccessful using a transfection method involving Lipofectin/Integrin-targeting 
peptide 1/DNA complexes previously shown to efficiently transfect this cell type 
(Estruch et al, 2001). This was despite achieving a transfection efficiency o f >50% 
with a GFP expression vector using the same transfection method and cells. We 
therefore attempted to express Artemis in cell lines. 293T cells are a human kidney 
tumour cell line and were initially used to confirm that we could express wild type 
Artemis by detection o f a c-terminal V5 tag. 293T cells were either mock transfected or 
transfected with pEXP3.2-Artemis-V5 and after a 24 hr incubation period cell lysates 
were prepared. Cell lysates were run on a 10 % SDS-PAGE denaturing gel and an 
immunoblot for V5 was performed. Wild type Artemis is a 78 kD protein and the 
addition of a c-terminal V5 tag should result in a 5 kD increase in size. Consistent with 
this, 24 hrs after transfection with pEXP3.2-Artemis-V5 a band was observed 
corresponding to a protein o f 83 kD, and this was absent in the mock transfected control 
(figure 6-1 la). There were also secondary bands present in transfected cells at 
approximately 75 and 50 kD that are likely to represent degradation products o f the 
transfected protein.
We next investigated whether transfected Artemis protein was expressed in the 
appropriate sub-cellular compartment to perform its role in DNA repair, i.e. the nucleus. 
Wild type Artemis coding region was transferred from pEXP-Artemis-V5 into the 
Gateway destination vector pDEST 47 in order to create an Artemis expression vector 
that produces a c-terminal GFP tagged Artemis protein (pEXP47-Artemis-GFP). 
pEXP47-Artemis-GFP was transiently transfected into 293T cells and the expression of 
GFP tagged Artemis was visualised by fluorescence microscopy 24 hrs after 
transfection. All positive cells (~20 %) showed the tagged protein essentially 
exclusively in the nucleus (excluding nucleoli) (figure 6-1 lb), which is consistent with 
its role in DNA repair. Cells transfected with pGFP and pEXP47-Artemis-GFP were
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Figure 6-11: Expression of wild type Artemis protein in 293T cells shows a nuclear
localisation, a) Western blot of Artemis expression. 293T cells were transiently transfected 
with pEXP3.2-Artemis-V5 and cell lysates prepared after a 24 hr incubation. Immunoblot 
analysis was performed using anti-V5 antibody, and a band of the correct size (83 kD) for V5- 
tagged Artemis was visualised. Actin expression levels were used as a loading control (bottom 
panel), b) 293 cells were transfected with pEXP47-Artemis-GFP and the sub-cellular 
localisation of GFP tagged Artemis was visualised by fluorescence microscopy 24 hrs after 
transfection. Artemis expression was confined to the nucleus (excluding nucleoli), c) 
Expression levels of transfected GFP tagged Artemis compared with GFP alone as measured by 
FACS analysis. Compared to transfection with GFP alone, there were less GFP-tagged Artemis 
positive cells, and those that were positive displayed a lower level of fluorescence.
also analysed by FACS to compare expression levels (figure 6-1 lc). Compared to 
transfection with GFP alone, the GFP tagged Artemis transfections resulted in a lower 
percentage of GFP positive cells, and those that were positive displayed considerably 
less fluorescence. This was despite using the same method of transfection for each 
plasmid, both of which utilised the Cytomegalovirus (CMV) promoter. The reason for 
the difficulties in expressing high levels o f exogenous Artemis protein in human cells 
remains unclear. Similar problems using Artemis expression vectors were encountered 
by our collaborators (P. Jeggo, personal communication).
Mock
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6.3.2 Expression of mutant Artemis proteins in human cells
To test the stability o f the two mutant Artemis proteins identified in F96 cells, we 
transfected human cells with expression vectors containing the full length transcripts 
(characterised in section 6.2.4) coding for the G126D or AL70 mutant Artemis proteins. 
We also investigated whether y-radiation had any effects on Artemis protein stability. 
Since 293T cells have an impaired p53 pathway, this was performed using the colon
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Figure 6-12: F96 mutant Artemis proteins are stable in the human carcinoma cell line 
HCT116. HCT116 cells were transfected with pEXP3.2-V5 expression vectors coding for V5 
tagged wild type Artemis (pEXP3.2-Art-V5), G126D mutant Artemis (pEXP3.2-ArtG126D-V5) 
or AL70 mutant Artemis (pEXP3.2-ArtAL70-V5). The two F96 mutants were also co­
transfected (F96mut Co-transfection). Mock and GFP (pGFP) transfected cells were used as 
controls. 24 hrs after transfection the cells were either treated with 1 Gy y-radiation (+y) or 
mock irradiated (-y), and cell lysates prepared after a further 4 hr incubation. The expression of 
the Artemis-V5 proteins, as detected by immunoblot analysis, is shown in the upper panel; non­
specific binding is shown below.
carcinoma cell line HCT116, which retains p53 function and typical DNA damage 
response pathways. HCT116 cells were either mock transfected or transfected with 
GFP (pGFP), wild type Artemis (pEXP3.2-Art-V5), G126D Artemis (pEXP3.2- 
ArtG126D-V5) or AL70 Artemis (pEXP3.2-ArtAL70-V5) expression vectors. We also 
co-transfected cells with both the G126D and AL70 Artemis mutants (F96mut Co­
transfection). 24 hours after transfection cells were either treated with 1 Gy y-radiation 
or mock irradiated, and cell lysates prepared after a further 4 hour incubation. Using an 
antibody directed against the c-terminal V-5 tag, an immunoblot of cell lysates was 
performed (figure 6-12). We found that the wild type and both mutant Artemis proteins 
were stable in eukaryotic cells with some differences in expression levels. Whilst the
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wild type and AL70 Artemis proteins were expressed at a similar level, the G126D 
mutant appeared to be expressed at a lower level. This may indicate that G126D mutant 
Artemis is not as stable in human cells as the wild type protein, although differences in 
transfection efficiency may have contributed to this effect. After irradiation the 
expression level o f G126D Artemis appeared to increase, y-radiation did not have any 
substantial effect on the expression levels o f wild type or AL70 mutant Artemis 
expression.
6.4 Discussion
Immunodeficient patients that demonstrate cellular radiosensitivity have been 
previously described with mutations in the Ligase IV and Artemis DSB repair genes.
We therefore examined these genes by sequence analysis in order to determine whether 
the radiosensitive immunodeficient patients that we had defined harbored similar 
mutations in these repair genes. The XRCC4 gene was also included in this 
investigation since this protein functions in a complex with Ligase IV to facilitate the 
final ligation step o f NHEJ DSB repair. Although not previously described, 
hypomorphic mutations in XRCC4 that impair this function may be expected to result in 
abrogated DSB repair and V(D)J recombination, resulting in radiosensitive 
immunodeficiency. These three genes were therefore good candidates for investigation 
by sequence analysis, and have sufficiently small coding regions to allow this method of 
investigation. The three patient lines that demonstrated the clearest radiosensitivity in 
fibroblast survival assays, GOS5, GOS23 and F96, were subjected to this candidate 
gene sequencing.
Patient GOS23 was an undefined immunodeficient patient that displayed developmental 
delay, which is also a characteristic observed in Ligase IV defective patients (O’Driscoll 
et al, 2001). Since this patient’s fibroblasts were found to be radiosensitive (section 4- 
2), this line was a good candidate to have mutations in either Ligase IV, or its closely 
associated partner XRCC4. Despite these indications we were unable to find any 
mutations in either o f these genes amplified from GOS23 cDNA, confirming that any 
potential defect in this patient must lie elsewhere in the DNA damage response. Since 
we received this biopsy in the closing stages o f this project, time and resources did not 
permit a full characterisation o f  this line.
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In the previous section we examined certain radiosensitive lines for evidence o f  
defective DSB repair by the analysis o f  unrepaired radiation-induced chromosome 
breaks and the removal o f  y-H2AX foci after irradiation. Despite being one o f the most 
exquisitely radiosensitive o f  all undefined lines examined (section 4), the GOS5 line 
showed no evidence o f a defect in DSB repair (section 5.4). Consistent with this 
finding, sequence analysis o f  the Ligase IV, XRCC4 and Artemis DSB repair genes 
confirmed there were no mutations in the coding region o f  these genes in GOS5 cells. 
These findings support the notion that the GOS5 line has a defect in another aspect of 
the damage response network that does not necessarily affect DSB repair, but is severe 
enough to confer a radiosensitive phenotype. This may involve the survival assessment 
process, whereby a certain cell fate (apoptosis or permanent arrest) is initiated once a 
specific threshold o f DNA damage is achieved. A defect in this process may set this 
threshold at an abnormally low level o f  damage, and confer radiosensitivity without any 
observable effects on DSB repair. Indeed, the GOS5 line grew slowly and displayed 
premature senescence at passage 9 (section 4.2), which may indicate that DSB arising 
from endogenous sources during routine tissue culture may be enough to induce an 
abnormal permanent arrest. After irradiation this survival outcome may result after an 
unusually low level o f  exogenous DNA damage in GOS5 cells that would not be 
sufficient to impair survival in control cells. This is consistent with FACS data that 
demonstrated the GOS5 line is more prone to the induction o f a population o f senescent 
like growth arrested cells after irradiation (section 4.3).
Although the F96 line had previously been shown to have no observable defect in DSB 
repair (Peake et al, 1999), we observed an elevated level o f unrepaired chromosome 
breaks after irradiation in these cells (section 5). Consistent with this finding, analysis 
of the removal o f radiation-induced y-H2AX foci demonstrated an elevated level of 
residual breaks in the F96 line that suggested a partial defect in DSB repair. This line 
was therefore a good candidate to harbor a mutation in a DSB repair gene, and we were 
able to identify two novel mutations in the Artemis DSB repair gene from F96 cells that 
was not present in two control lines (1BR and 48BR). We also found that the Artemis 
gene undergoes a complex series o f alternative splicing events that required thorough 
investigation in order to determine exactly what transcripts were present in control and 
F96 cells.
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Full length Artemis is a 78 kD protein encoded by 692 amino acids. Based on protein 
sequence analysis, Artemis can be divided into three distinct regions (figure 6-13a).
The first 155 amino acids, encoded for by exons 1-6, corresponds to the metallo-p- 
lactamase domain. Metallo-P-lactamase fold proteins, also known as class B p- 
lactamases, are a large family o f  proteins that were first described in bacteria, where 
they are responsible for the hydrolysis o f  the p-lactam ring o f certain antibiotics (Wang 
et al, 1999). A variety o f proteins widely expressed in all living organisms have 
subsequently been shown to possess a metallo-P-lactamase fold (Aravind et al, 1999). 
These enzymes have a broad range o f  substrates, most o f which present an ester bond 
and a negative charge. Artemis was first identified through its loose sequence 
homology with the yeast and murine DNA repair factors PS02 and SNM1 that 
represent a group o f metallo-p-lactamase enzymes involved in the metabolism of  
nucleic acids, which also includes the cleavage and polyadenylation-specific factor 
(CPSF) (Moshous et al, 2001). Further analysis revealed that residues 156-385, 
encoded by exons 7-13, displayed significant homology with both SNM1 and PS02 but 
also with a whole range o f other proteins present in a wide range o f organisms, 
including CPSF (Callebaut et al, 2002). This domain was therefore termed the p-CASP 
domain (P-Lactamase-CPSF, Artemis, SNM1 and PS02 domain), and is not an 
independent domain but is always found linked to a metallo-P-lactamase domain in 
proteins involved in nucleic acid metabolism. Finally, residues 386-692, encoded by 
exon 14, is designated the C-terminal domain and shows no homology with any known 
proteins.
The structure o f metallo-p-lactamase enzymes consists o f a four-layered p-sandwich 
with two mixed p-sheets flanked by a-helices, with a catalytic site composed o f two 
metal-binding sites located at one edge o f the p-sandwich (Wang et al, 1999). The 
binuclear Zn(II) centre (thought to utilise Mg in the case o f Artemis), used to perform 
the cleavage reaction, is located at the bottom o f a wide shallow grove. The catalytic 
site of metallo-P-lactamases is constituted by five highly conserved sequence motifs 
consisting mostly o f histidine and aspartic acid residues, which participate in metal 
coordination and hydrolysis reaction. The first four motifs o f Artemis were easily 
recognised (Moshous et al, 2001), and motif I corresponds to a conserved aspartic acid 
residue at position 17 (figure 6 -13a). The highly conserved HxHxDH signature that 
begins at residue 33 o f human Artemis typifies the second motif, which is representative
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Figure 6-13: Analysis of A rtem is p ro te in  sequence an d  the  proposed  active site, a) Artemis 
is composed of three identifiable regions, the metallo-p-lactamase homology domain (amino 
acids 1-155) coded by exons 1-6, the associated P-CASP domain (amino acids 156-385) coded 
by exons 7-13, and the COOH-terminal region (amino acids 386-692) coded by exon 14. Five 
motifs (I-V) that compose the catalytic site of bacterial P-lactamases are conserved in Artemis. 
Two residues may constitute the fifth domain, since both residues are required for nuclease 
activity. A hydrophobic amino acid, such as valine, at position 341 is typical of metallo-P- 
lactamases that act on DNA rather than RNA. The mutations identified in the F96 line resulting 
in AL70 and G126D changes to the Artemis protein are indicated, b) The catalytic site of 
Artemis proposed by Pannicke et al, 2004, involves the coordination of two metal ions by the 
conserved residues that constitute the metallo-P-lactamase/p-CASP active site. Residues 
thought to function in metal binding are shown in ball-and-stick representation (with yellow 
carbons, blue nitrogen, and red oxygen atoms). Two metal ions (magenta spheres) are bound by 
Asp37 and histidines 33, 35, 38, 115 and 319 and Asp 17, 136 and/or 165 may orient histidines 
38 and 33 for efficient metal coordination (dashed lines). A putative water molecule might 
complete the coordination pocket (red sphere) and two coordination sites on the active site 
metals (green spheres) may bind the DNA substrate, (adapted from Pannicke et al, 2004)
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of the entire family o f  metallo-p-lactamases. The third and fourth motifs correspond to 
the conserved H115 and D 136 residues respectively. Since the length between the 
fourth and fifth motifs is predicted to be highly variable in this class o f enzymes 
(Aravind et al, 1999) (Wang et al, 1999), the fifth motif o f Artemis was more difficult 
to assign. Thorough examination o f  the P-CASP domain suggested that this region 
participates in the formation o f  the metallo-p-lactamase enzymatic pocket within these 
enzymes by providing the fifth m otif necessary for metal coordination (Callebaut et al, 
2002). This function is likely to be performed by either the conserved D165 or H319 
residues, although both hypotheses are in fact supported by the loss o f Artemis activity 
in Asp 165 and His319 mutants (Pannicke et al, 2004) (Poinsignon et al, 2004). Finally, 
P-CASP family members that specifically interact with DNA targets can be 
distinguished from those involved in RNA metabolism regarding the nature o f a 
particular amino acid in a conserved m otif corresponding to V341 in Artemis, which is 
always a histidine in RNA specific proteins, whereas it is substituted by a hydrophobic 
amino acid such as valine in proteins acting on DNA.
The high conservation o f the active site histidines and aspartic acids between Artemis 
and metallo-p-lactamases suggests that Artemis binds two metal cofactors, consistent 
with the requirement o f Artemis nuclease activity for magnesium (Ma et al, 2002). D37 
and histidines 33, 35, 38, 115 and 319 have been proposed to directly coordinate the 
two proposed active site metals, whereas aspartic acids 17, 136 and/or 165 may form 
salt bridges to the HxHxDH m otif backbone and the side chain o f H38 and H33, 
respectively, to optimally stabilise this active site structure (figure 6-13b) (Pannicke et 
al, 2004). Mutation o f any one o f  the residues proposed to function in metal 
coordination results in abrogation o f  endonuclease (but not exonuclease) activity, 
although this effect was less severe with mutation o f  H38, since this change may only 
affect the binding o f one metal (Pannicke et al, 2004). The severe effect o f mutation of 
either D136 or D165 on endonuclease activity (Pannicke et al, 2004) suggests that both 
of these residues are located in the in the active site o f Artemis and participate in metal 
binding. Although the metallo-P-lactamase/pCASP domain o f Artemis has been shown 
to be sufficient for V(D)J recombination on chromosomal substrates, this region did not 
complement the radiosensitivity o f Artemis deficient cells (Poinsignon et al, 2004).
This suggests that while the C-terminal region o f Artemis is dispensable for the repair 
of DSBs during V(D)J recombination, it is required for the efficient repair o f radiation 
damage.
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Artemis transcripts can be spliced in multiple combinations, and we detected several 
alternative transcripts in both control and F96 cells. The majority o f alternative 
transcripts involved a frameshift that incorporates a premature stop codon within the 
metallo-P-lactamase domain, and results in severe truncation o f the Artemis protein at a 
range of locations between residues 38 (variant 4) and 108 (variant 3). Since these 
proteins retain only two o f the five conserved metal binding motifs proposed to form the 
catalytic site o f Artemis (figure 6-13), it is highly unlikely that these putative proteins 
would have any residual catalytic activity. Furthermore, transcripts with premature stop 
codons are subject to nonsense-mediated decay (Hilleren and Parker, 1999), and thus 
their proportion does not necessarily have to represent later protein levels.
2 variants expressed in the F96 line involved either deletion o f exon 9 (F96-V9) or 
deletion of the 5' portion o f exon 9 and deletion o f exon 10 (F96-V9/11). Both o f these 
splicing modes retain the original reading frame, and result in a small internal deletion 
within the p-CASP domain o f  Artemis. In the case o f F96-V9/11, 13 extra amino acids 
are incorporated at the site o f  this deletion due to a frameshift at the exon 9 alternative 
splice site, which is restored back to the original reading frame when spliced to exon 11. 
These changes to Artemis protein structure occur between the two residues proposed to 
function as the fifth catalytic domain o f  Artemis (figure 6-13), and do not directly affect 
either of these motifs. Although this may allow some residual catalytic activity, F96-V9 
and F96-V9/11 result in an internal deletion o f 34 and 67 amino acids respectively, and 
such large deletions within the P-CASP domain are likely to have a significant impact 
on the function o f the catalytic site, albeit indirectly. Further work is required in order 
to investigate the physiological significance o f the many Artemis splice variants 
observed in this project.
Half (14/28) of the Artemis transcripts cloned from F96 cells were full length 
transcripts, which suggests this may be the dominant species o f Artemis mRNA in these 
cells. Using these sequences, we identified two novel mutations in the F96 Artemis 
gene that were mutually exclusive and therefore expressed from separate alleles. These 
mutations, deletion o f codon 70 and a G377A missense mutation, are predicted to result 
in the production o f two distinct Artemis proteins, one harboring a deletion o f leucine 
70, and the other with a substitution o f glycine 126 for aspartic acid. Both leucine 70 
and glycine 126 are conserved in mouse and chicken Artemis homologues (figure 6-14)
187
58YLYCSPVTKELLLTSPKYRFWKKR7 9 
5 8 FLYCS PVTKELLLTS PKYRFWENR7 9 
? ? KLY CS PVTKELLLTN S KYAFWENH ? ?
Human Artemis (AJ296101) 
Mouse Artemis (NM175638) 
Chicken Artemis (XM428315)
115HCPGSVMFLFQGNNGTVLYTGDFR13 8 
115HCPGSVMFLFQGSNGTVLYTGDFR13 8 
??HCPGSVMFLFQGENGTVLYTGDFR? ?
Human Artemis (AJ296101) 
Mouse Artemis (NM175638) 
Chicken Artemis (XM428315)
Figure 6-14: Conservation of leucine 70 and glycine 126 in human, mouse and chicken 
Artemis proteins. Homologous sequence is shown in blue, with residues proposed to function 
in metal binding shown in bold. Residues corresponding to leucine 70 and glycine 126 of 
human Artemis are shown in red, and differences to the human sequence are shown in green. 
The chicken Artemis protein sequence was predicted from partial mRNA sequence by 
automated computational analysis, and is therefore incomplete. Numbers in parenthesis are 
GenBank identifiers.
As predicted, the mutations observed in the F96 line allow expression o f viable Artemis 
proteins, shown by the transfection o f HCT116 cells with expression vectors coding for 
each mutant. Although both mutations are within the metallo-p-lactamase domain, 
neither of the changes involves residues that are proposed to function in metal 
coordination within the active site (figure 6-13). Despite this, these changes may still 
have a deleterious influence on the catalytic site o f  Artemis, since their close proximity 
to essential residues may indirectly affect active site structure. This may not be to the 
same extent which mutations in metal binding residues abolish nuclease activity 
(Pannicke et al, 2004), but could result in a partially functional protein. This would be 
consistent with the modest post-radiation cell division phenotype displayed by the F96 
line compared to Artemis null cells (section 4.3), and the progressive lymphopaenia 
associated with apparently normal V(D)J recombination observed in patient F96 (Peake 
et al, 1999). In order to finally confirm the pathogenicity o f the F96 Artemis mutations, 
each of the mutant proteins could be stably expressed in Artemis deficient cells of the 
same genetic background, for example in CJ179 cells. Once achieved, DNA hairpin 
opening activity o f these proteins could be compared to that with expression o f the wild 
type protein. Similar expression experiments could be performed to determine whether 
each mutant Artemis protein was able to fully rescue the poor division observed in 
CJ179 cells during experiments with CFSE.
Most of the Artemis mutations identified in RS-SCID patients seem to represent null 
alleles, which result from genomic deletions covering several o f the 5 exons or involve 
the production o f severely truncated proteins (Moshous et al, 2001). This is likely to
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result in the complete inactivation o f  the metallo-p-lactamase/pCASP domain, reflected 
by the severe T-B-SCID phenotype o f these patients. In addition, a patient homozygous 
for a D165N mutation, a residue proposed to function in metal binding within the active 
site (figure 6-13), was reported as being clinically indistinguishable from patients with 
null mutations in Artemis (Ma et al, 2002). This emphasises the importance o f the 
proposed metal binding residues within the active site o f Artemis, but other patients 
have been described with mutations in surrounding residues similar to those observed in 
the F96 line. RS-SCID patients have been described with S32C (Le Deist et al, 2004), 
G118V and G135E (Noordzij et al, 2003) missense mutations, which lie within the 
metallo-p-lactamase/pCASP domain o f Artemis but do not involve the residues 
proposed to function in metal binding. Compared to a patient with a truncation at codon 
269 of the P-CASP domain, the patient harboring a G118V mutation demonstrated 
relatively high frequencies o f precursor B cells which suggested a partially functional 
V(D)J recombination pathway (Noordzij et al, 2003). Since patient F96 initially 
displayed relatively normal numbers o f lymphocytes, but subsequently developed 
lymphopaenia that was progressive with age, the Artemis mutations identified here are 
likely to be hypomorphic (Peake et al, 1999). This may allow a relatively normal level 
ofV(D)J recombination to occur, but the coding joins formed m aybe abnormal or 
unstable, a situation that could trigger the elevated levels o f spontaneous apoptosis 
observed in this patient. At this point other genetic factors, which may have an effect 
on lymphocyte survival, could contribute to this immunodeficient phenotype.
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Chapter 7: Analysis of p53 function and radiation 
induced gene expression in F96 cells
7.1 Background
Radiation induced DSBs activate the ATM kinase that phosphorylates transducer 
proteins that can signal the presence o f DNA damage to the cell cycle and apoptotic 
machinery. The p53 tumour suppressor protein plays a key role in this part o f the DNA 
damage response, and acts as a node or hub for the incoming stress signals it receives. 
ATM can directly and indirectly facilitate an accumulation and activation o f the p53 
tumour suppressor, the function o f  which largely depends on its transcriptional activator 
properties. ATM directly phosphorylates p53 on serine 15 (Banin et al, 1998) (Canman 
et al, 1998) (Khanna et al, 1998) (Nakagawa et al, 1999), which seems to enhance its 
transcriptional activator function (Lambert et al, 1998) (Dumaz and Meek, 1999).
Serine 15 phosphorylation is then thought to nucleate a series o f subsequent post- 
translational modifications on p53 that contribute to both its stabilisation and 
biochemical activation (as many as 17 sites in p53 undergo phosphorylation or 
acetylation) (Appella and Anderson, 2001). Phosphorylation o f serine-15, threonine 18 
and serine-20 stimulates the recruitment o f transcription factors including p300, CBP 
(both transcriptional co-activators and histone acetyl-transferases [HATs]) and P/CAF 
that stimulate p53 sequence specific DNA binding (Sakaguchi et al, 1998) (Liu et al, 
1999). Once activated, p53 is able to induce expression o f target genes involved in 
growth arrest and apoptosis.
Whilst investigating the cause o f  radiosensitivity in the F96 line, and concurrent with 
our characterisation o f the associated defect in repair, we obtained results that hinted at 
an enhanced p53 response in these cells. Furthermore, the F96 patient displayed a 
cellular radiosensitivity that was associated with increased spontaneous apoptosis of 
lymphocytes (Peake et al, 1999), a characteristic that may be associated with augmented 
p53 activity. Whilst this could result from unrepaired endogenous DSBs that promote 
p53 signaling and apoptosis, other genetic factors may also contribute to such a 
phenotype. We were therefore interested in determining the status o f the p53 signaling 
pathway in this line. In order to differentiate between these effects in control and F96 
cells, we employed low doses o f y-radiation that should be more physiologically
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relevant. This allowed us to identify important differences between control and F96 
cells with regard to p53 activation after irradiation. This differential response was then 
analysed on a genomic scale using oligonucleotide microarrays.
7.2 Characterisation of the p53 response in F96 cells
7.2.1 Analysis of p53 status in control and F96 cells
The radiosensitive line F96 is defective in DNA repair and we have identified two novel 
mutations in the Artemis DSB repair gene. This is likely to contribute to the poor 
survival of F96 cells after irradiation, although the exact mechanism o f cell inactivation 
is unknown. ATM signals the presence o f  DNA DSBs to the p53 tumour suppressor by 
direct and indirect mechanisms involving phosphorylation o f p53 on serine-15. This is 
believed to stabilise p53 levels within the nucleus and may also contribute to the 
activation of p53 dependent gene transcription that promotes cell cycle arrest and 
apoptosis. In order to detect any abnormalities in this process in the F96 line, we 
investigated p53 levels and serine-15 phosphorylation status in control and F96 cells. 
This was performed before and after exposure to y-radiation.
Control (1BR) cells exposed to lG y y-radiation demonstrated a marked increase in p53 
serine-15 phosphorylation 2 hours after treatment. There was also an increase in total 
p53 levels, although this was not as striking because unirradiated cells contained a 
significant amount o f non-phosphorylated p53. By 8 hours the amount o f serine-15 
phosphorylation and total p53 had decreased to near baseline levels (Figure 7-1). 
Compared to control cells, the induction o f serine-15 phosphorylation was more 
prominent in the F96 line 2 hours after irradiation, and this was sustained to a greater 
degree in these cells, with relatively high levels remaining after 8 hours compared with 
the near baseline level in controls.
We also noted that p53 isolated from F96 cells appeared to migrate at a slightly larger 
size both before and after irradiation. We hypothesised that this slight increase in size 
could result from certain post-translational modifications that were not present in 
control cells. We therefore investigated whether this shift was due to post-translational 
modifications such as phosphorylation or acetylation.
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Figure 7-1: p53 isolated from F96 cells displays retarded migration and elevated levels of 
radiation-induced serine-15 phosphorylation compared to control. In control cells there 
was a marked increase in the level of p53 serine-15 phosphorylation 2 hours after irradiation, 
but this had decreased to near baseline levels after 8 hours. The F96 line demonstrated more 
pronounced phosphorylation of p53 serine-15 2 hours after irradiation, and compared to control 
cells this was maintained at a relatively high level up to 8 hours post-irradiation. The amount of 
total p53 demonstrated a modest increase 2 hours after irradiation in both lines, with a 
substantial amount of non-phosphorylated p53 being present before irradiation. F96 p53 
migrated more slowly than p53 from the control cells, which may suggest the presence of 
additional post-translational modifications, or that p53 may not be wild type in the F96 line
In order to investigate whether additional phosphorylations were responsible for the 
shift in F96 p53, protein lysate isolated from control (1BR) or F96 cells before and after 
irradiation was subjected to phosphatase treatment using Calf Intestinal Alkaline 
Phosphatase (CIAP). This should remove any phosphate groups that are present on p53, 
and comparing the migration o f total p53 from treated extracts to mock treated lysate 
can confirm whether the slight shift in size observed was due to phosphorylation. The 
p53 serine-15 phosphorylation specific antibody used previously was employed to 
confirm that phosphatase treatment was successful, and as expected incubation with 
CIAP removed all detectable p53 serine-15 phosphorylation in both cell lines, before 
and after irradiation (figure 7-2a). When total p53 levels were examined these had not 
changed as a result o f the phosphatase treatment, and the slower migration of F96 p53 
was still observed. These results confirmed that the slow migration of F96 p53 
compared to control p53 was not due to additional phosphorylations.
We next investigated whether the slow migration o f F96 p53 was due to the presence of 
additional acetylations using Anacardic Acid (AA), a potent non-competitive inhibitor
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Figure 7-2: Phosphorylation and acetylation are not responsible for the slow migration of 
F96 p53, but acetylation may facilitate p53 stabilisation and phosphorylation, a)
Phosphatase treatment successfully removed p53 serine-15 phosphorylation in both the control 
and F96 lines, but did not affect the slow migration of total p53 from F96 cells, b) Control 
(1BR) and F96 cells were pre-treated with the acetylation inhibitor Anacardic Acid (AA) for 2 
or 12 hrs, before irradiation with 1 Gy and a further 4 hr incubation. DMSO only controls were 
treated for 12 hours prior to irradiation and a further 4 hr incubation. Cell lysates were then 
prepared and western blotted. AA did not affect the slow migration of F96 p53, although levels 
of total p53 and serine 15 phosphorylation were reduced for both the control and F96 lines in a 
dose dependent manner. This western blot was analysed by densitometry and the relative levels 
ofp53 serine-15 phosphorylation are shown.
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of the p300 and P/CAF acetyl transferases, which, are thought to be responsible for the 
acetylation of p53 (Liu et al, 1999). Pre-treatment o f  control (1BR) and F96 cells with 
AA for 2 and 12 hours prior to irradiation substantially decreased the induction p53 
serine-15 phosphorylation after a further 4 hour incubation (figure 7-2b). Total p53 
levels also appeared to decrease with AA treatment, but it is impossible to state if  a 
reduction in serine-15 phosphorylation caused a decrease in total p53 levels, or whether 
the reverse is true. Acetylation o f  p53 has previously been shown to promote p53 
stability and activity (Sakaguchi et al, 1998) (Ito et al, 2001), and an oncogenic 
transcription factor has recently been shown to impair p53 function by promoting de- 
acetylation (Insinga et al, 2004). Consistent with these studies our results show that AA 
conferred a reduction in the ability to signal to p53 after DNA damage, and suggest that 
this compound effectively inhibited p53 acetylation. Since treatment with AA did not 
affect the slow migration o f  F96 p53 compared to that from controls, this difference is 
not likely to result from the presence o f additional acetylations.
The final possibility investigated to explain the apparently larger size o f p53 from F96 
cells was to examine the coding sequence o f  this gene and compare this to the published 
sequence. Primers P5F and P7R were designed to amplify a 1426 bp fragment that 
encompassed the entire coding region o f  p53 using F96 cDNA as a template. This 
amplification was performed in three separate reactions and the PCR products were gel 
purified, and then sequenced in both directions using primers P5F, P6F, P7F, P7R and 
P5R (figure 7-3a). The sequence o f  F96 p53 was found to be normal except for one 
previously described polymorphism in codon 72, which involves a CGC to CCC base 
change and the substitution o f arginine for proline in the translated protein sequence 
(figure 7-3b). Although single amino acid substitutions are not usually expected to 
affect the electrophoretic mobility o f proteins, this polymorphism has previously been 
described to significantly alter the biochemical properties o f  p53. p53 with arginine at 
position 72 (p53Arg) has been shown to migrate more rapidly on denaturing gels than the 
proline72 form (p53pro), and a mixture o f both forms results in a doublet (Matlashewski 
et al, 1987). The single, slow migrating band o f p53 isolated from the F96 line is 
consistent with a homozygous p53pro genotype, compared to the fast migrating p53 from 
control (1BR) cells that indicated p53Arg.homozygosity. In order to confirm that 1BR 
cells were homozygous for p53Arg we amplified p53 from 1BR cDNA as described for 
the F96 line, and sequenced the 5' section o f the coding region that contained codon 72 
using primers P5F and P5R.
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Figure 7-3: Strategy for sequencing human p53 and the identification of codon 72 
polymorphisms in different fibroblast lines, a) PCR primers P5F and P7R were designed to 
amplify the entire coding sequence of p53. These were first used to amplify p53 from cDNA, 
and then in conjunction with primers P6F, P7F and P5R, were again used to sequence the gel 
purified PCR products, b) Chromatogram of anti-sense sequencing results for the region 205- 
225 bp from the ATG translation initiation codon that contains codon 72. 1BR cells appeared to 
be homozygous for CGC codon 72 sequence, which codes for arginine in the p53 protein, 
whereas F96 cells were homozygous for CCC in this position, which codes for proline. GOS5 
cells seem to be heterozygous for this polymorphism, illustrated by the double G/C peak for the 
middle base of codon 72 on the GOS5 sequence chromatogram.
195
Consistent with 1BR cells displaying only the fast-migrating form o f p53, these cells 
appeared to be homozygous for the CGC form o f  codon 72, which codes for Arginine in 
this position o f the p53 protein. Analysis o f  p53 status in GOS5 cells demonstrated that 
this line expressed both the slow- and fast- migrating forms o f p53, indicated by the 
presence o f a tight p53 doublet after gel electrophoresis for extended periods (figure 7- 
4a and results not shown). This suggested that GOS5 cells may be heterozygous for the 
p53 codon 72 polymorphism, and this was confirmed by sequence analysis. p53 was 
amplified from GOS5 cDNA as described above, and sequenced using primers P5F and 
P5R. As expected, a mixture o f  PCR products harbouring either the CGC (coding for 
arginine) or CCC (coding for proline) codon 72 polymorphism were amplified in this 
reaction, illustrated by the presence o f  a G/C double peak for the middle base o f codon 
72 on the GOS5 sequence chromatogram (figure 7-3b).
These two polymorphic variants o f  p53 have been reported to have different biological 
characteristics, with p53pr0 being a more functional transcriptional activator (Thomas et 
al, 1999). Further investigation revealed that whilst p53pr0 appears to be more efficient 
at inducing growth arrest, p53 Arg is more effective at initiating apoptosis (Pirn and 
Banks, 2004).
7.2.2 Analysis of p53 status in control and radiosensitive lines
Initial investigation into the status and activation o f  p53 in the radiosensitive F96 line 
has shown these cells display high levels o f p53 serine-15 phosphorylation after 
irradiation compared to control cells, and that this line is homozygous for the slow 
migrating p53pro polymorph, whereas the control line 1BR is homozygous for p53Arg- In 
order to evaluate whether the enhanced phosphorylation o f p53 observed in F96 cells 
occurs in other radiosensitive lines, and to determine if  any other radiosensitive lines are 
homozygous for p53pr0, we performed a western blot o f p53 phosphorylation for a range 
of different lines. This should indicate whether elevated levels o f DNA damage 
contribute to the enhanced p53 signalling observed, or if  this is more likely to result 
from the specific p53 isoform expressed in F96 cells. This analysis involved the 
additional control line 48BR, the undefined radiosensitive line GOS5, the Artemis 
deficient line CJ179, the Ligase IV deficient line 180BR and the AT line A-T1BR, 
along with the previously characterised 1BR and F96 lines (figure 7-4)
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Figure 7-4: p53 status and radiation induced serine-15 phosphorylation in control and 
radiosensitive lines, a-b) Western blots of total p53 and serine-15 phosphorylation 4 hours 
after exposure to lGy y-radiation. The control lines 1BR, 48BR and 249BR all displayed only 
the fast migrating form of p53 indicative of p53Arg. The Ligase IV defective line 180BR also 
contained only this form of p53, but the other radiosensitive lines GOS5 (undefined), CJ179 
(Artemis deficient), and A-T1BR (ATM deficient) all displayed a p53 doublet indicative of 
heterozygosity for the codon 72 polymorphism. Only the radiosensitive line F96 was associated 
with a single, slow migrating p53 band consistent with the homozygous p53Pr0 genotype of this 
line. These blots were analysed by densitometry and the normalised fold induction of p53 
serine-15 phosphorylation is presented in graph form (c). This experiment was repeated at least 
3 times for control and F96 cells; error bars represent 1 SD of the mean. All lines examined 
demonstrated radiation-induced p53 serine-15 phosphorylation except the A-T1BR line. Whilst 
F96 cells displayed significantly higher levels of radiation-induced serine-15 phosphorylation 
than the control line 1BR, all the remaining lines demonstrated normal induction of serine-15 
phosphorylation.
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The control line 48BR and the Ligase IV deficient line 180BR expressed only the fast 
migrating form o f p53 (figure 7-4a) indicating that, similar to 1BR cells, these lines are 
homozygous for p53Arg. The undefined radiosensitive line GOS5 and the known 
mutants CJ179 (Artemis) and A-T1BR (ATM) displayed a p53 doublet after gel 
electrophoresis indicative o f  a heterozygous genotype for the codon 72 polymorphism, 
which was confirmed in GOS5 cells by p53 sequence analysis (figure 7-3b). Hence, 
none of the lines examined expressed only p53Pro comparable to the F96 line (table 7-1).
Table 7-1: F96 was the sole line to express only the p53pro isoform
Primary line 1BR 48BR 249BR GOS5 F96 CJ179 180BR A-T1BR
Polymorph
expressed p53Arg p53Arg p53Arg
p53pro
p53Arg
p53pro p53pro
p53Arg p53Arg
p53pra
p53Arg
Examination of radiation-induced serine-15 phosphorylation revealed that AT cells 
displayed no significant induction after irradiation and, apart from the F96 line, all other 
radiosensitive lines were similar to controls in this respect. Only the F96 line 
demonstrated abnormally high levels o f  this radiation-induced modification. These 
differences in p53 activation were consistent when we repeated this experiment for 1BR 
and F96 cells, and examined another control line, 249BR. Similar to the other control 
lines examined, 249BR cells expressed only the fast migrating form o f p53 (p53Aia), and 
did not display the high levels o f  radiation-induced serine-15 phosphorylation 
associated with F96 cells. The level o f radiation-induced serine-15 phosphorylation 
was significantly higher in F96 cells than in the control line 1BR (figure 7-4c). A 
possible explanation for this may be that the repair defect in this line resulted in 
elevated levels o f DSBs and therefore enhanced damage signalling, but these 
experiments were performed 4 hours after irradiation, when the levels o f unrepaired 
DSBs were comparable between F96 and control cells (section 5.4.2). Furthermore, 
compared to controls the Ligase IV defective line 180BR displayed substantially higher 
levels of DSBs 4 hours after irradiation, but did not demonstrate the enhanced damage 
signalling associated with the F96 line. Together, these results suggest that the elevated 
levels of radiation-induced p53 signalling observed in F96 cells is not due to high levels 
of unrepaired DSBs, and is more likely to result from other factors present in this line. 
Since the heterozygous p53pro isoform expressed in CJ179 cells did not specifically 
display enhanced radiation-induced phosphorylation, it is unlikely this form of p53 is 
more susceptible to this modification, unless the presence o f p53Arg interferes with this
effect in some way. Therefore, other factors present in F96 cells may have contributed 
to the enhanced levels o f  radiation-induced serine-15 phosphorylation. This enhanced 
damage signalling may be further amplified during the induction o f p53 target genes, 
since p53pr0 has been shown to be a more potent transcriptional activator than p53Arg 
(Thomas et al, 1999).
During this experiment it became apparent that whilst y-irradiation o f primary 
fibroblasts induced the rapid phosphorylation o f p53 serine-15, the total levels o f p53 
did not increase substantially after treatment. In most primary lines this was associated 
with a significant amount o f unphosphorylated p53 that was present in unirradiated 
samples. Although it is not clear why basal levels o f total p53 were relatively high in 
this experiment, the lack o f  active p53 as suggested by differences in serine-15 
phosphorylation indicates that the p53 at time 0 is unlikely to be active and is probably 
located in the cytoplasm.
7.2.3 Examination of p21 induction after irradiation in control and F96 
cells
The F96 line had demonstrated abnormally high levels o f signalling to p53 after 
irradiation in the form o f serine-15 phosphorylation, which is thought to be involved in 
the stabilisation and activation o f  p53. We therefore investigated whether a target gene 
of p53, the Cdk inhibitor p21, was also induced at an abnormally high level in the F96 
line. Examination o f p21 mRNA levels by northern blot revealed that this gene was 
induced at significantly higher levels in F96 cells compared to the control line 1BR 
(figure 7-5a). Consistent with this result, radiation-induced p21 protein levels were also 
significantly higher in the F96 line compared to control (figure 7-5b). The AT line A- 
T1BR displayed no significant induction o f p21 mRNA or protein, which demonstrates 
the downstream effects o f  defective signalling to p53. These results are coherent with 
the abnormally high levels o f p53 s e r in e - 15-phosporylation observed after irradiation in 
F96 cells, and suggest that an unusually elevated p53 response is initiated in this line. 
This then manifests with the strong induction o f at least one p53 target gene.
A-T1BR
GAPDH
□  1BR 
■  F96
□  A-T1BR
A-T1BR
Actin
□  1BR
□  F96
□  A-T1 BR
Figure 7-5: F96 cells display elevated levels of p21 induction after irradiation, a) Northern 
blot of p21 mRNA levels 4 hours after exposure to lGy y-radiation. b) Western blot of p21 
protein levels 4 hours after exposure to lGy y-radiation. For control and F96 cells these 
experiments were repeated at least twice and the normalised fold induction of p21 calculated to 
give an average value, displayed in bar chart form underneath each representative blot. Error 
bars represent 1 SD of the mean. The F96 line displayed higher levels of p21 mRNA and 
protein induction after irradiation compared to control. The AT line A-T1BR demonstrated no 
significant induction of p21.
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7.2.4 Effect of F96 Artemis mutations on radiation-induced p53 serine-15 
phosphorylation
We have shown that the F96 line expresses only the fast migrating proline72 form of  
p53 (p53pro)» whereas all other lines examined were either heterozygous or homozygous 
for expression o f p53Aia. F96 cells were also found to display elevated levels o f p53- 
dependent gene transcription compared to control, and abnormally high levels o f p53 
serine-15 phosphorylation were observed after irradiation. Since we have previously 
shown that the F96 line has 2 novel mutations in the Artemis DSB repair gene, we were 
interested in ascertaining whether these mutant proteins were in some way responsible 
for the initiation o f the elevated p53 responses observed.
Attempts to transiently express the Artemis protein in the 1BR (control), F96 (Artemis 
mutant) and CJ179 (Artemis null) primary fibroblast lines or the equivalent line 
immortalised by stable expression o f  human telomerase (hTERT line) were 
unsuccessful despite achieving ~50 %  transfection efficiency with a GFP expression 
construct. This problem was also experienced by our collaborators (P. Jeggo, personal 
communication), and we concluded that the high levels o f Artemis protein produced by 
exogenous expression constructs were toxic to these fibroblast lines. In order to 
examine any effects o f these Artemis mutants on p53 we therefore had to use another 
cell system that we were able to transfect with Artemis, and that retained a wild type 
p53 response. This was achieved using HCT116 cells, a colon carcinoma cell line that 
retains wild type p53 and a normal DNA damage response pathway.
HCT116 cells were mock transfected or transfected with GFP (pGFP), wild type 
Artemis (pArt-V5), G126D mutant Artemis (pArt-G126D-V5) or AL70 mutant Artemis 
(pArt-AL70-V5) V5 tagged EXP3.2 expression constructs in duplicate. We also 
performed a co-transfection with equal amounts o f each Artemis mutant (Mut. Co-T) in 
an attempt to recreate the situation within F96 cells. After a 24-hour incubation to 
allow expression o f Artemis protein, one o f each transfected plate was exposed to 1 Gy 
y-radiation, and the other was mock irradiated. The cells were then incubated for a 
further 4 hours, before the isolation o f  total cellular protein. The western blot of  
Artemis expression displayed in section 6.3.2, figure 6-12, was generated using lysate 
from this experiment. This western blot was re-probed for p53 serine-15 
phosphorylation (figure 7-6a). Protein isolated from 1BR and F96 primary fibroblasts
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Figure 7-6: The presence of the F96 mutant Artemis proteins does not enhance radiation- 
induced p53 serine-15 phosphorylation in HCT116 cells, a) Western blot of HCT116 cells 
either mock transfected or transfected with V5-tagged EXP3.2 expression vectors coding for 
wild type Artemis (pArt), G126D Artemis (pArt-G126D), or AL70 Artemis (pArt-AL70). A co­
transfection with equal amounts of each Artemis mutant (Mut. Co-T) is also included, as well as 
transfection with GFP alone (pGFP). 24 hours after transfection cells were either mock 
irradiated (-y) or exposed to lGy y-radiation (+y) and total cellular protein isolated after a 
further 4-hour incubation. The final 2 lanes represent protein isolated from the 1BR and F96 
primary fibroblast lines 4 hours after lGy irradiation. Similar to the 1BR line, HCT116 cells 
express only the fast migrating form of p53 (p53Aia)- The G126D Artemis mutant was 
expressed at a lower level compared to the other Artemis transfections, which produced 
comparable amounts of 83 kD V5 tagged protein. The presence of the F96 Artemis mutants did 
not significantly affect radiation induced serine-15 phosphorylation, b) HCT116 cells were 
transfected with either a GFP-tagged wild type Artemis EXP47 expression vector (pArt-GFP) or 
co-transfected with equal amounts of each GFP-tagged F96 mutant (G126D and AL70) EXP47 
expression vector (Mut Co-T-GFP). 24 hours after transfection, half of each sample was either 
mock irradiated (-y) or exposed to 1 Gy y-radiation (+y), and after a further 4-hour incubation 
cells were sorted into GFP negative (GFP-ve) and GFP positive (GFP+ve) populations. Total 
cellular protein was then isolated and a western blot of p53 serine-15 phosphorylation 
performed. Transfection with either wild type Artemis or the F96 mutants resulted in a 
significant increase in p53 serine-15 phosphorylation in untreated cells, and irradiation only 
marginally increased this modification. The expression of the F96 mutant Artemis proteins did 
not result in the specific amplification of radiation-induced p53 serine-15 phosphorylation 
compared to that with wild type Artemis.
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4 hours after exposure to lG y y-radiation was also run on the same gel in order to 
determine whether the HCT116 cells expressed the fast (p53Aia) or slow (p53Pro) 
migrating polymorphic forms o f  p53.
Similar to 1BR cells, the HCT116 line expressed only the fast migrating form o f p53, 
suggesting this line is homozygous for p53Aia. A V5-tagged protein was detected in all 
of the Artemis transfections at the expected size o f 83 kD. The G126D mutant was 
expressed at a lower level compared to the other Artemis transfections, which produced 
comparable amounts o f V5 tagged protein. Irradiation increased p53 serine-15 
phosphorylation in all o f the transfected cells, and the presence o f either G126D or 
AL70 Artemis mutants, either alone or after co-transfection, did not increase the level of 
this radiation-induced modification. Although we were able to detect significant 
amounts of V5 tagged Artemis protein after these transfections, there was likely to be a 
substantial proportion o f untransfected cells in these populations. This was reflected 
when we transfected HCT116 cells with a GFP tagged Artemis construct and could only 
achieve a ~10 % transfection efficiency, despite achieving ~80 % efficiency with a GFP 
only expression vector. In order to address the problem o f low transfection efficiencies 
using Artemis constructs we performed an experiment that involved sorting the 
populations of transfected and untransfected cells within a sample. HCT116 cells were 
transfected with a GFP-tagged wild type Artemis EXP47 expression vector (pArt-GFP) 
or co-transfected with equal amounts o f each GFP-tagged F96 mutant (G126D and 
AL70) EXP47 expression vector. After a 24 hour incubation, half o f the transfected 
cells were exposed to 1 Gy y-radiation, while the remainder were mock irradiated. 4 
hours later these samples were sorted into GFP positive (therefore Artemis positive) and 
GFP negative (Artemis negative) populations. Total cellular protein was then isolated 
and a western blot o f p53 serine-15 phosphorylation was performed (figure 7-6b). 
Successful transfection o f  cells with either wild type Artemis or the F96 mutants 
resulted in a significant increase in p53 serine-15 phosphorylation in untreated cells, and 
irradiation only marginally increased this modification. This suggests that either the 
transfection process or the exogenous expression o f any form o f Artemis protein may 
initiate a damage response pathway that results in activation o f p53.
The expression o f the F96 mutant Artemis proteins did not result in the specific 
amplification o f radiation-induced p53 serine-15 phosphorylation, even after sorting 
specifically for transfected cells. The presence o f the F96 Artemis mutants was
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therefore not sufficient to induce abnormally high levels o f p53 activation and confer an 
F96 phenotype on another cell line. Since no evidence was obtained to suggest the F96 
mutant Artemis proteins are directly responsible for the enhanced p53 signalling 
observed, this phenotype is most likely to result from the homozygous expression o f the 
p53pro isoforms, the presence o f  a subset o f DSBs particularly potent in triggering p53, 
or other genetic factors specific to the F96 line, such as a reduced level o f p53 negative 
regulation. The separate expression o f  each o f  the polymorphic forms o f p53 (p53Arg 
and p53pro) in p53 mutant cells o f  the same genetic background would finally confirm 
whether radiation induced serine-15 phosphorylation is differentially regulated in an 
isoform specific manner.
7.3 Microarray analysis of the Artemis mutant F96 in response 
to ionising radiation
Because we had observed that the p53 response was elevated in the F96 line with 
respect to p53 serine-15 phosphorylation and the induction o f p21, we investigated this 
phenotype on a genomic scale by microarray analysis o f radiation-induced gene 
expression. F96 cells were compared to the control line 1BR, both before and after 
exposure to 1 Gy y-radiation.
12 Affymetrix U133A microarrays (3 x 1BR 0 Gy, 3 x 1BR lGy, 3 x F96 OGy and 3 x 
F96 1 Gy) were hybridised with cRNA prepared from the corresponding total RNA 
sample. Each replicate sample represented a separate RNA isolation experiment and 
quality control was performed using an Agilent Bioanalyser 2100 (section 2.15.1). Data 
was collected on an Affymetrix Scanner 3000, and primary expression data was 
summarised using the MAS5.0 algorithm. The data generated was then transferred to 
Genespring 6 for further analysis.
7.3.1 GeneChip Quality Control
Table 7-2: GeneChip Quality Control
Chip name Q Scale Factor Background % Call Av Signal GAPDH B-actin
IBROGy A 2.46 0.456 53.13 52.50% 266.6 1.17 1.96
1BR OGy B 2.54 0.458 56.41 51.60% 273.2 1.11 1.81
1BR OGy C 2.24 0.376 48.21 54.90% 248 1.2 2.02
1BR 1Gy A 2.47 0.32 55.49 54.50% 243.4 1.06 1.59
1BR 1Gy B 2.87 1.124 58.51 36.00% 372.1 1.06 2.38
1BR 1Gy C 2.76 0.684 59.12 47.50% 281.4 1.26 1.53
F96 OGy A 2.64 0.471 60.11 53.40% 251.1 1 1.27
F96 OGy B 5.27 0.439 141.58 47.20% 273.2 0.99 1.75
F96 OGy C 2.39 0.584 53.41 50.20% 265.3 1.15 1.31
F961 Gy A 2.32 0.535 52.19 51.80% 265.5 1.05 1.25
F961Gy B 2.26 0.577 50.01 51.80% 269 1.14 1.32
F961 Gy C 2.16 0.39 47.48 55.40% 247 1.32 2.51
Limits 5.0 3.5 fold 150 2 5 % 200-400 3 3
BioB spike-in control was detected in all arrays (sensitivity > 3 copies per cell).
1BR 1 Gy B has a lower % call and a higher scale factor (table 7-2), indicating low yield 
from the IVT, therefore the chip may have been slightly under-loaded. 1BR lG y B and 
F96 lGy C have slightly higher B-actin ratios, indicating slightly lower RNA quality. 
F96 OGy B has a slightly higher background. Overall, no arrays were outside the limits 
of acceptability (as defined by experience), and therefore all are included in the 
analysis.
7.3.2 Distributions
1BR lGy B and F96 lG y C had a slightly flattened distribution, but were within 
acceptable limits (figure 7-7). Ideally the 1BR lG y B experiment would have been 
repeated but the resources available did not allow for this. Subsequent examination of 
differentially expressed genes did not reveal any major bias conferred by this array.
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Figure 7-7: Distribution of normalised intensity for each of the 12 U133A microarrays 
used for analysis of radiation-induced gene expression
Initially we normalised the data within arrays to the median o f all genes (i.e. genes at 
the median level on each array had a value o f 1). Genes were then normalised across 
arrays to the median value o f that gene across all 12 arrays, to give a relative expression 
value per gene, per array.
7.3.3 Detection
Detection was based on the Affymetrix MAS5.0 algorithm, which gives a p value for 
the call of each probeset. We relaxed this to <0.1 (from <0.06) as we find from 
experience the Affymetrix detection limit to be over rigorous. On this basis 13,168 
transcripts, out o f a total o f 22283 total transcripts and controls, were detected in at least 
2 (out of 12) samples on the Affymetrix U133A array (figure 7-8).
206
F96 1 BR
Figure 7-8: 13,168 transcripts detected in at least 2 out of 12 samples. Expression levels 
were compared between F96 (left) and 1 BR (right) cells in any condition. Each line compares 
the mean expression level of a transcript in F96 to that in 1BR (n=6).
7.3.4 Cell specific variation
The majority of genes were expressed in both populations but 650 genes show a 2 fold 
or greater difference between 1 BR and F96 samples irrespective o f radiation treatment. 
273 of these show statistical significance (t test n = 6 p<0.05), and 51 survive Benjamini 
Hochberg false discovery correction. These represent the most robust differences 
between cell lines independent o f irradiation (figure 7-9), and are included in Appendix 
1 (7.3 Gene lists CD). Among groups o f related genes in this set are a large group of 
Hox and Sox genes (HoxAl 1, B2, B7, C6; Sox9 and 13), all but one (Sox 13) o f which 
are high in F96 and low in 1 BR samples. The significance o f this is not apparent, but 
the variation that exists between different fibroblast cell lines emphasises the possibility 
that additional “background” factors may affect p53 signalling.
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Figure 7-9: 51 genes differentially expressed in F96 (left) and 1BR (right) cells irrespective 
of irradiation.
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7.3.5 Effect of irradiation on gene expression in F96 and 1BR cells
We applied a low dose o f  y-radiation (lG y) to assess whether the F96 line responded 
differently to 1BR cells following IR. lG y was determined experimentally as a non­
saturating dose after 1BR and F96 (and other fibroblast lines) were exposed to different 
doses of y-radiation (0, 1,3,  and 6 Gy) and microarray analysis performed (data not 
shown).
Of the 13,168 detected genes, 2650 were changed by >1.4 fold in 1BR compared to 
2054 in F96 cells. O f these, 74 were significantly changed in 1BR (t test p <0.05) and 
144 in F96 cells. Lists o f  significantly changed genes are included in Appendix 1 (7.3 
Gene lists CD). From these 74 (1BR) and 144 (F96) genes changed by irradiation, 40 
were up regulated in 1BR and 80 in F96 cells. However, there was very little overlap 
between these groups. Only 2 genes, p21cipl and 217542_at, appear in both categories, 
although several others classify together i f  the stringency o f the t-test is relaxed. This is 
in contrast to comparable groups derived from higher doses o f irradiation (3 and 6 Gy), 
where many more genes classify together.
Many of the differentially induced genes do not elevate above the pre-irradiation levels 
observed in the opposite cell line (shown for the F96 line, genes highlighted in black, 
figure 7-10), which suggests these changes may not be functionally important in the 
response to DNA damage. A small group o f  genes were activated above 1BR irradiated 
levels in the F96 line, and this list contained at least 8 genes known to be targets o f p53 
(Velasco-Miguel et al, 1999) (Takimoto and El-Deiry, 2000) (Hellborg et al, 2001)
(Tan and Chu, 2002) (Vousden and Lu, 2002) (Bums et al, 2003) (figure 7-11). These 
genes are missing from the changes found in 1 BR with the exception o f  p21, and the 
induction of this gene is reduced considerably compared to that observed in the F96 
line.
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Figure 7-10: 80 genes were upregulated in the F96 line. Whilst many of the genes 
upregulated by IR in the F96 line did not show a similar pattern of expression in 1BR cells (top 
panel), many of the F96 upregulated genes increased only to a level similar to that in 1BR cells 
before irradiation (highlighted in black, bottom panel). A small group of genes were elevated 
after IR in F96 cells above that of 1BR irradiated levels (blue genes, bottom panel).
In order to confirm whether such p53 target genes are induced by higher doses of IR in 
the 1BR line, we analysed a preliminary experiment performed with Affymetrix U95A 
microarrays that involved doses o f 6 Gy y-radiation. After this higher dose of y- 
radiation, many more p53 target genes were induced in the 1BR line similar to that 
observed in F96 cells (figure 7-12), and some o f these genes corresponded to those that 
were selectively induced in the F96 line after lG y y-radiation. This indicates that 1BR 
cells are capable of inducing this wider p53 response, but only after higher levels of 
DNA damage.
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Figure 7-11: 7 p53 target genes elevated by IR in F96 cells but not in 1BR cells after 
exposure to lGy y-radiation. p21 was the only p53 target gene to be induced in both lines 
after irradiation, although this was considerably reduced in 1BR cells. Lines connect the mean 
values of triplicate measurements at the 2 doses.
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Figure 7-12: Selection of p53 target genes induced in 1BR and F96 cells after exposure to 6 
Gy y-radiation measured using Affymetrix U95A microarrays. Gene order is Cyclin G, 
Bax, Fas, PCNA, Fas (alt splice), Bax, DDB2, Bax (alt splice), PLK, GADD45, p21, IGFBP4, 
IGFBP3
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These results indicate that whilst a dose o f  1 Gy y-radiation was insufficient to initiate a 
global p53 response in 1BR cells, this network was clearly activated in the F96 line.
This could be due to inherent genetic factors such as the homozygous p53pr0 genotype 
of the F96 line, the persistence o f  elevated levels o f  unrepaired DSBs (which is unlikely 
since we measured RNA 4 hours after IR where no significant differences in overall 
repair were observed between these lines, section 5.4.2.) or the existence o f a small 
subset of breaks, enriched in Artemis deficient F96 cells, which are particularly potent 
in the triggering o f p53.
7.4 Discussion
We have identified a mild defect in DSB repair in the radiosensitive line F96 and 
confirmed the presence o f  2 novel mutations on separate alleles o f  the Artemis gene. 
Although this repair defect is likely to contribute to the poor survival o f F96 cells after 
irradiation due to a fraction o f  persistent, slowly repaired breaks, we also investigated 
p53 signalling in this line in order to identify any anomalies in the wider response to 
DNA damage.
ATM directly phosphorylates p53 on serine-15 (Banin et al, 1998) (Canman et al, 1998) 
(Khanna et al, 1998) (Nakagawa et al, 1999), which is then thought to nucleate a series 
of subsequent post-translational modifications that contribute to both the stabilisation 
and biochemical activation o f p53 (Appella and Anderson, 2001). Compared to the 
control line 1BR, F96 cells demonstrated a more pronounced radiation-induced 
phosphorylation o f p53 serine-15. Previous work has indicated that the total activity of  
ATM is dependent on the yield o f  DNA lesion, and this was associated with enhanced 
phosphorylation o f p53 serine-15 after higher levels o f  damage (Buscemi et al, 2004). 
The higher induction o f this modification observed in F96 cells may therefore have 
resulted from elevated levels o f  DNA damage 4 hours after irradiation that triggered 
enhanced p53 signalling, but results from the H2AX repair assay (section 5.4.2) are 
inconsistent with this hypothesis. H2AX analysis demonstrated that the repair defect in 
F96 cells does not become apparent until 24 hours after irradiation, and at 2 and 6 hours 
of repair time the F96 line has comparable levels o f unrepaired DSBs to that o f control 
cells. Furthermore, although the 180BR line (which is deficient in Ligase IV) displayed
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elevated levels o f H2AX foci 2-6 hours after irradiation, abnormally high levels o f 
radiation induced p53 phosphorylation were not observed. Together, these results 
suggest that high levels o f  unrepaired DSBs are not responsible for the enhanced p53 
signalling observed in the F96 line.
Whilst elevated levels o f  total DNA DSBs do not appear to be responsible for the 
enhanced p53 signalling associated with F96 cells, another possibility may be a 
difference in the species o f  DNA lesion that predominates after 4 hours. Artemis has 
been implicated in the repair o f  a subset o f  DNA DSBs, possibly complex lesions that 
require nucleolytic processing (Jeggo and O’Neill, 2002) (Riballo et al, 2004) and the 
accumulation o f p53 has been shown, within limits, to be enhanced after high LET 
irradiation that produces more complex DSBs (Fournier et al, 2004). The persistence o f 
complex breaks in the F96 line, although masked by the total level o f breaks, may 
therefore have promoted p53 signalling. If this were due to the absent repair o f complex 
DSBs then the Artemis null CJ179 line may also be expected to display enhanced p53 
signalling, but this was not observed. Therefore, i f  the initiating signal, i.e. the damage 
lesion itself, was responsible for the p53 effects observed in F96 cells, then the mutant 
Artemis proteins present must have modified the lesion in such a way to promote DSB 
signalling, an effect associated with hypomorphic mutations and not the total absence of 
Artemis protein. Whilst there is no precedence for this situation in the literature, the 
possibility cannot be dismissed.
In order to investigate whether the presence o f  mutant Artemis proteins in the F96 line 
were responsible for the enhanced p53 signalling observed, we transfected colon 
carcinoma cells, which retain a non mutated p53 pathway, with F96 mutant Artemis 
constructs. Previous experiments with expression vectors that incorporate a C-terminal 
GFP tag demonstrated relatively poor transfection efficiencies using Artemis constructs 
(~10 %), but we were able to sort cells into non-transfected (GFP -) and transfected 
(GFP +) populations by FACS. Cells transfected with either wild type or mutant 
Artemis constructs displayed increased p53 serine-15 phosphorylation, which may be 
attributed to the transfection procedure introducing DNA DSBs in a non-specific 
manner. Since there was no specific increase in radiation-induced p53 serine-15 
phosphorylation in cells expressing the F96 mutant Artemis proteins, this would suggest 
that these mutants are not responsible for the p53 effects observed. Certain limitations 
should be appreciated when interpreting results from these experiments. Despite
achieving favourable transfection efficiencies with other expression vectors, we were 
unable to express Artemis proteins in either primary fibroblasts or fibroblasts 
immortalised by stable expression o f  human telomerase catalytic subunit (hTERT). 
More appropriate experiments would have involved the transfection o f Artemis null 
CJ179 cells with mutant Artemis proteins, but since this was not possible we were 
restricted to the use o f cell lines. HCT116 cells are expected to express endogenous 
Artemis and this is not an ideal system to look for the effects o f exogenous mutant 
counterparts, since the endogenous protein may interfere with any mutant effects. In 
addition, the Cycle 3 GFP tag incorporated at the Artemis C-terminal in these 
experiments is predicted to add 27 kD to expressed proteins. Such a large modification 
may have impaired any function o f  the mutant Artemis proteins that promotes p53 
signalling. Whilst acknowledging these caveats, no evidence was obtained to suggest 
the F96 mutant Artemis proteins were responsible for the enhanced p53 signalling 
phenotype observed in this line.
To further investigate the enhanced damage signalling associated with F96 cells, we 
began to examine the p53 protein itself. After extended resolution on a denaturing gel, 
p53 from F96 cells displayed retarded electrophoretic mobility compared to that from 
control cells, indicative o f  a small increase in size. Although this could have resulted 
from additional post-translational modifications, we demonstrated this shift did not 
involve phosphorylation, and was also unlikely to result from additional acetylations, 
shown by treatment o f cells with anacardic acid, a potent non-competitive inhibitor of 
the p300 and PCAF acetyl transferases. p300 and PCAF are thought to be responsible 
for the acetylation o f p53 (Liu et al, 1999), which enhances its stabilisation and activity 
(Sakaguchi et al, 1998) (Ito et a l, 2001). Consistent with this, the apparent inhibition of 
these enzymes induced a dose dependent decrease in the stability o f  p53, and this was 
associated with reduced levels o f  serine-15 phosphorylation in control and F96 cells. 
Despite these changes, the electrophoretic mobility o f F96 p53 was still retarded. We 
therefore began to examine the coding sequence o f p53 in F96 cells for any differences 
that may account for this apparent discrepancy in size compared to p53 from control 
cells.
Analysis of the p53 coding region from F96 cells revealed expression o f a transcript that 
was wild type, but which contained a polymorphism in codon 72 that has been 
previously reported (Harris et a l, 1986) (Matlashewski et al, 1987). The amino acid
change that results from this polymorphism was shown to affect the electrophoretic 
mobility of p53, with p53pro (Proline in position 72) demonstrating reduced 
electrophoretic mobility compared to the p53Arg (Arginine in position 72) (Harris et al, 
1986) (Matlashewski et al, 1987). Since the p53 gene expressed in F96 cells coded for 
p53pro, this may have explained the differences in migration compared to p53 from the 
control line 1BR, and sequence analysis confirmed this hypothesis, revealing that 1BR 
cells expressed transcript coding for p53Arg. Furthermore, GOS5 cells that displayed a 
p53 doublet after gel electrophoresis, expressed transcripts coding for both the p53Pro 
and p53Arg forms, indicating this line was heterozygous for this polymorphism.
Out of the 8 primary lines examined, the F96 line was the only one to express just the 
fast migrating form o f  p53 indicating a homozygous p53pro genotype. A highly 
significant association between the p53 codon 72 polymorphism and ethnicity has been 
reported, with the frequency o f  the p53Pro allele showing a north-south cline from 17 % 
in Swedish Saamis to 63 %  in African Blacks (Nigerians) (Beckman et al, 1994). In 
White non-Hispanic Americans a homozygous p53pro genotype was shown to account 
for only 9 % of the population (Inserra et al, 2003) and a similar low frequency was 
reflected in the UK for two different White control populations (Rosenthal et al, 1998). 
Whilst the ethnicity o f  most patients in this project was unknown, the low frequency 
(0.12) of homozygous p53pr0 expression observed is consistent with a North European 
population, and since patient F96 was o f  White UK ethnicity, the homozygous p53Pro 
genotype observed is likely to represent a relatively rare occurrence.
F96 was also the only line to display enhanced p53 activation compared to controls. It is 
therefore tempting to speculate that the presence o f  only the p53pro variant in the F96 
line contributed to the elevated levels o f  p53 signalling. Whilst there have been no 
reports of either polymorphic form o f  p53 being more prone to serine 15 
phosphorylation, their transcriptional activities have been examined in detail.
Compared to the p53 Arg form, the p53Pro variant has previously been shown to be a more 
potent transcriptional activator by a magnitude o f approximately 2-fold (Thomas et al,
1999). This effect was observed using a reporter plasmid for the p21 promoter- 
enhancer, and consistent with this the p53pro variant was later found to induce a higher 
level of G1 arrest than the p53Arg form (Pirn and Banks, 2004). Our results compare 
well with these findings, since the homozygous p53pro F96 line was found to induce p21 
mRNA and protein to a level approximately double that o f the homozygous p53Arg 1BR
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line. It is therefore likely that the p53Pro genotype o f the F96 line contributed to the 
elevated levels o f p53-dependent gene transcription observed. Our results also suggest 
that the p53pro variant, when present in a homozygous setting, may be more prone to 
radiation-induced serine-15 phosphorylation than p53Arg, although other genetic effects 
such as Artemis mutations may contribute to this phenotype. The net result manifests as 
enhanced DNA damage signalling in the F96 line.
Another difference between the codon 72 variants o f p53 has been reported in their 
ability to induce apoptosis. In human tumour cells the p53Arg form was shown to be 
more efficient at inducing apoptosis than p53Pro (Thomas et al, 1999) (Pirn and Banks, 
2004). This difference was related to the ability o f  p53Arg to more efficiently translocate 
to the mitochondria (Dumont et a l, 2003) where p53 may promote apoptosis 
independent of its transcriptional activator properties (Mihara et al, 2003) (Leu et al, 
2004), but this translocation seems to occur only in tumour cells (Marchenko et al,
2000). Consistent with this, no evidence was found for the localisation o f p53 to the 
mitochondria in non-transformed human fibroblasts, and no correlation was observed 
between the p53 codon 72 polymorphism and apoptosis in normal human fibroblast 
lines homozygous for either allele after DNA damage (Dumont et al, 2003). This 
suggests that unlike in tumour cells, the enhanced ability o f  p53Arg to induce apoptosis 
directly at the mitochondria may not be relevant in primary cells. Conversely, in 
primary cells the differential transcriptional activator properties o f  the p53 variants may 
be more important. In this respect the expression o f  p53Pr0 may lead to enhanced p53 
dependent gene transcription, and we therefore investigated this on a genomic scale in 
the F96 line using Affymetrix microarray analysis.
Consistent with the enhanced p53 signalling observed in the F96 line, microarray 
analysis revealed an elevated p53 transcriptional response after irradiation in F96 cells 
compared to the control line 1BR. The induction o f p21 was elevated compared to 
control, and at least 7 other p53 target genes that did not change in controls were 
selectively induced in F96 cells. These results suggested that whilst a dose o f 1 Gy y- 
radiation was insufficient to initiate a global p53 response in 1BR cells, this network 
was clearly activated in the F96 line. This could be due to the persistence o f elevated 
levels of unrepaired DSBs, but this is unlikely since we measured RNA 4 hours after 
irradiation where no significant differences in overall repair were observed between 
these lines (section 5.4.2.).
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The relatively high level o f  p21 induction, observed in F96 cells may promote a more 
stringent growth arrest in this line after non-saturating doses o f y-radiation. Whilst this 
would allow time for repair mechanisms to function, such high levels o f  p21 may not be 
desirable. Cells released from p21 mediated overexpression have previously displayed 
growth retardation, cell death and decreased clonogenicity that was associated with 
abnormal mitotic events in subsequent divisions (Chang et al, 2000). These effects 
were correlated with the induction level o f  p21, which at high levels resulted in the 
depletion o f proteins involved in the control and execution o f mitosis. This study was 
performed in fibrosarcoma cells, and if  similar mechanisms exist in primary fibroblasts 
they may contribute to the delayed growth retardation observed in the F96 line after 
irradiation (section 4.3.2). Thus, the enhanced p53 signalling observed early after 
irradiation may have deleterious effects on survival during subsequent divisions in cells 
that would otherwise recover from the initial genotoxic insult.
The elevated level o f p21 induction and selective induction o f certain p53-target genes 
in the F96 line is likely to result, at least in part, from the elevated levels o f  p53 serine- 
15 phosphorylation observed in these cells after irradiation. Previous results have 
indicated that the role o f p53 serine-18 phosphorylation, the murine counterpart of 
serine 15, in regulating the transcription o f  p53 target genes is promoter specific (Chao 
et al, 2003). In addition to abrogated p21 induction, thymocytes homozygous for a p53 
mutant refractory to serine-18 phosphorylation (p53sl8A) displayed impaired induction 
of certain p53 target genes after irradiation, whilst others were unaffected. Amongst the 
transcriptional changes severely impaired in p53sl8A homozygous cells was the 
induction of the p53 target PLK2/SNK, which was also selectively induced in the F96 
line after irradiation. The high levels o f radiation-induced serine-15 phosphorylation in 
F96 cells may therefore contribute not only to elevated p21 induction, but also to the 
induction of certain p53 target genes in a promoter specific manner.
Of the group o f p53 target genes selectively induced in F96 fibroblasts it is noteworthy 
that Fas and TRAILR2, both apoptosis inducing death receptors (Walczak and 
Krammer, 2000), were included. Primary fibroblasts are notoriously resistant to 
apoptosis (Chung et al, 1998) (Dikomey et al, 1998) (Kawabe et al, 2001) (Zhang et al, 
2001a) and the p53-dependent induction o f  TRAILR2 has been shown to be restricted to 
cell types undergoing apoptosis and not cells undergoing exclusively p53 dependent G1
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arrest such as normal lung fibroblasts (Wu et al, 1999). Since F96 fibroblasts have 
demonstrated insignificant levels apoptosis at both early (Peake et al, 1999) and delayed 
(section 4.3.3.) time points after irradiation, it is intriguing that the expression o f these 
death receptor genes should be induced. Whilst the induction o f death receptors may 
not lead to the initiation o f  fibroblast apoptosis in vitro , it is tempting to speculate this 
may not be the case in vivo , where the ligands for such receptors (Fas-L and TRAIL) 
may be more readily available. The induction o f  death receptors may represent a 
mechanism whereby highly damaged fibroblasts are targeted for apoptosis by the Fas-L 
and/or TRAIL expressed on infiltrating lymphocytes in order to facilitate tissue repair. 
Indeed, primary human fibroblasts modified to express relatively high levels o f Fas 
receptor displayed widespread apoptosis after incubation with the Fas cross-linking 
antibody CH-11 (Freiberg et a l, 1997). Similarly, in murine fibroblasts UVB irradiation 
was shown to increase death receptor expression and subsequent levels o f apoptosis 
after incubation with the respective ligand (Kimura et al, 2001). F96 fibroblasts may
therefore be particularly sensitive to death receptor activation when presented with the 
cognate ligand after irradiation, a characteristic that could be investigated by incubating 
control and F96 fibroblasts with either TRAIL or Fas-L after irradiation and comparing 
levels of apoptosis.
The selective radiation-induced expression o f  Fas and TRAILR2 observed in F96 
fibroblasts may also have important implications for other cell types in the F96 patient. 
As well as demonstrating cellular radiosensitivity, this patient displayed a progressive 
immunodeficiency that was associated with increased levels o f  lymphocyte apoptosis 
(Peake et al, 1999). Although this increased apoptosis did not seem to be associated 
with deregulated Fas signalling, sensitivity to TRAIL-induced apoptosis was not 
examined. Human lymphoid cell lines differ in their sensitivity to TRAIL-induced 
apoptosis and whilst peripheral T cells appear resistant (Jeremias et al, 1998), activated 
thymocytes are sensitive to TRAIL mediated apoptosis (Simon et al, 2001). Since 
V(D)J recombination is monitored by the p53 pathway to limit aberrant recombination 
events (Guidos et al, 1996) (Perkins et al, 2002), the repair defect present in F96 cells 
may combine with the enhanced DNA damage signalling observed to promote TRAIL 
mediated thymocyte apoptosis and confer clinical immunodeficiency. Indeed, common 
variable immunodeficiency has previously been associated with high expression levels 
of other receptors o f  the TNF receptor family (TNF-R1 and TNF-R2) (Di Renzo et al, 
2001).
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We have described enhanced DNA damage signalling in the Artemis mutant line F96 
after irradiation. This manifested as elevated levels o f radiation-induced p53 serine-15 
phosphorylation, p21 induction, and the specific induction o f certain p53 target genes 
that was not observed in control cells after un-saturating doses o f y-radiation. There 
was no evidence to suggest these effects resulted from the direct activity o f the F96 
mutant Artemis proteins or elevated levels o f total unrepaired DSBs, although a subset 
of DSBs particularly potent in triggering the p53 response and enriched in F96 cells 
may have been involved. In contrast to all other primary lines examined, the F96 line 
was found to be homozygous for the p53pro polymorphic form o f p53, and this genetic 
variation may contribute to the elevated p53 responses described. F96 cells may 
therefore be hard-wired to induce p53 dependent endpoints such as growth arrest and 
apoptosis more readily. This enhanced damage signalling may combine with the 
deficiency in DNA repair observed, and possibly other factors intrinsic to the patient, to 
impair the survival o f fibroblasts irradiated in vitro , and hinder the development of 
functional lymphocytes in vivo.
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!Chapter 8: Conclusions
Double strand breaks (DSBs) in genomic DNA are induced by exogenous sources such 
a s  ionising radiation, but also arise during normal physiological processes such as 
V(D)J recombination during lymphocyte development. The induction o f DSBs leads to 
the activation o f proteins involved in DNA repair, and may initiate p53 dependent 
pathways that result in cell cycle arrest and/or apoptosis. Defects in this damage 
response network that impair the ability o f  cells to repair DSBs, both during V(D)J 
recombination and after irradiation, may therefore result in radiosensitive 
immunodeficiency. Radiosensitive immunodeficiency has been previously described in 
patients with mutations in DSB repair genes, whilst others have been described with no 
apparent deficiency in DNA repair. These patients may have defects in the damage 
assessment process that commits highly damaged cells to either permanent growth 
arrest or apoptosis. This project aimed to investigate undefined immunodeficient 
patients for evidence o f DNA damage response defects using established and novel 
techniques in order to gain insight into the processes involved in cellular 
radiosensitivity. Further investigation allowed us to delineate how incongruities in 
certain pathways may contribute to radiosensitive immunodeficiency.
As a population, the group o f  20 undefined immunodeficient patients examined were 
not significantly more radiosensitive than controls, suggesting these patients do not 
represent a distinct population with respect to cellular radiosensitivity. The range of  
sensitivities observed more likely reflects subtle genetic differences and polymorphisms 
that promote minor variations in radio sensitivity near to the control range. A more 
pronounced radiosensitivity similar to repair defective cells may be more indicative o f a 
mutation in a damage response protein that impairs protein function. Only a small 
proportion (~10 %) o f the undefined immunodeficient patients examined displayed this 
more pronounced phenotype. This indicates that the majority o f  undefined 
immunodeficient cases are not associated with radiosensitivity. Only those patients 
displaying a pronounced cellular radiosensitivity, similar to previously defined damage 
response mutants, should be classed as radiosensitive and further investigated along 
those lines.
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Fibroblast survival assays were used to identify radiosensitive patient lines that were 
classified into mild and intermediate groups o f  radiosensitivity. This is the established 
method of assessing cellular radiosensitivity, but such clonogenic assays are very time 
consuming. We therefore investigated radiation-induced lymphocyte apoptosis as a 
measure of cellular radiosensitivity, since this endpoint can be measured as early as 24 
hours after treatment. Despite some correlation with fibroblast survivals, radiation- 
induced lymphocyte apoptosis was found to be highly variable between different 
controls, and there were some discrepancies between repeat experiments with some 
patient samples. We therefore concluded that this endpoint was not reliable enough to 
use as a measure for cellular radio sensitivity.
Another limitation o f  fibroblast survival assays is they give no insight into the fate of 
cells that survive the initial genotoxic insult, but then fail to proliferate and form 
colonies. Primary fibroblasts are not prone to the induction o f apoptosis after 
irradiation (Chung et al, 1998) (Dikomey et al, 1998) (Kawabe et al, 2001) (Zhang et 
al, 2001a), but a substantial fraction o f  primary fibroblasts seem to be inactivated by a 
permanent growth arrest (Little et al, 1985) (Di Leonardo et al, 1994) (Yount et al,
1996) (Linke et al, 1997) (Williams et al, 1997) (Boyle et al, 1999) (Azzam et al,
2000). We therefore developed a novel assay for cellular radiosensitivity that focused 
on fibroblast division early after irradiation, and this was able to identify important 
differences between a control and repair defective line. The Artemis deficient CJ179 
line was more prone to the induction o f  a senescent like growth arrest than control cells, 
which is likely to result from the persistence o f unrepaired breaks for at least 3 days 
after irradiation as shown by y-H2AX foci enumeration. Consistently, the persistence o f  
breaks too severe for repair for several days after irradiation has previously been 
proposed as an initiation signal for stress-induced premature senescence (Naka et al, 
2004).
Despite showing impaired radiosensitivity survival similar to that o f  the Artemis null 
CJ179 line, the F96 line was only slightly more sensitive than control cells to the 
induction of an early, senescent-like growth arrest. Instead, after higher doses o f  
radiation the dividing F96 cells that emerged underwent a delayed growth arrest that 
was not associated with senescent like characteristics or substantial levels o f apoptosis. 
The specific causes o f this delayed arrest are unknown. Previous studies have described 
reactivation o f p53 numerous divisions after irradiation (Rugo et al, 2002) (Suzuki et al,
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2003b) and the induction o f  delayed chromosomal damage (Marder and Morgan, 1993) 
that is associated with delayed reproductive death (Chang and Little, 1991) (Suzuki et 
al, 1998). The observation that delayed chromosomal instability can be reduced by 
delayed plating, which allows more time for repair, suggests that these effects may be 
determined by the repair process o f  the initial radiation damage (Roy et al, 1999).
Chromosome break analysis and H2AX enumeration demonstrated an elevated level of 
unrepaired DNA damage in F96 cells 24 hours after irradiation suggesting defective 
repair, and sequence analysis confirmed this line was compound heterozygote for 
G126D and AL70 mutations in Artemis. Since these mutations do not directly modify 
any residues proposed to function in metal binding within the metallo-p-lactamase 
catalytic site (Pannicke et al, 2004) (Poinsignon et al, 2004), these mutant proteins are 
likely to retain partial function. This would be consistent with extended y-H2AX 
enumeration studies. In contrast to the Artemis null CJ179 line where y-H2AX foci 
persisted, in F96 cells these foci had returned to control levels by 72 hours. This slow 
repair is likely to represent the rejoining o f complex breaks that require nucleolytic 
processing before rejoining, a function previously proposed for Artemis (Jeggo and 
O’Neill, 2002). In addition, the high incidence o f dicentrics observed in F96 cells after 
irradiation may also indicate a high level o f DSB misrejoining. The mutant Artemis 
proteins in the F96 line may therefore eventually allow the repair o f complex breaks, 
albeit with slower kinetics and reduced fidelity. This could permit cells to divide a 
limited number o f times before the induction o f  a delayed growth arrest or cell death, 
possibly resulting from a delayed instability similar to that described above. Indeed, 
higher levels o f delayed reproductive death are observed in cells that retain a functional 
NHEJ pathway compared to those deficient in this process (Chang and Little, 1992). In 
Artemis null cells, the persistent level o f unrepaired breaks may simply induce 
premature senescence within the first 6 days o f irradiation. The arrested populations 
observed in these cell division experiments could be further investigated for y-H2AX 
foci, p53 signalling and chromosomal damage after cell sorting in order to better 
understand why these different cell fates are initiated.
The activity o f the F96 mutant Artemis proteins is currently being examined by our 
collaborators using an in vitro functional assay. The results presented here suggest 
these mutations are hypomorphic, which is consistent with the phenotype o f the F96 
patient. Although this patient displayed lymphopaenia that was progressive with age,
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this was relatively mild compared to that observed in Artemis null patients. There was 
also no appreciable alteration in the distribution o f lymphocyte subsets and T cells did 
not consist o f single or multiple abnormal clones (Peake et al, 1999). A partially 
functional V(D)J recombination pathway where RAG induced breaks are eventually 
rejoined, possibly with reduced fidelity, may be expected to confer such a phenotype. 
This would result in a significant amount o f mature lymphocytes, but these cells may be 
unstable. Just as F96 fibroblasts treated with y-radiation are destined to arrest after a 
certain amount o f divisions, F96 lymphocytes in vivo may be prone to apoptosis.
Indeed, elevated spontaneous apoptosis was observed in this patient’s lymphocytes in 
vitro (Peake et al, 1999). Since the ATM-p53 pathway is reported to monitor V(D)J 
recombination and remove abnormal cells (Guidos et al, 1996) (Perkins et al, 2002), we 
investigated this side o f the damage response network to determine if  any other factors 
may contribute to this radiosensitive immunodeficiency.
The F96 line demonstrated enhanced levels o f  radiation-induced serine-15 
phosphorylation compared to controls that did not coincide with the elevated level of  
unrepaired DSBs observed at later time points. This suggested other factors intrinsic to 
F96 cells may promote p53 signalling, but no evidence was found to suggest the mutant 
Artemis proteins were responsible for this effect. Further investigation revealed that out 
of 8 primary lines examined, the F96 line was the only one to be homozygous for 
proline at position 72 o f p53 (p53pro), a previously described polymorphism (Harris et 
al, 1986) (Matlashewski et al, 1987). Compared to the p53Arg form, the p53pro variant 
was shown to be a more potent transcriptional activator by a magnitude o f  
approximately 2-fold (Thomas et al, 1999). This effect was observed using a reporter 
plasmid for the p21 promoter-enhancer, and consistent with these results the F96 line 
was found to induce p21 to a level approximately double that o f control cells. This may 
not be desirable since cells released from p21 mediated overexpression have displayed 
growth retardation, cell death and decreased clonogenicity that was associated with 
abnormal mitotic events in subsequent divisions (Chang et al, 2000). Such an effect 
may therefore contribute to the delayed arrest observed in F96 cells using cell division 
analysis. Microarray analysis o f gene expression revealed a group o f p53 target genes 
were specifically induced in F96 fibroblasts after a non-saturating dose o f irradiation, 
and this included certain pro-apoptotic death receptors. Although this response may not 
have significant effects on fibroblast survival in vitro, this may not be the situation in 
vivo where death receptor ligands are available to induce apoptosis. Indeed, the
I
initiation of such a response in lymphocytes may be expected to enhance death 
signalling, which may contribute to the elevated levels o f  spontaneous apoptosis 
observed in lymphocytes from this patient.
Whilst we cannot be certain that the p53pr0 genotype o f F96 cells is solely responsible 
for this enhanced damage signalling, it is likely to contribute to this phenotype. The 
F96 patient died before this study began, therefore it was not possible to investigate 
other cell types such as lymphocytes for the enhanced damage signalling observed in 
fibroblasts. Although transient transfection o f  primary fibroblasts was not successful, it 
may be possible to generate stable cell lines from Artemis deficient cells that express 
each of the F96 mutant Artemis proteins. If this line was not homozygous for p53pr0, 
then any contribution o f  the Artemis mutants to enhanced damage signalling could be 
examined more thoroughly than was possible here. These lines could also be used to 
determine if  the expression o f  these mutants promotes the delayed arrest observed after 
irradiation, and what role the p53 codon 72 polymorphism may have in such delayed 
effects.
This thesis describes the discovery o f  2 novel Artemis mutations in a patient with 
progressive immunodeficiency associated with increased apoptosis o f lymphocytes and 
radiosensitivity o f fibroblasts. Comparing fibroblasts from this patient to those from an 
Artemis null line allowed us to investigate what mechanisms may promote such 
phenotypes (figure 8-1). In Artemis null patients, the absent repair o f complex DSBs in 
fibroblasts after irradiation leads to the early induction o f premature senescence, 
whereas lymphocytes in vivo are not able to repair coding ends during V(D)J 
recombination and are removed by apoptosis. This leads to severe immunodeficiency 
and radiosensitivity o f fibroblasts. In the F96 patient, partially functional Artemis 
proteins may allow the slow repair o f complex breaks, possibly with reduced fidelity. 
Whilst this is sufficient to escape early premature senescence, this aberrant repair may 
promote instability in subsequent divisions and lead to delayed cell inactivation. 
Similarly in lymphocytes, coding ends induced during V(D)J recombination may be 
rejoined in an unstable manner that after subsequent division and development triggers 
apoptosis. At this point, other genetic factors that enhance damage signalling may 
contribute to the induction o f  apoptosis in lymphocytes and the delayed growth arrest of 
fibroblasts.
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Figure 8-1: Mechanisms that may lead to distinct cell fates of lymphocytes in vivo and 
fibroblasts in vitro after DSB induction in Artemis deficient cells.
Further work is underway to evaluate the biochemical phenotype o f the F96 mutant 
Artemis proteins described in this thesis using functional assays for nuclease activity. 
Each mutant protein will be expressed in Artemis null cells and the relative efficiency of 
DNA hairpin and overhang cutting will be compared to that in the same cells expressing 
wild type protein. This should determine to what extent these changes in Artemis 
primary structure affect nuclease function, and confirm if  these changes do indeed 
represent the hypomorphic (“leaky”) mutations suggested by the results presented here. 
Once confirmed, these mutant Artemis proteins will be a useful resource for exploring 
the link between ATM, the repair o f DSB subsets and, given the enhanced p53 
signalling observed in F96 cells, the possible effect o f the repair complex on ATM 
mediated p53 activity, cell cycle arrest and apoptosis.
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Appendix 1
7.3 Gene Lists CD
This CD contains 5 Gene lists identified in the microarray analysis section 7.3 and is 
attached to the inside o f  the back cover.
Lists are: -
51 Genes differently expressed between 1BR and F96 lines irrespective o f irradiation 
(51 F96v 1 BRnoIR)
74 Genes changed with irradiation in 1BR cells 
(74changedl BR1 Gy)
144 Genes changed with irradiation in F96 cells 
(144changedF961 Gy)
40 Genes upregulated with irradiation in 1BR cells 
(40uplBRlGy)
80 Genes upregulated with irradiation in F96 cells 
(80upF961Gy)
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Appendix 2
Summary table of results obtained for each cell line
Cell line Lymphocyteapoptosis
Fibroblast
survival
Early
division Late division G1 Arrest
Chromo
break Y-H2AX Sequencing P53/p21
1BR n n n n n n n n
48BR n n n
G0S1 + + n n n
G0S2 n
G0S3 +
G0S4 +
G0S5 +/n ++ ++ n n n n
GOS10 +
G0S14 n + n n
G0S15 n
G0S16 n
G0S17 +
G0S18 n
G0S19 n
GOS20 n
G0S21 + n
GOS22 n
GOS23 ++ n
GOS25 n
GOS26 n
GOS27 n
F96 Spontaneous ++ + ++ n + + Artemis Elevated
CJ179 ++ ++ + + ++ n
AT1BR +++ ++ ++ Impaired ++ Impaired
n = normal response, + = mild positive result, ++  = positive result, ++ +  strong positive result.
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